Deepak 19 PDF

Deepak Nitrite Limited
48th Annual Report 2018-19
Promises Delivered
e
ad
M
es
is
om
Pr
Contents
Corporate Financial
Overview 01-44 Statements 129-238
Deepak Nitrite Limited - At a Glance 04 Standalone
Our Substantive Value Proposition 06 Independent Auditor’s Report 129
Our Manufacturing Prowess 08 Balance Sheet 136
Research & Development - 10 Statement of Profit and Loss 137
Our Strength and Differentiator Cash Flow Statement 138
Our Global Footprint 12 Statement of Changes in Equity 140
Message from the Chairman & 14
Managing Director
Notes to the Financial Statements 141
Consolidated
CEO’s Communique 18
CFO’s Communique 20 Independent Auditor’s Report 185
Our Board and Leadership Team 22 Balance Sheet 190
Our Strategic Business Units 26 Statement of Profit and Loss 191
Delivering our Promise of… Cash Flow Statement 192
Reducing Import Dependence 28 Statement of Changes in Equity 194
Leveraging our Strategy for 30 Notes to the Financial Statements 195
Stable Growth
Strengthening our Segmental 32
Performance
Forty-Eighth Annual General Meeting
Generating New Platforms for 34 Day & Date : Friday, June 28, 2019
Sustainable Growth
Time : 10:30 a.m.
Our Performance Scorecard - Standalone 36 Venue : Grand Mercure Vadodara Surya Palace,
Opposite Parsi Agiyari, Sayajigunj,
Financial Highlights for the last 37 Vadodara - 390 020
Ten Years
Being Recognised Across the World 38
Committed to Safety Quotient 40
Cautionary Statement Regarding Forward-Looking Statement
Committed to Make a Difference 42 This Report may contain certain forward-looking statements relating to the
future business, development and economic performance. Such Statements
Statutory may be subject to a number of risks, uncertainties and other important
Reports 45-128 factors, such as but not limited to (1) competitive pressure; (2) legislative and
regulatory developments; (3) global, macro-economic and political trends;
(4) fluctuations in currency exchange rates and general market conditions;
(5) delay or inability in obtaining approvals from authorities; (6) technical
Notice 45 developments; (7) litigations; (8) adverse publicity and news coverage, which
Management Discussion & Analysis 64 could cause actual developments and results to differ materially from the
statements made in this Report. Deepak Nitrite Limited assumes no obligation
Directors’ Report 73 to update or alter forward-looking statements whether as a result of new
information, future events or otherwise.
Corporate Governance Report 114
www.godeepak.com
Visit Company’s official website to download the Annual Report.
Corporate OVERVIEW
statutory reportS
financial statements
Corporate Information
CHAIRMAN EMERITUS STAKEHOLDERS’ RELATIONSHIP & COST AUDITORS
Shri C. K. Mehta INVESTORS’ GRIEVANCE COMMITTEE B. M. Sharma & Co.,
Shri S. K. Anand Cost Accountants
Chairman
BOARD OF DIRECTORS
Shri Deepak C. Mehta Shri Ajay C. Mehta INTERNAL AUDITORS
Member
Chairman & Managing Director Sharp & Tannan Associates,
Shri Umesh Asaikar Shri Umesh Asaikar Chartered Accountants
Member
Executive Director & Chief Executive Officer
Shri Sanjay Upadhyay Prof. Indira Parikh CORPORATE IDENTIty Number
Member
Director-Finance & Chief Financial Officer L24110GJ1970PLC001735
Shri Maulik D. Mehta NOMINATION & REMUNERATION
Whole-Time Director CORPORATE & rEGISTERED OFFICE
COMMITTEE
Shri Ajay C. Mehta Aaditya-I, Chhani Road,
Non-Executive Director
Shri Sudhir Mankad
Chairman Vadodara – 390 024, Gujarat
Shri Nimesh Kampani Tel: +91-265-2765200/3960200
Independent Director
Shri Sudhin Choksey
Member Fax: +91-265-2765344
Shri Sudhin Choksey Email: investor@godeepak.com
Shri S. K. Anand
Member Website: www.godeepak.com
Shri Sudhir Mankad
Independent Director Prof. Indira Parikh
Member PLANTS
Shri S. K. Anand Nitrite & Nitroaromatics Division
COMPANY SECRETARY & 4-12, GIDC Chemical Complex,
Dr. Richard H. Rupp COMPLIANCE OFFICER Nandesari – Dist., Vadodara – 391 340
Shri Arvind Bajpai Gujarat
Dr. Swaminathan Sivaram
Independent Director REGISTRAR AND Taloja Chemical Division
Prof. Indira Parikh SHARE TRANSFER AGENT Plot Nos. K/9-10, MIDC Taloja,
Link Intime India Private Limited Dist. Raigad – 410 208, Maharashtra
Shri Sanjay Asher C-101, 247 Park, L.B.S Marg,
Additional Director
Vikhroli (W), Mumbai – 400 083. Roha Division
Smt. Purvi Sheth Plot Nos. 1, 2, 26 & 27
Additional Director
BANKERS MIDC Dhatav, Roha,
State Bank of India Dist. Raigad – 402 116, Maharashtra
AUDIT COMMITTEE Bank of Baroda
Shri Sudhin Choksey Axis Bank Ltd. Hyderabad Specialties Division
Chairman Standard Chartered Bank Plot Nos. 70-A & B, 90-F/70-A and 22,
Shri Sudhir Mankad ICICI Bank Ltd. Phase I, Industrial Development Area,
Member DBS Bank Ltd. Jeedimetla, Tal. Quthbullapur Mandal,
Shri S. K. Anand The Hongkong and Shanghai Banking Dist. Ranga Reddy, Hyderabad – 500 055
Member Corporation Ltd. Telangana
AUDITORS Dahej Division

Plot No. 12/B/2, GIDC, Dahej,
Deloitte Haskins & Sells, LLP
Dist. Bharuch, Gujarat – 392 130
Chartered Accountants
Deepak Phenolics Limited
SECRETARIAL AUDITORS Phenol & Acetone
KANJ & Co. LLP Plot No. 12/B/1, GIDC, Dahej,
Company Secretaries Dist. Bharuch, Gujarat – 392 130
Promises Made. Promises Delivered. 01

Promises Made
Promises Delivered
As India embarked on its journey of becoming self-
reliant in chemicals, Deepak Nitrite was established with
a larger vision of securing this ambition of the country.
We realised that manufacturing chemicals indigenously
was inevitable - a need that was thus far met by imports
- and converted it into a significant business opportunity
Today, we take pride in having delivered on our commitments with enormous

determination and perseverance. We have translated our strategy into action by
setting up a massive global-scale greenfield manufacturing plant at Dahej for
production of Phenol and Acetone, through our wholly-owned subsidiary, Deepak
Phenolics Limited. We also exhibited measurable deliverables by commissioning
the plant within envisaged cost and time, making India less dependent on imports.
We remain committed to Responsible Chemistry, we have also made significant
achievements in People, Planet and Profits.
02 48th Annual Report 2018-19

Corporate OVERVIEW
statutory reportS
Today, we are on an
accelerated growth
path, with sustainable
competitive advantages
and best positioned to
leverage the changing
market dynamics.
Our past performance

has emboldened us
to move ahead with
determination, as a robust
and diversified Company.

Deepak Nitrite Limited - At a Glance
We are elevating ourselves to a higher position of strength by

upscaling our capabilities and manufacturing capacities. We are
also forward and backward integrated to gain greater security on
supplies and margins. With this, we are earning the dual advantages of
better economies of scale, improved cost competitiveness and hence, a
leadership position in the market place
Our Vision We are…

A preferred supplier to One of the fastest-growing
some of the biggest leading companies in India
chemical companies that adheres to
globally Responsible Care
To become the fastest
growing chemical The Leading manufacturer A market leader in Nitrites,
company with a of Organic and Inorganic Toluene, Xylidines,
diversified portfolio of chemicals, Fine and Brightening Agents (OBA)
intermediates. Speciality chemicals and Phenol-Acetone

Corporate OVERVIEW
statutory reportS
Some of the Industries We Cater to

6
Manufacturing Facilities
Dyes and Pigments Agrochemicals Pharmaceuticals Colourants 30

Countries and 6 Continents
Our Worldwide Presence
` 2,700+ Crores
Fuel Additives Detergents Textiles Paper Consolidated Revenue
` 268 Crores
Consolidated Profit Before Tax
Laminates Automobiles Paint Adhesives
142%
Our Responsible and Sustainable Growth in Consolidated PBT
Growth Engine
A diversified portfolio of value-added intermediates reduces
dependency on any single product
Deepak Phenolics Ltd.
Driven by product and application diversity and strengthened
by strategically located manufacturing facilities 100%
Achieved upto 100% Capacity
Exports to over 30 countries across 6 continents Utilisation in Phenol-Acetone
and Cumene Plants
New products – Phenol and Acetone to cater to almost 20
end-user ` 914 Crores
Revenue
Some of Our Key Customers
` 56 Crores
PBT

Our Substantive Value Proposition
We are delivering sustained growth TO become a consistent and

predictable value generator. We are embarking on a journey of
business transformation and resting on our sound financial strategy
to anchor healthy growth
Our Value Proposition

Giving the highest importance to safety, environment and health
Continuing our legacy of ethical business practices
Ensuring pride in our own performance by being agile, innovative and responsive

Corporate OVERVIEW
statutory reportS
Our Core Values
Innovativeness Ownership Responsiveness

Driving not just product Where the vision becomes Towards customers and all
ideas, but also innovation not just the company, but the other stakeholders,
in terms of processes, thus individual goal as well. and employees.
maximising growth.
Agility Performance Driven

Change is constant. Agility Rewarding performance across
equips the organisation verticals, thereby setting
to respond rapidly to a examples of leadership.
dynamic world.
We continue to drive our strategies through a key focus on introducing new

products, expanding our footprint in high-value intermediates, dynamically
improving production capacity and ensuring value-based pricing. We
continue our investments in strengthening our infrastructure, systems and
processes and fortifying our product portfolio to drive greater efficiencies.

Our Manufacturing Prowess
Our 6 State-of-the-Art
our state-of-the-art Manufacturing Facilities
manufacturing facilities,
we are building best-in-class
infrastructure and
fostering innovation and
in turn, powering the Indian
economy. Our primary goal is
to align ourselves with India’s
fundamental growth drivers
and the “Make in India” initiative
AND HELP INDIA TO BECOME a
global manufacturing hub
Nandesari, Gujarat
Dahej, Gujarat

Corporate OVERVIEW
statutory reportS
Taloja, Maharashtra Roha, Maharashtra
Hyderabad, Telangana Deepak Phenolics Limited, Dahej, Gujarat

Research & Development -
Our Strength and Differentiator
Our state-of-the-art Research & Development (R&D) facility acts
as a catalyst between the R&D trials and commercial production
of intermediates and enables us to seamlessly deliver quality
products. Our innovative facility has an ability to develop advanced
intermediates, with a TIMEBOUND product development and process
improvement
What Differentiates Us World-class infrastructure, R&D focus, custom

manufacturing expertise and global quality
Amongst the few Indian companies to be
adherence provides strong capabilities to
accredited with Responsible Care certification
cater to the needs of different end users
for global environment, safety and health
management based on the principles of
Responsibly leveraging the best of talent and
responsible chemistry
technologies and years of expertise to deliver
superior products and services

Corporate OVERVIEW
statutory reportS
Key R&D Strengths

Product innovation Expert process for different
product segments
Cost-effective and Advanced intermediates

eco-friendly process developed and
development commercialised for MNCs
Our Objectives
Keep adding new and innovative products to our portfolio to sustain and augment growth
Improving process chemistry, productivity and yield
Creating customer-centric solutions, impacting product performance
Working on cost leadership and creating value chain
Focussing on yield improvement with material and energy balance
Aiming at debottlenecking, energy reduction and time cycle reduction
Recognised by Department
State-of-the-art R&D facility at
of Scientific and Industrial
Nandesari, Gujarat
Research, Government of India

Our Global Footprint
Over the years, we have built enduring relationships with leading global
companies. We have established our presence in over 30 countries across the
globe, including USA, Europe, Japan, Latin America, South East and Far-East Asia
Canada
USA
Mexico
NORTH
aMERICA
Brazil
Argentina
SOUTH
aMERICA
Map not to scale. For illustrative purposes only

Corporate OVERVIEW
statutory reportS
Sweden Turkey Oman Indonesia

Germany Jordan China Philippines
Switzerland Saudi Arabia India Vietnam
Italy Kuwait Sri Lanka Hong Kong
Spain Bahrain Bangladesh Taiwan
France UAE Thailand Japan
UK Korea
ASIA
Europe
AFRICA
AUSTRALIA
Israel
South Africa

Message from the Chairman &
Managing Director
Dear Stakeholders,
We are pleased to present to
you our Annual Report for
FY 2018-19. This year marks
a significant landmark for
our stakeholders, who have
shared this journey with us and
contributed to our success.
Recalling our journey since the
beginning, I remember every
single year to be fulfilling in
each respect. The year has
been a remarkable one for
us not just financially, but
for some of the significant
milestones we achieved.

Corporate OVERVIEW
statutory reportS
World Economy industry are immense. Moreover, we Our consistent performance, focus
FY 2018-19 was a turbulent year for remain confident that efficient producers on profitable growth and a calibrated
the global economy, characterised by that prioritise R&D and innovation strategy towards expansion serves
geopolitical uncertainties and trade wars. with a focus on scaling via sustainable in the best long-term interest of our
Softening of commodity prices, demand operations will succeed in the long run. shareholders as it leads to better
deflation and the effect of escalating An essential reminder to this approach valuation. Our relentless focus on faster
trade tensions moderately impacted served as the recent crackdown on execution and operational excellence has
the pace of global growth. While the US polluting industries in China, which been one of the Company’s key strengths.
witnessed a moderate increase in GDP resulted in supply disruption of necessary It helps improve margins as well as
growth, this was more than offset by chemicals manufactured and exported sustain and gain free cash flows to create
other large economies such as China, from there. Due to this unforeseen new investments.
Euro area economies and some of development, most large customers
the Latin American nations. are on the path to de-risk their China Our Legacy gives us Pride
This had a spiralling impact on exposure and have been increasingly Today, Deepak Nitrite Limited is proud
interconnected economies, and in turn, seeking alternative channels, including to state that it has been carrying the
on global growth. India. It has provided a tailwind to growth legacy of responsible chemistry for about
and enhanced opportunities to chemical 50 years. We have built our corporate
Amidst all these, India continues to producers in India. strength by unshackling opportunities
be one of the fastest-growing major with enormous patience, determination,
economies in the world backed by We made Promises. and perseverance.
healthy domestic consumption. We Delivered them.
Successful implementation of the We are on a journey of planned Despite having started as a bulk
Government’s structural initiatives transformation. Our transformational commodity manufacturer, your Company
towards improving the ease of doing expansion, in terms of product portfolio has transformed its operations over the
business such as enhancing transparency, and geographical presence, is already years. It has expanded its offerings to
speeding up approvals, resolving policy taking shape and showing early signs include high-value fine and speciality
issues and fostering more significant of bearing fruit. Today, we are a robust chemicals, based on our core expertise
levels of value addition also played a and diversified institution, with a strong and the lateral and vertical integration
crucial role in sustaining performance. position in India’s chemical industry. of the existing products. Our robust
R&D capabilities have been stepped
India’s Chemical Industry – Rising In an uncertain business environment, up across the value chain, in-line with
Opportunities your Company delivered a resilient the expansion in product categories.
The global chemical industry has been performance in FY 2018-19. We delivered Additionally, our healthy client
a healthy contributor to the world GDP. on our promises made on the existing relationships have enabled us to create
It contributed USD 5.7 trillion or 7% lines of business as well as the recently deeper inroads into the existing markets,
to the world’s GDP. Due to uncertainty commissioned Phenol and Acetone widen our product portfolio and enter
on interest rates, trade tensions and project. On the back of a robust business newer markets. At the foundation of
slowing economic growth, global M&As model, diverse product portfolio and our transformational journey is our firm
in the chemical industry slowed down. geographies and a competitive operating commitment to being completely and
However, transactions undertaken profile, we created a superior position squarely aligned with reinforcing India’s
are being consolidated and absorbed, in the global chemicals market. Our positioning as a superpower and doing
and these are likely to pursue vast strategic and focus initiatives - such good for society.
opportunities in the global as reorienting of geographical focus,
chemicals market. strengthening product portfolio and Our Triple Bottomline Approach:
brownfield expansion - positively PEOPLE
Within this backdrop, we believe the impacted our verticals and enabled us to Our employees have been our most
opportunities for the Indian chemical deliver improved performance. significant assets. We believe that

none of our achievements would have our employees. There is also a deep and ‘Together for Sustainability’ which
been possible without the passion and focus on giving back to society and to makes it a “Preferred Supplier” for several
commitment of our employees. Today, the communities in which we operate. chemical multinationals. Additionally,
a dedicated team of professionals, Through Deepak Foundation, the your Company has steadily worked
nurtured over the years, have been Company is executing various healthcare, towards a reduced carbon footprint. It
driving the growth of your Company. skill development and education related has a key focus on reduction in resource
Among the several steps we are taking CSR programmes for the families of intensity in energy and water and greater
to grow sustainably, we are recruiting workers and local communities residing emphasis on products that are a part
and nurturing quality talent and create around our manufacturing facilities of the sustainable supply chains. Your
a work culture that ensures a high level and other remote areas, including tribal Company’s Phenol plant has been set
of performance and a conducive work areas. Over the years, the Foundation has up with the latest technologies. It is also
environment. During the year under progressed into a leading non-profit civil one of the most efficient units globally at
review, the Global Employer Branding society in Gujarat and has been executing this scale, in terms of water and energy
Institute and World HRD Congress several such initiatives to enhance lives of efficiency, further underscoring our
conferred Deepak Nitrite Limited with the the people. commitment to the planet.
“National Best Employer Brands 2018”.
PLANET PROFIT & PERFORMANCE
Our people-aligned business strategy As a responsible corporate citizen, your Your Company ended FY 2018-19 on an
has catapulted in organisation-wide Company strongly believes in sustainable exuberant note with double-digit growth
success. We will continue to create practices. Your Company is already a in Revenues, EBITDA and Profit Before
platforms to hire and nurture our talent member of the coveted accredited bodies Tax. It also managed to report higher
pool with a transformational vision for such as ‘Responsible Care,’ ‘Nicer Globe,’ volumes and realisations across critical
products, amidst rising prices of crude oil
and related petrochemical intermediates.
On consolidated basis, total revenues
for the year stood at ` 2,715 crore, while
We delivered on our promise EBITDA came in at ` 429 crore. Both PBT
and PAT recorded accelerated growth
of executing the plant and during the year at ` 268 crore and
` 174 crore, respectively. During the
getting it commissioned year, we continued our “bottom line
in record time – and with accretive” investments in solidifying
our capital structure and fortifying the
no cost or time over-runs. product portfolio. We are focussed
on strengthening our infrastructure,
This not only demonstrates systems, and processes to drive
our preparedness, it also greater efficiencies.
indicates our elevated We are “FUTURE-READY”

To sustain a growing business in size
manufacturing and marketing and complexity, we are strategically
capabilities. transforming our organisation and

becoming “future-ready.” We are making
continuous investments in our productive
assets, and our expansion strategies
are also devised keeping in mind our
in-depth risk-mitigated approach towards
incurring capital expansion.

Corporate OVERVIEW
statutory reportS
We take immense pride in stating that in record time – and with no cost or time Today, we are in a position to take
during the year we over-delivered on over-runs. This not only demonstrates advantage of market dynamics through
our promises of creating a global- our preparedness, it also indicates our our diversified portfolio and credibility
scale manufacturing plant within the elevated manufacturing and marketing among the customers and confident
envisaged cost and scheduled time. This capabilities. Our robust execution has of continuing our growth momentum.
was made possible through our qualities been a result of the seed marketing Being on a steep growth path, we are
of meticulous planning and precise efforts undertaken during the pre- confident about our growth prospects
execution. These attributes gave us the commissioning phase. With this, we have and building market share gains. We
confidence to leverage our key strengths enabled the country to become self- are ready for a promising future with
and capabilities and create massive reliant in the production of Phenol and
value for all our stakeholders. We also the multiple business drivers that will
Acetone and resulting in import savings. enable us to achieve our goals. We also
believe that our investments in cutting- The plant is well capacitated to address
edge research & development is not only believe our growth will be sustainable
India’s demand for Phenol and Acetone
altering our competitive capabilities, as it is predicated on the strengths of
and reduce its import dependence on
but also sustaining and bettering our our organisation. Some of these are
these chemical intermediates, based
performance in the future years. – an able and competent leadership,
on its cutting-edge technology as well
deep customer relationships, ability to
as resource and energy efficiency. Our
In light of a spirited performance innovate and develop new products,
philosophy of import substitution has
reported by your Company, the Board of expertise in complex chemistry, ability
Directors have recommended a dividend been converted into further action as
we succeeded in replacing the bulk of to cope up with change, globally
of ` 2 per equity share (100%) on a face
imports of Phenol and Acetone in the competitive manufacturing capabilities,
value of ` 2 each on an expanded capital
domestic market. and an efficient supply chain and
base. This is compared to a dividend of
distribution infrastructure.
` 1.30 per equity share (65%) declared in
the previous financial year. This project has undoubtedly added
another feather in our cap. We are of Vote of Thanks
Making India Self-reliant in the firm belief that this will enable On behalf of the Board, I thank the
Chemical Imports a quantum leap in your Company’s entire team at Deepak Nitrite Limited
FY 2018-19 has been a milestone year revenues and profits, and subsequently and Deepak Phenolics Limited and our
for the Company, as we commissioned open new avenues of growth from valued shareholders for their continued
our mega Greenfield project for forward-integration into value-added support and encouragement. We thank
manufacturing of Phenol and Acetone at derivatives. you for having your continued faith
Dahej in Gujarat in November 2018. More in our strength and capabilities and
importantly, we successfully ramped up Moving Ahead our employees for their tireless efforts
its capacity utilisation above 80% within Your Company’s strategic focus on the towards achieving our goals.
first few months of commissioning, performance of People, Planet and Profit
which in itself is a positive achievement. have built a formidable foundation We are on an exciting journey towards
I congratulate the entire team at Deepak that will serve multiple growth levers in becoming a diversified chemical
Phenolics Limited for their tireless efforts the years ahead. We are traversing the powerhouse. We are proud to have been
in achieving the above. I am also happy journey forward with an unwavering associated with you as we continue on
to highlight that our dedicated logistics faith in our conviction, as we continue to our voyage of responsible growth and
team has been successful in despatching innovate with vigour and passion value creation.
approximately 75% of the average for taking your Company to a higher
capacity utilisation in the first quarter horizon of excellence. We remain
of commissioning. focussed on executing our clear-cut Best Regards,
strategies on cost optimisation, adding
We delivered on our promise of executing new products, tapping new markets and Deepak C. Mehta
the plant and getting it commissioned expanding our capacities. Chairman and Managing Director

CEO’s Communique
Dear Stakeholders,
I am glad to share with all of you the
accomplishments of your Company during
Fiscal Year 2019 as well as the progress
towards its strategic plan. The year gone
by has been memorable on several fronts.
Not only did we demonstrate a robust all-
around performance which surpassed our
internal operational targets, but we also
commissioned our mega-greenfield facility
of Phenol and Acetone at Dahej, Gujarat,
on November 1, 2018. This marks the
successful culmination of a three-year
project that had been meticulously
planned and seamlessly executed.
We have achieved capacity utilisation
of over 80% in Phenol and Acetone
since the commencement of
operations, which is not a simple
feat. In addition to high usage,
the Company seamlessly
managed a sophisticated
logistics and distribution
network which exhibits the
depth of our operational
preparedness.

Corporate OVERVIEW
statutory reportS
EVOLUTION AND STRATEGIC DIRECTION Today, I take pride in saying that your With this, we are not only delivering
Those of you who know Deepak Nitrite’s Company has worked hard to elevate its growth, but also building a stronger,
(DNL) history would be aware that the operational capabilities. This has been more resilient company which can
origin of the company was based on the possible through the tireless efforts of all continue to grow sustainably.
fact of desire to substitute imports and our associates to execute the business
to adopt the ‘Make in India’ concept. The strategy devised by the management I genuinely believe that Deepak Nitrite’s
vision, which had first given shape with team and guided by our accomplished future is even brighter. We have multiple
Sodium Nitrite and Sodium Nitrate nearly Board. Your Company has created a businesses driving our growth. We have
half a century ago and the commissioning robust platform and invested in the right unique capabilities that are becoming
of this Phenol and Acetone plant housed ingredients to ensure continued earnings increasingly vital. We are serving
within Deepak Phenolics, marks the momentum in the years ahead. customers that are benefiting from
coming of a full circle for your Company. strong demand for their products. Our
The focus, within DNL, has been relationships, product innovations,
Over the years, DNL has demonstrated to persevere in carefully selected consistent delivery of high-quality
its ability to add value by forward products, elevate competencies and products and services are unlocking new
integration. It first understands and aspire for cost leadership. It creates opportunities. With a proven track record,
creates strong capabilities around basic an obsession towards enhancing hunger for growth, extensive product
chemical compounds. Later, it aims to operating efficiencies which are attained range, and capacities based on the latest
elevate its operational excellence to by optimising production processes technological innovations, amplified by
their forward uses to deliver growth through debottlenecking initiatives committed employees, we are confident
and capture more value by moving up and re-evaluating the value chain on an of surpassing more milestones, as we
the chain. We have done this earlier too ongoing basis to explore opportunities move ahead.
to emerge as the only fully integrated for backward integration. Our cost
producer of Fluorescent Whitening leadership position in key building blocks Last, but not the least, our pool of talent
Agents. The addition of sizeable unlocks new avenues for growth such as is our wealth which helps us propel our
capacities for Phenol and Acetone new products, new customers and new growth into the higher orbits. We highly
within our fold opens up new avenues markets. This enables us to scale our appreciate and respect the value of our
of growth for your Company, based on offerings by enhancing capacities through human resources. We continue to
its strategy of value-added products by expansion, which further elevates our expand, nurture and retain our pool of
forward integration, which our country is competitive positioning. human ability.
currently importing.
ENVIRONMENT AND SUSTAINABILITY
Thank you for being on this journey
PERFORMANCE AND OPERATIONAL As a signatory of Responsible Care, DNL
with us.
EXCELLENCE assigns the highest importance to safety,
During the year under review, we environment, and health. Adherence
witnessed good progress in each of our to the most stringent pollution control
Strategic Business Units, driven by a norms at all of its manufacturing facilities
combination of management initiatives supporting various initiatives in the Best Regards,
to grow these units and the ability to areas of reduction in carbon footprints
capitalise on opportunities arising from and energy efficiency enhancement to Umesh Asaikar
shifts in the global industry landscape. preserve and protect the environment. Executive Director & Chief Executive Officer

CFO’s Communique
Dear Stakeholders,
FY 2018-19 has been an
exciting one for Deepak Nitrite
Limited (DNL) amidst a range
of micro and macro-economic
events, including those across
geographies. While we have
seen regional protectionism,
tension around energy
resources, a clear change in
industry scenario in China,
and growth in the USA and EU
economies, your Company
has reported its highest-ever
turnover and profit. This
performance has been driven
by a passionate and energetic
team and supported by sound
corporate governance and a
prudent capital structure.

Corporate OVERVIEW
statutory reportS
EFFICIENT HANDLING OF PROJECT & Phenol plant through its wholly-owned ENHANCED CREDIT RATING
TEAM BUILDING subsidiary DPL within envisaged project It gives us pleasure in informing you that
In a significant development for your cost of ` 1,400 crore. Your Company has your Company has been assigned a long-
Company, its greenfield facility for the fully funded the committed equity into term rating of AA- Stable and a short-term
manufacture of Phenol and Acetone this project. Apart from commissioning rating of A1+ by CRISIL Limited, while
at Dahej, Gujarat, through the wholly- the Phenol plant, your Company also the credit rating of Deepak Phenolics
owned subsidiary Deepak Phenolics spent on capital expenditure towards Limited has also undergone a significant
Limited (DPL), was commissioned on enhancing capacities in the existing SBUs upgradation assigned by ICRA Limited :
November 1, 2018. The Greenfield facility of Basic Chemicals and Fine & Speciality long-term rating from ICRA BBB Stable to
has made excellent progress in a short Chemicals segment. This was aimed ICRA A- Stable and short-term rating from
period of time. One, we have efficiently at capitalising on the ensuing demand A3+ to A2+.
handled the project through successful available across crucial products.
stabilisation and optimal capacity Moreover, we have further plans of SHAREHOLDER VALUE CREATION
utilisation during the first few months growth across SBUs, given the buoyant Our foremost objective of all our above
after commissioning; and two, we also demand expected in the near future. initiatives and our business plan is to
delivered positive EBITDA and PBT within generate value for our shareholders on
a very short span of commissioning. After all such initiatives, your Company a sustainable basis. In this backdrop, I
has been able to reduce the intensity in am delighted to share that our Board has
The credit for this, undoubtedly, goes to working capital. The capital structure also recommended a Dividend of 100%, i.e.,
the entire team of DPL which undertook remains healthy with standalone gearing ` 2 per share on a Face Value of ` 2 each,
the project with seamless planning and at around 0.30X and consolidated gearing in light of the improved performance of
execution. Care was taken to identify and at around 1.10X. We may keep in mind the Company.
invest in an experienced and capable that the entire investment of the Phenol
team at DPL to ensure timely completion plant shall yield its first complete year of We take this opportunity to convey
of the plant, rapid scale-up of operations, result in FY 2019-20, which should make that with untiring efforts, we have
and smooth conduct of complicated the cacapital structure even healthier. been able to deliver on our promises
logistics. Our seed marketing Having said this, I take this opportunity – turning around the Performance
initiative undertaken during the pre- to convey that your Company has clear Product business segment, flawless
plans of growth commencing in the commissioning of the Phenol project
commissioning phase also played a vital
current financial year, both in existing within cost, retaining a healthy capital
role in establishing DPL in a leadership
products and in new products. Once structure, and a rapid ramp-up of the
position in the domestic market.
operationalised, the contributions Phenol facility.
This project goes a long way to support out of such growth plans are also
Let me assure you that we endeavour to
the ‘Make in India’ initiative of the expected to make the Company’s capital
build onto this momentum and create
Government. It has a capacity of structure healthier.
further value for all our stakeholders.
producing 2,00,000 MTPA of Phenol and
1,20,000 MTPA of its co-product Acetone, A NEW BUSINESS SEGMENT -
supported by an in-house facility to PHENOLICS Best Regards,
manufacture 2,60,000 MT of Cumene for Upon commencement of the operations
captive consumption. of the Phenol plant, we have created Sanjay Upadhyay
a separate segment “Phenolics” in our Director-Finance & Chief Financial Officer
CAPITAL STRUCTURE consolidated results. This segment shall
During the financial year under review, report operational numbers of both
your Company commissioned the Phenol and Acetone.

Our Board and Leadership Team
SHRI Deepak C. Mehta

Chairman & Managing Director
Shri Deepak C. Mehta’s business acumen, leadership skills and dynamism have
enabled Deepak Nitrite Limited to take swift strides forward and achieve many
milestones in the last 40 years. An active participant at industry forums, he has
been the Chairman of the National Chemicals Committee at FICCI. He is a science
graduate from the University of Bombay.
SHRI Umesh Asaikar

Executive Director & CEO
Shri Umesh Asaikar has been associated with Deepak Nitrite Limited as a Chief
Executive Officer since September 2008. He holds a Bachelor’s degree in Mechanical
Engineering from the Indian Institute of Technology Bombay, and Master’s Degree in
Management Science from Jamnalal Bajaj Institute of Management Studies. He is an
associate member of the Institute of Cost Accountants of India . He is also a certified
coach and member of the International Coach Federation.
He has around 40 years of varied experience in the areas of Sales and Marketing,
Manufacturing, Commercial and Business Management across industries, including
pharmaceuticals, vitamins and fine chemicals etc. He has held various leadership
positions in companies such as Parke-Davis Limited, Piramal Healthcare Limited
(erstwhile Nicholas Piramal Limited) and Piramal Glass Limited (erstwhile Gujarat
Glass Limited).
SHRI Sanjay Upadhyay

Director - Finance & CFO
Shri Sanjay Upadhyay is an Associate Member of the Institute of Cost Accountants of
India. He is also a Fellow Member of the Institute of Company Secretaries of India. He
has completed an Advanced Management Programme from Wharton, USA. He has vast
experience in the areas of Finance, Accounts, Commercial and Secretarial Functions. He
is associated with the Company since 1994.
SHRI Maulik Mehta

Whole-Time Director
Shri Maulik D. Mehta holds a Bachelor’s Degree in Business Administration from
University of Liverpool, UK. He has also done Masters in Organisational Psychology from
Columbia University, USA. Shri Mehta has more than 9 years of experience in the areas of
Business Development. During the span of his career, he has held important positions,
including Product Head in the Company.
He also heads the Strategy cell of the Company and has taken several landmark
decisions to elevate the Company to a new height.

Corporate OVERVIEW
statutory reportS
SHRI Ajay C. Mehta

Non-Executive Director
With extensive experience, a comprehensive approach and industry foresight, Shri Ajay
C. Mehta has paved the way for innovation and excellence at Deepak Nitrite Limited.
He has been actively associated with the organisation since 1984. He is a science
graduate with Honours and a Master of Science in Chemical Engineering from the
University of Texas, USA.
SHRI Nimesh Kampani

Shri Nimesh N. Kampani is a commerce graduate from Sydenham College, Mumbai and
a fellow member of the Institute of Chartered Accountants of India. He is the founder
and Chairman of the JM Financial Group, one of India’s leading players in the financial
services space.
He has pioneering contributions into developments of Capital Markets. He has several
landmark corporate deals to his credit which make him distinguished in the country.
Shri Kampani has served as a member of several important committees constituted
by the Ministry of Finance, Government of India, Reserve Bank of India, Securities
and Exchange Board of India, BSE Limited, National Stock Exchange of India Limited,
Confederation of Indian Industry (CII), Federation of Indian Chambers of Commerce and
Industry (FICCI) and Institute of Chartered Accountants of India. He is Chairman of the
CII National Council on Financial Sector Development.
SHRI Sudhin Choksey

Shri Sudhin Choksey has extensive experience in functional areas of finance, commerce
and general management, both in India and abroad. He is the Managing Director of
GRUH Finance Ltd. and a Fellow Member of the Institute of Chartered Accountants
of India. He is a Director on the Board of Gujarat Ambuja Exports Ltd., HDFC Credila
Financial Services Pvt. Ltd. and Light Microfinance Pvt. Ltd.

SHRI Sudhir Mankad
Shri Sudhir Mankad, IAS (Retd.) has served in senior positions, both with the
Government of India and Government of Gujarat. His last assignment was as Chief
Secretary, Government of Gujarat. Additionally, he has served as a Director/Chairman on
the Board of several cement, power, fertiliser and finance companies. He is associated
with several educational institutions and NGOs. He holds a Master’s degree in History
from the University of Delhi. He is also a Director on the Board of Reserve Bank of India.
DR. Richard H. Rupp

Dr. Richard H. Rupp has held various top level positions in leading multinational
companies such as Hoechst AG (Germany), Lonza (Switzerland) and Allessachemie
(Germany). His experience encompasses a mix of scientific, technical as well as
managerial roles. He is well-acquainted with the USA, European, Asian and Indian sub-
continent markets. Dr. Rupp holds a Ph.D in Chemistry from the University of Karlsruhe,
Germany, and has completed a programme for Executive Development from IMD at
Lausanne, Switzerland.
SHRI S. K. Anand
Shri S. K. Anand has a rich experience of 46 years in the field of Project Management,
Operations, Corporate Planning, Quality Management, Health, Safety and Environment
Management, Energy Management and Strategic Planning in Petrochemicals, refining
and other allied industries. He is a Bachelor of Engineering (Chemical) from Delhi
University and has done a Petrochemical Course from I.I.P., Dehradun. He has also done
an advanced management course from IIM Ahmedabad.
DR. Swaminathan Sivaram

Dr. Swaminathan Sivaram is a polymer chemist by profession and a mentor as well
as a science administrator of distinction. He is a former director of the CSIR - National
Chemical Laboratory, Pune. Currently, he is an Honorary Professor and INSA Senior
Scientist of the Indian Institute of Science Education and Research (IISER), Pune. He has
authored over two hundred and twenty papers in peer-reviewed journals, edited two
books and authored one book. He has fifty-one issued US and European patents and fifty-
two Indian patents to his credit. Dr. Sivaram is a highly decorated scientist / technologist
with numerous awards and honours to his credit. He was conferred Padma Shri by the
President of India in 2006.
Dr. Sivaram is an alumnus of IIT-Kanpur. He earned a PhD. in Chemistry and DSc (h.c)
from Purdue University, W. Lafayette, Indiana, USA.

Corporate OVERVIEW
statutory reportS
PROF. Indira Parikh

Prof. Indira Parikh is the Founder President of FLAME (Foundation for Liberal and
Management Education). Previously, she was the Dean of IIM-Ahmedabad from 2002
to 2005. She was a faculty member at IIM-Ahmedabad for over 30 years. She has
specialised in organisation development and design, and institution building. She holds
a Ph.D from Gujarat University, Ahmedabad and an MA from University of Rochester.
She has designed and offered management development programmes for managerial
role effectiveness, issues of roles and identity, and stress and self-renewal for men
and women in organisations. She has been a consultant to various national and
international organisations, both in private and public sectors.
Shri SANJAY ASHER

Additional Director
Shri Sanjay Asher holds a Bachelor’s degree in commerce and a Bachelor’s degree in
law from the University of Bombay. He has been a practising advocate since 1991, and
was admitted as a solicitor in 1993. He is also a qualified Chartered Accountant. He is
presently a senior partner with Crawford Bayley & Co, which is India’s oldest law firm,
established in 1830. He specialises in the fields of corporate law and commercial law,
corss-border M&A, joint ventures, and capital markets, and advises large, medium and
small business enterprises on these subjects.
Smt. PURVI SHETH

Additional Director
Smt. Purvi Sheth has completed her Bachelor’s Degree in Arts, Economics & Political
Science from St. Xavier’s College, Mumbai University and obtained a CPD Business
Strategy & Leadership Management from Wharton Business School, USA.
Smt. Purvi helps create business opportunities and competitive advantage via Strategic
HR management. She has helped several businesses effectively cultivate talent
engagement through advanced leadership processes and implementation in impacting
business performance and productivity.

Our Strategic Business Units
We are consistently sharpening each of our business verticals

through determined innovation, capacity expansion, AND NEW product
launch, and achieving scale to widen the value-add in everything we
do. Our journey is marked by our impactful play within each of our
business segments and a continuous commitment to advance on our
productivity across our product portfolio
Despite market challenges, we pursued selective opportunities in the domestic and export markets, which enabled us to grow volumes
across all our business segments. While we achieved brownfield expansions in Basic Chemicals and Fine & Speciality Chemicals, the
Performance Products segment has turned around and became profitable. Today, all our established business segments continue to
benefit from a positive demand environment, firm realisations and increasing market opportunities.
BASIC CHEMICALS FINE & Speciality CHEMICALS

Brownfield expansion and improved Encouraging traction from key products
product mix led to strong REALISATION due to a positive demand scenario helped
Quick Facts: drive growth
Basic Chemicals find application in dyes and pigments, Quick Facts:
The segment produces specialised and niche molecules
agrochemicals and fuel additives.
from various processes and requires technical skills and
technological competencies in handling potentially
Performance Highlights: hazardous reactions. These chemical intermediates
We attained cost leadership in these products of high find application in agrochemicals, pigments,
volume and higher realisation. The segment reported pharmaceuticals and personal care segments.
sustained growth momentum as we enhanced Performance Highlights:
capacities of key products. Our key value differentiation has been our long-term
strategic relationships with customers and stringent
monitoring of quality and timely supply. The segment
Key Focus Area:
witnessed volume growth with capacity expansion
Through full integration capabilities, we developed
and backward integration initiatives. There was firm
an extensive network of global clientele, earning a
realisation in select products, which led to a strong growth
significant competitive advantage.
in topline. Brownfield expansion to enhance capacities of
major products will further aid growth momentum, apart
from introduction of new products soon.
Key Focus Area:
We continue to emphasise on better quality, stickiness
of relationships, sustainable operations and global
best practices for suppliers and customers. We are
also focussed on improving the product basket and
leveraging domestic and international demand.

Corporate OVERVIEW
statutory reportS
PERFORMANCE PRODUCTS PHENOLICS

Our continued focus on MARGIN-DRIVEN LARGEST STATE-OF-THE-ART AND MOST EFFICIENT
growth and customer ACCEPTANCE delivered INDIAN PHENOL AND ACETONE PLANT
enhanced profitability Quick Facts:
Quick Facts: Local availability of Phenol and Acetone is expected to
The segment finds application in textiles, paper and boost the production of derivatives and downstream
detergents with its key value in the characteristic products, which will expand the overall market in
of the main product. It needs globally recognised the country.
certifications and customer approvals.
Performance Highlights:
Performance Highlights:
The Performance Products segment has been Within a short span of time, the plant stabilised and
completely turned around due to careful planning and touched 100% capacity utilisation. Within a few months
reorientation of focus towards customers and end-user of commissioning, it reported positive EBITDA and
industries that have been exhibiting steady growth and PBT and enabled the creation of a robust supply chain
value high-quality and differentiated products.
infrastructure and logistics.
With robust demand from local customers and with
benefits arising out of supply disruptions in China, we Key Focus Area:
are poised to climb the next frontier of growth. We are currently fulfilling India’s growing demand
for Phenol and Acetone. We are also evaluating the
Key Focus Area:
The strategy to differentiate product, price and market possibilities to develop facilities for downstream
is yielding positive results. In addition, favourable integration. Together, we can boost production of
demand-supply trend is expected to result in improved derivatives and downstream products to give an impetus
realisations and solid performance. to the expansion of the Indian
chemical industry.

Delivering our Promise of...
Reducing Import Dependence
We delivered the global-scale Phenol and Acetone plant within costs. The plant,
commissioned during the year, is aligned with India’s journey to become self-reliant
in chemical intermediates and reduce import dependence. With this, we not only
delivered our promise of enabling India address its current demand for Phenol and
Acetone, we also enabled the country earn long-term savings on imports

Corporate OVERVIEW
statutory reportS
We achieved a significant milestone as we kick-started

commercial production at our mega Greenfield plant for Phenol
and Acetone – within stipulated time and cost.
Spread across an area of around 60 acres, the plant has been set
up by its wholly-owned subsidiary Deepak Phenolics Limited. The
plant is squarely aligned with the Government’s “Make in India”
initiative. Local availability of Phenol and Acetone will boost
production of derivatives and downstream intermediates, thus
expanding the overall market size. The plant will also pave the
way to enter various derivatives business, supported by its ability
to manufacture cumene for captive consumption.
Delivering our Promises Delivering our Promises to

Making India self-reliant in production of Stakeholders
Phenol and Acetone Plant commissioned within cost and time
Reducing India’s import dependence on Plant stabilised and touched 100%
chemical intermediates capacity utilisation within a short
Taking care of India’s demand-supply gap in span of time
Phenol and Acetone Reported positive EBITDA and Profit
At full capacity, plant is projected to result in Before Tax within few months of
import savings of around USD 400 Million commissioning
Driving our goal of being the fastest-growing Created robust supply chain infrastructure
Indian chemical intermediates manufacturer and logistics
Capacities at State-of-the-Art Facility
2,00,000 MTPA 120,000 MTPA 260,000 MT

Phenol Co-product Acetone Cumene
IoT-enabled and Harnessing the Amongst the most
environment-friendly plant power of technology modern plants in the
and data industry

Leveraging our Strategy for
Stable Growth
During the year, we reinforced our market position and expanded our presence by
adding more customers and geographies through a diversified portfolio and market
credibility. We are further delivering on our promise of improving productivity through
clear-cut strategies on tapping new markets and expanding capacities and cost
optimisation

Corporate OVERVIEW
statutory reportS
Going Forward…
As we move ahead, we will be building on our market share gains by further adding on capacities, customers, geographies and new
products, heading onto a stable growth path. Today, we are well placed to leverage the growing opportunities in India’s chemicals
industry. The established business segments continue to benefit from a positive demand environment and firm realisations.
We are confident of continuing the growth momentum backed by our growth strategy.
We are delivering on our promises by...
Doing More of the Same Inculcating Cost Efficiencies

We enhanced the capacities in Basic A clear strategy of being cost-efficient helped
Chemicals and Fine & Speciality Chemicals us deliver our promise of improved EBITDA
to help us deliver our promise of improved and earn the benefits of operating leverage,
performance. contributing to enhanced profitability.
Adding More Products Exploring New Geographies

We delivered our promise of building more We delivered our promise of adding more
product lines. The Phenol and Acetone plant markets by leveraging the increasing
at Dahej enables us to manufacture value- international opportunity and becoming a
added import substitutes. favoured supply chain partner.

Strengthening our Segmental
Performance
We delivered our promise of turning around Performance Products segment by
reorienting our geographical focus, efficient plant utilisation and product-wise
change. The segment also benefited from improved demand and pricing trends
in local and export markets. We also strengthened Basic Chemicals and Fine &
Speciality Chemicals through brownfield expansion, full capacity utilisation and
backward integration

Corporate OVERVIEW
statutory reportS
Strategic Initiatives that led us to deliver growth

Better pricing and cost management
Pursuing selective opportunities in domestic and export markets
Capacity enhancement and improved utilisation of key products
Expansion in key building blocks enabled catering to higher demand from
end-user industries
Being a fully integrated supplier of OBA led to capitalising on shifts in the industry
landscape and evolving market opportunities
Moving from Promises to Achievements:

Basic Chemicals Fine & Speciality Chemicals
Brownfield capacity expansion in major Brownfield capacity expansion in major
products products
Rising demand in local and export markets Backward integration
Improved product mix leading to strong Firm realisation in select products
realisation gains
Cost leadership initiatives
Performance Products Deepak Phenolics Limited

Reorientation of focus on customers and Setup facility to locally manufacture
end-user together 2,00,000 MTPA of Phenol and 1,20,000
MTPA of Acetone
Efficient utilisation of plant, improved
product mix and other operating efficiencies Achieved ramp-up of capacity utilisation;
contributed to significant forex savings
Differentiated products, price and market
Widening of customer base and new
geographies
Full integration of value chain

Generating New Platforms for
Sustainable Growth
Besides captive utilisation of existing capacities, the mega greenfield plant to
manufacture Phenol and Acetone will help boost production of derivatives and
downstream intermediates. This is helping the Company realise pockets of new
opportunities and gear up to fully capitalise on them

Corporate OVERVIEW
statutory reportS
The Greenfield plant is serving as a How are we Delivering on our

springboard for downstream products, Promise?
which are by themselves value-added import The Company is expected to benefit out of
substitutes. Besides captive utilisation of the fast ramp-up and full capacity utilisation.
capacities, this will expand the market size It is also expected to benefit out of forward
with penetration into Phenol derivatives. integration of its products into value-added
downstream products
With Phenol derivatives being import
dependent, opening new growth verticals
Securing market for Acetone with product
quality meeting pharma standards
Driving growth by addressing the domestic
demand for Phenol
Capturing domestic market of Phenol and
addressing robust growth being currently
witnessed in the country

Our Performance Scorecard - Standalone
We are not only holding onto our gains, we are also building on them
by improving our market share positions. Strong growth in the base
business and commencement of the Phenol-Acetone plant resulted in
better RoCE and free cash flows in the medium-term
Application-wise Sales Funds Outflow

FY 2018-19 FY 2017-18 FY 2018-19 FY 2017-18
3% 3% 3% 3% 2% 3% 1% 2%
4%
3% 7% 5%
1%
10% 8% 1% 3%
2% 6%
7%
58% 58% 54% 9% 57%
26% 28% 9%
12% 12%
Colour Agro Cost of Materials Operational Expenses

Fuel Pharma Others Employee Benefits Expenses Selling & Admin Expenses
Finance Costs Research & Development Expenses
Depreciation Dividend & Dividend Tax Income Tax Retained Earning*
*Proposed dividend shall be accounted as and when declared by the Company
Revenue (` in Lakhs)
1,79,192
1,47,923
1,33,573
1,32,716
1,31,527
1,26,963
1,21,153
1,01,940
96,838
84,729
82,445
81,040
76,907
56,893
58,039
51,085
51,676
51,128
50,056
46,798
45,047
2018-19 2017-18 2016-17 2015-16 2014-15 2013-14 2012-13

Export Domestic Total
EBITDA / PBT (` in Lakhs)

30,823
21,437
21,250
16,822
15,240
14,017
12,208
11,354
9,133
8,122
7,392
6,774
5,815
5,258
2018-19 2017-18 2016-17* 2015-16 2014-15 2013-14 2012-13

EBITDA PBT
*Excludes exceptional income

Corporate OVERVIEW
statutory reportS
Financial Highlights for the last Ten Years
Sr. Ind-AS Indian GAAP

Particulars UOM*
No.
Consolidated Standalone Standalone
2018-19 2017-18 2016-17 2015-16 2014-15 2013-14 2012-13 2011-12 2010-11 2009-10
Total ` in
1 271504 179451 1,49,077 1,32,442 1,33,727 1,32,922 1,27,140 1,03,010 79,273 67,742 54,646
Income Lakhs
YoY Growth % 60.80 20.38 12.56 (0.96) 0.61 4.55 23.42 29.94 17.02 23.97 (6.25)
` in
2 EBITDA 42902 30823 21,437 15,240# 16,822 14,017 11,354 8,122 5,811 6,217 5,449
Lakhs
Profit /
` in
3 (Loss) Before 26798 21250 12,208 7,392# 9,133 6,774 5,815 5,258 3,159 3,696 3,032
Lakhs
Taxation
Percentage
to Total % 9.87 11.84 8.19 5.58 6.83 5.10 4.57 5.10 3.98 5.46 5.55
Income
Profit /
` in
4 (Loss) After 17366 13804 8,346 5,194# 6,515 5,344 3,833 3,782 2,308 2,580 2,001
Lakhs
Taxation
Percentage
to Total % 6.40 7.69 5.60 3.92 4.87 4.02 3.01 3.67 2.91 3.81 3.66
Income
` in
5 Equity 2728 2728 2,728 2,614 2,326 2,091 1,045 1,045 1,045 1,045 1,045
Lakhs
` in
6 Net Worth 107158 105785 94,384 73,213 47,589 34,683 30,752 28,060 25,278 23,791 21,944
Lakhs
` in
7 Debt 118652 32761 46,153 57,355 49,520 54,451 50,504 33,546 17,096 5,958 9,256
Lakhs
Dividend
` in
8 on Equity 2728## 2728## 1,773 1,569 1,395 1,045 1,045 837 628 628 523
Lakhs
Capital
Percentage % 100## 100## 65 60 60 50 100 80 60 60 50
9 EPS ` 12.73 10.12 6.34 4.43 6.07 5.11 36.63 36.15 22.06 24.65 21.82
Book
10 ` 79 78 72 62 44 34 294 268 242 235 210
Value**
Net Debt/
11 % 110.73 30.97 48.90 78.34 104.06 157.00 164.23 119.55 67.63 25.04 30.33
Equity Ratio
*UOM: Units of Measurement

** In FY 2014-15, the Company has split its Equity share from face value of ` 10 each to ` 2 each and issued Bonus shares in the ratio of 1:1. Hence, Book
Value is not comparable
#
Excludes Exceptional Income
Proposed dividend shall be accounted as and when declared by the Company
##

Being Recognised Across the World
Star of Baroda Award

Bhaskar Group, a well-known media
house in the country, awarded
Deepak Nitrite Limited, the Star of
Baroda Award for being the most
Responsible Chemical Company in
the country.
Shri Maulik Mehta, Whole Time Director of Deepak Nitrite Limited receiving award from Shri Nitin
Patel, Hon. Deputy Chief Minister, Gujarat
Deepak Nitrite Limited

makes to Fortune 500
exclusive club of Fortune
India Magazine
Shri Maulik Mehta, Whole Time
Director, DNL received felicitation of
top 25 wealth creator under
mid-size category on behalf of the
comany from Shri Jayant Sinha,
Hon. Union Minister of State for
Civil Aviation and Shri Chaudhary
Birendra Singh, Hon. Union Minister
of Steel at Fortune 500 award
ceremony

Corporate OVERVIEW
statutory reportS
National Best Employer

Brands 2018
At an event held at Taj Lands End,
Mumbai, the Global Employer
Branding Institute and World HRD
Congress conferred Deepak Nitrite
Limited with National Best Employer
Brands 2018.
NATIONAL BEST EMPLOYER BRANDS 2018 received by (Second from left to right) Shri Rajesh Palkar,
Dr Prashant Rao and Shri Mahesh Phadke
Gujarat Brand Leadership

Awards 2018
Deepak Foundation was felicitated with
NGO Leadership Award at Gujarat Brand
Leadership Awards 2018 for its valuable
contribution towards the upliftment of
the society. The award was conferred in
presence of Dr. R.L. Bhatia, Founder of
World CSR Day and World Sustainability Day
at Radison Blu, Ahmedabad on
September 27, 2018.
The Gujarat Brand Leadership Awards 2018 was conferred in presence of Dr. R.L. Bhatia, Founder of
World CSR Day and World Sustainability Day
Shram Award by
Government
of Gujarat
Marking Deepak Nitrite’s unwavering
commitment toward employee
health and safety, the Government of
Gujarat conferred Shri Jaydeep Patel
from HAS Plant, Shram Award on
February 17, 2019.
The Government of Gujarat conferred Shri Jaydeep Patel from HAS Plant, Shram Award
on February 17, 2019.

Committed to Safety Quotient
With over two decades of experience in the chemicals industry, we are

cognisant of how important safety is at our manufacturing plants and
to maintain that trend, Our organised contingency safety precautions
and intensive training programmes have the capability to address any
unforeseen accidents that may occur during the manufacturing process
Environmental Sustainability
We see environmental sustainability as a creative opportunity to fundamentally strengthen our business, while
contributing to the society and creating a social, environmental and economic impact.

Corporate OVERVIEW
statutory reportS
Winning Accolades:
Shram Award by Government of Gujarat – Won Training to Contract Workers
by Jaydeep Patel of HAS Plant o Training to Contract Supervisor
o External and Internal Training to DPL
Various Safety Activities:
o Training to Contract Workers
National Fire Service Week o Safety Talk with Workers
o Flag Hoisting
o Fire Martyrs Homage Safety Activities
o Safety Quiz HSE Training o Certified First Aiders Training by
Red Cross
Road Safety Week 2019 o Safety Committee Meetings
o Road Safety Rally o Safety Promotional Activity
o Road Safety Training to Drivers
o Road Safety Quiz Fire Training to Contract Workers
Product Safety
30th National Road Safety Week

Committed to Make a Difference
At DEEPAK NITRITE LIMITED, we are advancing our policies on corporate

activities in social, environmental and ethical aspects. We understand
our social responsibility to develop assets that CO-EXIST in harmony
with the environment and with the communities. We are contributing
to the local society, working with communities and producing ways of
living for the future
While we are committed to make a difference in the lives of people around the world, we are
also committed to being responsive towards our key stakeholders – the communities. We
aim to especially support those from the socially and economically backward groups – the
underprivileged and marginalised sections. We have identified the CSR priorities where we
are confident of making the greatest impact. We continue to carry out activities based on our
chosen pillars for Corporate Social Responsibility.
OUR KEY CSR PILLARS To promote facility as teaching facility for maternal and child
health courses, such as CPS and DNB
1. Comprehensive Emergency Obstetric &
New Born Care 2. Mobile Health Units
The project aims to provide primary healthcare services to
This public-private partnership has been set up with the
people residing in remote and tribal areas at Dahej in Gujarat
objective of serving as a comprehensive emergency medical
and Roha in Maharashtra through Universal Health Coverage.
unit for maternal and newborn care for over 1 Lakh tribal
population. This initiative is spread across 5 tribal blocks of Key Objectives:
Chota Udepur district in Gujarat. It seeks to increase the
To reduce out-of-pocket expenses on treatment by
number of beneficiaries receiving free-of-cost services in
beneficiaries
order to reduce their out-of-pocket expenses on
health services. To reach out to at least 50% of the households in the
catchment through mobile health services
Key Aim:
To ensure that 80% of those needing referral are linked to
To link health facility with tertiary care facility to provide
tertiary care facilities
immediate and timely referral of complicated cases
Link facility with 3 Mobile Health Units to reach out to To develop
beneficiaries in remote areas the location as
Demographic
Surveillance Site to
assess the impact
To link services
with Government
health facility
for promotion of
immunisation and
family planning
services

Corporate OVERVIEW
statutory reportS
Beneficiary Coverage
Dahej Roha Total
OPD Patients 18,258 16,021 34,279
Health Awareness Beneficiaries 3,304 8,480 11,784
Health Camp 4 4 8
Average OPD/Month 1,521 1,335 2,857
Average OPD/Day 73 63 137
3. Skills Building Course 4. Mobile Library Services

The Home Health Aide project has been implemented Mobile library service has been provided as a part of our
at Vadodara and Hyderabad, which aims to increase the initiative for improving education of young children, their
employability of over 330 youths per annum. It aims to achieve reading and comprehension skills by 50%. The programme
this by providing skill development trainings to gain wage aims to move at least 50% students in Grade 1 and 2 to Grade 4
employment opportunities. on the basis of cognitive assessment rubric in a year’s time. This
included story telling sessions, children’s presentations and
community events, and lending and borrowing services. This
289 initiative has resulted in an improvement in reading, narration,
imagination and creative skills and confidence among children.
Candidates registered in FY 2019 As part of the environment sustainability, the Tree Plantation
Drive was undertaken by planting 200 plants in 4 schools to
10
enable environment protection.
No. of Batches Completed
Key Objectives:
100% internship to all registered beneficiaries to provide them
hands-on training in healthcare services
At least 80% of trained youth secure certification from National
Skill Development Corporation at the completion of course
At least 80% of certified trainees secure wage employment as
per the Minimum Wages Act
Key Activities:
To provide access to age appropriate story books in regional
language to children
To assess literacy level of children out-of-school within specific
age groups
To increase regularity in attendance amongst school-going
children
To impart skills amongst local youths in the art of story telling

Locations under Focus
Nandesari, Roha, Hyderabad,
Gujarat Maharashtra Andhra Pradesh
Children availing mobile 1,209 children 1,824 children 1,141 children

library services across 11 schools across 25 villages across 11 schools
Children attending sessions 46.5% 60.71% 87.3%
Conducting Story Telling Sessions 663 1,732 364
Events promoting cognitive development 39 41 15
5. De-Addiction and Rehabilitation Centre

A de-addiction and Rehabilitation Centre has been set up at Hyderabad with
the aim of generating awareness on ill-effects on alcohol consumption. The
547
Programme also aims at educating households on the consequences of alcohol No. of Addicts Identified
addiction and methods of prevention to lead a healthy and meaningful life.
143
Undergoing Rehabilitation
20
Fully Rehabilitated
Key Objectives:
To create awareness and educate around 25,000 people annually on
ill-effects of alcoholism on the individual, family and society at large
To evolve culture-specific models for prevention of alcoholism and

substance, and treatment and rehabilitation of addicts
To establish appropriate linkages between State interventions and voluntary

efforts in the field of alcoholism and substance abuse prevention
To increase community participation and public cooperation in reduction of

demand for dependence-producing substances

Corporate OVERVIEW
statutory reportS
Notice
NOTICE is hereby given that the Forty Eighth Annual General Meeting RESOLVED FURTHER THAT where in any financial year
of Members of DEEPAK NITRITE LIMITED will be held at Grand during the tenure of Shri Deepak C. Mehta, the Company
Mercure Vadodara Surya Palace, Opposite Parsi Agiyari, Sayajigunj, incurs a loss or its profit are inadequate, the Company shall
Vadodara – 390 020 on Friday, June 28, 2019 at 10:30 a.m. to continue to pay to Shri Deepak C. Mehta, the remuneration
transact the following businesses: as set out in the Explanatory Statement, by way of salary,
perquisites, incentives and other allowances, as a “minimum
ORDINARY BUSINESS: remuneration” subject to the limits and condition specified
1) To receive, consider, approve and adopt the Standalone and in Schedule V of the Companies Act, 2013 and rules made
Consolidated Audited Balance Sheet, Statement of Profit thereunder or such other limits as may be prescribed by the
and Loss, Cash Flow Statement and Changes in Equity for Central Government and approval of Members and/or Central
the Financial Year ended March 31, 2019, together with the Government required, if any.
Directors’ Report and the Auditor’s Report thereon.
RESOLVED FURTHER THAT the Board be and is hereby
2) To consider declaration of Dividend on Equity Shares for the authorized to do all such acts, deeds and things as it may
Financial Year ended March 31, 2019. deem necessary and authorise executives of the Company
for the purpose of giving effect to the re-appointment of Shri
3) To appoint a Director in place of Shri Sanjay Upadhyay (DIN:
Deepak C. Mehta as Chairman and Managing Director of the
01776546), who retires by rotation at this Annual General
Company as mentioned above.”
Meeting, in terms of Section 152(6) of the Companies Act, 2013
and, being eligible, has offered himself for re-appointment.
5) Re-appointment of Shri Sudhin Choksey (DIN: 00036085)
as an Independent Director of the Company for a second
SPECIAL BUSINESS:
term of 3 consecutive years.
4) Re-appointment of Shri Deepak C. Mehta (DIN: 00028377)
To consider and if thought fit, to pass with or without
as Chairman & Managing Director of the Company.
modification(s), the following Resolution as a Special
To consider and if thought fit, to pass with or without
Resolution:
modification(s), the following Resolution as an Ordinary
Resolution:
“RESOLVED THAT pursuant to provisions of Sections 149, 152

“RESOLVED THAT in accordance with the provisions of
and any other applicable provisions, if any, of the Companies
Sections 196, 197 and 203 read with Schedule V and all other Act, 2013 (“the Act”) read with Schedule IV to the Act and the
applicable provisions of the Companies Act, 2013 (“the Act”) Companies (Appointment and Qualification of Directors) Rules,
and the Companies (Appointment and Remuneration of 2014 and those contained in the Securities and Exchange Board
Managerial Personnel) Rules, 2014 (including any statutory of India (Listing Obligations and Disclosure Requirements)
modification(s) or re-enactment thereof, for the time being in Regulations, 2015 (“Listing Regulations”) (including any
force), approval of the Company be and is hereby accorded for statutory modification(s) or re-enactment(s) thereof for the
the re-appointment of Shri Deepak C. Mehta (DIN: 00028377) time being in force), Shri Sudhin Choksey (DIN: 00036085),
as Chairman & Managing Director of the Company, for further Independent Non-Executive Director of the Company who
period of five (5) years with effect from December 14, 2018, on has submitted a declaration under Section 149(7) of the Act
the terms and conditions including remuneration as set out in and Regulation 25(8) of the Listing Regulations that he meets
the Explanatory Statement annexed to the Notice convening the criteria for independence as provided in the Act and the
this Meeting. Listing Regulations and who is eligible for re-appointment, be
and is hereby re-appointed as an Independent Non-Executive
RESOLVED FURTHER THAT the Board of Directors of the
Director of the Company to hold office for a second term of
Company (hereinafter referred to as “the Board” which term three (3) consecutive years with effect from August 8, 2019 till
shall be deemed to include any Committee of the Board) be August 7, 2022.
and is hereby authorized to alter and/or vary the terms and
conditions of the said re-appointment in accordance with RESOLVED FURTHER THAT the Board of Directors of the

the provisions of the Act including remuneration within the Company be and is hereby authorised to do all such acts,
overall limits prescribed under Section 197 read with Schedule deeds and things as it may deem necessary and authorise
V to the Act, or any statutory modification(s) or re-enactment executives of the Company for the purpose of giving effect to
thereof. this Resolution.”

6) Re-appointment of Shri Sudhir Mankad (DIN: 00086077) the criteria for independence as provided in the Act and the
as an Independent Director of the Company for a second Listing Regulations and who is eligible for re-appointment, be
term of 3 consecutive years. and is hereby re-appointed as an Independent Non-Executive
To consider and if thought fit, to pass with or without Director of the Company to hold office for a second term of
modification(s), the following Resolution as a Special three (3) consecutive years with effect from August 8, 2019
Resolution: till August 7, 2022 as well as to continue to hold the position
of Independent Non-Executive Director beyond the age of
seventy five (75) years.
and any other applicable provisions, if any, of the Companies
Act, 2013 (“the Act”) read with Schedule IV to the Act and the RESOLVED FURTHER THAT the Board of Directors of the

Companies (Appointment and Qualification of Directors) Company be and is hereby authorised to do all such acts,
Rules, 2014 and Regulation 17(1A) and other applicable deeds and things as it may deem necessary and authorise
of the Securities and Exchange Board of India (Listing executives of the Company for the purpose of giving effect to
Obligations and Disclosure Requirements) Regulations, 2015 this Resolution.”
(“Listing Regulations”), as amended (including any statutory
modification(s) or re-enactment thereof for the time being 8)
Re-appointment of Dr. Swaminathan Sivaram (DIN:
in force), Shri Sudhir Mankad (DIN: 00086077), Independent 00009900) as an Independent Director of the Company
Non-Executive Director of the Company who has submitted for a second term of 3 consecutive years.
a declaration under Section 149(7) of the Act and Regulation To consider and if thought fit, to pass, the following Resolution
25(8) of the Listing Regulations that he meets the criteria as a Special Resolution:
for independence as provided in the Act and the Listing
Regulations and who is eligible for re-appointment, be and “RESOLVED THAT pursuant to provisions of Sections 149, 152

is hereby re-appointed as an Independent Non-Executive and any other applicable provisions, if any, of the Companies
Director of the Company to hold office for a second term of Act, 2013 (“the Act”) read with Schedule IV to the Act and the
three (3) consecutive years with effect from August 8, 2019 Companies (Appointment and Qualification of Directors)
till August 7, 2022 as well as to continue to hold the position Rules, 2014 and Regulation 17(1A) and other applicable
of Independent Non-Executive Director beyond the age of provisions of the Securities and Exchange Board of India
seventy five (75) years. (Listing Obligations and Disclosure Requirements) Regulations,
2015 (“Listing Regulations”) as amended (including any
statutory modification(s) or re-enactment thereof for the time
Company be and is hereby authorised to do all such acts, being in force), Dr. Swaminathan Sivaram (DIN: 00009900),
deeds and things as it may deem necessary and authorise Independent Non-Executive Director of the Company who
executives of the Company for the purpose of giving effect to has submitted a declaration under Section 149(7) of the Act
this Resolution.” and Regulation 25(8) of the Listing Regulations that he meets
the criteria for independence as provided in the Act and the
7)
Re-appointment of Shri Sandesh Kumar Anand (DIN: Listing Regulations and who is eligible for re-appointment, be
00001792) as an Independent Director of the Company and is hereby re-appointed as an Independent Non-Executive
for a second term of 3 consecutive years. Director of the Company to hold office for a second term of
To consider and if thought fit, to pass with or without three (3) consecutive years with effect from August 8, 2019
modification(s), the following Resolution as a Special till August 7, 2022 as well as to continue to hold the position
Resolution: of Independent Non-Executive Director beyond the age of

and any other applicable provisions, if any, of the Companies RESOLVED FURTHER THAT the Board of Directors of the

Act, 2013 (“the Act”) read with Schedule IV to the Act and the Company be and is hereby authorised to do all such acts,
Companies (Appointment and Qualification of Directors) Rules, deeds and things as it may deem necessary and authorise
2014 and Regulation 17(1A) and other applicable provisions of executives of the Company for the purpose of giving effect to
the SEBI (Listing Obligations and Disclosure Requirements), this Resolution.”
2015, (“Listing Regulations”) as amended (including any
statutory modification(s) or re-enactment thereof for the time 9) Re-appointment of Dr. Richard H. Rupp (DIN: 02205790)
being in force), Shri Sandesh Kumar Anand (DIN: 00001792), as an Independent Director of the Company for a second
Independent Non-Executive Director of the Company who term of 3 consecutive years.
has submitted a declaration under Section 149(7) of the Act To consider and if thought fit, to pass, the following Resolution
and Regulation 25(8) of the Listing Regulations that he meets as a Special Resolution:

Corporate OVERVIEW
statutory reportS
“RESOLVED THAT pursuant to the provisions of Sections


149, 152 and any other applicable provisions, if any, of the Company be and is hereby authorised to do all such acts,
Companies Act, 2013 (“the Act”) read with Schedule IV to deeds and things as it may deem necessary and authorise
the Act and the Companies (Appointment and Qualification executives of the Company for the purpose of giving effect to
of Directors) Rules, 2014 and those contained in the this Resolution.”
Securities and Exchange Board of India (Listing Obligations
and Disclosure Requirements) Regulations, 2015 (“Listing 11) Appointment of Smt. Purvi Sheth (DIN: 06449636) as an
Regulations”) (including any statutory modification(s) or re- Independent Director of the Company.
enactment thereof for the time being in force), Dr. Richard H. To consider and if thought fit, to pass with or without
Rupp (DIN: 02205790), Independent Non-Executive Director modification(s), the following Resolution as an Ordinary
of the Company who has submitted a declaration under Resolution:
Section 149(7) of the Act and Regulation 25(8) of the Listing
Regulations that he meets the criteria for independence as “RESOLVED THAT pursuant to the provisions of Sections 149,
provided in the Act and the Listing Regulations and who is 152 of the Companies Act, 2013 (“Act”) read with Schedule
eligible for re-appointment, be and is hereby re-appointed IV and all other applicable provisions of the Act and the
as an Independent Non-Executive Director of the Company Companies (Appointment and Qualification of Directors)
to hold office for a second term of three (3) consecutive years Rules, 2014 and pursuant to the applicable provisions of the
with effect from August 8, 2019 till August 7, 2022. Securities and Exchange Board of India (Listing Obligations
and Disclosure Requirements) Regulations, 2015 (“Listing
ESOLVED FURTHER THAT the Board of Directors of the
R Regulations”) (including any statutory modification(s) or
Company be and is hereby authorised to do all such acts, re-enactment thereof for the time being in force), Smt.
deeds and things as it may deem necessary and authorise Purvi Sheth (DIN: 06449636), who has been appointed as an
executives of the Company for the purpose of giving effect to Additional Director of the Company by the Board of Directors
this Resolution.” with effect from May 3, 2019 in terms of Section 161 (1) of the
Act and Articles of Association of the Company and who has
10) Appointment of Shri Sanjay Asher (DIN: 00008221) as an submitted a declaration under Section 149(7) of the Act and
Independent Director of the Company. Regulation 25(8) of the Listing Regulations that she meets
To consider and if thought fit, to pass with or without the criteria for independence as provided in the Act and the
modification(s), the following Resolution as an Ordinary Listing Regulations and in respect of whom the Company has
Resolution: received a notice in writing from a Member under Section 160
of the Act proposing her candidature for the office of Director,
“RESOLVED THAT pursuant to the provisions of Sections 149,
be and is hereby appointed as an Independent Non-Executive
152 of the Companies Act, 2013 (“Act”) read with Schedule Director of the Company to hold office for a term of three (3)
IV and all other applicable provisions of the Act and the consecutive years upto June 27, 2022
Companies (Appointment and Qualification of Directors)
Rules, 2014 and pursuant to the applicable provisions of the RESOLVED FURTHER THAT the Board of Directors of the

Securities and Exchange Board of India (Listing Obligations Company be and is hereby authorised to do all such acts,
and Disclosure Requirements) Regulations, 2015 (“Listing deeds and things as it may deem necessary and authorise
Regulations”) (including any statutory modification(s) or re- executives of the Company for the purpose of giving effect to
enactment thereof for the time being in force), Shri Sanjay this Resolution.”
Asher (DIN: 00008221), who has been appointed as an
Additional Director of the Company by the Board of Directors 12) Payment of Managerial Remuneration under Section 197
with effect from May 3, 2019 in terms of Section 161 (1) of the of the Companies Act, 2013.
Act and Articles of Association of the Company and who has To consider and if thought fit, to pass with or without
submitted a declaration under Section 149(7) of the Act and modification(s), the following Resolution as a Special
Regulation 25(8) of the Listing Regulations that he meets Resolution:
the criteria for independence as provided in the Act and the
Listing Regulations and in respect of whom the Company has “RESOLVED THAT in supersession of the Ordinary Resolution

received a notice in writing from a Member under Section 160 passed by the Members at the 44th Annual General Meeting
of the Act proposing his candidature for the office of Director, of the Company held on August 7, 2015 and pursuant to
be and is hereby appointed as an Independent Non-Executive the second proviso to Sub-Section (1) of Section 197 of the
Director of the Company to hold office for a term of three (3) Companies Act, 2013 (“the Act”) as amended vide Companies
consecutive years upto June 27, 2022. (Amendment) Act, 2017 effective from September 12, 2018 and

all other applicable provisions, if any, of the Act and the Rules thereof, every year for a period of five (5) years with effect
made thereunder (including any statutory modification(s) or from April 1, 2019, as the Board of Directors may from time
re-enactment thereof for the time being in force), approval to time determine, on the net profits of the Company for
of the Members be and is hereby accorded for payment of each Financial Year, computed in the manner laid down in
managerial remuneration for the Financial Year 2019-20 and all Section 198 of the Companies Act, 2013, in accordance with
subsequent Financial Years, in excess of the limits prescribed the provisions of the Act and/or approval of Members, to be
under the second proviso to Sub-Section (1) of Section 197 of divided amongst them in such manner as the Board may,
the Act as under: from time to time, determine.
(a) exceeding five per cent (5%) of net profits of the Company ESOLVED FURTHER THAT the Board of Directors of the
R
calculated in accordance with Section 198 of the Act
Company be and is hereby authorised to do all such acts,
(“Net Profits”) to any one Managing Director or Whole
deeds and things as it may deem necessary and authorise
Time Director or Manager;
executives of the Company for the purpose of giving effect to
(b) where there is more than one Managing Director or this Resolution.”
Whole Time Director, exceeding ten per cent (10%) of
14) Payment of remuneration to Executive Directors who are
the Net Profits of the Company to all such Directors and
Manager; and Promoters or members of Promoter Group.
(c) exceeding one percent (1%) of Net Profits of the Company To consider and if thought fit, to pass with or without
to all Directors who are neither Managing Director nor modification(s), the following Resolution as a Special
Whole Time Director of the Company. Resolution:
“RESOLVED THAT pursuant to the provisions of Regulation

RESOLVED FURTHER THAT the total managerial remuneration

17(6)(e) of the Securities and Exchange Board of India (Listing
payable by the Company to its Directors, including Managing
Obligations and Disclosure Requirements) Regulations, 2015
Director and Whole-time Director, in respect of any Financial
and subject to Section 197 and other applicable provisions
Year shall not exceed eleven per cent (11%) of the net profits
of the Companies Act, 2013 (including any statutory
of the Company for that Financial Year computed in the
modification(s) or re-enactment thereof for the time being in
manner laid down in Section 198 of the Act except as may be
authorized by the Company in general meeting, subject to the force), the approval of the Company be and is hereby accorded
provisions of Schedule V to the Act. for payment of remuneration to the Executive Directors who
are Promoters or members of Promoter Group as under:

Company be and is hereby authorized to do all such acts, (a) annual remuneration to an Executive Director who is
deeds and things as it may deem necessary and authorise a Promoter or member of Promoter Group, exceeding
executives of the Company for the purpose of giving effect to ` 5 Crores or 2.5 per cent (2.5%) of the net profits of the
this Resolution.” Company computed in accordance with Section 198
of the Companies Act, 2013 (“Net Profit”), whichever is
13) Payment of remuneration to Non- Executive Directors. higher; or
To consider and if thought fit, to pass, the following Resolution
(b) aggregate annual remuneration to Executive Directors
as an Ordinary Resolution:
who are Promoters or members of Promoter Group,
where there is more than one such Executive Director,
RESOLVED THAT pursuant to the provisions of Sections
“
exceeding 5 per cent (5%) of the Net Profit.
197, 198 and all other applicable provisions of the
Companies Act, 2013 and the Companies (Appointment ESOLVED FURTHER THAT the approval herein granted
R
and Remuneration of Managerial Personnel) Rules, 2014 for payment of remuneration to Executive Directors who are
(including any statutory modification(s) or re-enactment Promoters or members of Promoter Group (“such Executive
thereof for the time being in force) and the applicable Directors”) shall be effective for the Financial Year commenced
provisions contained in the Securities and Exchange Board from April 1, 2019 and for subsequent years till the expiry of
of India (Listing Obligations and Disclosure Requirements) respective term of such Executive Directors.
Regulations, 2015 (“Listing Regulations”), the Non-
Executive Directors of the Company (i.e. Directors other than RESOLVED FURTHER THAT the Board of Directors of the

Managing Director(s) and/or the Whole-time Director), be Company be and is hereby authorized to do all such acts,
paid remuneration by way of commission, in addition to the deeds and things as it may deem necessary and authorise
sitting fees and re-imbursement of expenses for attending executives of the Company for the purpose of giving effect to
the meetings of the Board of Directors or Committees the above Resolution.”

CORPORATE OVERVIEW
STATUTORY REPORTS
FINANCIAL STATEMENTS
15) Ratification of remuneration of the Cost Auditor for the NOTES:

Financial Year 2019-20. 1. A statement pursuant to Section 102 of the Companies Act,
To consider and if thought fit, to pass with or without 2013 with respect to the Special Business set out in the Notice
modification(s), the following Resolution as an Ordinary is annexed.
Resolution:
2.
A MEMBER ENTITLED TO ATTEND AND VOTE AT THE
“RESOLVED THAT pursuant to the provisions of Section 148 48TH ANNUAL GENERAL MEETING IS ENTITLED TO
and all other applicable provisions of the Companies Act, APPOINT A PROXY TO ATTEND AND VOTE ON A POLL
2013 read with the Companies (Audit and Auditors) Rules, INSTEAD OF HIMSELF / HERSELF AND A PROXY NEED NOT
2014 (including any statutory modification(s) or re-enactment BE A MEMBER OF THE COMPANY.
thereof, for the time being in force), the remuneration payable The instrument appointing the Proxy, in order to be valid and
to M/s. B. M. Sharma & Co., Cost Accountants (Firm Registration effective, should be lodged / deposited with the Company at
No. 00219), appointed by the Board of Directors of the Company its Registered Office not less than 48 (forty eight) hours before
to conduct the audit of the cost records of the Company for the
the commencement of the Annual General Meeting (“the
Financial Year ending March 31, 2020 amounting to ` 7,50,000/-
Meeting”).
(Rupees Seven Lakhs Fifty Thousand only) plus applicable
tax, travelling and other out of pocket expenses incurred by A person can act as a Proxy on behalf of Members not exceeding
them in connection with the aforesaid audit, be and is hereby 50 (fifty) and holding in the aggregate not more than 10% (ten
ratified and approved.” percent) of the total share capital of the Company carrying
voting rights. A Member holding more than 10% (ten percent)
of the total share capital of the Company carrying voting rights
By Order of the Board of Directors may appoint a single person as Proxy and such person shall
not act as a Proxy for any other person or Member.
Arvind Bajpai 3.
Corporate Members intending to send their authorised
Place: Vadodara Company Secretary representative(s) to attend the Meeting are requested to
Date : May 3, 2019 Membership No.: FCS-6713 send to the Company a certified copy of the Board resolution
Address: A/2/202, Labh Exotica, authorising their representative(s) to attend and vote on their
Nr. Pratham Vatika, Gotri, behalf at the Meeting.
Vadodara - 390 021
Registered Office: 4. Members / Proxies are requested to bring duly filled Attendance
Aaditya-I, Chhani Road Slip to attend the Meeting, along with their copy of Annual
Vadodara – 390 024, Gujarat Report.
Tel: +91-265-2765200, 396 0200 5. The relevant documents referred to in this Notice requiring
Fax: +91-265-2765344
approval by the Members at the Meeting shall be available
Email: investor@godeepak.com
for inspection by the Members at the Registered Office of the
Website: www.godeepak.com
Company on all working days, except Saturdays and Sundays,
CIN: L24110GJ1970PLC001735
during business hours, up to the date of the Meeting. This
Notice and the Annual Report will also be available on the
Company’s website www.godeepak.com for download.
6. The Register of Members of the Company will be closed from

Friday, June 21, 2019 to Friday, June 28, 2019 (both days
inclusive).
7. The Dividend as recommended by the Board of Directors, if

approved at the Meeting, will be paid within statutory time
limit of 30 days, as under:
(a) To all Beneficial Owners in respect of shares held in
dematerialised form as per the data made available by
the National Securities Depository Limited and Central
Depository Services (India) Limited as at the close of
business hours on June 20, 2019.

(b) To all Members in respect of shares held in physical form and Refund) Rules, 2016 amended from time to time, which
after giving effect to valid transfers in respect of transfer inter alia requires the Company to transfer the equity shares
requests lodged with the Company on or before the close on which the dividend has remained unpaid or unclaimed for
of business hours on June 20, 2019. a continuous period of seven years, to a special demat account
to be opened by Investor Education and Protection Fund
8.
Members holding shares in dematerialised mode are Authority (‘IEPF Authority’). The said Shares, once transferred
requested to intimate all changes pertaining to their bank to the said demat account of the IEPF Authority can be claimed
details, National Electronic Clearing Service (NECS), Electronic after following due procedure prescribed under the said IEPF
Clearing Service (ECS), mandates, nominations, power of rules.
attorney, change of address/name, e-mail address, contact
numbers, etc. to their Depository Participant (DP) only, and not 13. The Notice of the Annual General Meeting along with the
to the Company’s Registrar & Share Transfer Agent. Annual Report for the Financial Year 2018-19 is being sent by
electronic mode to those Members whose e-mail addresses
Changes intimated to the Depository Participant will then be are registered with the Company / Depositories Participant,
automatically reflected in the Company’s records which will unless any Member has requested for a physical copy of the
help the Company and its Registrar & Share Transfer Agent to same. For Members who have not registered their e-mail
provide efficient and better services to the Members. addresses, physical copies are being sent by the permitted
mode.
9. Members holding shares in physical form are requested to
intimate all changes pertaining to their bank details, National The route map showing directions to reach the venue of
Electronic Clearing Service (NECS), Electronic Clearing Service the Meeting is provided in the Notice after the Explanatory
(ECS), mandates, nominations, power of attorney, change Statement.
of address / name, etc. to the Company’s Registrar & Share
Transfer Agent, quoting their Registered Folio Number. The 14. To support the ‘Green Initiative’, the Members who have not
Bank Account particulars of the Members will be printed on registered their e-mail addresses are requested to register the
the Dividend Warrant. same with the Company’s Registrar & Share Transfer Agent/
their respective Depository Participants. Members whose email
10. Members holding shares in physical form are requested to ids are already registered may update the changes therein, if
consider converting their shareholding in dematerialised any. This may be treated as an advance opportunity in terms
form to eliminate all risks associated with physical shares and of proviso to Rule 18(3) (i) of the Companies (Management and
for ease of portfolio management. Members can contact the Administration) Rules, 2014.
Company or the Company’s Registrar & Share Transfer Agent
for assistance in this regard. 15.
The Securities and Exchange Board of India (SEBI) has
mandated the submission of Permanent Account Number
11. Members seeking any information with regard to the Annual (PAN) by every participant in securities market. Members
Accounts are requested to write to the Company at an early holding shares in electronic form are, therefore, requested to
date, so as to enable the Management to keep the information submit their PAN to their Depository Participants with whom
ready at the Meeting. they are maintaining their demat accounts. Members holding
shares in physical form can submit their PAN to the Company/
12. In terms of the provisions of Section 124 and other applicable Company’s Registrar & Share Transfer Agent.
provisions of the Companies Act, 2013, the amount of dividend
not encashed or claimed within 7 (seven) years from the date of 16.
The information on Directors seeking appointment/re-
its transfer to the unpaid dividend account, will be transferred to appointment/variation in terms of appointment at the
the Investor Education and Protection Fund (‘IEPF’) established Annual General Meeting pursuant to Regulation 36(3) of the
by the Central Government. Accordingly, the unclaimed dividend Securities and Exchange Board of India (Listing Obligations
in respect of the Financial Year 2011-12 is due for transfer to the and Disclosure Requirements) Regulations, 2015 and as per
said Fund in August, 2019. Members who have not yet encashed Secretarial Standard 2 on General Meetings is provided in
their dividend warrant(s) pertaining to the dividend for the Annexure - I to this Notice.
Financial Year 2011-12 onwards, are requested to lodge their
claims with the Company for the same. 17.
In compliance with the provisions of Section 108 of the
Companies Act, 2013 read with Rule 20 of Companies
Attention of Members is invited to the provisions of Section (Management and Administration) Rules, 2014 as amended,
124(6) of the Companies Act, 2013 read with Investor Education and Regulation 44 of SEBI (Listing Obligations and Disclosure
and Protection Fund Authority (Accounting, Audit, Transfer Requirements) Regulations, 2015 (‘LODR’ or ‘Listing

Corporate OVERVIEW
statutory reportS
Regulations’), the Company is pleased to provide the facility iii. Now Enter your User ID :
to Members, to exercise their right to vote on Resolutions a. For CDSL: 16 digits beneficiary ID,
proposed to be considered at the Meeting by electronic means
b. For NSDL: 8 Character DP ID followed by 8 Digits Client ID,
and the business may be transacted through such voting.
c. Members holding shares in Physical Form should enter
18. Members, whose names appear in the Register of Members / Folio Number registered with the Company.
list of Beneficial Owners as on Friday, June 21, 2019 (“Cut-off
Date”) are entitled to vote on the Resolutions set forth in this iv. Enter the Image Verification as displayed and Click on Login.
Notice. A person who is not a Member as on the Cut-off Date
should treat this Notice for information purposes only. v. If you are holding shares in demat form and had logged on to
www.evotingindia.com and voted on an earlier voting of any
19. The Company has entered into an arrangement with Central company, then your existing password is to be used.
Depository Services (India) Limited (“CDSL”) for facilitating
remote e-Voting for the Meeting. The Members may cast their vi. If you are a first time user follow the steps given below:
votes on electronic voting system to be provided by CDSL from
For Members holding shares in Demat Form and Physical
place other than the venue of the Meeting (“remote e-Voting”). Form
The remote e-Voting will commence on Tuesday, June 25, PAN Enter your 10 digit alpha-numeric PAN
2019 (9:00 a.m.) and will end on Thursday, June 27, 2019 issued by Income Tax Department
(5:00 p.m.). The remote e-Voting module shall be disabled (Applicable for both demat
by CDSL for voting thereafter. Once the vote on a Resolution shareholders as well as physical
is cast by the Member, he/she shall not be allowed to change shareholders)
it subsequently. The Members desiring to vote through remote • Members who have not updated
e-Voting are requested to refer to the detailed procedure given their PAN with the Company/
herein in the Notice. Depository Participant are
requested to use the sequence
20. In addition, the facility for voting through Polling Paper shall be number which is printed on
made available at the Meeting and the Members attending the Address Sticker.
Meeting who have not cast their vote by remote e-Voting shall Dividend Bank Enter the Dividend Bank Details or Date
be able to exercise their right at the Meeting through Polling Details of Birth (in dd/mm/yyyy format) as
Paper. OR recorded in your demat account or in
Date of Birth the Company records in order to login.
21. Members who have cast their vote by remote e-Voting prior (DOB)
• If both the details are not recorded
to the Meeting may also attend the Meeting but shall not be with the Depository Participate
entitled to cast their vote again. or Company, please enter the
Member ID/ Folio Number in the
22. In case of joint holders attending the Meeting, only such joint Dividend Bank Details filed as
holder who is higher in the order of names will be entitled to mentioned in instruction (iii).
vote.
After entering these details appropriately, click on “SUBMIT”
23. The voting rights of Members shall be in the proportion of their tab.
shareholding in the Company as on Cut-off Date.
vii. Members holding shares in physical form will then directly
24. The Company has appointed Shri Dinesh Joshi, Practising reach the Company selection screen. However, members
Company Secretary (Membership No.: FCS-3752), Designated holding shares in demat form will now reach ‘Password
Partner, M/s. KANJ & Co. LLP, Company Secretaries, Pune, as Creation’ menu wherein they are required to mandatorily
the Scrutinizer, to scrutinize the entire voting process including enter their login password in the new password field. Kindly
remote e-Voting in a fair and transparent manner. note that this password is to be also used by the demat holders
for voting for resolutions of any other company on which they
PROCEDURE FOR REMOTE E-VOTING are eligible to vote, provided that company opts for e-voting
I. The instructions for shareholders voting electronically are as through CDSL platform. It is strongly recommended not to
under: share your password with any other person and take utmost
care to keep your password confidential
i.
The Members should log on to the e-voting website
www.evotingindia.com.
viii. For Members holding shares in physical form, the details can be
ii. Click on Shareholders. used only for e-voting on the Resolutions contained in this Notice.

ix. Click on the EVSN for “Deepak Nitrite Limited” on which you • A scanned copy of the Board Resolution and Power of
choose to vote. Attorney (POA) which they have issued in favour of the
Custodian, if any, should be uploaded in PDF format in
x. On the voting page, you will see “RESOLUTION DESCRIPTION” the system for the Scrutinizer to verify the same.
and against the same the option “YES/ NO” for voting. Select
the option YES or NO as desired. The option YES implies that II. In case you have any queries or issues regarding e-voting,
you assent to the Resolution and option NO implies that you you may refer the Frequently Asked Questions (“FAQs”)
dissent to the Resolution. and e-voting manual available at www. evotingindia.com,
xi. Click on the “RESOLUTIONS FILE LINK” if you wish to view the under help section or write an email to
entire Resolution details. helpdesk.evoting@cdslindia.com.
xii. After selecting the Resolution you have decided to vote on, III.
Members can cast their vote online from June 25, 2019
click on “SUBMIT”. A confirmation box will be displayed. If you (9:00 a.m.) till June 27, 2019 (5:00 p.m.). Remote e-Voting shall
wish to confirm your vote, click on “OK”, else to change your not be allowed beyond the said period.
vote, click on “CANCEL” and accordingly modify your vote.
IV. Any person, who acquires shares of the Company and become
xiii. Once you “CONFIRM” your vote on the Resolution, you will not
Member of the Company after dispatch of the notice and
be allowed to modify your vote.
holding shares as of the Cut-off Date i.e. June 21, 2019, may
xiv. You can also take a print of the votes cast by clicking on “Click obtain the login ID and password by sending a request at
here to print” option on the Voting page. helpdesk.evoting@cdslindia.com or at vadodara@linkintime.
co.in. However, if he/she is already registered with CDSL for
xv. If a demat account holder has forgotten the login password remote e-Voting then he/she can use his/ her existing User ID
then Enter the User ID and the image verification code and and password for casting vote. If you forgot your password,
click on Forgot Password & enter the details as prompted by you can reset your password by using “Forgot User Details/
the system. Password” option available on www.evotingindia.com or
contact CDSL at the Toll Free No.: 1800-22-5533.
xvi. Shareholders can also cast their vote using Mobile app - “m
- Voting”. Shareholders may log in to m-Voting using their
V. A person, whose name is recorded in the Register of Members or
e-voting credentials to vote for the company resolution(s).
in the list of Beneficial Owners maintained by the Depositories
xvii. Note for Non – Individual Shareholders and Custodians: as on Cut-off Date only shall be entitled to avail the facility
of remote e-Voting as well as voting at the Meeting through
• on-Individual Shareholders (i.e. other than Individuals,
N
Polling Paper.
HUF, NRI etc.) and Custodian are required to log on
to www.evotingindia.com and register themselves as
VI. The result of voting at the Meeting including remote e-Voting
Corporates.
shall be declared after the Meeting but not later than Forty
• scanned copy of the Registration form bearing stamp
A Eight Hours of the conclusion of the Meeting.
and sign of the entity should be emailed to helpdesk.
evoting@cdslindia.com. VII. The result declared along with the Report of the Scrutinizer shall
be placed on the website of the Company www.godeepak.com
• fter receiving the login details, user would be able to link
A
and on the website of CDSL immediately after the declaration
the account(s) for which they wish to vote on.
of result by the Chairman or a person authorised by him in
• he list of accounts linked in the login should be emailed
T writing. The Company shall simultaneously forward the results
to helpdesk.evoting@cdslindia.com and on approval of to BSE Limited and National Stock Exchange of India Limited
the accounts they would be able to cast their vote. where the shares of the Company are listed.

Corporate OVERVIEW
statutory reportS
EXPLANATORY STATEMENT PURSUANT TO SECTION 102 OF THE COMPANIES ACT, 2013.
Item No.: 4 subject to and in accordance with the provisions of Section 197
The Board of Directors of the Company at their meeting held on and other relevant provisions of the Companies Act, 2013 (the
October 26, 2018 approved the re-appointment of Shri Deepak “Act”) (including any statutory modifications or re-enactments
C. Mehta as the Chairman & Managing Director of the Company thereof, for the time being in force).
for further period from December 14, 2018 to December 13, 2023,
subject to approval of Members of the Company, at the remuneration (D) The aggregate remuneration inclusive of Salary, Commission,
recommended by the Nomination and Remuneration Committee of Perquisites, Allowances and other benefits payable to Shri
the Board and approved by the Board. Deepak C. Mehta, shall always be subject to and in accordance
with the provisions of Section 197 read with Schedule V of the
The Nomination and Remuneration Committee, at their meeting Act (including any statutory modifications or re-enactments
held on May 3, 2019, reviewed the remuneration payable to Shri thereof, for the time being in force).
Deepak C. Mehta as the Chairman & Managing Director of the
Company and recommended the revision in remuneration payable (E) The aforesaid remuneration payable to Shri Deepak C. Mehta
to Shri Deepak C. Mehta effective from April 1, 2019. shall be reviewed by the Board after close of each Financial
Year, and based on the Profits made by the Company in
The terms of appointment including remuneration of Shri Deepak that Financial Year, Shri Deepak C. Mehta shall be paid such
C. Mehta as the Chairman & Managing Director, as recommended by enhanced remuneration as the Board may decide subject to
the Nomination and Remuneration Committee are as under: and in accordance with the provisions of Section 197 and other
applicable provisions of the Act read with Schedule V of the
(A) Salary and Perquisites Act (including any statutory modifications or re-enactments
Shri Deepak C. Mehta shall be paid fixed amount of ` 323 thereof, for the time being in force).
Lakhs (Rupees Three Hundred Twenty Three Lakhs only) per
(F) Shri Deepak C. Mehta shall not be entitled to sitting fees for
annum, with effect from December 14, 2018 till March 31, 2019,
attending meetings of the Board or any Committee thereof.
proportionately and ` 650 Lakhs (Rupees Six Hundred Fifty
Lakhs only) per annum from April 1, 2019, by way of salary, (G) Shri Deepak C. Mehta as the Chairman & Managing Director,
house rent allowance, other allowances, and retirement shall perform such duties and exercise such powers bestowed
benefits including but not limited to Company’s contribution on him from time to time by the Board of Directors of the
to provident fund, superannuation fund or annuity fund, Company.
gratuity or such remuneration as may be determined by the
Board or Committee thereof from time to time. (H) Shri Deepak C. Mehta shall not be liable to retire by rotation as
a Director of the Company.
(B)
The perquisites, allowances and other benefits shall
include but not be limited to the following: The details of Shri Deepak C. Mehta as required under the provisions
1) Rent free furnished residential accommodation in lieu of Regulation 36(3) of the Listing Regulations and other applicable
of House Rent Allowance as may be agreed between the provisions are provided in Annexure – I to this Notice.
Company and Shri Deepak C. Mehta.
Shri Deepak C. Mehta satisfies all the conditions set out in Part-I of
2) Re-imbursement of gas, electricity, water charges and Schedule V to the Act as also conditions set out under Sub-Section
furnishings. (3) of Section 196 of the Act for being eligible for re-appointment.
3) Re-imbursement of medical expenses incurred for self He is not disqualified from being appointed as Director in terms of
and members of his family, as per rules of the Company. Section 164 of the Act.
4) Leave travel concession for self and members of his
A copy of the Agreement entered into between the Company and
family, as per rules of the Company.
Shri Deepak C. Mehta is open for inspection by the Members at the
5) Fees of clubs subject to maximum of two clubs. Registered Office of the Company during normal business hours on
6) Medical insurance, as per rules of the Company. any working day, excluding Saturday.
7) Personal Accident Insurance, as per rules of the Company. Shri Deepak C. Mehta and his relatives Shri Ajay C. Mehta and Shri
8) Provision of car and telephone at residence. Maulik Mehta are interested in the Ordinary Resolution set out at
Item No. 4 of the Notice, which pertains to the re-appointment and
(C) In addition to the remuneration as stated in (A) above, Shri remuneration payable to Shri Deepak C. Mehta.
Deepak C. Mehta shall also be paid a Commission, calculated
with reference to the Net Profits of the Company in a particular Save and except the above, none of the other Directors / Key
Financial Year, as may be determined by the Board of Directors, Managerial Personnel of the Company / their relatives are, in any

way, concerned or interested, financially or otherwise, in this The Board recommends the Special Resolution set out at Item No. 5
Ordinary Resolution. of the Notice for approval by the Members.
The Board recommends the Ordinary Resolution set out at Item No. Item No.: 6
4 of the Notice for approval by the Members. Shri Sudhir Mankad (DIN: 00086077) is an Independent Non-
Executive Director of the Company. He is also the Chairman of the
Item No.: 5 Nomination & Remuneration Committee and member of the Audit
Shri Sudhin Choksey (DIN: 00036085) is an Independent Non- Committee and Corporate Social Responsibility Committee of
Executive Director of the Company. He is also the Chairman of the Directors of the Company.
Audit Committee and a member of the Nomination & Remuneration
Committee of the Board of Directors of the Company. Pursuant to the requirement of Companies Act, 2013 (“the Act”) and
Clause 49 of erstwhile Listing Agreement, Shri Sudhir Mankad was
Pursuant to the requirement of Companies Act, 2013 (“the Act”) and appointed as an Independent Director at the 43rd Annual General
Clause 49 of erstwhile Listing Agreement, Shri Sudhin Choksey was Meeting of the Company held on August 8, 2014 for a term of five (5)
appointed as an Independent Director at the 43rd Annual General consecutive years upto August 7, 2019.
Meeting of the Company held on August 8, 2014 for a term of five (5)
consecutive years upto August 7, 2019. As per Section 149(10) of the Act, an Independent Director can hold
office for a term upto five (5) consecutive years on the Board of a
As per Section 149(10) of the Act, an Independent Director can hold Company and may be re-appointed for another term upto five (5)
office for a term upto five (5) consecutive years on the Board of a consecutive years, with the approval Members of the Company by
Company and may be re-appointed for another term upto five (5) way of Special Resolution.
consecutive years, with the approval Members of the Company by
way of Special Resolution. In the opinion of the Board of Directors of the Company, Shri Sudhir
Mankad fulfils the conditions for appointment of Independent
In the opinion of the Board of Directors of the Company, Shri Sudhin
Director as specified in the Act and the SEBI (Listing Obligations and
Choksey fulfils the conditions for appointment of Independent
Disclosure Requirements) Regulations, 2015 (“Listing Regulations”)
and is independent of the management.
Disclosure Requirements) Regulations, 2015 (“Listing Regulations”)
and is independent of the management. The Board of Directors at its meeting held on May 3, 2019, on
the recommendation of the Nomination and Remuneration
The Board of Directors at its meeting held on May 3, 2019, on the
Committee and based on the performance evaluation, considers
recommendation of the Nomination and Remuneration Committee
that given his background and experience and contributions
and based on the performance evaluation, considers that given
made by him during his tenure, the association of Shri Sudhir
his background and experience and contributions made by him
Mankad would be beneficial to the Company and it is desirable
during his tenure, the association of Shri Sudhin Choksey would
to re-appoint Shri Sudhir Mankad as an Independent Director
be beneficial to the Company and it is desirable to re-appoint Shri
for another term of three (3) consecutive years with effect from
Sudhin Choksey as an Independent Director for another term of
August 8, 2019.
three (3) consecutive years with effect from August 8, 2019.
Copy of the draft letter of appointment of Shri Sudhin Choksey Further, as per requirement of Regulation 17(1A) of the Listing
setting out the terms and conditions of appointment are available Regulations, which are effective from April 1, 2019, a person who
for inspection by the Members of the Company without any fee at has attained the age of 75 years, can continue the directorship
the Registered Office of the Company. in a company with the approval of Members by way of Special
Resolution. Since Shri Sudhir Mankad is approaching the age of 72
The details of Shri Sudhin Choksey as required under the provisions years and in order to continue his directorship upon his attaining
of Regulation 36(3) of the Listing Regulations and other applicable the age of 75 years, during the second term of his appointment,
provisions are provided in Annexure – I to this Notice. the Board also recommends the continuation of directorship of
Shri Sudhir Mankad beyond the age of 75 years, for approval by the
Shri Sudhin Choksey does not hold by himself or for any other Members of the Company.
person on a beneficial basis, any shares in the Company. Shri
Sudhin Choksey has given a declaration that he meets the criteria Copy of the draft letter of appointment of Shri Sudhir Mankad
of independence as provided in Section 149(6) of the Act and setting out the terms and conditions of appointment are available
Regulation 16(1)(b) of the Listing Regulations. for inspection by the Members of the Company without any fee at
the Registered Office of the Company.
None of the Directors or Key Managerial Personnel of the Company
or their relatives except Shri Sudhin Choksey are, in any way, The details of Shri Sudhir Mankad as required under the provisions
concerned or interested, financially or otherwise, in the Special of Regulation 36(3) of the Listing Regulations and other applicable
Resolution set out at Item No. 5 of the Notice. provisions are provided in Annexure – I to this Notice.

Corporate OVERVIEW
statutory reportS
Shri Sudhir Mankad does not hold by himself or for any other person has attained the age of 75 years, can be appointed or continue the
on a beneficial basis, any shares in the Company. Shri Sudhir Mankad directorship in a company with the approval of Members by way of
has given a declaration that he meets the criteria of independence Special Resolution. Since Shri Sandesh Kumar Anand has attained
as provided in Section 149(6) of the Act and Regulation 16(1)(b) of the age of 75 years, the Board also recommends the approval for the
the Listing Regulations. appointment of Shri Sandesh Kumar Anand, who has attained the
age of 75 years, by the Members of the Company.
None of the Directors or Key Managerial Personnel of the Company or
their relatives except Shri Sudhir Mankad are, in any way, concerned Copy of the draft letter of appointment of Shri Sandesh Kumar
or interested, financially or otherwise, in the Special Resolution set Anand setting out the terms and conditions of appointment are
out at Item No. 6 of the Notice. available for inspection by the Members of the Company without
any fee at the Registered Office of the Company.
The Board recommends the Special Resolution set out at Item No. 6
of the Notice for approval by the Members. The details of Shri Sandesh Kumar Anand as required under the
provisions of Regulation 36(3) of the Listing Regulations and other
Item No.: 7 applicable provisions are provided in Annexure – I to this Notice.
Shri Sandesh Kumar Anand (DIN: 00001792) is an Independent Non-
Executive Director of the Company. He is also a member of the Audit None of the Directors or Key Managerial Personnel of the Company
Committee and Stakeholders’ Relationship & Investors Grievance or their relatives except Shri Sandesh Kumar Anand are, in any way,
Committee of Directors of the Company. concerned or interested, financially or otherwise, in the Special
Resolution set out at Item No. 7 of the Notice.
Pursuant to the requirement of Companies Act, 2013 (“the Act”)
and Clause 49 of erstwhile Listing Agreement, Shri Sandesh Kumar The Board recommends the Special Resolution set out at Item No. 7
Anand was appointed as an Independent Director at the 43rd Annual of the Notice for approval by the Members.
General Meeting of the Company held on August 8, 2014 for a
Item No.: 8
consecutive term of five (5) consecutive years upto August 7, 2019.
Dr. Swaminathan Sivaram (DIN: 00009900) is an Independent Non-
As per Section 149(10) of the Act, an Independent Director can hold Executive Director of the Company. He is also a member of the
office for a term upto five (5) consecutive years on the Board of a Corporate Social Responsibility Committee and Risk Management
Company and may be re-appointed for another term upto five (5) Committee of the Board of Directors of the Company.
consecutive years, with the approval Members of the Company by
way of Special Resolution. Pursuant to the requirement of Companies Act, 2013 (“the Act”) and
Clause 49 of erstwhile Listing Agreement, Dr. Swaminathan Sivaram
The Board of Directors at its meeting held on May 3, 2019, on the was appointed as an Independent Director at the 43rd Annual
recommendation of the Nomination and Remuneration Committee General Meeting of the Company held on August 8, 2014 for a term
and based on the performance evaluation, considers that given his of five (5) consecutive years upto August 7, 2019.
background and experience and contributions made by him during
his tenure, the association of Shri Sandesh Kumar Anand would As per Section 149(10) of the Act, an Independent Director can hold
be beneficial to the Company and it is desirable to re-appoint Shri office for a term upto five (5) consecutive years on the Board of a
Sandesh Kumar Anand as an Independent Director for another term Company and may be re-appointed for another term upto five (5)
of three (3) consecutive years with effect from August 8, 2019. consecutive years, with the approval Members of the Company by
way of Special Resolution.
Shri Sandesh Kumar Anand does not hold by himself or for any other
person on a beneficial basis, any shares in the Company. Shri Anand The Board of Directors at its meeting held on May 3, 2019, on the
has given a declaration that he meets the criteria of independence recommendation of the Nomination and Remuneration Committee
as provided in Section 149(6) of the Companies Act, 2013 (“the and based on the performance evaluation, considers that given his
Act“) and Regulation 16(1)(b) of the SEBI (Listing Obligations and background and experience and contributions made by him during
Disclosure Requirements) Regulations, 2015 (“Listing Regulations”). his tenure, the association of Dr. Swaminathan Sivaram would
be beneficial to the Company and it is desirable to re-appoint Dr.
In the opinion of the Board of Directors of the Company, Shri Sandesh Swaminathan Sivaram as an Independent Director for another term
Kumar Anand fulfils the conditions for appointment of Independent of three (3) consecutive years with effect from August 8, 2019.
Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) Dr. Sivaram does not hold by himself or for any other person on a
and is independent of the management. beneficial basis, any shares in the Company. Dr. Sivaram has given a
declaration that he meets the criteria of independence as provided
Further, as per requirement of Regulation 17(1A) of the Listing in Section 149(6) of the Act and Regulation 16(1)(b) of the Listing
Regulations, which are effective from April 1, 2019, a person who Regulations.

In the opinion of the Board of Directors of the Company, Dr. He does not hold by himself or for any other person on a
Swaminathan Sivaram fulfils the conditions for appointment beneficial basis, any shares in the Company. Dr. Rupp has given
of Independent Director as specified in the Act and the Listing a declaration that he meets the criteria of independence as
Regulations and is independent of the management. provided in Section 149(6) of the Act and Regulation 16(1)(b) of
the Listing Regulations.
Further, as per requirement of Regulation 17(1A) of the Listing
Regulations, which are effective from April 1, 2019, a person who In the opinion of the Board of Directors of the Company, Dr. Richard
has attained the age of 75 years, can continue the directorship in a H. Rupp fulfils the conditions for appointment of Independent
company with the approval of Members by way of Special Resolution. Director as specified in the Act and the Listing Regulations and is
Since Dr. Swaminathan Sivaram is approaching the age of 72 years independent of the management.
and in order to continue his directorship upon his attaining the
age of 75 years, during the second term of his appointment, the Copy of the draft letter of appointment of Dr. Richard H. Rupp
Board also recommends the continuation of directorship of Dr. setting out the terms and conditions of appointment are available
Swaminathan Sivaram beyond the age of 75 years, for approval by for inspection by the Members of the Company without any fee at
the Members of the Company. the Registered Office of the Company.
Copy of the draft letter of appointment of Dr. Swaminathan Sivaram The details of Dr. Richard H. Rupp as required under the provisions
setting out the terms and conditions of appointment are available of Regulation 36(3) of the Listing Regulations and other applicable
for inspection by the Members of the Company without any fee at provisions are provided in Annexure – I to this Notice.
the Registered Office of the Company.
None of the Directors or Key Managerial Personnel of the Company or
The details of Dr. Swaminathan Sivaram as required under the their relatives except Dr. Richard H. Rupp are, in any way, concerned
provisions of Regulation 36(3) of the Listing Regulations and other or interested, financially or otherwise, in the Special Resolution set
applicable provisions are provided in Annexure – I to this Notice. out at Item No. 9 of the Notice.
None of the Directors or Key Managerial Personnel of the Company The Board recommends the Special Resolution set out at Item No. 9
or their relatives except Dr. Swaminathan Sivaram are, in any way, of the Notice for approval by the Members.
concerned or interested, financially or otherwise, in the Special
Resolution set out at Item No. 8 of the Notice. Item No.: 10
Shri Sanjay Asher (DIN: 00008221) has been appointed by the
The Board recommends the Special Resolution set out at Item No. 8
Board of Directors as an Additional Director on the Board of the
of the Notice for approval by the Members.
Company w.e.f. May 3, 2019. As per the provisions of Section 161 of
the Companies Act, 2013 (“the Act”), he holds office as an Additional
Item No.: 9
Director upto the ensuing Annual General Meeting of the Company.
Dr. Richard H. Rupp (DIN: 02205790) is an Independent Non-
Executive Director of the Company. The Company has received a notice under Section 160 of the Act
together with a deposit of ` 1,00,000/- from a Member proposing
Pursuant to the requirement of Companies Act, 2013 (“the Act”) and his candidature as an Independent Non-Executive Director of
Clause 49 of erstwhile Listing Agreement, Dr. Richard H. Rupp was the Company. In accordance with the provisions of the Act, it is
appointed as an Independent Director at the 43rd Annual General proposed to appoint Shri Sanjay Asher as an Independent Non-
Meeting of the Company held on August 8, 2014 for a term of five (5) Executive Independent Director of the Company for a term of three
consecutive years upto August 7, 2019. (3) consecutive years upto June 27, 2022.
As per Section 149(10) of the Act, an Independent Director can hold Shri Sanjay Asher has given a declaration to the Board that he
office for a term upto five (5) consecutive years on the Board of a meets the criteria of independence as provided under Section
Company and may be re-appointed for another term upto five (5) 149(6) of the Act and Regulation 16(1)(b) of the Listing Regulations.
consecutive years, with the approval Members of the Company by In the opinion of the Board, Shri Sanjay Asher fulfils the conditions
way of Special Resolution. specified in the Companies Act, 2013 and rules made thereunder for
his appointment as an Independent Director of the Company and
The Board of Directors at its meeting held on May 3, 2019, on the is independent of the management. The Board considers that his
recommendation of the Nomination and Remuneration Committee association would be of immense benefit to the Company and it is
and based on the performance evaluation, considers that given his desirable to avail services of Shri Sanjay Asher as an Independent
background and experience and contributions made by him during Director.
his tenure, the association of Dr. Richard H. Rupp would be beneficial
to the Company and it is desirable to re-appoint Dr. Richard H. Rupp The details of Shri Sanjay Asher as required under the provisions
as an Independent Director for another term of three (3) consecutive of Regulation 36(3) of the Listing Regulations and other applicable
years with effect from August 8, 2019. provisions are provided in Annexure – I to this Notice.

Corporate OVERVIEW
statutory reportS
A copy of the draft Letter of Appointment of Shri Sanjay Asher as an Item No.: 12
Independent Director will be available for inspection without any As per the provisions of Section 197 of the Companies Act, 2013
fee for the members at the Registered Office of the Company during (“the Act”) the overall managerial remuneration to Directors shall
normal business hours on any working day, excluding Saturdays. not exceed 11 per cent (11%) of the net profits of the Company
calculated in accordance with Section 198 of the Act (“Net Profit”)
None of the Directors or Key Managerial Personnel of the Company and should be within the sub-limits as prescribed under the second
or their relatives except Shri Sanjay Asher are, in any way, concerned proviso to Sub-Section (1) of Section 197 of the Act.
or interested, financially or otherwise, in the Ordinary Resolution set
out at Item No. 10 of the Notice. Prior to the amendments brought in by Companies (Amendment)
Act, 2017 in Section 197, the Company may, with the approval
The Board recommends the Ordinary Resolution set out at Item No. of the Members at the general meeting, pay remuneration to the
10 of the Notice for approval by the Members. Managing Director, Whole Time Director or Manager, in excess of
5 per cent (5%) of the Net Profit for a particular financial year and
Item No.: 11 where there is more than one such Directors, in excess of 10 per
Smt. Purvi Sheth (DIN: 06449636) has been appointed by the Board cent (10%) of the Net Profit to all of them together and to the Non-
of Directors as an Additional Director on the Board of the Company Executive Directors in excess of 1 per cent (1%) of the Net Profit of
w.e.f. May 3, 2019. As per the provisions of Section 161 of the the Company. Accordingly, the Company had obtained the approval
Companies Act, 2013 (“the Act”), she holds office as an Additional of Members of the Company by way of Ordinary Resolution at the
Director upto the ensuing Annual General Meeting. 44th Annual General Meeting of the Company held on August 7, 2015
for payment of managerial remuneration in excess of the sub-limits
The Company has received a notice under Section 160 of the Act prescribed under the erstwhile second proviso to Sub-Section (1) of
together with a deposit of ` 1,00,000/- from a Member proposing Section 197 of the Act.
her candidature as an Independent Non-Executive Director of However, as per the amendments made by the Companies
the Company. In accordance with the provisions of the Act, it is (Amendment) Act, 2017 in the second proviso to Sub-Section (1) of
proposed to appoint Smt. Purvi Sheth as an Independent Non- Section 197 of the Act, which were made effective from September
Executive Director for a term of three (3) consecutive years upto 12, 2018, the said approval of the Members of the Company has to
June 27, 2022. be obtained by way of Special Resolution.
Smt. Purvi Sheth has given a declaration to the Board that she Accordingly, approval of the Members is being sought for the Special
meets the criteria of independence as provided under Section Resolution as set out under Item No. 12 of the Notice for payment of
149(6) of the Act and Regulation 16(1)(b) of the Listing Regulations. remuneration to Directors in excess of sub-limits prescribed under
In the opinion of the Board, Smt. Purvi Sheth fulfils the conditions the provisions of Section 197 of the Act for the Financial Year 2019-20
specified in the Companies Act, 2013 and rules made thereunder for and subsequent years.
her appointment as an Independent Director of the Company and Further, the total managerial remuneration to all the Directors shall
is independent of the management. The Board considers that her be within the limit of 11% of the Net Profit as prescribed under
association would be of immense benefit to the Company and it is Section 197 of the Companies Act, 2013, except as may be authorized
desirable to avail services of Smt. Purvi Sheth as an Independent by the Company in general meeting, subject to the provisions of
Director. Schedule V to the Act.
None of the Key Managerial Personnel of the Company / their
The details of Smt. Purvi Sheth as required under the provisions of
relatives, other than the Directors to the extent of remuneration
Regulation 36(3) of the Listing Regulations and other applicable
which may be paid to them in accordance with the provisions of
provisions are provided in Annexure – I to this Notice.
Section 197 of the Companies Act, 2013, are concerned or interested,
financially or otherwise, in the Special Resolution set out at Item No.
A copy of the draft Letter of Appointment of Smt. Purvi Sheth as an
12 of the Notice.
Independent Director will be available for inspection without any
fee for the members at the Registered Office of the Company during The Board recommends the Special Resolution as set out at Item
normal business hours on any working day, excluding Saturdays. No. 12 of the Notice for approval by the Members.
None of the Directors or Key Managerial Personnel of the Company Item No.: 13
or their relatives except Smt. Purvi Sheth are, in any way, concerned The Members had, at the 43rd Annual General Meeting of the
or interested, financially or otherwise, in the Ordinary Resolution set Company held on August 8, 2014, approved the payment of
out at Item No. 11 of the Notice. remuneration by way of commission to Non-Executive Directors
of the Company, for a period of five (5) years commencing with
The Board recommends the Ordinary Resolution set out at Item No. Financial Year 2014-15, not exceeding 1% (one per cent) of the
11 of the Notice for approval by the Members. net profits of the Company as determined in accordance with

the provisions of Section 197, 198 of the Companies Act, 2013. None of the other Directors / Key Managerial Personnel of the
Accordingly, the remuneration to the Non-Executive Directors as Company / their relatives are, in any way, concerned or interested,
above can be paid till the Financial Year 2018-19. financially or otherwise, in the Special Resolution set out at Item No.
14 of the Notice.
Further, as per the provisions of Regulation 17 (6) of the Listing
Regulations, all fees / compensation, payable to Non-Executive The Board recommends the Special Resolution set out at Item No.
Directors shall be fixed by the Board of Directors and shall require 14 of the Notice for approval by the Members.
approval of shareholders in general meeting.
Item No.: 15
In view of the above, approval of Members is being sought for
The Board, on the recommendation of the Audit Committee, has
payment of commission to Non-Executive Directors as set out in the
approved the appointment and remuneration of M/s. B. M. Sharma
Ordinary Resolution at Item No. 13 of this Notice.
& Co., Cost Accountants (Firm Registration No. 00219) as the Cost
The said remuneration to Non-Executive Directors shall be in Auditors to conduct the audit of the cost records of the Company for
addition to the sitting fee and re-imbursement of expenses payable the Financial Year 2019-20.
to them for attending meetings of the Board and Committees Upon recommendation of the Audit Committee, the remuneration of
thereof. the Cost Auditors was fixed by the Board of Directors at ` 7,50,000/-
(Rupees Seven Lakhs Fifty Thousand only) plus applicable tax and
Save and except all the Non-Executive Directors of the Company
out of pocket expenses for performing the audit as mentioned
and their relatives, none of the other Directors / Key Managerial
above.
Personnel of the Company / their relatives are, in any way, concerned
or interested, financially or otherwise, in the Ordinary Resolution set In accordance with the provisions of Section 148 of the Companies
out at Item No. 13 of the Notice. Act, 2013 read with the Companies (Audit and Auditors) Rules, 2014,
the remuneration payable to the Cost Auditors has to be ratified by
The Board recommends the Ordinary Resolution as set out at Item
the Members of the Company.
No. 13 for approval by the Members.
Accordingly, approval of the Members is sought for the Ordinary
Item No.: 14: Resolution as set out at Item No. 15 of the Notice for ratification of
As required under Regulation 17 (6)(e) of the Securities and Exchange the remuneration payable to the Cost Auditors for the Financial Year
Board of India (Listing Obligations and Disclosure Requirements) ending March 31, 2020.
(Amendment) Regulations, 2018 (‘Listing Regulations’), inserted
None of the Directors or Key Managerial Personnel of the Company
by SEBI (Listing Obligations and Disclosure Requirements)
or their relatives are, in any way, concerned or interested, financially
(Amendment) Regulations, 2018, the fees or compensation payable
or otherwise, in the Ordinary Resolution set out at Item No. 15 of the
to executive directors who are promoters or members of the
Notice.
promoter group of the listed entity, shall be subject to the approval
of the shareholders by special resolution in general meeting, if – The Board recommends the Ordinary Resolution set out at Item No.
15 of the Notice for approval by the Members.
(i)
Annual remuneration payable to such executive director
exceeds ` 5 Crore or 2.5 per cent (2.5%) of the net profits of the
listed entity, whichever is higher; or
By Order of the Board of Directors
(ii) Where there is more than one such director, the aggregate
annual remuneration to such directors exceeds 5 per cent (5%)
of the net profits of the listed entity Arvind Bajpai
Further, the approval of the shareholders under the said Regulation Place: Vadodara Company Secretary
shall be valid only till the expiry of the terms of such director. Date : May 3, 2019 Membership No.: FCS-6713
Address: A/2/202, Labh Exotica,
In view of the above and in order to have a flexibility for payment Nr. Pratham Vatika, Gotri,
of annual remuneration to the Executive Director(s) who are Vadodara-390021
Promoter(s) or Member(s) of Promoter Group in excess of the limits Registered Office:
as mentioned in Regulation 17 (6)(e) of the Listing Regulations from
Aaditya-I, Chhani Road
Financial Year 2019-20 and for subsequent years, till the expiry of
Vadodara – 390 024, Gujarat
respective term of such Executive Directors, it is necessary to obtain
Tel: +91-265-2765200, 396 020
the approval of shareholders by way of Special Resolution.
Fax: +91-265-2765344
Shri Deepak C. Mehta and Shri Maulik Mehta are deemed to be Email: investor@godeepak.com
concerned or interested in the Special Resolution as set out under Website: www.godeepak.com
Item No. 14 of the Notice. CIN: L24110GJ1970PLC001735

Corporate OVERVIEW
statutory reportS
Annexure – I
Name of the Director Shri Deepak C. Mehta Shri Sanjay Upadhyay
Date of Birth December 12, 1956 July 20, 1961
Age 62 Years 57 Years
Director Identification Number 00028377 01776546
Qualifications Bachelor of Science from University of Bombay. Associate Member of the Institute of Cost Accountants
of India and Fellow Member of the Institute of Company
Secretaries of India. Advanced Management Programme
from Wharton, USA.
Terms and Conditions of As detailed in the Explanatory Statement of Item No. 4. As per Ordinary Resolution passed at the 46th Annual
appointment or re-appointment General Meeting of the Company held on June 26, 2017
along with details of remuneration
sought to be paid
Remuneration paid / payable for ` 906.60 Lakhs ` 294.40 Lakhs
the Financial Year 2018-19
Expertise in specific functional Management & Leadership Finance, Taxation & Management
areas
Date of first appointment on the June 14, 1978 April 28, 2017
Board
Shareholdings in the Company as 2,12,16,331 Equity Shares Nil
on March 31, 2019
Disclosure of relationships Father of Shri Maulik D. Mehta and Brother of Shri Ajay Not related to any of the Directors or Key Managerial
between directors inter-se. C. Mehta Personnel of the Company.
The number of Meetings of the No. of Board Meetings Board Meetings No. of Board Meetings Board Meetings
Board attended during the held Attended held Attended
F.Y. 2018-19 4 4 4 4
Directorship in other Companies Listed Companies Listed Companies
as on March 31, 2019 Nil Nil
Non- Listed Companies Non- Listed Companies
Deepak Novochem Technologies Limited Deepak Novochem Technologies Limited
Deepak Phenolics Limited Deepak Phenolics Limited
Lakaki Works Private Limited
Forex Leafin Private Limited
Pranawa Leafin Private Limited
Greypoint Investments Private Limited
Hardik Leafin Private Limited
Sundown Finvest Private Limited
Stigma Credits and Capital Private Limited
Checkpoint Credit and Capital Private Limited
Skyrose Finvest Private Limited
Stepup Credits and Capital Private Limited
Stiffen Credits and Capital Private Limited
Deepak Cybit Private Limited
Sofotel Infra Private Limited
BAIF Institute for Sustainable Livelihoods and
Development
Deepak Research and Development Foundation
Kawant Development Corporation
Chairmanship/Membership of Audit Committee Audit Committee
Committees of other Board Deepak Phenolics Limited- Member Deepak Novochem Technologies Limited - Chairman
Deepak Novochem Technologies Limited - Member Nomination & Remuneration Committee
Nomination & Remuneration Committee Deepak Phenolics Limited - Member
Deepak Phenolics Limited- Member Deepak Novochem Technologies Limited - Chairman
Deepak Novochem Technologies Limited - Member Corporate Social Responsibility Committee
Corporate Social Responsibility Committee Deepak Novochem Technologies Limited - Member
Deepak Novochem Technologies Limited - Member Deepak Phenolics Limited - Member

Name of the Director Dr. Richard H. Rupp Shri S. K. Anand
Date of Birth June 27, 1947 December 10, 1942
Qualifications Ph.D. in Chemistry from University of Karlsruhe, Germany. Bachelor of Engineering (Chemical) from Delhi University
Executive Development from IMD at and has done Petrochemical Course from I.I.P., Dehradun.
Lausanne, Switzerland. Advanced Management course at the Indian Institute of
Management, Ahmedabad.
Terms and Conditions of As per draft letter of appointment available for inspection As per draft letter of appointment available for inspection
appointment or re-appointment by the Members at the Registered Office of the Company. by the Members at the Registered Office of the Company.
sought to be paid
Remuneration paid / payable for Sitting Fees ` 1,20,000 Sitting Fees ` 3,60,000
the Financial Year 2018-19 Commission ` 10,00,000 Commission ` 25,00,000
Total ` 11,20,000 Total ` 28,60,000
Expertise in specific functional Scientific, technical as well as managerial expertise. He Project Management, Operations, Corporate Planning,
areas is well-acquainted with the USA, European, Asian and Quality Management, Health, Safety and Environment
Indian sub-continent markets. Management, Energy Management, Strategic Planning in
petrochemicals.
Date of first appointment on the May 27, 2008. November 4, 2011
Board
Shareholdings in the Company as Nil Nil
on March 31, 2019
Disclosure of relationships between Not related to any of the Directors or Key Managerial Not related to any of the Directors or Key Managerial
directors inter-se. Personnel of the Company. Personnel of the Company.
F.Y. 2018-19 4 2 4 4
as on March 31, 2019 Nil Nil
Nil Deepak Phenolics Limited
Sunrise Industries (India) Limited
Optimum Diagnostics and Research Private Limited
Chairmanship/Membership of Nil Audit Committee
Committees of other Board Deepak Phenolics Limited – Chairman
Sunrise Industries (India) Limited – Chairman
Corporate Social Responsibility Committee
Deepak Phenolics Limited - Member
Nomination & Remuneration Committee
Deepak Phenolics Limited – Chairman
Name of the Director Shri Sudhin Choksey Shri Sudhir Mankad

Date of Birth January 31, 1954 August 5, 1947
Qualifications Fellow Member of the Institute of Chartered Accountants Master’s degree in History from the University of Delhi.
of India.
sought to be paid
Remuneration paid / payable for Sitting Fees ` 2,70,000 Sitting Fees ` 2,85,000
the Financial Year 2018-19 Commission ` 10,00,000 Commission ` 10,00,000
Total ` 12,70,000 Total ` 12,85,000
Expertise in specific functional Shri Sudhin Choksey has extensive experience in Strategy, Management & Leadership
areas functional areas like finance, commerce and general
management, both in India and abroad.
Date of first appointment on the March 30, 2005 May 13, 2009
Board
on March 31, 2019

Corporate OVERVIEW
statutory reportS
Name of the Director Shri Sudhin Choksey Shri Sudhir Mankad

Disclosure of relationships Not related to any of the Directors or Key Managerial Not related to any of the Directors or Key Managerial
between directors inter-se. Personnel of the Company. Personnel of the Company.
F.Y. 2018-19 4 3 4 3
as on March 31, 2019 Gujarat Ambuja Exports Limited Navin Fluorine International Limited
GRUH Finance Limited Swaraj Engines Limited
GRUH Finance Limited
Light Microfinance Private Limited Gujarat International Finance Tec-City Company Limited
HDFC Credila Financial Services Private Limited Mahindra Intertrade Limited
GIFT SEZ Limited
Committees of other Board Gujarat Ambuja Exports Limited – Chairman Mahindra Intertrade Limited - Chairman
Corporate Social Responsibility Committee Swaraj Engines Limited - Member
GRUH Finance Limited - Member Stakeholder Relationship Committee
GRUH Finance Limited- Member
GRUH Finance Limited - Chairman
Swaraj Engines Limited - Member
Corporate Social Responsibility Committee
Mahindra Intertrade Limited - Member
Swaraj Engines Limited - Chairman
GRUH Finance Limited - Member
Navin Fluorine International Limited - Chairman
Name of the Director Dr. Swaminathan Sivaram Shri Sanjay Asher

Date of Birth November 4, 1946 November 26, 1963
Qualifications Ph.D in Chemistry and DSc (h.c) from Purdue University, Bachelor’s Degree in Commerce and in Law from the
W. Lafayatte, Indiana, USA University of Bombay. He is also a qualified Chartered
Accountant and a Solicitor
sought to be paid
Remuneration paid / payable for Sitting Fees ` 1,80,000 Sitting Fees
the Financial Year 2018-19 Commission ` 8,00,000 Commission NA
Total ` 9,80,000 Total
Expertise in specific functional Basic research, process/product R&D and S&T Over twenty nine years of experience in the field of law
areas management, both in industry and academia and corporate matters. He is presently a senior partner at
M/s. Crawford Bayley and Co., and deals with corporate
laws, mergers and acquisitions and capital market
transactions.
Date of first appointment on the May 9, 2013 May 3, 2019
Board
on March 31, 2019
Disclosure of relationships Not related to any of the Directors or Key Managerial Not related to any of the Directors or Key Managerial
between directors inter-se. Personnel of the Company. Personnel of the Company.
The number of Meetings of the No. of Board Meetings Board Meetings Attended
Board attended during the held NA
F.Y. 2018-19 4 4
as on March 31, 2019 Supreme Petrochem Limited Sudarshan Chemical Industries Limited
Asian Paints Limited Tribhovandas Bhimji Zaveri Limited
GMM Pfaudler Limited Ashok Leyland Limited
Apcotex Industries Limited Finolex Industries Limited
Balkrishna Industries Limited

Name of the Director Dr. Swaminathan Sivaram Shri Sanjay Asher
Directorship in other companies Non- Listed Companies Non- Listed Companies
as on March 31, 2019 Gharda Chemicals Limited Lonza India Private Limited
Vyome Therapeutics Limited Kineco Kaman Composites- India Private Limited
Aic Iiser Pune Seed Foundation Siporex India Private Limited
Finolex Plasson Industries private Limited
SK Restaurants Private Limited
Auxilo Finserve Private Limited
Bajaj Allianz General Insurance Company Limited
Bajaj Allianz Life Insurance Company Limited
N V Advisory Services Private Limited
Arch Protection Chemicals Private limited
Orbit Electricals Private Limited
Sahyadri Hospitals Limited
Committees of other Board GMM Pfaudler Limited- Chairman Ashok Leyland Limited-Chairman
Stakeholder Relationship Committee Sudarshan Chemical Industries Limited-Member
GMM Pfaudler Limited- Chairman Bajaj Allianz Life Insurance Company Limited- Member
Nomination & Remuneration Committee Bajaj Allianz General Insurance Company Limited-
GMM Pfaudler Limited- Chairman Member
Apcotex Industries Limited - Member Stakeholder Relationship Committee
Ashok Leyland Limited-Chairman
Sudarshan Chemical Industries Limited- Chairman
Tribhovandas Bhimji Zaveri Limited-Member
Balkrishna Industries Limited-Member
Sudarshan Chemical Industries Limited- Member
Finolex Industries Limited- Member
Bajaj Allianz Life Insurance Company Limited- Member
Bajaj Allianz General Insurance Company Limited-
Member
Name of the Director Smt. Purvi Sheth

Date of Birth May 31, 1972
Age 46 Years
Director Identification Number 06449636
Qualifications Bachelor’s Degree in Arts, Economics & Political Science from St. Xavier’s College, Mumbai University and
obtained a CPD Business Strategy & Leadership Management from Wharton Business School, USA
Terms and Conditions of appointment As per draft letter of appointment available for inspection by the Members at the Registered Office of the
or re-appointment along with details of Company.
remuneration sought to be paid
Remuneration paid / payable for the Sitting Fees
Financial Year 2018-19 Commission NA
Total
Expertise in specific functional areas Strategic HR Management. talent management through advanced leadership processes and
implementation.
Date of first appointment on the Board May 3, 2019
Shareholdings in the Company as on March Nil
31, 2019
Disclosure of relationships between Not related to any of the Directors or Key Managerial Personnel of the Company.
directors inter-se.
The number of Meetings of the Board NA
attended during the F.Y. 2018-19
Directorship in other Companies as on Listed Companies

March 31, 2019 Nil
Non- Listed Companies
Nirigyan Information Consulting and Services Private Limited
Chairmanship/Membership of Committees Nil
of other Board

Corporate OVERVIEW
statutory reportS
Route map - 48th Annual General Meeting of Deepak Nitrite Limited
Grand Mercure
Vadodara Surya Palace
Grand Mercure Vadodara Surya Palace,

Opposite Parsi Agiyari, Sayajigunj,
Vadodara – 390 020
Gujarat.
Landmark: Parsi Agiyari Ground

Management Discussion & Analysis
GLOBAL ECONOMIC SCENARIO China is projected to run a current account deficit in 2019, which
The Financial Year 2018-19 was characterised by fears of sharp will be after decades of witnessing a surplus situation. Also, it has
slowing down of global economic growth due to an increasing changed its forecast to a range of 6-6.5% and further targeted to go
degree of deglobalisation. World economic growth is projected down to 5.5%, the slowest since 2009. Its erstwhile robust economic
to moderate from 3% in 2018 to 2.9% in 2019 on an annualised growth engine seems to have slowed down as it faces pressures
basis, as consumer and business spending weakened, such as the trade war with the U.S., a global economic slowdown
advanced-economy growth decelerated, and recovery in major and a decline in domestic consumption. A modest weakening of
commodity-exporting emerging market and developing economies China’s industrial sector is likely owing to softening of export growth
levelled off. This deceleration is due to a combination of tariff and a crackdown on the polluting industry. The structural slowdown
wars, quantitative barriers impeding the free movement of people, is expected to be offset partly by a moderate pick-up in other large
products and services, and geo-political protectionism, such as economies, including India.
Brexit, and its associated impact.
INDIAN ECONOMIC SCENARIO
Even as the U.S. economy has demonstrated an uptick recently it
is believed the trade war with China will lead to slower growth. The The Central Statistics Office revised the growth rate for India in Fiscal
growth in the Eurozone slipped to a 4 year low in the second half of 2018-19 from 7.2% to 7%. While the first half witnessed strong growth
Calendar Year 2018 and a forecast by the European Commission has trends, growth in the second half was impacted by a liquidity crisis
revised the estimate downward to 1.3% in 2019 owing to softening in the BFSI sector as well as global macro-economic events. Even as
exports and slowing external demand. growth moderated, India remained the fastest growing large economy
in the world. Further, growth has been quite broad-based and domestic
Economic Growth in 2019 macro-economic indicators have remained largely stable.
The International Monetary Fund (IMF) has predicted that over the Domestic demand has strengthened as the benefits of structural
next decade, reverse globalisation will make the playing field of reforms such as the Goods & Services Tax harmonisation,
global economies uneven, resulting in reduced ability to leverage improvement in governance in PSU banks and their recapitalisation
existing competitive advantages. The consequences of escalating take effect. Growth remained healthy despite multiple external
trade actions are undeniable: higher prices in China and the U.S., challenges including volatile oil prices and rupee volatility which
less purchasing power for consumers in these countries, higher served to place pressures on demand, inflation, current account,
input costs, heightened financial market volatility, and possibly
and public finances. However, business investment and exports
higher interest rates. These effects are likely to spill over from these
remained fairly robust.
countries into integrated markets. There are considerable downside
risks which includes the possibility of disorderly financial market According to US-based rating agency Moody’s report “Global Macro
volatility and rising vulnerability of some emerging markets and Outlook for 2019 and 2020”, India is less exposed to a slowdown in
developing economies to such disruption. There are also signs global manufacturing trade growth if compared with other major
of a deteriorated risk appetite among investors and a potential Asian economies and the emerging markets, and it is poised to grow
slowdown in China. at a relatively stable pace over the next two years. Announcement of
the direct cash transfer program for farmers and the middle-class tax
Moreover, with no let-up in the US-China trade war, growth forecast
relief measures will also contribute to the fiscal stimulus. With the
point to more pain ahead, not just for the developed economies, but
on-going reforms beginning to impact the economy now positively,
for the emerging market economies too. Trade tensions, including
there is renewed optimism about India’s growth prospects in the
the imposition of tariffs by large economies, have resulted in a
upcoming years. It’s believed that improvement in the governance
material impact on global commodity markets, leading to trade
of public banks will help avoid a new wave of non-performing loans
diversion and widening price differentials among countries.
and support the investment recovery.
Asia to drive Global Economic Growth Private consumption is projected to remain firm, and investment
Asia is seen driving the global economy in 2019, with high-growth growth is also expected to continue as the benefits of recent policy
economies such as India, Indonesia, Malaysia, China, Philippines, reforms begin to materialise and credit rebounds. Strong domestic
and Turkey leading the way. India is expected to be one of the fastest demand and resumption of investment cycle will boost demand for
growing economies in the world, with structural reforms and higher crude, metals, materials and other imports which may widen India’s
investments driving economic activity. Growth in Emerging Markets current account deficit. Inflation is projected to rise somewhat above
and Developing Economies, is projected to mature during the latter the midpoint of the Reserve Bank of India’s (RBI) target range of 2%
part of 2019. to 6%, mainly owing to energy and food prices. Economic growth

Corporate OVERVIEW
statutory reportS
is seen moderately accelerating on the back of steady government and overseas markets, following plant shutdowns in China, currently
expenditure, largely stable rural incomes, faster private consumption, the world’s largest producer and exporter. The decline in supply
and investment growth. from China offers opportunities for Indian players to ramp up their
supply to the world market and explore new markets for sustained
Economic growth in India is expected to accelerate moderately to
exports. Meanwhile, competitive cost of labour and accommodative
7.5% in FY 2019-20, according to a World Bank forecast, attributing
government policies are also set to help the chemical sector in India.
it to an upswing in consumption and investment pick-up. India
Besides, most large chemical companies maintain adherence to
will continue to retain its tag as the world’s fastest-growing large
strict pollution norms, especially in Gujarat and Maharashtra.
economy.
Key Growth Enablers
INDUSTRY OUTLOOK AND TRENDS
The chemical industry is expected to be the key contributor and
The calendar Year 2018 represents the 6th year of an extended
a catalyst in achieving the target of US$ 1 Trillion manufacturing
upcycle in the global chemical markets, characterised by robust
economy by 2028, from the current US$ 380 Billion.
demand, tight supply, and strong profitability. This extended period
of profitability caused a surge in reinvestment planning activities in The country’s consumption growth story largely drives the chemical
North America, the Middle East, China, and other Asian locations. industry in India. The per capita consumption of chemicals in India
At the same time, many risks represent potential drags on global is 1/10th of the world average with India being a low consumption
growth, including rising crude oil prices, domestic fiscal policy and country even among the developing nations. With nearly US$ 15
currency fluctuations, geopolitical tensions, and realignment of Trillion of Chinese exports in chemicals and plastics subject to
trade barriers. US tariffs, India is set to gain market share in the global chemical
industry, estimated to be around US$ 4.7 Trillion. Significant
Additionally, trade barriers and imposition of tariffs announced
opportunities lie ahead for Indian chemical companies arising
by the US on imported Chinese products are likely to have spill-
out of emerging possibilities in US-China trade war as well as
over effects, several customers are keen to de-risk the supply
shutting down of capacities in China. The domestic industry is also
chain reliance on the Chinese market and are seeking alternative tapping the intermediates opportunity and exploiting meaningful
suppliers, which is favorable for India. Innovation and elevation of demand. Given the mature market conditions of China, India is
product suites will be an important factor as many companies will expected to be the next engine of growth rendering opportunities
consider this as their key competitive advantage. Depreciation of to players engaged in the chemical value chain – extending from
INR vs USD will be an added advantage for Indian enterprises who agrochemicals, dyes, pigments, and specialty chemicals, which sees
are seeking to replace China’s market share in global trade due to the strongest tailwinds along with petrochemicals at the same time.
these tariffs.
Further, Indian chemical companies are enhancing capabilities and
Domestic Chemical Industry investing greater amounts in R&D to elevate their offerings. India
The domestic chemical industry is forecasted to grow at a CAGR of continues to gain traction from major countries and is likely to grow
9% to touch US$ 304 Billion by FY 2024-25 from US$ 163 Billion in multifold in the coming decade. Specialty chemical companies
FY 2017-18, according to the India Chem Strategy Report by FICCI. have witnessed a sharp increase in demand for their products over
Growth is likely to be driven by rising demand in end-use segments the last few years. In the Specialty Chemicals segment, production
picked up by 3.7% in 2018 and is expected to witness another 2.2%
for specialty chemicals and petrochemicals. India’s chemical
rise in 2019. Gains led by an improvement in oilfield chemicals,
industry is one of the fastest growing in the world, currently ranked
electronic chemicals, coatings, adhesives, cosmetic chemicals, and
the 3rd largest in Asia and 6th largest globally concerning output,
flavors and fragrances. In the years ahead, the demand for Specialty
after US, China, Germany, Japan and Korea, stated the Report. The
Chemicals is expected to grow in line with gains in the industrial
domestic chemical industry is said to have attracted FDI investment
and construction sectors. Specialty chemical players, with presence
of US$ 1.3 Billion during FY 2017-18, about 3% of the total FDI inflows
across the value chain, have observed significant improvement in
into India.
their operating margins.
The chemical sector continued to maintain its strong performance
trajectory, driven by the increasing competency of Indian players Future Industry Outlook
across the globe as disruption in China’s chemical market continues The Government has announced plans to ensure robust market size
to persist. The basic chemical players stand to benefit from high for Indian players through the implementation of a new policy in the
demand volumes and strong commodity chemical prices globally, Indian chemical space to strengthen domestic production and curb
aiding them to sustain higher margins and higher volumes. imports. A complete revamp of the current Petroleum, Chemicals &
Petrochemicals Investment Regions (PCPIRs) policy will encourage
Increasing Capacities effective and long-term investments in the sector and boost margins
The domestic chemical companies are set to invest the highest ever for Indian chemical players. The industry will also see some global
on capacity expansions to cater to rising demand from domestic companies investing in the Indian chemicals space.

Reducing Dependence on Chemical Imports along with supply disruptions in China, led to your Company further
India continues to be a net importer of chemicals. Organic, strengthening its market position in some of the key products in its
inorganic and agrochemicals account for almost US$ 33 Billion of portfolio.
India’s imports. Despite India’s rising stature in the global chemical
industry, domestic manufacturing of certain intermediates and On a consolidated basis, too, your Company performed and
value added chemicals is significantly below the volumes required progressed well, mainly supported by commencement of
by the consuming industries. With demand increasing steadily production of the Phenol and Acetone facility at the domestic area
both due to local market absorption and capturing of global of Petroleum, Chemicals & Petrochemicals Investment Region
market share, leading chemical companies have recognised the (PCPIR) at Dahej in Gujarat. The plant can produce 200,000 MTPA
growth opportunities and are focused on undertaking high-level of phenol and 120,000 MTPA for co-product acetone, supported
investments, addressing challenges in the supply value chain and by the capacity to manufacture 260,000 MT of cumene for captive
incorporating better and advanced technology to elevate their consumption.
competencies and reducing India’s import dependence. In a key achievement, the plant was not only stabilised in the
first quarter of its operations, but its capacity utilisation was also
PERFORMANCE OF YOUR COMPANY ramped up to touch 100% during Q4 of FY 2018-19, apart from
During the year, your Company continued its investments in fortifying constantly operating more than 80% during the last quarter of FY
its diversified portfolio and also strengthening its infrastructure and 2018-19, thereby resulting in consolidated revenues of ` 2,715 Crore.
processes to drive greater efficiencies, supported by its financial Additionally, the facility manufacturing delivered positive EBITDA
strength. Your Company is strategically preparing itself for the next and PBT in the first few months of its operations.
phase of growth through value-added capabilities, new capacities,
continuous perseverance, and inventiveness. It is taking on new During the year under review, your Company entailed a capital
opportunities which are bottom line accretive and margin accretive. expenditure of around ` 67 Crore towards brownfield expansions
in Basic Chemicals and Fine & Specialty Chemicals segments,
The expansion strategies have been devised keeping in mind its
to enhance the capacities of major products and also towards
risk-mitigating approach towards incurring capex and making
increasing operational efficiencies.
continuous investments into the productive assets to become
“future ready” and deliver on our promises. Your Company continues to reward its shareholders well. Given
improved performance, your Company declared a Dividend of ` 2
In FY 2018-19, your Company reported solid performance driven
per Equity Share in FY 2018-19, on a face value of ` 2, amounting to
by growth across all the Strategic Business Units (SBUs). Revenue
100%. The Dividend rate has increased from ` 1.30 per Equity Share
including other income grew to ` 1,795 Crore, higher by 20% from
in FY 2017-18 on an expanded capital base.
FY 2017-18. The EBITDA stood at ` 308 Crore, up by 44% from the
previous year translating into EBITDA margins of 17.2%, higher by
OVER-DELIVERING ON OUR PROMISES
280 basis points (bps). Margin expansion was a result of product-
Your Company not only delivered on all its promises, but by going
mix adjustments, better realisation, and cost leadership initiatives.
beyond stated targets and achieving some targets ahead of time it
Profit Before Tax (PBT) was ` 212 Crore, an improvement of 74% from
has actually over-delivered by accomplishing the commissioning
last year. Profit After Tax (PAT) stood at ` 138 Crore, representing an
of its large greenfield project. The project, which is India’s largest
improvement of 65% compared to the previous year.
phenol-acetone plant, has been completed within the stipulated
Domestic Revenues constitute a major part of your Company’s time and project cost. More importantly, complex logistics and
turnover at 68%, while export revenues represented 32%. Domestic material management has been undertaken in a seamless manner.
topline witnessed a year-on-year growth of 25% owing to robust All requisite tests, dry runs, process evaluation and safety audits
demand from agrochemicals and pigment applications, amongst have been undertaken in a comprehensive manner. Commissioning
others. On the other hand, exports grew by 14% on account of of this plant is also significant from the viewpoint of positioning
encouraging demand trajectory for our key products in the global India as a global power in chemical intermediates. The plant is
markets. expected to reduce India’s import dependence for phenol and take
care of the demand-supply gap and make the country self-reliant in
Overall, the performance in FY 2018-19 was largely driven by a
the production of phenol and acetone.
combination of volume growth and higher realisations for some key
products across all the Strategic Business Units (SBUs). These factors Lower logistics, better inventory management and quality
will attribute to an encouraging demand in end-user industries advantage over imports will be some key incentives for import
and several initiatives undertaken by the key management to substitution. Local availability of phenol and acetone will also boost
enhance product throughput, drive operating efficiencies and the production of intermediates, thus diversifying the applications
increase capacities of select products. More importantly, given your for these products and further expanding India’s overall market
Company’s agile nature, it was swiftly able to move its manufacturing reducing even imports of these downstream intermediates. With
towards products enjoying a better demand scenario. The above, this, your Company is not only encouraging value-added specialty

Corporate OVERVIEW
statutory reportS
chemicals but also making available the intermediates to the your Company manufactures Specialty Chemicals such as
downstream units. Thus, in addition to its own efforts of saving Xylidines, Oximes, Cumidines etc amongst others. Products in
precious foreign exchange resources for the country it will also act the respective, segment are customised as per requirements
as an enabler for other enterprises to do so. of the client and typically manufactured in low volumes, as
they enjoy higher value. Emphasis is on quality, the stickiness
PERFORMANCE OF BUSINESS UNITS of relationships, sustainable operations as well as global best
Deepak Nitrite is a multi-product company that manufactures a practices for suppliers and customers.
diversified product portfolio of Basic Chemicals (BC), Fine and
User Industries for Fine & Specialty Chemicals:
Specialty Chemicals (FSC), and Performance Products (PP), while its
manufacturing facilities located at Nandesari and Dahej in Gujarat; • Agro-chemicals
Roha and Taloja in Maharashtra; and Hyderabad in Telengana. • Colorants
Your Company is the market leader in almost all the products it • Pigment
manufactures. Even as the operations are now predominantly • Pharmaceuticals and personal wellness
domestic, it enjoys significant footprint offshore, especially into
Your Company’s revenues from this segment in FY 2018-19
Europe, USA, Japan, Latin America, South East, and Far-East Asia
stood at ` 536 Crore, higher by 16% year-on-year, while EBIT
- an export network spanning over 30 countries. Your Company is improved by 10%. This segment reported steady performance
focused on expanding its footprint in high-value intermediates. during the year on the back of firm realisation gains in select
Multiple levers and strategic initiatives are fueling the steep and products as well as positive demand scenario. This was
sustainable growth trajectory. further aided by benefits accruing from backward integration
initiatives and capacity expansion for established products.
1. Basic Chemicals FSC segment is on track to demonstrate strong performance
Under Basic Chemicals, your Company manufactures in the ensuing years as your Company has expanded its
Nitrites, Nitro Toluidines, Fuel Additives. Cost leadership is product offerings and also enhanced certain capacities which
the foremost competitive advantage required here to drive will allow it to expand its basket of products and cater to the
growth and profitability as these chemicals are high-margin robust demand environment.
high-volume products with greater price sensitivity. These
chemicals are manufactured as per standard specifications 3. Performance Products
and are dependent on raw material availability and pricing. Performance Products are application chemicals, it consists
of two products - Optical Brightening Agent (OBA) and its pre-
User Industries for Basic Chemicals:
cursor, DASDA. Your Company is the world’s only fully-integrated
• Colorants manufacturer of OBA, with vertical integration from Toluene to
• Rubber chemicals PNT and further into DASDA and OBA. These products have
• Explosives stringent requirements in terms of performance and technical
specifications. Your Company has developed an extensive
• Dyes
network of global clientele and undertaken meticulous efforts
• Pigments to position its products into right geographies, cater to high-
• Food colors value end-users and elevate operational efficiencies.
• Pharmaceuticals User Industries for Performance Products:
• Petrol & diesel blending • Paper
• Agrochemicals • Detergents
In FY 2018-19, Basic Chemicals reported sales of ` 893 Crore, an • Textiles
increase of 17% YoY owing to improved product-mix as well as The Performance Products segment demonstrated excellent
higher realisations. The performance of Basic Chemicals has to performance in FY 2018-19 with revenues of ` 403 Crore,
be seen in light of heightened volatility in both crude oil prices recording 35% growth YoY with positive EBIT of ` 83 Crore.
and related petrochemical intermediates and also disruption Performance of this segment is driven by a combination of
caused in Chinese Chemical Industry . The EBIT increased by factors such as focused re-orientation of customer industries
36% during the year. and geographies by the Company, shutdown of capacities in
China and enhanced operational performance. Our position
2. Fine & Speciality Chemicals as a fully integrated supplier of OBA have enabled us to
The Fine & Specialty Chemicals segment consists of specialised capitalise on shifts in the industry landscape resulting in the
and niche products created from various processes and elevation of performance. This segment now contributes 22%
requiring technical skills and expertise. Under this segment, to the Company’s total revenues.

GEOGRAPHICAL PERFORMANCE Key Financial Ratios FY FY Change Reason
Domestic Revenues for FY 2018-19 stood at ` 1,212 Crore, as 2018-19 2017-18 (%)
compared to ` 968 Crore in FY 2017-18. Export revenues amounted Operating Profit Margin 14.20 10.90 31 Improved
to ` 580 Crore, as compared to ` 511 Crore in the previous year. (%) (EBIT) profitability due
to better sales
1500
realisation
1,212
Net Profit Margin (%) 11.80 8.20 45 Improved

1200 (PBT) profitability due
to better sales
900 realisation
*However, Net Worth included ` 560 Crores provided as equity to Deepak

580
600 Phenolics Limited, return of which for full year is to come in FY 2019-20.
300 COMMENCEMENT OF PHENOL & ACETONE GREENFIELD PLANT

Deepak Phenolics Limited (DPL), a wholly-owned subsidiary of
0 Deepak Nitrite Limited, commenced commercial production at its
Domestic Revenues Export Revenues mega Greenfield facility of Phenol and Acetone plant at Dahej in
Gujarat in November 2018. The facility has an installed capacity to
As compared to the previous year, your Company’s exports have manufacture 200,000 MTPA of Phenol and 120,000 MTPA of Acetone.
grown at 14% in FY 2018-19. Shifts in global supply chain, performance Further, it has also facility to manufacture 260,000 MTPA of Cumene
enhancement in key geographies and deeper customer engagement for captive consumption. The facility makes your Company a market
enabled better performance. This momentum was further supported leader and highly competitive in terms of logistics and inventory
by Company’s efforts of running plants at optimum capacities with management, operating efficiencies and favorably positions it to
streamlined processes. In FY 2018-19, Europe contributed 57%, as capture opportunities emerging from production of downstream
compared to 46% in the previous financial year. Asia also showed products.
an improvement during the year and contributed 21%, while the US
The foremost objective of venturing into phenol and acetone is to
contributed 14%.
tap the growing domestic demand and hence substitute imports,
Others as India imported almost 80% of its phenol-acetone requirements.
8% We are proud to share that the Company not only managed to
successfully stabilise the plant during the 5 months of operation
US during FY 2018-19 but also successfully ramped up its capacity
14%
utilisation above 80% of the total utilisation. During the fourth
Europe quarter, the plant touched 100% utilisation indicating its readiness
Asia 57% to scale up further towards optimum utilisation.
21%
During the year, the Company achieved a key milestone by replacing
the bulk of imports of Phenol and Acetone in the local market and
at present it has a market share of around 55% in the country. It has
SIGNIFICANT CHANGES IN KEY FINANCIAL RATIOS been a forerunner in tapping the import substitution opportunity
in India, which will go towards creating long-term benefits for the
Key Financial Ratios FY FY Change Reason
country. Additionally, your Company has also been successful in
2018-19 2017-18 (%)
producing and selling pharma grade acetone.
Debtors Turnover Ratio 5.21 4.04 29 Faster realisation
Inventory Turnover Ratio 7.72 7.92 (3) - Your Company proudly states that its robust supply chain
Interest Coverage Ratio 5.96 4.03 48 Higher profitability management has resulted in smooth and seamless working of the
& reduction in facility and is expecting it to become further efficient so to yield
borrowings better saving. This is commendable on two counts. Firstly, this has
Current Ratio 1.79 1.78 -- been achieved within few months of commissioning, hence the
Debt Equity Ratio 0.31 0.49 (37) Higher profitability & rapid ramp-up indicates a high level of preparedness. Secondly,
reduction in overall the transportation of the raw materials and finished goods involve
borrowings complexities which are appropriately and efficiently managed.
Return on Net Worth (%) 13.05 8.84 48 Improved These efforts also paved the way to achieving a positive EBITDA and
profitability* PBT during its maiden months of operation post commissioning of

Corporate OVERVIEW
statutory reportS
the plant. Your Company has demonstrated its leadership position increase in operating leverage, higher operating margins, and better
in this space and will now explore opportunities in downstream return ratios.
derivatives to further elevate its performance.
SWOT ANALYSIS
Phenol is a versatile industrial organic chemical and it is used
to produce a wide variety of chemical intermediates including Strengths
bis-phenol-A, phenolic resins, cyclohexanone etc. It is consumed Extensive Product Portfolio with Application Diversity: Over
in a large range of end-use segments such as laminates, the years, your Company has widened its product offerings to have
automobile, foundry, paints, rubber, surfactants, pharma, and a diversified product portfolio and insulate itself from any slowdown
agro-chemicals, among others. On the other hand, Acetone in a particular product or category to de-risk itself. Its diversified
is predominantly used in the production of pharmaceuticals product portfolio caters to multiple end-user industries such as
apart from its significant applications in paints, adhesives, and agrochemicals, rubber, pharmaceuticals, colorants, and textiles,
thinners among others. Acetone, as we know, is a co-product of amongst others. Additionally, superior infrastructure at various
the phenol manufacturing process. locations and balanced contribution from domestic and export
markets have resulted in steady growth for your Company. Further,
Considering the cross-country movement of over 6 Lakhs MT most of the products are contracted with pass through clauses
of explosive/hazardous materials, DPL is committed towards enabling the company to be remunerated for its value addition
improving the safety standards for road transportation. DPL has while minimising adverse impact from raw material fluctuation.
interfaced with Loss Control Services (LCS) for ‘First Respondents’
services with an aim to minimise the environmental and social Expanding Global Footprint and Long-term Customers:
impact of in-transit incidents. LCS has a strong network of First Your Company has an emerging presence across the key export
Respondents stationed every 120 kms between the facility and geographies e.g. the US, Europe and China, among others. Today,
DPL’s sources/destinations. LCS’s teams possess adequate know- it exports to more than 30 countries across 6 continents and is
how and experience in handling materials and are equipped with a further expanding its wings. Moreover, your Company’s customer-
24-hour central control room. centric approach has led to a long-standing association with most
large customers across the globe. Customer stickiness, as well as
ON A SOLID AND SUSTAINABLE GROWTH PATH a diversified portfolio, ensures that it is not dependent on a single
With a rich legacy, history of manufacturing excellence, application to drive growth.
diversified product portfolio, loyal customer base, experienced
Driving Sustainability across Value Chain: Your Company
leadership and a robust financial position, your Company has the
works relentlessly towards reducing its carbon footprint through
key ingredients in place for sustained growth. Commissioning of
socially responsible initiatives. Being the accredited members of
the new plant for manufacturing Phenol and Acetone, launch of
‘Responsible Care’ and ‘Together for Sustainability,’ your Company
new products, small capacity expansions and debottlenecking in
has successfully created a benchmark for other chemical companies
Basic Chemicals and Fine & Specialty Chemicals are seen driving
through its sustainability initiatives and innovative spirit.
earnings, going forward. This will be supported by the improving
performance trajectory of the Performance Products segment. Strong Supply Chain Capability: Your Company’s strong supply
With a strong platform in place, capacities offering headroom for chain can offer quality servicing and in-market execution by creating
growth, a roadmap for further value addition, your Company is stronger ties with its suppliers and customers. This is enabling your
favorably positioned for capturing the rising opportunities in the Company to get closer to a diverse set of consumers and suppliers
global chemicals & specialty chemicals space. across geographies.
THE 5 Ms OF EFFICIENCY Strong Technical Skills: Your Company possesses high levels
Your Company enjoys the strategic advantage of attaining of technical expertise in the areas of Nitration, Hydrogenation,
sustainability across the 5 Ms of efficiency – Man, Material, Oxidation, and Diazotisation. An experienced team keenly focuses
Machines, Methods, and Money – resulting in lean manufacturing on managing these skills efficiently and in a manner that results in
operations and performing with high efficiency. Also, it is investing higher plant utilisation.
in environmental sustainability throughout its business operations
Your Company’s presence in the chemical industry for several
by optimising resource use and appropriate treatment of effluents.
decades has facilitated it to develop multiple technical capabilities
In addition, it has undertaken steps to process joint products and by
products in its operations to derive further value and provide niche chemistries to its customers. As a practice, it
continues to work on complex and hazardous chemical processes
Your Company has high potential for business scalability with by leveraging its expertise in indigenous development and also its
limited incremental capital intensity. Its steady shift to value-added capability in developing, managing, storing and handling various
products enables enriched margins. It remains poised to reap the types of chemicals in quantities ranging from few kilos to several
benefits from increasing capacity utilisation that will lead to an tons. Technical expertise is a strong competitive advantage of your

Company, as it provides comfort to its customers that the processes Collaborative Measures through “Make In India”: The
will be undertaken safely and in a cost-competitive manner while Government initiatives through “Make in India,” with a strong focus
adhering to the highest standards of quality. on manufacturing, has proved significantly beneficial to chemical
players in gaining easy regulatory clearances, besides opening
Proficient Management Team: Your Company has a proficient
up huge opportunities for foreign collaboration. Your Company
management team which understands industry dynamics and
has always been at the forefront in supporting the Government
trends and also possesses sound domain knowledge. It has an
and is also confident in exploring more such investment and
established track record in the industry and is largely instrumental in
manufacturing opportunities with time.
developing the key strategies to accelerate the growth momentum.
Your Company’s management team contributes significantly to its Encouragement to Indian Exporters: India’s international trade
success while adhering to the Code of ‘Responsible Care’ and ethical has significantly improved over the past few years, facilitating your
values. Company in gaining key market insights and identifying additional
scope for new business avenues. An impetus towards this, has been
Weaknesses the shutdown of China’s chemical factories, which has provided an
Volatility in Raw Material Prices: The entire chemical industry opportunity to Indian exporters to open up new channels of trade
is impacted by volatility in prices of raw materials, as this is and create a whole new market, which bodes well for the future
directly linked to the prices of end-products and comprises of a growth of your Company.
major component in the chemical process. This is a way of life in
Favorable Government Initiatives: The year under review has
the chemical intermediates industry and your Company ensures
been an impressive one for India’s chemical sector in terms of
that a majority of the products are contracted with pass through
growth and productivity. The key initiatives of the Government
clauses thereby minimising adverse impact from raw material
such as 100% Foreign Direct Investment (FDI_ under the automatic
fluctuation.
approval route and the Draft National Chemical Policy proves to be
Lack of Alternative Energy Sources: A manufacturing company is beneficial for chemical companies, such as yours, and has resulted
constantly in need of a significant amount of power and electricity in an enhanced focus on R&D initiatives and technological advances.
in its processes of manufacturing and waste management. As non-
conventional energy is presently unfeasible and alternative fuels Threats
have several limitations, your Company makes use of conventional Obsolescence of Products and processes: With the advent of
fuels such as coal and furnace oil for power generation. Additionally, new technologies and new materials, there are risks to established
as an economy, India is still familiarising itself with these “energy products. Further, the discovery of newer, more efficient processes
efficient” sources. However, being a ‘Responsible Care’ Company, to manufacture chemical compounds can threaten the viability of
your Company in the process of adopting several strategies to widen some of your Company’s product lines. Further, the obsolescence
its scope of green endeavors. of products owing to lack of demand or import substitution also
affects the Company’s business model. However, your Company has
Currency Fluctuations: Fluctuation in exchange rates is a
a diversified portfolio of products which helps it mitigate these risks
regular operating risk. However, in recent years the degree of
by shifting its manufacturing resources towards alternate products.
volatility has sharpened and the Company has to guard itself
Further, your company constantly upgrades its processes through
against sudden, adverse movements. As your Company exports
technical improvements brought in by its in-house R&D team.
a wide range of products to various geographies, there is a
perennial currency risk that is pro-actively managed by hedging Lack of Talent Pool: Efficient and hard-working human capital
of exposure. Further, being a net exported your Company can is a rare and valuable resource today. India lacks widespread and
benefit from depreciation in the rupee. abundant availability of technically skilled laborers. Your Company
has initiated several measures to develop talent and undertakes
Opportunities comprehensive training for skill development, understand business
Substitute for Imports: Your Company takes pride in the fact complexities and adherence to global best practices. In addition,
that it’s Make In India-aligned Phenol and Acetone plant, which DNL has various initiatives in place to encourage high quality talent
commenced commercial production during the year, has created to shift to Vadodara which is gradually becoming a hub for chemical
a new benchmark for chemical companies in terms of import companies that have invested in the Dahej PCPIR.
substitution. Making these chemicals locally available offers
significant advantages to India as it not only facilitates the ease of MANAGEMENT OUTLOOK
performing operations but also reduce the time-lag with zero import Your Company has been a prominent player in India’s chemical
costs. Your Company will continue to explore further opportunities industry and is poised to reap the benefits of shifts in the global
in downstream derivatives to elevate its growth momentum. industry landscape. In addition to this, the Government’s support

Corporate OVERVIEW
statutory reportS
and key initiatives for the benefit of the industry has created Phenol and Acetone
multiple growth opportunities for domestic chemical companies, Your Company’s foray into the “Phenol-Acetone” market is resonant
such as yours. with its core expansion strategy of entering products that are import
dependent, scalable and aligned with its existing product portfolio.
Your Company remains well positioned to harness new
With a global scale plant, key capabilities to replace the import-
opportunities from our comprehensive domain knowledge, decades
dependent market, coupled with a strong demand environment,
of experience, and continuous innovation that have enabled us to
your Company is expected to be a leader in these as well as
deliver a consistent performance. The Company intends to keep
downstream products.
driving growth by repeatedly winning in the chosen geographies and
markets and creating enhanced value for all the stakeholders. With RISK MANAGEMENT
an enhanced focus on development, it is confident of continuing on Being a diversified and prudent enterprise, your Company
its promising growth trajectory in the times to come. continues to focus on a system-based approach to manage risks.
Its risk management and mitigation processes are embedded in
Basic Chemicals to Maintain Growth Momentum its key corporate strategies of developing a portfolio of world-class
In the fiscal year of FY 2019-20, Basic Chemicals is projected to products matching organisational capabilities, with ample market
continue the positive growth momentum, backed by stable demand opportunities.
visibility across key end-user industries. The underlying strategy for
Your Company remains focused on building distributed leadership
the segment is to focus on cost leadership. As a result, it is well placed
and succession planning processes and is coming up with ways to
to capitalise on the supply disruption in China and subsequent de-
enhance organisational capabilities. Accordingly, risk management
risking by customers which is creating further growth opportunities. has always been an integral part of your Company. Backed by strong
This, along with benefits reaped from Brownfield expansions, will internal control systems, existing Risk Management Framework and
drive your Company’s growth and enable it to improve profitability policies have laid down the roles and responsibilities of various
in a sustainable manner. business segments regarding the managing of risks, covering a
range of responsibilities, right from strategic to operational. These
Improving Penetration and Backward Integration of FSCs to responsibilities today offer a strong foundation for appropriate risk
drive growth and profitability management procedures, their effective implementation as well
Your Company’s strong in-house R&D team has successfully as the independent monitoring and reporting handled by Internal
developed several various products and optimise processes Audit and the top management team.
enabling your Company to enjoy a clear leadership position in
Your Company has set appropriate structures to monitor and manage
the market. Today, these products are widely used as chemical inherent business risks proactively. A strong and independent
intermediaries across industries such as agrochemicals, Internal Audit function at the corporate level carries out risk-focused
pharmaceuticals and personal care, among others. The Fine & audits across all the product segments and points out identified and
Specialty Chemcials segment will always focus on a constant supply constantly strengthened. Accordingly, raw material pricing risks,
of new high value molecules to cater to newer opportunities. The commodity risks and currency fluctuation risk effectively managed
segment has demonstrated its nimbleness in the past and will by its proficient and capable team. It also has appropriate checks
continue to demonstrate this strength. and balances in place and aims to minimise the adverse impact of
these risks on its operations.
Performance Products – Sustaining the momentum in
Performance INTERNAL CONTROL FRAMEWORK
The vertical of Performance Products, which derives most of its Your Company’s Corporate Governance policy guides its conduct
demand from paper, detergents and textile products, is projected of affairs, while its management team remains committed to
to witness a marked improvement in scale. As informed earlier, your the financial and accounting policies, as well as systems and
Company’s various strategies like change in product mix, modifying processes. Your Company’s Planning & Review Processes and the
new geographical reach, changing customer blend, increasing Risk Management Framework provide the requisite foundation
operational efficiencies - have worked favourably for the company. for internal financial controls concerning its Financial Statements.
Improvised customer relationships and sustainable supply of high The preparation is based on significant accounting policies that
quality product have steered DNL into becoming a preferred partner are carefully selected by the Management and approved by the
and this has been supported by re-orientation of product portfolio Audit Committee and the Board. These policies are reviewed and
and target markets all of which have resulted in better performance. updated from time to time. The key Management reviews these

systems, Standard Operating Procedures, and controls and audited fairness. Several initiatives are being implemented across segments
by an Internal Audit Team, whose findings and recommendations to strengthen the processes of talent management, capability
are reviewed by the Audit Committee and tracked through to development, and performance. Considered together, all these have
implementation. been significantly making a positive impact on talent attraction,
retention, and commitment.
Your Company has in place adequate internal financial controls
concerning the financial statements. Such controls have been
Your Company’s HR function continues to align its strategic
assessed during the year, taking into consideration the essential
interventions and processes with its long-term vision in creating
components of internal controls. Based on the results of such an
and also growing value for the Indian chemical industry and the
assessment carried out by the key Management, no reportable
stakeholders. These are one of the key drivers of improved business
material weakness or significant deficiencies or operation of
performance of your Company.
internal financial controls, observed. Your Company ensures that
regular audit and review processes reinforce the systems on an
Your Company’s talent management promise continues to play
on-going basis.
a key role in attracting and retaining the “best-in-class” talent.
HUMAN RESOURCE DEVELOPMENT Performance management also serves to align individual and team
Your Company’s Human Resource Development practices are performance with the larger strategic goals of the organisation. As
broadly guided by the key principles of relevance, consistency and on March 31, 2019, your Company had 1,362 permanent employees.
DISCLAIMER: This Report contains forward-looking statements that involve risks and uncertainties. When used in this Report, the words ‘anticipate,’ ‘belief,’
‘estimate,’ ‘expect,’ ‘intend,’ ‘will’ and other similar expressions as they relate to the Company and its Businesses are intended to identify such forward-looking
statements. The Company undertakes no obligation to update or revise any forward-looking statements publicly, whether as a result of new information,
future events, or otherwise. Actual results, performances or achievements could differ materially from those expressed or implied in such forward-looking
statements. Readers are cautioned not to place undue reliance on these forward-looking statements that speak only as of their dates. This Report should be
read in conjunction with the financial statements included herein and the notes to it.

Corporate OVERVIEW
statutory reportS
Directors’ Report
Dear Shareholders,
Your Directors have pleasure in presenting the Forty Eighth Annual Report together with the Audited Statement of Accounts for the
Financial Year (FY) ended March 31, 2019.
Financial Results
The Company’s financial performance for the year ended March 31, 2019 is summarized below:
(` In Crores)
Standalone Results Consolidated Results
Particulars
2018-19 2017-18 2018-19 2017-18
Total Revenue (Gross) 1794.52 1,490.77 2715.04 1,688.47
Less : Excise Duty on sale of Goods - 24.25 - 24.73
Total Revenue (Net of Excise Duty) 1794.52 1,466.52 2715.04 1,663.74
Operating Profit Before Depreciation, Finance Cost, Exceptional Item 308.23 214.37 429.02 208.60
and Tax
Less : Depreciation and Amortization expenses 52.88 51.95 77.79 52.60
Less : Finance Costs 42.85 40.34 83.25 45.15
Profit before Tax 212.50 122.08 267.98 110.85
Less : Tax expenses 74.46 38.62 94.32 31.83
Net Profit for the Year 138.04 83.46 173.66 79.02
Other Comprehensive Income (2.67) 0.86 (2.84) 0.86
Total Comprehensive income for the Year 135.37 84.32 170.82 79.88
Surplus brought forward from previous year 402.32 342.02 380.61 324.76
Balance available for Appropriation 537.64 426.20 548.16 404.49
PERFORMANCE REVIEW supply disruption in China. The Revenue from exports stood at
Standalone ` 580.39 Crores compared to ` 510.85 Crores last year.
In FY 2018-19, Total Revenue including Other Income stood at The Chemical Industry in India is witnessing an unprecedented
` 1794.52 Crores as against ` 1490.77 Crores in FY 2017-18. growth opportunity largely due to International events. For a
EBITDA came in at ` 308.23 Crores in FY 2018-19, higher by 44% company like Deepak Nitrite, which is into chemical intermediates,
as compared to ` 214.37 Crores in FY 2017-18. Raw material costs the opportunity stands accentuated as its products support a wide
stood at ` 976.17 Crores as against ` 843.82 Crores in FY 2017-18, range of industries. In the current scenario, Chemical Intermediates
up by 16%. are witnessing a big jump in demand both due to growing demand
from domestic end user industries and reduced availability of
Profit Before Tax (PBT) excluding Exceptional Items stood at ` 212.50 intermediates from China. Your Company expects the situation to
Crores as compared to ` 122.08 Crores in FY 2017-18. The Profit After
remain conducive in the foreseeable future.
Tax (PAT) excluding Exceptional Items came in at ` 138.04 Crores
as compared to ` 83.46 Crores in FY 2017-18. Favourable shift in At this backdrop, Your Company was able to ensure peak
product mix, strategic modifications in geography, end-user based performance amidst fluctuating pricing of Raw Materials and
better customer selection, various cost leadership initiatives across volatility in Foreign Exchange.
business segments led to better PAT performance. The Depreciation
and Finance Costs during the year stood at ` 52.88 Crores and Consolidated
` 42.85 Crores respectively. In FY 2018-19, Total Revenue including Other Income stood at
` 2,715.04 Crores as against ` 1,688.47 Crores in FY 2017-18.
Domestic Revenues stood at ` 1,211.53 Crores from ` 968.38 Crores
in FY 2017-18, representing a growth of 25% owing to strong demand EBITDA came in at ` 429.02 Crores in FY 2018-19, higher by 106% as
trends from local customers. Your Company, apart from reasons compared to ` 208.60 Crores in FY 2017-18. Raw material costs stood at
explained above, has also been benefitted due to production and ` 1,646.70 Crores as against ` 1,038.79 Crores in FY 2017-18, up by 59%.

Profit Before Tax excluding Exceptional Items stood at ` 267.98 UPDATE ON PHENOL AND ACETONE PROJECT
Crores as compared to ` 110.85 Crores in FY 2017-18. The Profit The Members are aware that your Company, through its wholly
After Tax excluding Exceptional Items came in at ` 173.66 Crores as owned subsidiary, Deepak Phenolics Limited (‘DPL’), commenced
compared to ` 79.02 Crores in FY 2017-18. Apart from reasons cited commercial production at a state-of-the-art plant at Dahej to
above for better performance, the newly commissioned Phenol- manufacture 200,000 MTPA of Phenol and 120,000 MTPA of its
Acetone manufacturing facility performed well and contributed to co-product Acetone on November 1, 2018. This is supported by
PBT, PAT sizably within a very short time of its operation exhibiting manufacturing facility of 260,000 MT of Cumene, which is a feedstock
sustainability of this business. The depreciation and finance for manufacturing Phenol and Acetone.
costs during the year stood at ` 77.79 Crores and ` 83.25 Crores
With this, your Company addresses the opportunity offered by the
respectively.
supply deficit in the domestic market which is majorly being met
The Domestic Revenues stood at ` 2,106.55 Crores from ` 1,164.22 by imports. In addition to being cost competitiveness as a domestic
Crores in FY 2017-18, representing a growth of 81% owing to supplier to domestic end users, your Company started leveraging
strong demand trends from local customers and also due to on the latest manufacturing technologies in its state-of-the art plant
commencement of operation of Phenol - Acetone plant which are which is efficient in every aspect.
sold in domestic market, being import substitutes. The Revenue
The plant is expected to save approx. USD 350 – 400 mn of Foreign
from Exports stood at ` 593.38 Crores compared to ` 511.96 Crores
Exchange every year by way of value addition of petrochemicals
last year.
which otherwise was being converted to low value LPG or was being
exported.
DIVIDEND
Based on your Company’s Performance, the Board of Directors With an objective of developing working relationships with major
of your Company is pleased to recommend a Dividend of ` 2/- clients across India as well as establishing strong marketing and
(Rupees Two only) per Equity Share for the year ended March distribution channels, DPL had worked on seed marketing of Phenol
31, 2019 on 13,63,93,041 Equity Shares of ` 2/- each, as against to understand and penetrate in the market. The seed marketing
` 1.30 (Rupee One and Paisa Thirty only) per Equity Share in the activity helped DPL to leverage its relationship to sell large
previous year. manufacturing quantities. DPL has appointed distributors across
India for selling and distributing Phenol and Acetone. It also has well
The total amount of Dividend, if declared by the Members, including tied up transportation and other logistics requirements which is one
Dividend Tax, will be ` 32.89 Crores (Previous Year ` 21.83 Crores). of the key requirements for handling such large volume of moving
inbound and outbound materials.
DIVIDEND DISTRIBUTION POLICY
Regulation 43A of the Securities and Exchange Board of India FINANCE
(Listing Obligations and Disclosure Requirements) Regulations, Your Company tries to strike a balance in its capital structure on a
2015 (‘Listing Regulations’) requires top 500 listed entities, based on consolidated level while efficiently managing its working capital,
market capitalization calculated as on March 31 of every Financial thereby maintaining debt at a reasonable level. During the year
Year, to formulate a Dividend Distribution Policy and disclose the under review, the total debt of your Company decreased due to
same in their Annual Report and on their websites. scheduled repayments and improved working capital management.
Accordingly, the Board of Directors of your Company has However, as your Company commissions its expansion projects,
adopted a Dividend Distribution Policy, which aims to ensure on a consolidated level, the consolidated debt level has gone up.
fairness, sustainability and consistency in distributing profits to This level is expected to normalise as the Phenol-Acetone project
the Shareholders. The Dividend Distribution Policy is attached has started generating revenue and it shall operate for the whole
as Annexure - A and is also available on the website of your year from FY 2019-20 onwards. Your Company has already provided
Company at www.godeepak.com. entire committed equity to its Phenol-Acetone project. On a
consolidated basis, Debt Equity Ratio of your Company is at 1.11
SHARE CAPITAL which is reasonably comfortable given the size of its Phenol-
The Paid-up Equity Share Capital of your Company as on March 31, Acetone project and associated debt.
2019 was ` 27.27 Crores comprising of 13,63,93,041 Equity Shares of Interest costs increased marginally during the year due to repayment
` 2/- each. Your Company has not issued any Equity shares during of low cost Foreign Currency debt, increase in the Libor and
the Financial Year 2018-19. increase in market rate in Rupee borrowing. Depreciation increased
due to regular growth and maintenance Capex. Your Company
TRANSFER TO RESERVES has an active team to manage its Foreign Exchange exposures to
Your Company proposes to transfer ` 5 Crores to the General minimise risk arising out of imports and exports. Due to prudent
Reserves out of the amount available for appropriation. fund management, your Company has been able to effectively

Corporate OVERVIEW
statutory reportS
manage its cash flows. There is always an effort to reduce the overall re-appointment of Shri Sudhin Choksey, Shri Sudhir Mankad, Shri
interest costs. On a standalone basis, Debt/Equity as on March 31, Sandesh Kumar Anand, Dr. Swaminathan Sivaram and Dr. Richard
2019 is reduced to 0.31 compared to 0.49 as on March 31, 2018, while H. Rupp as Independent Directors of your Company for second term
on a consolidated level, Debt/Equity ratio stood at 1.11 times, as of three (3) consecutive years are given in the Notice for approval by
mentioned above. the Members.
ICRA Limited re-affirmed the long-term rating of [ICRA] A+ and Short Shri Nimesh Kampani and Prof. Indira Parikh, Independent
Term rating of [ICRA] A1+ assigned to the fund based limits and Directors of the Company have expressed their desire not to be re-
non-fund based limits of your Company. ICRA also re-affirmed the appointed as Independent Directors of the Company for second
short-term rating of [ICRA] A1+ assigned to the Commercial Paper term. Accordingly, the Board of Directors do not recommend their
programme. The outlook on the long-term rating has been revised re-appointment as Independent Directors of the Company for
from Stable to Positive. second term. The first term of appointment of Shri Nimesh Kampani
Further, CRISIL Limited has assigned the Long-Term rating as CRISIL and Prof. Indira Parikh is upto August 7, 2019 and August 8, 2019,
AA- Stable and Short term rating as CRISIL A1+ to your Company. respectively.
DIRECTORS KEY MANAGERIAL PERSONNEL

During the year under review, following are the changes in the As required under Section 203 of Companies Act, 2013 of Companies
composition of Directors: Act, 2013 read with Rule 8 of the Companies (Appointment and
Remuneration of Managerial Personnel) Rules, 2014 following
Shri Umesh Asaikar (DIN: 06595059) was re-appointed as a Whole- persons are the Key Managerial Personnel of the Company:
time Director designated as the Executive Director & CEO of your
Company for a period from May 9, 2018 to May 31, 2020. The said 1. Shri Deepak. C. Mehta, Chairman & Managing Director
re-appointment was approved by the Members at the 47th Annual 2. Shri Umesh Asaikar, Executive Director & CEO
General Meeting of your Company held on August 3, 2018. 3. Shri Sanjay Upadhyay, Director-Finance & CFO
Shri Deepak C. Mehta (DIN: 00028377) was re-appointed as the 4. Shri Maulik Mehta, Whole-time Director
Chairman & Managing Director of your Company w.e.f. December 5. Shri Arvind Bajpai, Company Secretary
14, 2018 for a period of five (5) years, subject to the approval by the
Members. MEETINGS OF THE BOARD
Pursuant to Provision of Section 152 of the Companies Act, 2013, During FY 2018-19, Four (4) Board Meetings were held. The details of
Shri Sanjay Upadhyay (DIN: 01776546), Director-Finance & Chief Board Meetings with regard to their dates and attendance of each of
Financial Officer, retires by rotation at the ensuing Annual General the Directors thereat have been set out in the Report on Corporate
Meeting and being eligible, has offered himself for re-appointment. Governance, which forms part of this Report.
The Board recommends his re-appointment for approval by the
Members. INDEPENDENT DIRECTORS
The Board of Directors of your Company appointed Shri Sanjay The Independent Directors of your Company have furnished the
Asher (DIN: 00008221) and Smt. Purvi Sheth (DIN: 06449636) as declaration that they meet the criteria of independence as provided
Additional Directors at their meeting held on May 3, 2019, As per in Section 149 (7) of the Companies Act, 2013 and Regulation 25(8) of
provisions of the Companies Act, 2013, Shri Sanjay Asher and the Securities and Exchange Board of India (Listing Obligations and
Smt. Purvi Sheth hold office as Additional Director upto the ensuing Disclosure Requirements) Regulations, 2015.
Annual General Meeting. The Board of Directors of your Company confirms that the
Your Company has received notice from a Member proposing Independent Directors fulfill the conditions specified in Section 149
candidature for the appointment of Shri Sanjay Asher and (6) of the Act and Regulation 16(1)(b) of the Listing Regulations and
Smt. Purvi Sheth as Independent Directors for a period of three are independent of the management.
(3) consecutive years alongwith requisite fees. The Resolution(s)
for the appointment of Shri Sanjay Asher and Smt. Purvi Sheth as PERFORMANCE EVALUATION
Independent Directors are given in the Notice for approval by the Pursuant to the provisions of Companies Act, 2013 and SEBI
Members. (Listing Obligations and Disclosure Requirements) Regulations,
Shri Sudhin Choksey, Shri Sudhir Mankad, Shri Sandesh Kumar 2015 (‘Listing Regulations’), the Board of Directors have carried out
Anand, Dr. Swaminathan Sivaram and Dr. Richard H. Rupp, annual evaluation of its own performance, Board Committees and
Independent Directors have consented to act as Independent individual Directors.
Directors for the second term, subject to approval of shareholders by The performance of the Board / Committee was evaluated after
way of Special Resolution. Accordingly, Special Resolutions for the seeking inputs from all the Directors / Committee members on the

basis of the defined criteria including composition and structure, No.: 117366W/W-100018), were appointed for a period of
effectiveness of meetings, information and functioning. five (5) years at the 46th Annual General Meeting held on
June 26, 2017.
Performance evaluation of Independent Directors was done by the
entire Board, excluding the Independent Director being evaluated, The Companies (Amendment) Act, 2017 has waived the
on the basis of following evaluation criteria: requirement for ratification of the appointment of Statutory
• Relevant Knowledge, Expertise and Experience. Auditor by the shareholders at every Annual General Meeting.
Hence, the ratification of appointment of Statutory Auditors
• Devotion of time and attention to your Company’s long term
by your Company is not required. Accordingly, the Statutory
strategic issues.
Auditor will continue to hold office till the conclusion of the
• Addressing the most relevant issues for your Company. 51st Annual General Meeting of the Company approved by the
• Discussing and endorsing your Company’s strategy Members at the 46th Annual General Meeting of the Company.
• Professional Conduct, Ethics and Integrity.
(B) Secretarial Auditors
• nderstanding of Duties, Roles and Function as Independent
U
ursuant to the provisions of Section 204 of the Companies
P
Director.
Act, 2013 read with the Companies (Appointment and
Your Directors have expressed their satisfaction to the evaluation Remuneration of Managerial Personnel) Rules, 2014, the
process. Secretarial Audit for the year ended March 31, 2019 was
carried out by the Secretarial Auditors, M/s. KANJ & Co. LLP,
AUDIT COMMITTEE Company Secretaries, Pune. The Board of Directors of your
The Audit Committee consists of all Independent Directors Company has appointed M/s. KANJ & Co. LLP, Company
with Shri Sudhin Choksey as the Chairman of the Committee. Secretaries, Pune to carry out Secretarial Audit of your
The other members of the Audit Committee are Shri Sudhir Company for FY 2019-20.
Mankad and Shri S. K. Anand. The terms of reference of the
(C) Cost Auditors
Audit Committee, details of meetings held during the year and
attendance of members are set out in the Report on Corporate The Board of Directors of your Company has appointed
Governance, which forms part of this Report. M/s. B. M. Sharma & Co., Cost Accountants, to conduct
audit of your Company’s cost records for FY 2019-20 at a
STATUTORY AUDITOR’S REPORT remuneration of ` 7,50,000/- (Rupees Seven Lakhs Fifty
The observations made in the Auditor’s Report of M/s. Deloitte Thousand only) plus applicable tax, travelling and other out
Haskins & Sells LLP, Chartered Accountants, read together with of pocket expenses in connection with the said Audit. As
relevant notes thereon, are self-explanatory and hence do not call required under the provisions of Companies Act, 2013, the
for any comments. There is no qualification, reservation, adverse remuneration of Cost Auditors as approved by the Board of
remark or disclaimer by the Statutory Auditors in their Report. Directors is subject to ratification by the shareholders at the
ensuing Annual General Meeting.
REPORTING OF FRAUD BY AUDITORS The Cost Audit Report will be filed within the prescribed period
There was no instance of fraud during the year under review, which of 180 days from the close of the Financial Year.
required the Statutory Auditors to report to the Audit Committee
and/or Board under Section 143(12) of the Act and the rules made (D) Internal Auditors
thereunder. The Board of Directors has appointed M/s. Sharp & Tannan
Associates, Chartered Accountants, as Internal Auditors of your
SECRETARIAL AUDITOR’S REPORT Company to conduct the Internal Audit for FY 2019-20.
The Secretarial Audit Report of M/s. KANJ & Co. LLP, Company
Secretaries, Pune, for the Financial Year ended March 31, 2019 FIXED DEPOSITS
does not contain any qualification, reservation, adverse remark or During FY 2018-19, your Company has not accepted or renewed any
disclaimer by the Secretarial Auditors. Fixed Deposits.
The Secretarial Audit Report in Form MR-3 is annexed as As on March 31, 2019, 37 warrants aggregating to ` 7,43,507 issued
Annexure - B, which forms part of this Report. by your Company to the respective deposit holders towards
compulsory repayment of deposits and interest thereon in
AUDITORS accordance with the provisions of Section 74 of the Companies Act,
(A) Statutory Auditors 2013, remained uncleared. There has been no default in repayment
The Statutory Auditor of your Company, M/s. Deloitte Haskins of deposits or interest thereon during the year and there are no
& Sells LLP, Chartered Accountants, (Firm Registration deposits outstanding as on March 31, 2019.

Corporate OVERVIEW
statutory reportS
VIGIL MECHANISM The annual Financial Statements of the subsidiaries and related
Your Company has adopted a Whistle Blower Policy, to provide a detailed information will be kept at the Registered Office of your
formal vigil mechanism to the Directors and employees to report Company, as also at the Registered Offices of the respective
their concerns about unethical behaviour, including actual or Subsidiary Companies and will be available to investors seeking
suspected leak of unpublished price sensitive information, actual or information at any time. They are also available on the website
suspected fraud or violation of your Company’s Code of Conduct or of your Company. The Consolidated Financial results reflect the
ethics policy. The Policy provides for adequate safeguards against operations of subsidiary Companies, Deepak Phenolics Limited and
victimisation of employees who avail of the mechanism and also Deepak Nitrite Corporation Inc. Your Company has adopted a Policy
provides for direct access to the Chairman of the Audit Committee. for determining Material Subsidiaries in terms of Regulation 16(1)(c)
It is affirmed that no personnel of the Company has been denied of the Listing Regulations. The Policy, as approved by the Board, is
access to the Audit Committee. uploaded on your Company’s website.
The Whistle Blower Policy is available on the website of your PERFORMANCE OF SUBSIDIARIES
Company at https://www.godeepak.com/investor-compliances/ (a) Deepak Phenolics Limited
Deepak Phenolics Ltd. (DPL), a wholly-owned subsidiary
RELATED PARTY TRANSACTIONS of your Company commenced commercial production
All Related Party Transactions that were entered into during the at its Mega-Plant for manufacturing Phenol & Acetone on
Financial Year were on an arm’s length basis, in the ordinary November 1, 2018.
course of business and were in compliance with the applicable
DPL has reported Revenue from Operations of ` 913.50 Crores
provisions of the Companies Act, 2013 (‘the Act’) and the Listing
for the period ended March 31, 2019 and Net Profit for the
Regulations. There were no materially significant Related Party
period was ` 35.88 Crores.
Transactions entered into by your Company during the year that
would have required shareholders’ approval under the Listing (b) Deepak Nitrite Corporation Inc. (USA)
Regulations or the Act. Deepak Nitrite Corporation Inc. (‘DNC’) is a wholly owned
subsidiary company incorporated in the United States of
All Related Party Transactions are placed before the Audit
America to cater to the marketing requirements of your
Committee for approval. Prior omnibus approval of the Audit
Company in North and South American region. DNC actively
Committee is obtained for the transactions which are repetitive
does market research and scouts for market and potential
in nature. A statement of all Related Party Transactions is placed
customers for your Company’s products in the North and
before the Audit Committee for its review on a quarterly basis,
South American region. DNC also provides warehousing,
specifying the name of the Related Party, nature and value of the
distribution and customer relationship management
transactions.
services.
In line with the requirements of the Act and Listing Regulations, During FY 2018-19 the Total Revenue of DNC was USD 1,78,347
your Company has adopted a Policy on Related Party and the Net Income for the period was USD 4,888.
Transactions which is available on your Company’s website
Pursuant to the provisions of Section 129(3) of the Companies
at www. godeepak.com.
Act, 2013 read with Rule 5 of the Companies (Accounts) Rules,
Details of transactions with Related Parties are provided in the 2014, a statement containing salient features of the Financial
accompanying Financial Statements. There were no transactions Statements of your Company’s subsidiaries in Form AOC-1 is
with Related Parties during the year which would require to be attached to the Financial Statements.
reported in Form AOC-2.
PARTICULARS OF LOANS, GUARANTEES AND INVESTMENTS
SUBSIDIARY / ASSOCIATE COMPANIES AND CONSOLIDATED UNDER SECTION 186 OF THE COMPANIES ACT, 2013
FINANCIAL STATEMENTS The Particulars of Loans granted and Investments made by your
As required under Rule 8(1) of the Companies (Accounts) Rules, Company have been disclosed in the Financial Statements, forming
2014, the Board’s Report has been prepared on a Standalone basis. part of the Annual Report.
The Consolidated Financial Statements of your Company and MATERIAL CHANGES AND COMMITMENTS
its subsidiaries, prepared in accordance with Indian Accounting There have been no material changes and commitments affecting
Standards notified under the Companies (Indian Accounting the financial position of your Company since the close of Financial
Standards) Rules, 2015 (‘Ind AS’), forms part of the Annual Report Year i.e. since March 31, 2019 and the date of this Report. Further, it
and are reflected in the Consolidated Financial Statements of your is hereby confirmed that there has been no change in the nature of
Company. business of your Company.

DIRECTORS’ RESPONSIBILITY STATEMENT NOMINATION AND REMUNERATION POLICY
Pursuant to the requirement of Section 134(5) of the Companies Act, Your Company has adopted a Nomination and Remuneration Policy
2013 (“the Act”), the Board of Directors of your Company, to the best for the Directors, Key Managerial Personnel and Senior Management
of their knowledge and ability, confirm that: employees pursuant to the requirement of Section 178 of the
(a) in the preparation of the Annual Accounts, the applicable Companies Act, 2013 and Listing Regulations.
accounting standards have been followed and there are no
material departures; The Nomination and Remuneration Policy of your Company is
(b) they have selected accounting policies and applied them annexed as Annexure - E.
consistently and made judgments and estimates that are
reasonable and prudent so as to give a true and fair view of the EXTRACTS OF ANNUAL RETURN
state of affairs of your Company at the end of the Financial Year Pursuant to Section 92(3) of the Companies Act, 2013 read with Rule
and of the profit of your Company for that period; 12(1) of the Companies (Management and Administration) Rules,
(c) they have taken proper and sufficient care for the maintenance 2014, the extract of the Annual Return in the prescribed form i.e.
of adequate accounting records in accordance with the Form MGT-9 is annexed herewith as Annexure – F, which forms part
provisions of the Companies Act, 2013 for safeguarding the of this Report.
assets of your Company and for preventing and detecting
fraud and other irregularities; Annual Return
(d) they have prepared the Annual Accounts on a going concern Pursuant to provisions of Section 92 (3) of the Companies Act,
basis; read with Rule 8A (1) of the Companies (Accounts) Rules, 2014 as
(e) they have laid down internal financial controls to be followed amended from time to time, your Company has uploaded draft
by your Company and that such internal financial controls are Annual Return for the Financial Year ended March 31, 2019 on the
adequate and are operating effectively; website of your Company at https://www.godeepak.com/investor-
compliances/.
(f) they have devised proper systems to ensure compliance with
the provisions of all applicable laws and that such systems
PARTICULARS OF EMPLOYEES
were adequate and operating effectively.
Disclosures with respect to the remuneration of Directors and
CORPORATE GOVERNANCE employees as required under Section 197 of the Companies Act,
A separate report on Corporate Governance is provided together 2013 and Rule 5(1) of Companies (Appointment and Remuneration of
with a Certificate from Shri Dinesh Joshi, a Practising Company Managerial Personnel) Rules, 2014 have been annexed to this report
Secretary, M/s. KANJ & Co. LLP, Company Secretaries, Pune regarding as Annexure - G.
compliance of conditions of Corporate Governance as stipulated
under Listing Regulations. Details of employee remuneration as required under provisions
of Section 197 of the Companies Act, 2013 and Rule 5(2) and 5(3)
BUSINESS RESPONSIBILITY REPORT of the Companies (Appointment and Remuneration of Managerial
The Business Responsibility Report on your Company’s business as Personnel) Rules, 2014 are available at the Registered Office of your
required by Regulation 34(2) of the Listing Regulations, initiatives on Company during working hours, 21 days before the 48th Annual
environmental, social and governance aspects forming part of this General Meeting and shall be made available to any shareholder on
Report is annexed as Annexure - C. request. Such details are also available on your Company’s Website
www.godeepak.com.
CORPORATE SOCIAL RESPONSIBILITY
The Corporate Social Responsibility (CSR) activities of your Company CONSERVATION OF ENERGY & TECHNOLOGY ABSORPTION AND
are being implemented through Deepak Foundation, the group’s FOREIGN EXCHANGE EARNINGS AND OUTGO
charitable trust encompassing social interventions in various
Pursuant to the requirement of Section 134(3)(m) of the Companies
developmental domains such as Health, Education, Livelihood, etc.
Act, 2013 read with Rule 8(3) of the Companies (Accounts) Rules,
During FY 2018-19, your Company has spent ` 250 Lakhs on CSR 2014, the relevant data pertaining to the Conservation of Energy,
activities, against the requirement of ` 213 Lakhs, being 2% of Technology Absorption and Foreign Exchange Earnings and Outgo
average of the net profits for the preceding three years. are provided in Annexure - H of this Report.
Your Company has a policy on Corporate Social Responsibility
and the same has been posted on the website of the Company at STATE OF COMPANY’S AFFAIRS
www.godeepak.com. The Report on CSR activities in terms of the The state of your Company’s affairs is given under the heading
requirements of Companies (Corporate Social Responsibility Policy) ‘Performance Review’ and various other headings in this Report and
Rules, 2014 is annexed herewith as Annexure - D, which forms part in the Management Discussion and Analysis, which forms part of the
of this Report. Annual Report.

Corporate OVERVIEW
statutory reportS
SIGNIFICANT OR MATERIAL ORDERS PASSED AGAINST THE in time and corresponding mitigation measures are effective.
COMPANY This provides a proactive and value adding review process which
Pursuant to the requirement of Section 134(3)(q) of the Companies enables maintaining the risk profile at an acceptable level in a
Act, 2013 read with Rule 8(5)(vii) of the Companies (Accounts) Rules, rapidly changing environment.
2014, it is confirmed that during FY 2018-19 there were no significant
or material orders passed by the Regulators or Courts or Tribunals RESEARCH & DEVELOPMENT
impacting the going concern status and your Company’s operations Your Company has a Research & Development (R&D) facility at
in future. Nandesari, Gujarat with pilot plants at Roha, Maharashtra and
Nandesari, Gujarat. The Department of Scientific and Industrial
SECRETARIAL STANDARDS OF ICSI Research (DSIR), New Delhi, on behalf of Government of India vide
Your Company is in compliance with the Secretarial Standards on letter August 10, 2017 has recognized your Company’s in-house R&D
Meetings of the Board of Directors (SS - 1) and General Meetings facilities for further period of 3 years i.e. upto March 31, 2020.
(SS - 2) issued by The Institute of Company Secretaries of India and
Your Company continues to invest in a comprehensive Research &
approved by the Central Government.
Development programme leveraging its world-class infrastructure,
benchmarked processes, state-of-the-art technology and a
INTERNAL CONTROL SYSTEMS
business-focused R&D strategy.
Your Company has in place adequate Internal Control Systems,
including Internal Financial Controls. The Internal Control System is Your Company’s R&D center at Vadodara focuses on innovation of
exercised through documented policies, guidelines and procedures new compounds in order to substitute imports of pharmaceutical
to ensure compliance with various policies, practices and statutes, and agrochemical intermediates, innovation and development
and that all assets are safeguarded and protected against loss from of specality chemicals and personal care intermediates and value
unauthorised use or disposition and that those transactions are added products from by-products.
authorised, recorded and reported correctly.
Your Company continues to focus its R&D efforts on process
The Internal Auditor carries out extensive audits throughout the year improvement of its existing products, recovery of products from
across all locations and across all functional areas. effluents. The R&D departments also helps in troubleshooting in
manufacturing departments.
The audit observations and corrective actions taken thereon
are periodically reviewed by the Audit Committee to ensure Your Company is a knowledge led entity and has spruced up its
effectiveness of the Internal Control System. The Internal Control R&D facility for innovation and to collaborate with its customers
system is designed to ensure that the financial and other records to understand consumer preference and develop new product
are reliable for preparing Financial Statements and other data, and applications to cater to the needs of its customers. Your Company
for maintaining accountability of persons. focuses its R&D efforts to develop cost effective, cleaner technologies
to improve profitability. Through its R&D capabilities, your Company
RISK MANAGEMENT has been successful in developing and enhancing its portfolio of
Your Company has in place a Risk Management framework to cutting edge products. Your Company believes that its ability to
identify, evaluate and monitor business risks and challenges develop new product applications and ability to customize products
across your Company. The Risk Management Policy, pursuant to to suit customer needs have helped in expanding its customer base,
Section 134 of the Companies Act, 2013 has been adopted based thereby enabling it to establish leadership position.
on this framework. The Risk Management Policy provides for
creation of a Risk Register, identification of risks and formulating SAFETY, HEALTH & ENVIRONMENT
mitigation plans. The enterprise risks for your Company are Your Company believes in responsible chemistry for sustainable
identified by the respective Risk Managers and presented future through its commitment to the principles of Responsible
to the Board for review. Your Company has duly constituted Care. The continual improvement of safety, health, environment
Risk Management Committee. The Committee reviews your protection, energy and resources efficiency and social responsibility
Company’s performance against identified risks, formulates is inbuilt in the strategy of your Company.
strategies towards identifying new and emergent risks that
may materially affect your Company’s overall risk exposure and Your Company has laid down policies, principles and standards
reviews the Risk Management Policy and structure. which are mandatory for all its manufacturing units for adherence.
It aims to achieve excellence in environment protection, health
The Board of Directors reviews the risk assessment and management and safety across its businesses. Your Company’s
minimization procedures regularly. The Risk Register gets updated Environment, Health and Safety (EHS) Policy also specifies the EHS
periodically, to ensure that the risks remain relevant at any point requirements to be observed by its suppliers, contractors & others.

Your Company has adopted global principles of sustainable HUMAN RESOURCES
development, Responsible Care and management system Your Company considers its employees as most valuable resource
standards. It has undertaken several environmental initiatives in and ensures strategic alignment of Human Resource practices
the areas of reduction in greenhouse gases and energy efficiency to business priorities and objectives. Your Company’s constant
programs. endeavour is to invest in people and processes to improve human
capital for the organisation and service delivery to its customers.
Your Company has system to ensure compliance to the requirements
Attracting, developing and retaining the right talent will continue
of applicable laws and regulations. Manufacturing locations of
to be a key strategic initiative and the organisation continues to
your Company has facilities for the proper treatment of effluents.
be focussed on building up the capabilities of its people. Given
Your Company’s emissions, effluents and wastes are within the
growth plans of your Company, an important strategic focus
permissible limits. of your Company is to continue not only to nurture its human
Employees’ health and safety is accepted as a core business capital, but also proactively focus on preparing all employees for
value at your Company. The top management of your Company the challenges of the future. Your Company strives to provide a
continuously works towards establishing, sustaining and improving healthy, conducive and competitive work environment to enable
the safety culture. the employees excel and create new benchmarks of productivity,
efficiency and customer delight. Your Company always believes
All manufacturing plants and corporate office of your Company in maintaining mutually beneficial industrial relations with the
has Quality, Environment & Occupational Health & Safety Union, which are of paramount importance for success of any
Management Systems as per revised standards for ISO 9001, ISO organisation and hence the industrial relations have always been
14001 & OHSAS 18001. smooth, cordial and trusting.
Your Company has Process Safety Management (PSM) system at INSURANCE

all manufacturing locations. It has carried out Safety Integrity Level
All the insurable interests of your Company including inventories,
(SIL) based HAZOP studies and Layer of Protection Analysis (LOPA)
buildings, plant and machinery are adequately insured against risk
study for existing and new processes and products. The outcomes of
of fire and other risks.
these studies are being used to enhance Process Automation in all
the Units, which in turn improves process safety at the sites. DISCLOSURE AS REQUIRED UNDER SECTION 22 OF THE SEXUAL
Your Company had zero lost time incidents during the year. HARASSMENT OF WOMEN AT WORKPLACE (PREVENTION,
Good engineering practices, preventive checking systems, safety PROHIBITION AND REDRESSAL) ACT, 2013
awareness and training has helped your Company in maintaining its Your Company has in place an Anti-Discrimination and Harassment
operations and workplace free from incidents. Policy in line with the requirements of the Sexual Harassment of
Women at Workplace (Prevention, Prohibition and Redressal) Act,
Your Company regularly monitors the occupational health of 2013. An Internal Complaints Committee has been set up to redress
employees working in designated hazardous areas with respect to the complaints received regarding sexual harassment at workplace.
exposure to hazardous chemicals and processes. It also monitors All employees (permanent, contractual, temporary, trainees) are
employees for any indications of lifestyle or work-style related covered under this Policy. No complaint was received from any
diseases and provides counseling. Well-equipped Occupational employee during FY 2018-19 and hence no complaint is outstanding
Health Centers are in place at all manufacturing locations to monitor as on March 31, 2019 for redressal.
health of employees on regular basis.
ACKNOWLEGDEMENT
Your Company has accepted and implemented the principles of
Your Directors place on record their deep appreciation to employees
Together for Sustainability (TfS) and has fetched the prestigious 75%
at all levels for their hard work, dedication and commitment. The
score in Together for Sustainability (TfS) Audit by Intertek.
Board also places on record its appreciation for the continued
Your Company is founder member of Nicer Globe initiative. It takes cooperation and support received by your Company during the year
utmost care during transportation and ensures compliance with from investors, bankers, financial institutions, customers, business
all checks and measures for a safe and secured delivery. All raw partners, all regulatory and government authorities and other
materials and products within supply chain framework of your stakeholders.
Company are transported in a secure manner, for the safety of its
customers, carriers, suppliers, distributors and contractors. For and on behalf of the Board
Your Company proactively fulfills the environmental requirements Deepak C. Mehta

of customers by delivering products that match international Place: Vadodara Chairman & Managing Director
standards. Date : May 3, 2019 (DIN: 00028377)

Corporate OVERVIEW
statutory reportS
Annexure - A
Dividend Distribution Policy
1. INTRODUCTION 4.3. “Dividend” includes any interim dividend.
The Securities and Exchange Board of India (SEBI) on July 8, 4.4. “Financial Year” a consecutive period of 12 months
2016 has notified the SEBI (Listing Obligations and Disclosure ending March 31.
Requirements) (Second Amendment) Regulation, 2016.
4.5. “Policy” means this Dividend Distribution Policy.
Vide these Regulations, SEBI has inserted Regulation 43A
after Regulation 43 of SEBI (Listing Obligations and Disclosure 4.6. “Regulations” shall mean SEBI (Listing Obligations and
Requirements) Regulation, 2015, which requires top five Disclosure Requirements) Regulation, 2015, including
hundred listed entities (based on market capitalization any amendments, modifications, clarifications or re-
calculated as on March 31 of every Financial Year) to formulate enactment thereof, for the time being in force.
a Dividend Distribution Policy, which shall be disclosed in its
Annual Report. 5. DECLARATION OF DIVIDEND
5.1
Subject to provisions of the Act, Dividend may be
Deepak Nitrite Limited (‘the Company’), being one of the five
declared and paid out of:
hundred companies as per the criteria mentioned above; the
Board of Directors has approved and adopted this Dividend (a) Profits of the Company for the Financial Year for
Distribution Policy at their meeting held on May 4, 2018, being which the Dividend is to be paid after setting off
the effective date of the Policy. carried over losses of the previous Financial Year
and depreciation not provided in the previous
2. OBJECTIVES AND SCOPE Financial Year(s);
This Policy lays down the broad framework which will
(b)
Undistributed profits of the previous Financial
act as a guiding principle for the purpose of declaring or
Years remaining undistributed after providing for
recommending Dividend during or for any Financial Year, by
depreciation in accordance with the Act and/or
the Company.
Regulations; or
The intent of the Policy is to broadly specify the external and
(c) Out of (a) and (b) both.
internal factors including financial parameters that shall be
considered while declaring Dividend and the circumstances
5.2
Before declaration of Dividend, the Company may
under which shareholders of the Company may or may not
transfer a portion of its profits to reserves of the Company
expect Dividend and how the retained earnings shall be
as may be considered appropriate by the Board at its
utilized etc.
discretion.
The Policy, however, is not an alternative to the decision
making process of the Board for recommending Dividend and 6. PARAMETERS FOR DECLARATION OF DIVIDEND
the Board may take into consideration other factors as well in 6.1
The Board of Directors may consider the following
addition to those numerated in this Policy. financial parameters, internal and external factors while
recommending or declaration of the Dividend:
3. APPLICABILITY
A. Financial Parameters / Internal Factors
This Policy shall apply to the Dividend on the Equity Shares of
• Operating cash flow of the Company
the Company. Presently, the Company has only one class of
Equity Shares. • Profit earned during the Financial Year and
available for distribution.
This Policy shall not apply to determination and declaration
of Dividend on preference shares, as and when issued by the • Earnings Per Share (EPS)
Company, as the same will be as per the terms of issue of such
preference shares, approved by the shareholders. • Gross Dividend payout ratio
• Financial Ratios
4. DEFINITIONS
• Business expansion and growth
“Board of Director” or “Board” shall mean the Board of
4.1.
Directors of the Company, as constituted from time to time. • Company’s liquidity position and future cash flow
need
4.2. “Companies Act” or “Act” shall mean the Companies
• Stipulation / covenants in loan Agreements
Act, 2013 and Rules framed thereunder, including
any amendments, modifications, clarifications or re- • Such other factors as the Board may deem fit from
enactment thereof, for the time being in force. time to time

B. External Factors • Such purpose as may be permitted under the Act and/or
• Economic environment Regulations
• Capital markets 9. PROCEDURE

• Global conditions 9.1 Pursuant to provisions of the Act, the Regulations and
• Industry outlook and growth rate the Policy, interim Dividend approved by the Board of
Directors will be confirmed by the shareholders and final
• Economic and regulatory framework Dividend, if any, recommended by the Board of Directors,
• Governmental policies will be subject to shareholders’ approval, at the ensuing
Annual General Meeting of the Company.
6.2 While recommending or declaring Dividend, the Board
will consider adequacy of profit calculated in accordance 9.2 The Members, whose name appears in the Register of
with the applicable provisions of the Act and Indian Member as on Record Date/Book Closure, as may be
Accounting Standards. The Board of Directors may, in decided by the Board of Directors, shall be entitled for
exceptional circumstances, consider utilising retained Dividend.
earning for declaration of Dividend subject to the
provisions of the Act and/or Regulations. 9.3 The Dividend shall be paid to the Members within the
limit prescribed under the Act and/or Regulations.
7. CIRCUMSTANCES UNDER WHICH SHAREHOLDERS MAY OR 9.4 The Company shall ensure compliance of provisions of
MAY NOT EXPECT DIVIDEND
the Act and/or Regulations and this Policy in relation to
Dividend payout is a crucial decision as it determines the share Dividend declared by the Company.
of profit to be distributed amongst the shareholders and share
of profit to be retained in the business. The decision seeks
10. PARAMETERS WITH REGARD TO VARIOUS CLASSES OF
to balance the dual objectives of appropriately rewarding
SHARES
shareholders through Dividends and retaining profits in order
to maintain a healthy capital adequacy ratio to support future Since the Company has issued only one class of Equity Shares
growth. The shareholders of the Company may not normally with equal voting rights, all the Members of the Company are
expect Dividend in the following circumstances, subject to entitled to receive the same amount of Dividend per Equity
discretion of Board of Directors: Share. The Policy shall be suitably revised at the time of issue
of any new class of shares depending upon the nature and
• I n case the Company has incurred losses or inadequacy
guidelines thereof.
of profit
• I t would in the interest of the Company to re-invest / 11. DISCLOSURES
plough back the profits of the Company for major The Dividend Distribution Policy shall be disclosed in the
expansion / diversification requiring major funding Annual Report and on the website of the Company.
• Any other unforeseen event which would restrict ability
to recommend Dividend 12. REVIEW AND AMENDMENTS
12.1 This Policy will be reviewed by the Board of Directors of
8. UTILISATION OF RETAINED EARNINGS the Company as they deem necessary.
The Board of Directors may retain its earnings in order to
12.2 The Board of Directors on its own can amend this Policy,
make better use of available funds and increase the value of
the stakeholders in the long run. The decision of utilisation of as and when deem fit.
the retained earnings of the Company shall be based on the 12.3 In case of any amendment(s), clarification(s), circular(s)
following: etc. issued by the relevant authorities, not being
• Market expansion plan consistent with the provisions laid down under this Policy,
then such amendment(s), clarification(s), circular(s)
• Product expansion plan
etc. shall prevail upon the provisions hereunder and
• Increase in production capacity this Policy shall stand amended accordingly from the
effective date as laid down under such amendment(s),
• Replacement of capital assets
clarification(s), circular(s) etc.
• Diversification of business
• Long term strategic plans For and on behalf of the Board
• Dividend payment Deepak C. Mehta

• uch other criteria as the Board may deem fit from time
S Place: Vadodara Chairman & Managing Director
to time Date : May 3, 2019 (DIN: 00028377)

Corporate OVERVIEW
statutory reportS
Annexure - B
Form No. MR-3

SECRETARIAL AUDIT REPORT
FOR THE FINANCIAL YEAR ENDED MARCH 31, 2019
[Pursuant to Section 204(1) of the Companies Act, 2013 and Rule No. 9 of the Companies
(Appointment and Remuneration of Managerial Personnel) Rules, 2014]
To, (v)
Foreign Exchange Management Act, 1999 and the rules
The Members, and regulations made thereunder to the extent of Foreign
Deepak Nitrite Limited, Direct Investment, Overseas Direct Investment and External
Aaditya-I, Chhani Road, Commercial Borrowings.
Vadodara 390 024,
(vi) The following Regulations and Guidelines prescribed under the
Gujarat.
Securities and Exchange Board of India Act, 1992 (‘SEBI Act’):-
We have conducted the Secretarial Audit of the compliance a. The Securities and Exchange Board of India (Substantial
of applicable statutory provisions and the adherence to good Acquisition of Shares and Takeovers) Regulations, 2011;
corporate practices by Deepak Nitrite Limited (hereinafter called
b. Securities and Exchange Board of India (Prohibition of
the “Company”). Secretarial Audit was conducted in a manner
Insider Trading) Regulations, 2015;
that provided us a reasonable basis for evaluating the corporate
conducts/statutory compliances and expressing our opinion c. The Securities and Exchange Board of India (Issue of
thereon. Capital and Disclosure Requirements) Regulations,
2018: There were no events occurred during the period
Based on our verification of the Company’s books, papers, minute which attracts provisions of these Regulations, hence not
books, forms and returns filed and other records maintained applicable.
by the Company and also the information provided by the
Company, its officers, agents and authorized representatives d.
The Securities and Exchange Board of India (Share
during the conduct of Secretarial Audit, we hereby report that in Based Employee Benefits) Regulations, 2014: There were
our opinion, the Company has, during the audit period covering no events occurred during the period which attracts
the Financial Year ended on March 31, 2019, complied with the provisions of these Regulations, hence not applicable.
statutory provisions listed hereunder and also that the Company e. The Securities and Exchange Board of India (Issue and
has proper Board-processes and compliance-mechanism in Listing of Debt Securities) Regulations, 2008: There were
place to the extent, in the manner and subject to the reporting no events occurred during the period which attracts
made hereinafter: provisions of these Regulations, hence not applicable.
We have examined the books, papers, minute books, forms and f. The Securities and Exchange Board of India (Registrars
returns filed and other records maintained by the Company for to an Issue and Share Transfer Agents) Regulations,
the Financial Year ended on March 31, 2019 according to the 1993: There were no events occurred during the period
provisions of: which attracts provisions of these Regulations, hence not
applicable.
(i)
The Companies Act, 2013 (the Act) and the rules made
thereunder; g. The Securities and Exchange Board of India (Delisting of
Equity Shares) Regulations, 2009: There were no events
(ii) The Securities Contracts (Regulation) Act, 1956 (‘SCRA’) and
occurred during the period which attracts provisions of
the rules made thereunder;
these Regulations, hence not applicable; and
(iii) The Depositories Act, 1996, and the Regulations and Bye-laws
h. The Securities and Exchange Board of India (Buyback
framed thereunder;
of Securities) Regulations, 2018 : There were no events
(iv) The Depositories Act, 2018, and the Regulations and Bye-laws occurred during the period which attracts provisions of
framed thereunder; these Regulations, hence not applicable.

(vii) Other laws as applicable specifically to the Company; Adequate notice is given to all Directors to schedule the Board
a) The Environment (Protection) Act, 1986, Meetings. Agenda and detailed notes on agenda were sent at least
seven days in advance, and a system exists for seeking and obtaining
b) The Water (Prevention & Control of Pollution) Act, 1974,
further information and clarifications on the agenda items before
c) The Air (Prevention & Control of Pollution) Act, 1981, the meeting and for meaningful participation at the meeting.
d) Public Liability Insurance Act, 1991,
All the decision in the Board meetings were carried through by
e) Explosives Act, 1884,
majority while there were no dissenting members’ views and hence
f) Hazardous Wastes (Management, Handling and Trans- not captured and recorded as part of the Minutes.
boundary Movement) Rules, 2008,
g) Petroleum Act, 1934 and Rules made thereunder. We further report that:
There are adequate systems and processes in the Company

e have also examined compliance with the applicable clauses of
W
commensurate with the size and operations of the Company to
the following:
monitor and ensure compliance with applicable laws, rules,
(i) Secretarial Standards issued by The Institute of Company regulations and guidelines.
Secretaries of India; and
(ii) The Securities and Exchange Board of India (Listing Obligations We further report that during the audit period, the Company
and Disclosures requirements) Regulations, 2015. does not has any events having a major bearing on it’s affairs
in pursuance of the above referred laws, rules, regulations,
uring the period under review the Company has generally complied
D
guidelines, standards, etc.
with the provisions of the mentioned Acts, Rules, Regulations,
Guidelines, Standards, etc.
For KANJ & CO. LLP
We further report that: Company Secretaries
The Board of Directors of the Company is duly constituted with

proper balance of Executive Directors, Non-Executive Directors and
Independent Directors. There were no changes in the composition Dinesh Joshi
of the Board of Directors that took place during the period under Date: May 3, 2019 Designated Partner
review. Place: Pune Membership No: FCS- 3752 CP No: 2246

Corporate OVERVIEW
statutory reportS
To,
The Members,
Deepak Nitrite Limited,
Aaditya-I, Chhani Road,
Vadodara 390024,
Gujarat.
Our report of even date is to be read along with this letter.
1. Maintenance of secretarial record is the responsibility of the management of the Company. Our responsibility is to express an opinion
on these secretarial records based on our audit.
2. We have followed the audit practices and processes as were appropriate to obtain reasonable assurance about the correctness of the
contents of the secretarial records. The verification was done on test basis to ensure that correct facts are reflected in secretarial records.
We believe that the processes and practices, we followed provide a reasonable basis for our opinion.
3. We have not verified the correctness and appropriateness of financial records and Books of Accounts of the Company.
4. Wherever required, we have obtained the management representation about the compliance of laws, rules and regulations and
happening of events etc.
5. The compliance of the provisions of Corporate and other applicable laws, rules, regulations, standards is the responsibility of
management. Our examination was limited to the verification of procedures on test basis.
6. The Secretarial Audit Report is neither an assurance as to the future viability of the Company nor of the efficiency or effectiveness with
which the management has conducted the affairs of the Company.
For KANJ & CO. LLP

Company Secretaries
Dinesh Joshi
Date: May 3, 2019 Designated Partner
Place: Pune Membership No: FCS- 3752 CP No: 2246

Annexure - C
Business Responsibility Report
[As per Regulation 34(2)(f) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015]
SECTION A: GENERAL INFORMATION ABOUT THE COMPANY
1 Corporate Identity Number (CIN) of the Company : L24110GJ1970PLC001735

2 Name of the Company : Deepak Nitrite Limited
3 Registered Address : Aaditya-I, Chhani Road, Vadodara -390 024, Gujarat, India
4 Website : www.godeepak.com
5 E-mail -Id : investor@godeepak.com
6 Financial Year reported : April 1, 2018 to March 31, 2019
Sector(s) that the Company is engaged in (industrial activity Commodity Chemicals
7 :
code-wise) NIC Code: 24121
8 List of three key products/services that the Company 1) Sodium Nitrite
manufactures/provides (as per Balance sheet) : 2) Ethyl Hexyl Nitrate (EHN)
3) Optical Brightening Agent
9 Total number of locations where business activity is undertaken (a) Number of International Locations - 01#
by the Company : (b) Number of National Locations - 09
#
through wholly-owned subsidiary
10 Markets served by the Company : National and International
SECTION B: FINANCIAL DETAILS OF THE COMPANY

1 Paid up Capital (INR) : ` 2,727.86 Lakhs
2 Total Turnover (INR) : ` 1,79,191.87 Lakhs
3 Profit After Tax (INR) : ` 13,804.21 Lakhs
4 Total Spending on Corporate Social Responsibility (CSR) as Company’s total spending on CSR for the Financial Year 2018-19
:
percentage of profit after tax (%) is ` 250 Lakhs which is 1.81% of PAT.
5 List of activities in which expenditure in 4 above has been incurred:-
A. Health Care
l Comprehensive Emergency Obstetric Newborn Care (CEmONC)
l Mobile Health Unit
l Help Desk Project
l Integrated Child Development Scheme
l De-addiction and Rehabilitation Center
B. Skill Development/ Education
l English & Maths Education at Nandesari School
l Home Health Aide Course
l Mobile Library
l Samaj Suraksha Sankul - Vocational Training
l Enterprenual Activities through SHG
SECTION C: OTHER DETAILS

1 Does the Company have any Subsidiary Company/ Companies? : Yes. The Company has 2 wholly owned subsidiaries.
2 Do the Subsidiary Company/Companies participate in the The subsidiary companies participate in the BR initiates of the
BR Initiatives of the parent company? If yes, then indicate the : Company by following the basic principles and practices of the
number of such subsidiary company(s) Parent Company, to the extent applicable.
3 Do any other entity/entities (e.g. suppliers, distributors etc.) that The Company encourages its Business Associates to support
the Company does business with, participate in the BR initiatives Company’s BR initiatives, to the extent feasible.
:
of the Company? If yes, then indicate the percentage of such
entity/entities?

Corporate OVERVIEW
statutory reportS
SECTION D: BR INFORMATION
1. Details of Director/Directors responsible for Business Responsibility
a Details of the Director/Directors responsible for a DIN Number : 06595059
implementation of the BR policy/policies b Name : Shri Umesh Asaikar
c Designation : Executive Director & CEO
b Details of the BR head a DIN Number : 06595059
b Name : Shri Umesh Asaikar
c Designation : Executive Director & CEO
d Telephone Number : 0265-3960200
e Email ID : umesh@godeeepak.com
2. Principle-wise (as per National Voluntary Guidelines (NVGs)) Business Responsibility (BR) Policy/policies
At Deepak Nitrite Limited, Business Responsibility is guided by “National Voluntary Guidelines (NVGs) on Social, Environmental and
Economic Responsibilities of Business” released by the Ministry of Corporate Affairs, which articulates nine principles as below:
P1 Businesses should conduct and govern themselves with Ethics, Transparency and Accountability.
P2 Businesses should provide goods and services that are safe and contribute to sustainability throughout their life cycle.
P3 Businesses should promote the well-being of all employees.
P4 Businesses should respect the interests of, and be responsive towards all stakeholders, especially those who are disadvantaged,
vulnerable and marginalised.
P5 Businesses should respect and promote Human Rights.
P6 Business should respect, protect and make efforts to restore the environment.
P7 Businesses, when engaged in influencing public and regulatory policy, should do so in a responsible manner.
P8 Businesses should support inclusive growth and equitable development.
P9 Businesses should engage with and provide value to their customers and consumers in a responsible manner.
(a) Details of Compliances
S.
Question(s) P1 P2 P3 P4 P5 P6 P7 P8 P9
No.
1 Do you have a policy/ policies for Y Y Y Y Y Y Y Y Y
2 Has the policy being formulated in consultation with Yes
the relevant stakeholders?
3 Does the policy conform to any national / Most of the policies are aligned to various standards such as Responsible
international standards? If yes, specify? care principles, Together for Sustainability System, ISO 9001, ISO 14001 &
OHSAS 18001 system.
4 Has the policy being approved by the Board? Is yes, Policies mandated under the Companies Act, 2013 and the SEBI (LODR)
has it been signed by MD/ owner/ CEO/ appropriate Regulations, 2015 are approved by the Board and other policies are
Board Director? approved by the Executive Director & Chief Executive Officer of the
Company and signed by the Executive Director & Chief Executive Officer
of the Company.
5 Does the Company have a specified committee The Company has Audit Committee, Corporate Social Responsibility
of the Board/ Director/ Official to oversee the Committee to oversee implementation of respective policies. For
implementation of the policy? other policies, the Functional Heads are authorized to oversee the
implementation thereof.
6 Indicate the link for the policy to be viewed online? The policies which are mandatorily required to be placed on the website
of the Company can be viewed on https://www.godeepak.com/investor-
compliances/. All other policies are available on the Company’s internal
network.

S.
Question(s) P1 P2 P3 P4 P5 P6 P7 P8 P9
No.
7 Has the policy been formally communicated to all All the policies have been communicated to all relevant internal and
relevant internal and external stakeholders? external stakeholders of the Company. The policies for all relevant internal
stakeholders are available on the internal network and for external
stakeholders, the policies are available on Company’s website www.
godeepak.com
8 Does the Company have in-house structure to Yes, the Company has necessary structure in place to implement the
implement the policy/ policies? policies.
9 Does the Company have a grievance redressal Yes, the Company provides the redressal mechanism for all kinds of
mechanism related to the policy/ policies to address grievances.
stakeholders’ grievances related to the policy/
policies?
10 Has the Company carried out independent audit/ The Policy relating to Environment, Health and Safety are evaluated by
evaluation of the working of this policy by an internal as well as external ISO audit agencies. Other policies are evaluated
internal or external agency? internally or by respective Committee.
3. Governance related to BR
a. Indicate the frequency with which the Board of Directors, Committee of the Board or CEO to assess the BR performance of the
Company. Within 3 months, 3-6 months, Annually, More than 1 year
The Chairman & Managing Director, the Executive Director & CEO, the Director - Finance & CFO, the Whole-time Director review
the Business Responsibility performance of the Company during the monthly review meetings. The action points that emerge
from the discussions at these meetings are recorded, implemented wherever necessary and reviewed in the subsequent meet-
ings. Besides, the CSR Committee of the Board reviews the social performance of the Company on yearly basis.
b. Does the Company publish a BR or a Sustainability Report? What is the hyperlink for viewing this report? How frequently it is
published?
The Business Responsibility Report forms part of the Directors’ Report. The Report can be viewed on the website of the Company
at www.godeepak.com.
SECTION E: PRINCIPLE-WISE PERFORMANCE

Principle 1 : Businesses should conduct and govern themselves with Ethics, Transparency and Accountability
1. Does the policy relating to ethics, bribery and The Company strives to adhere to the highest standards of integrity and
corruption cover only the company? Does it extend behavior and ensure compliance and adherence to law and internal
to the Group/Joint Ventures/ Suppliers/Contractors/ policies through its compliance systems.
NGOs /Others?
The Board of Directors of the Company has also adopted a Code
of Conduct (‘Çode’) which applies to the Directors, Key Managerial
Personnel, Senior Management and other employees of the Company.
The Company obtains an annual confirmation affirming compliance
with the Code from the Directors, Key Managerial Personnel and the
Senior Management employees every year.
2. How many stakeholder complaints have been received The Company has not received any complaint from any stakeholders
in the past financial year and what percentage was relating to ethics, bribery and corruption during the Financial Year
satisfactorily resolved by the management? If so, 2018-19.
provide details thereof, in about 50 words or so.

Corporate OVERVIEW
statutory reportS
Principle 2 : Businesses should provide goods and services that are safe and contribute to sustainability throughout their life cycle
1. List up to 3 of your products or services whose design has Sodium Nitrite
incorporated social or environmental concerns, risks and/or Optical Brightening Agent
opportunities. Ethyl Hexyl Nitrate
2. For each such product, provide the following details in respect The Company is in process to establish the procedures for sustainable
of resource use (energy, water, raw material etc.) per unit of sourcing including transportation. Currently, the Company expects
product (optional): its suppliers to abide by Responsible Care, ISO 9001 and ISO 14001
a. Reduction during sourcing/production/ distribution Standard.
achieved since the previous year throughout the value
chain?
b. Reduction during usage by consumers (energy, water)
has been achieved since the previous year?
3. Does the Company have procedures in place for sustainable Company is in process to implement system for sustainable sourcing.
sourcing (including transportation)? If yes, what percentage of Environmental concerns are being assessed while Supplier evaluation.
your inputs was sourced sustainably?
4. Has the Company taken any steps to procure goods and The Company gives preference to the manufacturers and service
services from local & small producers, including communities providers located near-by. The Company provides feedback to them
surrounding their place of work? If yes, what steps have been to improve their quality in compliance to its requirement, enhance
taken to improve their capacity and capability of local and capacity and capability particularly in the areas of manufacturing and
small vendors? fabrication and safety, health and environment.
5. Does the Company have a mechanism to recycle products Yes. Mechanism is in place to ensure sale /reuse/recycle waste
and waste? material, wherever feasible.
Principle 3: Businesses should promote the wellbeing of all employees

1. Total number of Employees There were 1,362 permanent employees as on March 31, 2019.
2. Total number of employees hired on temporary/contractual/ There were 1,760 employees hired on temporary/contract/casual
casual basis basis as on March 31, 2019.
3. Number of permanent women employees. There were 32 permanent women employees as on March 31, 2019.
4. Number of permanent employees with disabilities There were 10 permanent employees with disabilities as on March 31,
2019.
5. Do you have an employee association that is recognized by Yes, The Company has recongnised unions in Nandesari, Roha, Taloja
management and Hyderabad.
6. What percentage of your permanent employees is members of 20% of the total permanent employees are members of recongnised
this recognized employee association? union.
7. Number of complaints relating to child labour, forced labour, involuntary labour, sexual harassment in the last Financial Year and
pending, as at the end of the Financial Year.
S. Category No. of Complaints filed during No of Complaints pending as

No. the Financial Year at the end of Financial Year
1 Child Labour / Forced Labour / Involuntary Labour Nil Nil
2 Sexual Harassment Nil Nil
3 Discriminatory Employment Nil Nil
8. Percentage of under mentioned employees who were given safety & skill up-gradation training in the last year?
S. Employees Category Employees imparted safety Employees imparted skill
No. training up-gradation training
a. Permanent Employees 91.92% 70.48%
b. Permanent Women Employees 96.50% 100.00%
C. Casual/Temporary/Contractual Employees 93.63% 49.63%
d. Employees with Disabilities 87.50% 100.00%

Principle 4 :Businesses should respect the interests of, and be responsive towards all stakeholders, especially those who are
disadvantaged, vulnerable and marginalized.
1. Has the Company mapped its internal and external The Company has mapped its internal and external stakeholders.
stakeholders? They are community, consumers, customers, employees,
Government, lenders, NGOs and the Shareholders.
2. Out of the above, has the Company identified the The Company has identified poor, tribals, women and children as
disadvantaged, vulnerable & marginalized stakeholders. marginalized and disadvantaged groups through needs assessment
and engagement with local communities in and around the Company’s
manufacturing sites under its Corporate Social Responsibility (CSR)
initiatives. The Company has undertaken various programmes under
its CSR Policy in the areas of health, education and livelihood for such
marginalized and disadvantaged groups.
3. Special initiatives taken by the Company to engage with the The initiatives undertaken by the Company for the disadvantaged,
disadvantaged, vulnerable and marginalized stakeholders vulnerable and marginalized stakeholders are elaborated in Principle
8 and in the Annexure – D of the Directors’ Report.
Principle 5: Businesses should respect and promote human rights

1. Does the policy of the Company on Human Rights cover The Company follows its policy on Human Rights which are
only the Company or extend to the Group / Joint Ventures / applicable to the Company, its Subsidiary and Contractors.
Suppliers / Contractors / NGOs / Others?
2. How many stakeholder complaints have been received in The Company has not received any stakeholder complaints in the
the past Financial Year and what percent was satisfactorily Financial Year 2018-19 related to Human Rights.
resolved by the management?
Principle 6: Business should respect, protect, and make efforts to restore the environment
1. Does the policy related to Principle 6 cover only the Company or The policy related to Principle 6 covers the Company, its Subsidiaries,
extends to the Group / Joint Ventures / Suppliers / Contractors Joint Ventures, Suppliers, Contractors and NGOs.
/ NGOs / others?
2. Does the Company have strategies/initiatives to address global The Company practices global principles of sustainable development
environmental issues such as climate change, global warming, and principles of Responsible Care. It includes global environmental
etc? If yes, please give hyperlink for webpage etc. issues such as climate change, global warming etc.
3. Does the Company identify and assess potential environmental Yes. The Company identifies and assess potential environmental risk
risks? relating to its business, if any.
4. Does the Company have any project related to Clean Company adopts clean development mechanism wherever feasible.
Development Mechanism? If Yes, whether any environmental However, such projects was not undertaken during the year.
compliance report is filed?
5. Has the Company undertaken any other initiatives on – clean The Company is continuously improving its environmental
technology, energy efficiency, renewable energy, etc. If yes, performance for its existing products and do thorough analysis for
please give hyperlink for web page etc. new products.
6. Are the Emissions / Waste generated by the Company within Yes. The effluents, emissions and wastes generated by the
the permissible limits given by CPCB/SPCB for the Financial manufacturing facilities of the Company are within the permissible
Year being reported? limits given by SPCB.
7. Number of show cause / legal notices received from CPCB/ There are no show cause / legal notices received from Central and
SPCB which are pending (i.e. not resolved to satisfaction) as at State Pollution Control Boards which are pending as at the end of
the end of Financial Year. Financial Year 2018-19.

Corporate OVERVIEW
statutory reportS
Principle 7: Businesses, when engaged in influencing public and regulatory policy, should do so in a responsible manner
1. Is the Company a member of any trade and chamber or As on March 31, 2019, your Company is a member of the following
association? If Yes, Name only those major ones that your trade associations:
business deals with. a. FICCI: The Federation of Indian Chambers of Commerce and
Industry
b. FGI: Federation of Gujarat Industries
c. GEO: Gujarat Employees Orgranisation
d. ICC: Indian Chemical Council
2. Have you advocated/lobbied through above associations for The Company supports the initiatives taken by above associations in
the advancement or improvement of public good? If yes specify their endeavor for the advancement or improvement of public good.
the broad areas (drop box: Governance and Administration,
Economic Reforms, Inclusive Development Policies, Energy
security, Water, Food Security, Sustainable Business Principles,
Others).
Principle 8 : Businesses should support inclusive growth and equitable development

1. Does the Company have specified programmes/initiatives/ The Company takes up programme/ initiatives/ projects in pursuit
projects in pursuit of the policy related to Principle 8? of the principle of inclusive growth and equitable development
in pursuance of its Corporate Social Responsibility (‘CSR’) Policy.
Detailed information about the specified programme and initiatives
undertaken during the Financial Year 2018-19 in pursuit of the CSR
Policy has been given in Annexure - D to the Directors’ Report.
2. Are the programmes/projects undertaken through in-house The programmes/projects are undertaken through Implementing
team/own foundation/external NGO/government structures/ Agency, Deepak Foundation and Deepak Medical Foundation.
any other organization?
3. Have you done any impact assessment of your initiative? The CSR programmes and their impacts/ outcomes are monitored
and reviewed by the CSR Committee of the Board and management
periodically, to understand the impact of these programmes.
4. What is your Company’s direct contribution to community During the Financial Year 2018-19, the Company spent ` 250 Lakhs
development projects. on various CSR initiatives, detailed in Annexure - D to the Directors’
Report.
5. Have you taken steps to ensure that this community Implementation of the CSR programmes/projects is ensured through
development initiative is successfully adopted by the site visits, obtaining periodic progress reports from Implementing
community? Agency.
Principle 9: Businesses should engage with and provide value to their customers and consumers in a responsible manner
1. What percentage of customer complaints/consumer cases are There were no customer complaints / consumer cases pending as at
pending as on the end of Financial Year. the end of Financial Year 2018-19.
2. Does the Company display product information on the product Yes, the Company adheres to all the applicable statutory laws
label, over and above what is mandated as per local laws? regarding product labeling and displays relevant information on
product label.
3. Is there any case filed by any stakeholder against the Company There have been no cases relating to unfair trade practices,
regarding unfair trade practices, irresponsible advertising and/ irresponsible advertising and/or anti-competitive behavior against
or anti-competitive behavior during the last five years and the Company during the last five years and as at the end of Financial
pending as at end of Financial Year. Year 2018-19.
4. Did the Company carry out any consumer survey/ consumer Customer satisfaction surveys are being conducted frequently for
satisfaction trends? feedback, betterment of the products and improving delivering
mechanism.
For and on behalf of the Board
Deepak C. Mehta
Place : Vadodara Chairman & Managing Director
Date : May 3, 2019 (DIN: 00028377)

Annexure - D
Report 0n Corporate Social Responsibility
1. A brief outline of the Company’s Corporate Social Responsibility (CSR) Policy, including overview of projects or programs proposed to
be undertaken and a reference to the web-link to the CSR Policy and projects or programs:
Outline of Company’s CSR Policy:
The Company’s CSR policy is to remain a responsible corporate entity mindful of its social responsibilities to all stakeholders including
consumers, shareholders, employees, local community and society at large.
Overview of Projects or programs undertaken:
Various projects and programs are being undertaken as per the CSR policy of the Company. The major Programs are CEmONC, Mobile
Health Unit, Help Desk Project, ICDS, De-addiction and Rehabilitation Centre in the field of Healthcare and Skill Development Educations.
The details of these programs undertaken by the Company during the Financial Year 2018-19 are provided as under.
Weblink to the CSR Policy of the Company:
https://www.godeepak.com/investor-compliances/
2. The Composition of CSR Committee: The CSR Committee comprises of Shri Sudhir Mankad as Chairman and Dr. S. Sivaram, Shri Deepak
C. Mehta and Shri Umesh Asaikar as members.
3. Average Net Profit of the Company for the last three Financial Years: ` 10,648 Lakhs
4. Prescribed CSR Expenditure (two percent of the amount as in item 3 above): ` 213 Lakhs.
5. Details of CSR Spent during the Financial Year
(a) Total amount to be spent for the Financial Year: ` 213 Lakhs
(b) Amount unspent, if any: NIL
(c) Manner in which the amount was spent during the Financial Year is detailed below:
(` In Lakhs)
(1) (2) (3) (4) (5) (6) (7) (8)
Sr. CSR project Sector in Projects or programs Amount Amount spent on the Cumulative Amount
No. or activity which the (1) Local area or other outlay projects or programs expenditure Spent: Direct
identified project is (2) Specify the State (budget) Sub-heads up to the or through
covered and District Where project or 1. Direct reporting Implementing
projects or programs was programs Expenditure On period Agency
undertaken wise projects or programs
2. Overheads
1 CEmONC1 Health care Jabugam 39.00 50.14 138.63 Implementing
Dist.: Vadodara 0.00 (88.49) Agency
State: Gujarat
50.14
2 English & Maths Skill Nandesari 3.00 2.31 3.43 Implementing
Education at Development/ Dist: Vadodara 0.10 (1.02) Agency
Nandesari School Education State: Gujarat
2.41
3 Mobile Health Unit Health Dahej 26.51 25.00 128.13 Implementing
Care Dist: Bharuch 1.59 (101.54) Agency
State: Gujarat
26.59
4 Help Desk Project Health Care Vadodara 15.00 12.38 50.03 Implementing
Dist: Vadodara 1.26 (36.39) Agency
State: Gujarat 13.64
5 Mobile Health Unit Health Care Roha 22.70 20.44 84.13 Implementing
Dist: Raigad 2.01 (61.68) Agency
State: Maharashtra 22.45

Corporate OVERVIEW
statutory reportS
(` In Lakhs)
(1) (2) (3) (4) (5) (6) (7) (8)
Sr. CSR project Sector in Projects or programs Amount Amount spent on the Cumulative Amount
No. or activity which the (1) Local area or other outlay projects or programs expenditure Spent: Direct
identified project is (2) Specify the State (budget) Sub-heads up to the or through
covered and District Where project or 1. Direct reporting Implementing
projects or programs was programs Expenditure On period Agency
undertaken wise projects or programs
2. Overheads
6 ICDS2 Health Care Nandesari 29.00 26.78 110.44 Implementing
Dist: Vadodara 1.87 (81.79) Agency
State: Gujarat 28.65
7 DOHC3 Health Care Nandesari - - 74.15 Implementing
Dist: Vadodara (74.15) Agency
State: Gujarat
8 Home Health Aide Skill Vadodara 40.00 33.24 112.53 Implementing
Course Development/ Dist: Vadodara 2.15 (77.14) Agency
Education State: Gujarat 35.39
Hyderabad
Dist: Hyderabad
State: Telangana
9 Mobile Library Skill Roha 15.00 12.28 37.63 Implementing

Development/ Dist: Raigad 1.08 (24.27) Agency
Education State: Maharashtra 13.36
10 De-addiction and Health Care Hyderabad 17.70 15.73 46.88 Implementing
Rehabilitation Dist: Hyderabad 1.38 (29.77) Agency
Center State: Telangana 17.12
11 Mobile Library Skill Nandesari 10.36 11.21 12.15 Implementing
Development/ Dist: Vadodara 0.94 - Agency
Education State: Gujarat 12.15
12 Mobile Library Skill Hyderabad 11.63 8.00 8.49 Implementing
Development/ Dist: Hyderabad 0.48 - Agency
Education State: Telangana 8.48
13 Entrepreneurial Skill Nandesari 5.70 4.62 5.22 Implementing
Activities through Development/ Dist: Vadodara 0.60 - Agency
SHG Education State: Gujarat
5.22
14 Samaj Suraksha Skill Vadodara 2.50 2.50 2.50 Implementing
Sankul Development/ Dist: Vadodara - - Agency
Education State: Gujarat
2.50
15 Management Cost - NA 11.90 11.90 44.72 Implementing
(32.82) Agency
TOTAL 250.00 250.00
1. Comprehensive Emergency Obstetric Newborn Care.

2. Integrated Child Development Scheme
3. Deepak Occupational Health Centre
4. Figures in Brackets are of previous Financial Year i.e. 2017-18.
6. The CSR Committee of the Company hereby confirms that the implementation and monitoring of CSR Policy is in compliance with CSR
objectives and policy of the Company.
Deepak C. Mehta Sudhir Mankad

Chairman & Managing Director Chairman of CSR Committee
(DIN: 00028377) (DIN: 00086077)
Place : Vadodara
Date : May 3, 2019

Annexure - E
Nomination and Remuneration Policy
1. INTRODUCTION business performance and practices in comparable
A transparent, fair and reasonable process for determining companies, also to financial and commercial health of the
the appropriate remuneration at all levels of the Company is Company as well as prevailing laws and government/other
required to ensure that shareholders remain informed and guidelines, to ensure that pay structures are appropriately
confident in the management of the Company. To harmonize aligned and the levels of remuneration remain appropriate.
the aspirations of human resources consistent with the
2.3.
While designing the remuneration package it should be
goals of the Company and in terms of the provisions of the
ensured:
Companies Act, 2013 and the rules made thereunder and the
Listing Regulations as amended from time to time, this policy (i) The level and composition of remuneration is reasonable
on nomination and remuneration of Directors on the Board of and sufficient to attract, retain and motivate person,
the Company, Key Managerial Personnel and other employees to ensure the quality required to run the Company
in the Senior Management is formulated in compliance successfully.
with Section 178 of the Companies Act, 2013 read with the (ii) Remuneration to Directors, Key Managerial Personnel
applicable rules thereto and of the Listing Regulations with the and Senior Management employees involves a balance
Stock Exchanges. between fixed and incentive pay reflecting short and long
This Policy shall act as a guideline for determining, inter- term performance objectives appropriate to the working
alia, qualifications, positive attributes and independence of of the Company and its goals.
a Director, appointment and removal of the Directors, Key 2.4. Some part of the remuneration package may be linked to the
Managerial Personnel and Senior Management employees
achievement of corporate performance targets of the Company
and matters relating to the remuneration for the Directors, Key
and a strong alignment of interest with stakeholders.
Managerial Personnel and other employees.
2.5.
The Committee shall observe the set of principles and
Pursuant to the requirement of Section 178 of the Companies
objectives as envisaged under the Companies Act, 2013 (“Act”)
Act, 2013 and the Listing Regulations with the Stock
(including Section 178 thereof), rules framed there under
Exchanges, the Company has a duly constituted Nomination
and the Listing Regulations including, inter-alia, principles
and Remuneration Committee.
pertaining to determining qualifications, positive attributes,
integrity and independence.
2. OBJECTIVE OF THE POLICY
2.1. The objective of this Policy is to outline a framework to ensure 2.6. In this context, the following Policy has been formulated by the
that the Company’s remuneration levels are aligned with best Nomination and Remuneration Committee and recommended
industry practices and are good enough to attract and retain to the Board of Directors for adoption.
competent Directors on the Board, Key Managerial Personnel
and the Senior Management Personnel of the quality required. 3. EFFECTIVE DATE
The key objectives of this Policy include: This Policy shall be effective from the date of its adoption by
(i)
guiding the Board in relation to appointment and the Board.
removal of Directors, Key Managerial Personnel and
Senior Management employees. 4. DEFINITIONS
4.1. In this Policy the following terms shall have the meaning
(ii) evaluating the performance of the members of the Board
assigned to them:
and provide necessary report to the Board for further
evaluation of the Board. (i) “Act” means The Companies Act, 2013 and rules made
thereunder.
(iii) recommending to the Board the remuneration payable
to the Directors and setting forth a policy for determining (ii) “Board of Directors” or “Board” means the Board of
remuneration payable to Key Managerial Personnel and Directors of the Company.
Senior Management employees.
(iii)
“Committee” means Nomination and Remuneration
2.2. While determining the remuneration for the Directors, Key Committee of Board of Directors of the Company,
Managerial Personnel and Senior Management employees, constituted in accordance with the provisions of Section
regard should be given to prevailing market conditions, 178 of the Act and the Listing Regulations.

Corporate OVERVIEW
statutory reportS
(iv) “Company” means “Deepak Nitrite Limited.” 4.2. Unless the context otherwise requires, words and expressions
used in this Policy and not defined herein but defined in
(v)
“Director” shall mean a member of the Board of
the Companies Act, 2013 and/or Listing Regulations as
Directors of the Company appointed from time to time
may be amended from time to time shall have the meaning
in accordance with the Articles of Association of the
Company and provisions of the Act. respectively assigned to them therein.
(vi) “Employees’ Stock Option” means the option given to 5. APPLICABILITY

the Directors, other than Independent Directors, officers This Policy is applicable to:
or employees of a Company or of its holding company
or subsidiary company or companies, if any, which gives (i)
Directors (Managing Director, Executive Director,
such directors, officers or employees, the benefit or Independent Director and Non-Independent Director)
right to purchase, or to subscribe for, the shares of the (ii) Key Managerial Personnel
company at a future date at a pre-determined price.
(iii) Senior Management employees
(vii) “Executive Director” shall mean a Director who is in the
whole-time employment of the Company other than 6. NOMINATION AND REMUNERATION COMMITTEE
Managing Director.
6.1. Role of the Committee:
(viii) “Financial Year” shall mean the period ending on the 31st (a) Identifying persons who are qualified to become Director
day of March every year. and who may be appointed in Senior Management cadre
(ix) “Independent Director” shall mean a Director referred in accordance with the criteria laid down, recommend to
to in Section 149 (6) of the Act read with the Listing the Board their appointment and removal and shall carry
Regulations. out evaluation of every Director’s performance.
(x) “Key Managerial Personnel” or “KMP” shall have the (b) Formulating the criteria for determining qualifications,
meaning ascribed to it in the Act. positive attributes and independence of a Director
and recommend to the Board, a policy, relating to the
(xi) “Listing Regulations” shall mean Securities and Exchange
Board of India (Listing Obligations and Disclosure remuneration for the Directors, Key Managerial Personnel
Requirements) Regulations, 2015 as amended from time and Senior Management employees.
to time and for the time being in force. (c) Formulating the criteria for evaluation of Independent
(xii) “Managing Director” means a Director who, by virtue Directors and the Board.
of the Articles of Association of the Company or an
(d) Devising a policy on Board diversity.
agreement with the Company or a resolution passed
in its general meeting, or by its Board of Directors, is (e)
Ensuring that the Board comprises of a balanced
entrusted with substantial powers of management of the combination of Executive Directors and Non-Executive
affairs of the Company and includes a Director occupying Directors.
the position of Managing Director, by whatever name
called. (f)
The Committee shall take into consideration and
ensure the compliance of provisions under Schedule
(xiii)
“Policy” or “this Policy” means, “Nomination and V of the Companies Act, 2013 for appointing and
Remuneration Policy.”
fixing remuneration of Managing Directors / Executive
(xiv)
“Remuneration” means any money or its equivalent Directors.
given or passed to any person for services rendered
(g) While approving the remuneration, the Committee shall
by him and includes perquisites as defined under the
take into account financial position of the Company,
Income-tax Act, 1961.
trend in the industry, qualification, experience and past
(xv) “Senior Management” means officers/personnel of the performance of the appointee.
Company who are members of its core management
team excluding Board of Directors and shall comprise (h) any other role as may be specified by the Board.
all members of management one level below Chief
Executive Officer / Managing Director / Whole-time 6.2. Composition of the Committee
Director including Chief Executive Officer and shall (a)
The Committee shall comprise of at least three (3)
specifically include Chief Financial Officer and Company Directors, all of whom shall be non-executive Directors
Secretary. and at least half shall be Independent Directors.

(b) The Board shall reconstitute the Committee as and when 7. APPOINTMENT AND REMOVAL OF DIRECTORS, KEY
required to comply with the provisions of the Act and/or MANAGERIAL PERSONNEL AND SENIOR MANAGEMENT
the Listing Regulations. EMPLOYEES
(c) Membership of the Committee shall be disclosed in the 7.1.
The Committee shall identify and ascertain the integrity,
Annual Report. qualification, expertise and experience of the person for
appointment as a Director, KMP and Senior Management
(d) Term of the Committee shall continue unless terminated employee.
by the Board of Directors.
7.2. A person should possess adequate qualifications, expertise
6.3. Chairman of the Committee and experience for the position he/ she is considered for
appointment as a Director, Key Managerial Personal or Senior
(a) Chairman of the Committee shall be an Independent
Management employee.
Director.
7.3. The Company shall not appoint or continue the employment
(b) Chairman of the Company (whether Executive or non-
of any person as Managing Director / Executive Director who
Executive) may be appointed as a member of the
has attained the age of seventy years. Provided that the term
Committee but shall not Chair the Committee.
of the person holding this position may be extended beyond
(c) In the absence of the Chairman, the members of the the age of seventy years with the approval of shareholders
Committee present at the meeting shall choose one by passing a special resolution based on the explanatory
amongst them to act as Chairman. statement annexed to the notice for such motion indicating
(d) Chairman of the Committee shall be present at the the justification for such appointment.
Annual General Meeting or may nominate some other 7.4. The appointment as recommended by the Committee to the
member to answer the shareholders’ queries. Board shall be subject to the approval of the Board.
6.4. Frequency of the Meetings of the Committee 7.5. Criteria for appointment of Independent Director:
The meeting of the Committee shall be held at such intervals 7.5.1. The proposed appointee shall comply with the criteria
as may be required. specified in the relevant provisions of the Act and/or
the Listing Regulations. He or she shall not, directly or
6.5. Committee Member’s Interest indirectly, represent the interest of any specific vendor
or customer or stakeholder and shall have business
(a)
A member of the Committee is not entitled to be
reputation and strong ethical standards and possess
present when his or her own remuneration is discussed
leadership skills and business experience including
at a meeting or when his or her performance is being
board procedures.
evaluated.
7.5.2. The Independent Director shall fulfill the qualification
(b)
The Committee may invite such executives, as it
and requirements specified under the Act and Listing
considers appropriate, to be present at the meetings of
Regulations.
the Committee.
7.5.3. He or she shall also declare his or her independent status
6.6. Quorum prior to their appointment to the Board and maintain
The quorum necessary for transacting business at a meeting the same during his or her tenure as an Independent
of the Committee shall be two (2) members or one-third of the Director. Being a Director of the Company, he or she
members of the Committee, whichever is greater. shall adhere to the Code of Conduct stipulated for the
Director.
6.7. Voting at the Meeting
7.6. Criteria for appointment of Managing Director / Executive
(a) Matters arising for determination at Committee meetings
Director:
shall be decided by a majority of votes of members
7.6.1.
The Company can have more than one Managing
present. Any such decision shall for all purposes be
Director or Executive Director.
deemed a decision of the Committee.
7.6.2.
The appointee(s) shall have good educational
(b) In the case of equality of votes, the Chairman of the
background, preferably with specialization in the field.
meeting will have a casting vote.
He shall have exemplary skills and leadership qualities
to lead the Company or as the case may be the function
assigned to him.

Corporate OVERVIEW
statutory reportS
7.6.3. Depending on the role and responsibility, he shall have depending upon the requirement of the relevant
hands on experience in the relevant field. For example position.
as ED (Operations) is expected to have adequate
7.8.2.
The Committee has discretion to decide whether
knowledge and experience about the plant operations
qualification, expertise and experience possessed by
and related issues. The suitability of the candidate shall
a person are sufficient / satisfactory for the concerned
be determined on a case to case basis by the Committee.
position.
Being a Director of the Company, Managing Director /
Executive Director shall adhere to the Code of Conduct 7.8.3. Senior Management employees shall adhere to the Code
stipulated for the Director. of Conduct stipulated for the Senior Management.
7.6.4. He shall fulfill the conditions as specified under Part I of
7.9. Term / Tenure
Schedule V of the Act. However, in case the conditions
specified under Part I of Schedule V of the Act is not 7.9.1. Managing Director and Executive Director
fulfilled, such appointments shall be subject to the The Company shall appoint or re-appoint any person
approval of the Central Government. as its Managing Director / Executive Director for a term
not exceeding five years at a time. No re-appointment
7.7. Criteria for appointment of KMPs: shall be made earlier than one year before the expiry
7.7.1. Pursuant to the requirement of Section 203 of the Act, of the term.
the Company is required to appoint a Managing Director
7.9.2. Independent Director
/ Manager / Chief Executive Officer and in their absence
an Executive Director as Whole Time KMP. (a) An Independent Director shall hold office for a term
up to five consecutive years on the Board of the
7.7.2.
The Company may also appoint a Chief Executive Company and will be eligible for re appointment
Officer (CEO) who may or may not be a Director. The on passing of a special resolution by the Company
qualification, experience and stature of the CEO could and disclosure of such appointment in the Board’s
be in line with that of the Executive Director. Where the report.
CEO is designated as KMP, he shall act subject to the
superintendence and control of the Board. (b) No Independent Director shall hold office for more
than two consecutive terms, but such Independent
7.7.3. The Company is also required to appoint a Chief Financial Director shall be eligible for appointment after
Officer (CFO) as KMP as per the requirement of the Act. expiry of three years of ceasing to become an
The CFO shall preferably be a Chartered Accountant or a Independent Director.
Cost & Management Accountant or holds an equivalent
qualification and have relevant work experience. He Provided that an Independent Director shall not,
shall be well versed with finance function including but during the said period of three years, be appointed
not limited to funding, taxation, forex and other core in or be associated with the Company in any other
matters. As required under the Listing Regulations, the capacity, either directly or indirectly.
appointment of CFO shall be subject to approval of the (c) The Independent Director shall comply with the
Audit Committee. requirement of number of directorships he or she
7.7.4. As required under the said Section of the Act, a Company can hold as prescribed under the provisions of
Secretary (CS) is also required to be appointed by the the Act or the Listing Regulations including any
Company as a KMP. The CS shall have the prescribed amendment thereto from time to time.
qualification and requisite experience to discharge the
duties specified in law and as may be assigned by the 7.10. Familiarization Programme for Independent Directors
Board / Managing Director / Executive Director from time The Company shall familiarize the Independent Directors
to time. with the Company, their roles, rights, responsibilities in
the company, nature of the industry in which the company
7.7.5. KMPs, other than Managing Director and/or Executive
operates, business model of the company, etc., through
Director shall adhere to the Code of Conduct stipulated
various programmes.
for the Senior Management.
7.8. Criteria for appointment of Senior Management 7.11. Evaluation
employees: 7.11.1. Subject to Schedule IV of the Companies Act, 2013 and
7.8.1.
Senior Management employees shall possess the Listing Regulations, the Committee shall carry out the
requisite qualifications, expertise and experience evaluation of Directors periodically.

7.11.2. The performance evaluation of Independent Directors Company in a particular Financial Year, as may be
shall be done by the entire Board of Directors, excluding determined by the Board of Directors, subject to the
the Director being evaluated. overall ceiling stipulated in Section 197 and other
relevant provisions of the Act or Listing Regulations.
7.11.3. The Independent Directors at their separate meeting
shall review, on yearly basis, the performance of Non-
8.1.3. The Managing Director shall be entitled to the following
Independent Directors and the Board as a whole.
perquisites / allowances:
7.11.4. The Independent Directors at their separate meeting
(i)
Housing – Rent free furnished residential
shall also review, on yearly basis, the performance of
accommodation. In case no accommodation is
the Chairperson of the Company, taking into account
provided by the Company, Managing Director shall
the views of Executive Directors and Non-Executive
be paid house rent allowance as may be decided by
Directors.
the Board of Directors.
7.11.5. The entire process of the Performance Evaluation shall
be kept in strict confidence and shall not be disclosed (ii) Re-imbursement of gas, electricity, water charges
to any person except to those required to perform their and furnishings.
duties under the Act. (iii) Re-imbursement of medical expenses incurred for
7.11.6. All the records of Performance Evaluation process and self and members of his family, as per rules of the
outcome shall be maintained by the Company Secretary Company.
of the Company and shall be kept at the Registered (iv) Leave travel concession for self and members of his
Office of the Company. Such records shall be preserved family, as per rules of the Company.
till such time as may be decided by the Board from time
to time or as required under the Act. (v) Fees of clubs subject to maximum of two clubs.
(vi) Medical insurance, as per rules of the Company.

7.12. Removal
Due to reasons for any disqualification mentioned in the Act, (vii) Personal Accident Insurance, as per rules of the
rules made thereunder or under any other applicable laws, Company.
rules and regulations, the Committee may recommend, to the
(viii) Provision of car and telephone at residence.
Board with reasons recorded in writing, removal of a Director,
KMP and Senior Management employees subject to the (ix)
Company’s contribution to provident fund,
provisions and compliance of the applicable laws, rules and superannuation fund or annuity fund, gratuity and
regulations. encashment of leave, as per rules of the Company.
7.13. Retirement (x) Retirement and other benefits, as per rules of the
Company.
The Director, KMP and Senior Management employees shall
retire as per the applicable provisions of the Act and/or the
8.1.4. The remuneration and commission to be paid to the
prevailing policy of the Company. The Board will have the
Managing Director shall be as per the statutory provisions
discretion to retain the Director, KMP, Senior Management
of the Act and the rules made thereunder for the time
employees in the same position / remuneration or otherwise
being in force and shall be subject to the approval of the
even after attaining the retirement age, in the interest and for
shareholders of the Company and Central Government,
the benefit of the Company, in accordance with the provisions
wherever required.
of the Act and approval of members, wherever required.
8.1.6. The Managing Director shall not be entitled to sitting
8. REMUNERATION fees for attending the meetings of the Board or any
8.1. Remuneration to Managing Director: Committee thereof.
8.1.1.
The remuneration comprising of salary, allowance,
perquisites and other benefits payable to Managing 8.2. Remuneration to Executive Director:
Director will be determined by the Committee and 8.2.1. Fixed Pay
recommended to the Board for approval. (a) Executive Director shall be eligible for a monthly
remuneration as may be approved by the Board
8.1.2. In addition to the remuneration as stated in 8.1.1. above, on the recommendation of the Committee in
Managing Director shall also be paid a Commission, accordance with the provisions of the Act and rules
calculated with reference to the Net Profits of the made thereunder for the time being in force.

Corporate OVERVIEW
statutory reportS
(b) The Fixed Pay of Executive Director shall comprise existing remuneration structure of Executive
of salary, perquisites, allowances and other Director shall be recommended by the Chairman
benefits. The perquisites, allowances and other & Managing Director of the Company to the
benefits to the Executive Director shall include but Committee based upon the individual performance
not be limited to the following: and also the Company’s performance as per policy
of the Company.
(i) Re-imbursement of medical expenses incurred
for self and members of his family, as per policy (b)
The Committee shall review the payment of
of the Company. Variable component of the remuneration of the
Executive Director for a particular Financial Year and
(ii) Leave travel concession for self and members of
increments to the existing remuneration structure
his family, as per policy of the Company.
of Executive Director as recommended by the
(iii) Medical and other insurances, as per policy of Chairman & Managing Director of the Company and
the Company. recommend the same to the Board for its approval.
Such Variable component and proposed enhanced
(iv) Company Car with Driver.
remuneration as recommended by the Committee
(v)
Company’s contribution to provident fund, to the Board should be within the overall limits of
superannuation fund or annuity fund, gratuity managerial remuneration as prescribed under the
and encashment of leave, as per the policy of Act and rules made thereunder.
the Company. (c)
The Executive Director shall also be entitled
(vi) Retirement and other benefits, as per policy of to reimbursement of all legitimate expenses
the Company. incurred by him while performing his duties and
such reimbursement will not form part of his
(vii) Hardship Allowance as applicable in accordance remuneration.
with the policy of the Company.
8.2.5. Executive Director shall not be entitled to sitting fees
(c) The break-up of the pay scale and quantum of for attending meetings of the Board or any Committee
perquisites including, employer’s contribution to thereof.
P.F., pension scheme, medical expenses etc. shall
be decided and approved by the Board on the 8.3. Minimum Remuneration
recommendation of the Committee and approved Where, in any financial year, the Company has no profits or its
by the shareholders and Central Government, profits are inadequate, the Company shall pay remuneration
wherever required.
to its Managing Director(s) and Executive Director(s) in
8.2.2. Variable Pay accordance with the provisions of Schedule V of the Act and if
In addition to the salary, perquisites, allowances it is not able to comply with such provisions, with the previous
and other benefits as mentioned above, Executive approval of the Central Government.
Director will also be entitled to a Variable Pay by way
of Performance Linked Incentive. This amount shall be 8.4. Remuneration to Independent Director and Directors
paid annually after the end of each Financial Year. The other than Managing Director/ Executive Director:
Performance Linked Incentive shall be in the range of 8.4.1. Sitting Fees
0% to 20% of cost to the Company, which will be entirely The Independent Director / Directors other than
based on the individual’s performance and Company’s Managing Director and Executive Director may receive
performance as per policy of the Company. remuneration by way of fees for attending meetings of
Board or Committee thereof.
8.2.3. Loyalty Bonus
Provided that the amount of such fees shall not exceed
In addition to the above, Executive Director shall also
the maximum amount as provided in the Act, per
be entitled for the Loyalty Bonus as per policy of the
meeting of the Board or Committee or such amount as
Company.
may be prescribed by the Central Government from time
to time.
8.2.4. Payment of Variable component / Increments
(a)
Payment of Variable component of the The Sitting Fee paid to Independent Directors, shall
remuneration of the Executive Director for a not be less than the Sitting Fees payable to other
particular Financial Year and increments to the Directors.

8.4.2. Commission on the Net Profits 8.6.4. Fixed Pay
Apart from receiving the Sitting Fees and reimbursement The Fixed Pay of KMP and Senior Management employees
of expenses for attending meetings of Board or shall comprise of salary, perquisites, allowances and
Committees thereof, Independent Director(s) / Non- other benefits as per policy of the Company. The break-
Independent Director(s) may be paid Commission on up of the pay scale and quantum of perquisites including
the Net Profits of the Company for a particular Financial but not limited to employer’s contribution to P.F., pension
Year within the monetary limit prescribed under the Act scheme, medical expenses etc. shall be decided by the
or approved by shareholders in accordance with the Managing Director / Executive Director.
provisions of the Act. The amount of Commission payable
to each Independent Director / Non-Independent 8.6.5. Variable Pay
Director for a particular Financial Year shall be decided The remuneration of KMP and Senior Management
by the Chairman of the Company and shall be approved employees will also comprise performance linked
by the Board. variable pay which may vary from 0% to 16% of the cost
to the Company. This amount of variable pay shall be
8.4.3. Stock Options paid annually after the end of each Financial Year and will
Independent Director shall not be entitled to any stock be entirely based on the individual’s performance and
option of the Company. Company’s performance as per policy of the Company.
Such Variable Pay for a particular Financial Year shall be
8.5. Provisions for excess remuneration decided by the Managing Director / Executive Director.
If any Director draws or receives, directly or indirectly by way of 8.6.6. Hardship Allowance and Loyalty Bonus
remuneration any such sums in excess of the limits prescribed
In addition to the above, KMP and Senior Management
under the Act or without the prior sanction of the Central
employees shall also be entitled for the Hardship
Government, where required, he / she shall refund such
Allowance, as may be applicable and Loyalty Bonus as
sums to the Company and until such sum is refunded, hold
per policy of the Company.
it in trust for the Company. Subject to the approval of Central
Government, the Shareholders of the Company may waive
8.7. The remuneration to other employees of the Company shall
recovery of such excess remuneration by passing an Ordinary
be governed by DNL HR Policy.
Resolution.
8.8 Loans and Advances to Employees
8.6. Remuneration to KMP and Senior Management
employees: (a) The Loan, advance and other financial assistance facilities
to the employees shall be governed by the DNL HR policy
8.6.1.
The remuneration to KMP and Senior Management
as amended from time to time and shall be considered
employees shall comprise of Fixed Pay and Variable Pay
as a part of ‘conditions of service’ for employees of the
and governed by the DNL HR Policy.
Company.
8.6.2. The Committee may authorize the Managing Director / (b)
Advances to the employees for the purpose of
Executive Director to determine from time to time the performance of his duties shall be governed by the
remuneration payable to KMP and Senior Management DNL HR Policy as amended from time to time and shall
employee including their increments. The powers of be considered as a part of ‘conditions of service’ for
the Committee in this regard may be delegated to the employees of the Company.
Managing Director / Executive Director.
9. BOARD DIVERSITY
8.6.3. Remuneration of a KMP at the time of their appointment
9.1. The Board of Directors shall have the optimum combination
will be recommended by the Managing Director /
of Directors from the different areas / fields like operations,
Executive Director to the Committee. The Committee
projects, production, management, quality assurance, finance,
shall review such remuneration and recommend
legal, sales and marketing, research and development, Human
the same to the Board for approval. Any subsequent
Resources etc. or as may be considered appropriate.
modification to the remuneration of KMP shall be
decided by the Managing Director / Executive Director as 9.2. The Board shall have at least one Director who has accounting
may be authorized by the Committee. or related financial management expertise.

Corporate OVERVIEW
statutory reportS
10. DISCLOSURE In case of any amendment(s), clarification(s), circular(s) etc.

This Policy shall be disclosed in the Board’s Report. issued by the competent authorities, not being consistent
with the provisions laid down under this Policy, then such
11. REVIEW OF THE POLICY amendment(s), clarification(s), circular(s) etc. shall prevail
This Policy shall be reviewed by the Committee after every upon the provisions hereunder and this Policy shall stand
three years. amended accordingly from the effective date as laid down
under such amendment(s), clarification(s), circular(s) etc.
12. AMENDMENTS TO THE POLICY
The Board of Directors on its own and / or as per the
recommendations of Nomination and Remuneration
Committee can amend this Policy, as and when deemed fit.
Deepak C. Mehta
Date : May 3, 2019 (DIN: 00028377)

Annexure - F
Form No. MGT - 9

EXTRACT OF ANNUAL RETURN
FOR THE FINANCIAL YEAR ENDED MARCH 31, 2019
[Pursuant to section 92(3) of the Companies Act, 2013 and Rule 12(1) of the Companies
(Management and Administration) Rules, 2014]
i. REGISTRATION AND OTHER DETAILS:

i) CIN : L24110GJ1970PLC001735
ii) Registration Date : June 6, 1970
iii) Name of the Company : Deepak Nitrite Limited
iv) Category/Sub-Category of the Company : Public Company/Limited by Shares
v) Address of the Registered Office and Contact Details : Aaditya-I, Chhani Road,
Vadodara- 390 024, Gujarat, India
Tel: 91-265-276 5200/ 396 0200
Fax No. : 91-265- 276 5344
vi) Whether listed Company : Yes
vii) Name, Address and Contact Details of Registrar and : Link Intime India Private Limited
Share Transfer Agent C-101, 247 Park, L. B. S. Marg,
Vikhroli (West), Mumbai – 400 083.
Tel: 022 - 2594 6970
Toll free number: 1800 1020 878
Email: rnt.helpdesk@linkintime.co.in
II. PRINCIPAL BUSINESS ACTIVITY OF THE COMPANY:
Business activities contributing 10% or more of the total turnover of the Company:-
Sr. Name and Description of main Products/Services NIC Code of the Product/ % to Total Turnover of the
No. Service Company
1. Sodium Nitrite 24121 17%
2. Optical Brightening Agent 24121 13%
3. Ethyl Hexyl Nitrate 24121 10%
III. PARTICULARS OF HOLDING, SUBSIDIARY AND ASSOCIATE COMPANIES:

Sr. Name and Address CIN/GLN Holding/ % of Shares held Applicable
No of the Company Subsidiary/ Section
Associate
1. Deepak Phenolics U24100GJ2011PLC064669 Subsidiary 100% 2(87)(ii)
Limited
First Floor, Aaditya-II,
Chhani Road,
Vadodara - 390024,
Gujarat, India
2. Deepak Nitrite NA Subsidiary 100% 2(87)(ii)
Corporation Inc.
10801, Johnston Road,
Suit 204, Charlotte,
NC 28226, USA

Corporate OVERVIEW
statutory reportS
IV. SHAREHOLDING PATTERN (Equity share Capital Break up as percentage of Total Equity):
(i) Category-wise Share Holding
Category of Shareholders No. of Shares held at the Beginning of the No. of Shares held at the End of the % change
Financial Year 2018-19 Financial Year 2018-19 during the
Demat Physical Total % of total Demat Physical Total % of total year
Shares Shares
A. Promoters1 Indian
Individuals/ H.U.F 22867361 - 22867361 16.77 22847361 - 22847361 16.75 (0.02)
Central/State Government(s) - - - - - - - - -
Financial Institutions/ Banks - - - - - - - - -
Bodies Corporate 38031106 - 38031106 27.88 38325107 - 38325107 28.10 0.22
Any Other (specify) - - - - - - - - -
Sub-Total (A)(1) 60898467 - 60898467 44.65 61172468 - 61172468 44.85 0.20
Foreign
Non Resident Individuals/ - - - - - - - - -
Foreign Nationals
Bodies Corporate - - - - - - - - -
Institutions - - - - - - - - -
Qualified Foreign Investor - - - - - - - - -
Any Other (specify) - - - - - - - - -
Sub Total (A)(2) - - - - - - - - -
Total holding of Promoter 60898467 - 60898467 44.65 61172468 - 61172468 44.85 0.20
(A)=(A)(1)+(A)(2)
B. Public Shareholding
Non Institutions
Mutual Fund/UTI 17051856 9000 17060856 12.51 20384369 9000 20393369 14.95 2.44
Financial Institutions/ Banks 731449 1100 732549 0.54 701224 1100 702324 0.52 (0.02)
Central/State Government(s) - - - - - - - - -
Venture Capital Funds - - - - - - - - -
Alternate Investment Funds 905651 - 905651 0.66 86600 - 86600 0.06 (0.60)
Insurance Companies 132575 - 132575 0.10 - - - - (0.10)
Foreign Portfolio Investor 15199212 - 15199212 11.14 14023615 - 14023615 10.28 (0.86)
Foreign Venture Cap. Inv - - - - - - - - -
Any Other (specify)
Foreign Banks 1350 - 1350 0.00 1350 - 1350 0.00 -
Sub-Total (B)(1) 34022093 10100 34032193 24.95 35197158 10100 35207258 25.81 0.86
Central Government/ State
Government(s)/ President of
India
Central Government / State 225040 - 225040 0.16 225040 - 225040 0.16 -
Government(s)
Sub Total (B)(2) 225040 - 225040 0.16 225040 - 225040 0.16 -
Non Institutions
Bodies Corporate 13184875 - 13184875 9.67 9272433 - 9272433 6.80 (2.87)
Individuals
i) Holding nominal Share 19236371 1439780 20676151 15.16 20415467 1210495 21625962 15.86 0.70
Capital upto ` 1 Lakh
ii) Holding nominal Share 4732438 158540 4890978 3.59 5944459 108170 6052629 4.44 0.85
Capital in excess of ` 1 Lakh
Any Other(specify)
Trusts 1292 - 1292 0.00 8186 - 8186 0.01 0.01
Hindu Undivided Family 1458508 - 1458508 1.07 1504262 - 1504262 1.10 0.03
Individual NRI- Rep.- Non Rep. 759718 6050 765768 0.56 1049315 6050 1055365 0.77 0.21
Clearing Member 259769 - 259769 0.19 208355 - 208355 0.16 (0.03)
NBFC registered with RBI - - - - 61083 - 61083 0.04 0.04
Sub-Total (B)(3) 39632971 1604370 41237341 30.24 38463560 1324715 39788275 29.18 (1.06)
Total Public shareholding 73880104 1614470 75494574 55.35 73885758 1334815 75220573 55.15 (0.20)
(B)=(B)(1)+(B)(2)+(B)(3)
TOTAL = (A)+(B) 134778571 1614470 136393041 100.00 135058226 1334815 136393041 100.00 -
C. Shares held by - - - - - - - - -
Custodians and against
which Depository Receipts
have been issued
GRAND TOTAL = (A)+(B)+(C) 134778571 1614470 136393041 100.00 135058226 1334815 136393041 100.00 -
1. Includes Shareholding of Promoter Group.

(ii) Shareholding of Promoters
A. Details of Shareholding of Promoters
Sr. Shareholder’s Name Shareholding at the beginning of Shareholding at the end of the % Change in
No. the Financial Year 2018-19 Financial Year 2018-19 shareholding
No. of % of Total % of Shares No. of % of Total % of Shares during the
Shares Shares Pledged/ Shares Shares Pledged/ Year
of the Encumbered of the Encumbered
Company to Total Company to Total
Shares Shares
1. Chimanlal K. Mehta* 86430* 0.07 - 86430* 0.07 - -
2. Deepak C. Mehta 21236331 15.57 - 21216331 15.56 - (0.01)
3. Ajay C. Mehta - - - - - - -
4. Kantaben C. Mehta 970000 0.71 - 970000 0.71 - -
5. Ila D. Mehta 396010 0.29 - 396010 0.29 - -
6. Maulik D. Mehta 131300 0.10 - 131300 0.10 - -
7. Meghav D. Mehta 47290 0.03 - 47290 0.03 - -
8. Checkpoint Credits and Capital Private Limited 7206050 5.28 - 7206050 5.28 - -
9. Stepup Credits and Capital Private Limited 6915580 5.07 - 6915580 5.07 - -
10. Stigma Credits and Capital Private Limited 6178100 4.53 - 6178100 4.53 - -
11. Skyrose Finvest Private Limited 3777356 2.77 - 3802357 2.79 - 0.02
12. Pranawa Leafin Private Limited 2246000 1.65 - 2304000 1.69 - 0.04
13. Forex Leafin Private Limited 2169780 1.59 - 2169780 1.59 - -
14. Stiffen Credits and Capital Private Limited 8379940 6.14 - 8379940 6.14 - -
15. Sundown Finvest Private Limited 812300 0.60 - 833300 0.61 - 0.01
16. Storewell Credits and Capital Private Limited - - - 190000 0.14 - 0.14
17. Hardik Leafin Private Limited 346000 0.25 - 346000 0.25 - -
Total 60898467 44.65 - 61172468 44.85 - 0.20
* Includes 8040 shares held as the Karta of HUF.
(iii) Change in Promoter’s Shareholding

Sr. Shareholder’s Name Shareholding at the beginning of Transactions during the year Cumulative Shareholding at
No. the Financial Year 2018-19 the end of the
Financial Year 2018-19
No. of Shares % of Total Date Increase/ No. of Shares % of Total
held Shares of the (Decrease) held Shares of the
Company Company
1 Deepak C. Mehta 21236331 15.57
Transfer by way of Gift 12-Apr-2018 (20000) 21216331 15.56
At the end of the Year 21216331 15.56
2 Skyrose Finvest 3777356 2.77
Private Limited
Market Purchase 29-Sep-2018 1 3777357 2.77
Market Purchase 25-Feb-2019 21000 3798357 2.78
3 Pranawa Leafin 2246000 1.65
Private Limited
Market Purchase 01-Mar-2019 8000 2304000 1.69
4 Sundown Finvest 812300 0.60
Private Limited
5 Storewell Credits and - -
Capital Private Limited

Corporate OVERVIEW
statutory reportS
(iv) Shareholding of Top Ten Shareholders (Other than Directors, Promoters and Holders of GDRs and ADRs)
Sr No. Name & Reason of Increase/ Shareholding at the Transactions during the year Cumulative Shareholding at
Decrease Beginning of the the end of the
Financial Year 2018-19 Financial Year 2018-19
No of Shares % of Total Date Increase/ No of Shares % of Total

Company Company
1 Reliance Capital Trustee Co. 6421199 4.71 6421199 4.71
Limited - A/C Reliance Small
Cap Fund
Market Purchase 13-Jul-2018 40282 6461481 4.74
Market Purchase 12-Oct -2018 7853 6479334 4.75
Market Purchase 26-Oct-2018 7000 6486334 4.76
Market Purchase 02-Nov-2018 50000 6536334 4.79
Market Purchase 09 Nov 2018 715200 7251534 5.32
At the end of Year 7497953 5.50
2 Aditya Birla Sun Life Trustee 4088798 3.00 4088798 3.00
Private Limited*
Market Purchase 27-Apr-2018 111000 4199798 3.08
Market Purchase 04-May-2018 130000 4329798 3.17
Market Purchase 08-Jun-2018 16600 4376398 3.21
Market Purchase 10-Aug-2018 36300 4441198 3.26
Market Purchase 14-Dec-2018 5000 6185198 4.53
Market Purchase 28-Dec -2018 18000 6213198 4.56
Market Purchase 04-Jan-2019 100000 6313198 4.63
3 Franklin India Smaller 5622951 4.12 5622951 4.12
Companies Fund
Market Sale 05-Oct-2018 (44700) 5578251 4.09
* Includes A/c Aditya Birla Sun Life Small Cap Fund and Aditya Birla Sun Life Pure Value Fund


Company Company
4 DCS Infotech Private Limited 4648720 3.41 4648720 3.41
5 IDFC Sterling Value Fund 3227489 2.37 3227489 2.37
6 L & T Mutual fund Trustee 5339770 3.91 5339770 3.91
Limited -L & T India Value Fund
Market Sale 14-Sep-2018 (720169) 5039094 3.69
Market Sale 21-Sep-2018 (250000) 4789094 3.51
Market Sale 16-Nov-2018 (108922) 4892168 3.59
Market Sale 21-Dec -2018 (91383) 5268089 3.86

Corporate OVERVIEW
statutory reportS

Company Company
Market Sale 28-Dec-2018 (441231) 4826858 3.54
Market Sale 31-Dec-2018 (144760) 4682098 3.43
Market Sale 04-Jan-2019 (260014) 4422084 3.24
Market Sale 11-Jan-2019 (61350) 4360734 3.20
Market Sale 08-Feb-2019 (331000) 4029734 2.95
Market Sale 08-Mar-2019 (518875) 3510859 2.57
Market Sale 15-Mar-2019 (113081) 3397778 2.49
Market Sale 22-Mar-2019 (60708) 3337070 2.45
7 SBI Magnum Multicap Fund 2222994 1.63 2222994 1.63
Market Sale 19-Oct-2018 (242296) 2834970 2.08
Market Sale 26-Oct-2018 (74846) 2760124 2.02
Market Sale 02-Nov-2018 (250000) 2510124 1.84
Market Sale 14-Dec-2018 (27000) 2788266 2.04
Market Sale 01-Feb-2019 (150000) 2638266 1.93
8 Riddhi Siddhi Gluco Biols Limited 743462 0.55 743462 0.55
9 Edelweiss Custodial Services 650123 0.48 650123 0.48
Limited
Market Sale 06-Apr-2018 (11664) 638459 0.47
Market Sale 27-Apr-2018 (10712) 634448 0.47
Market Sale 01-Jun-2018 (12121) 689751 0.51
Market Sale 30-Jun -2018 (1543) 786367 0.58
Market Sale 13-Jul -2018 (39712) 803410 0.59
Market Sale 20-Jul-2018 (4821) 798589 0.59
Market Sale 03 -Aug -2018 (8375) 800423 0.59


Company Company
Market Sale 17-Aug-2018 (22263) 866022 0.63
Market Sale 24-Aug-2018 (57307) 808715 0.59
Market Sale 07-Sep-2018 (11140) 867855 0.64
Market Sale 29-Sep-2018 (95785) 790538 0.58
Market Sale 05-Oct-2018 (3321) 787217 0.58
Market Sale 02-Nov-2018 (6003) 846298 0.62
Market Sale 09-Nov-2018 (28734) 817564 0.60
Market Sale 16-Nov-2018 (48833) 768731 0.56
Market Sale 23-Nov-2018 (50098) 718633 0.53
Market Sale 25-Jan-2019 (12424) 1201554 0.88
Market Sale 08-Feb-2019 (1302) 1203933 0.88
Market Sale 22-Feb-2019 (316709) 895688 0.66
Market Sale 15-Mar-2019 (10073) 887995 0.65
Market Sale 22-Mar-2019 (46298) 841697 0.62
Market Sale 29-Mar-2019 (19592) 822105 0.60
Market Sale 30-Mar-2019 (200) 821905 0.60
10 Ashish Kacholia - - - -
11 ICICI Lombard General 4003030 2.93 4003030 2.93
Insurance Company Limited
Market Sale 06-Apr-2018 (650000) 3353030 2.46
Market Sale 20-Apr-2018 (87525) 3265505 2.39
Market Sale 27-Apr-2018 (35000) 3230505 2.37
Market Sale 04-May -2018 (192807) 3037698 2.23
Market Sale 11-May-2018 (29280) 3008418 2.21
Market Sale 05-Oct-2018 (228722) 2779696 2.04

Corporate OVERVIEW
statutory reportS

Company Company
Market Sale 12-Oct-2018 (259269) 2520427 1.85
Market Sale 19-Oct-2018 (166840) 2353587 1.73
Market Sale 26-Oct-2018 (97372) 2256215 1.65
Market Sale 02-Nov-2018 (500000) 1756215 1.29
Market Sale 09-Nov-2018 (252264) 1503951 1.10
Market Sale 16-Nov-2018 (206380) 1297571 0.95
Market Sale 23-Nov-2018 (173019) 1124552 0.82
Market Sale 30-Nov-2018 (213929) 910623 0.67
Market Sale 07-Dec-2018 (138433) 772190 0.57
Market Sale 14-Dec-2018 (215470) 556720 0.41
Market Sale 21-Dec-2018 (364076) 192644 0.14
Market Sale 28-Dec-2018 (192644) - -
At the end of the Year - -
12 Fidelity Puritan Trust-Fidelity 1767259 1.30 1767259 1.30
Low-Priced Stock Fund
Market Sale 06-Apr-2018 (73307) 1693952 1.24
Market Sale 13-Apr 2018 (42317) 1651635 1.21
Market Sale 20-Apr-2018 (95314) 1556321 1.14
Market Sale 27-Apr-2018 (363433) 1192888 0.87
Market Sale 04-May-2018 (82143) 1110745 0.81
Market Sale 11-May-2018 (85440) 1025305 0.75
Market Sale 18-May-2018 (184992) 840313 0.62
Market Sale 25-May-2018 (53766) 786547 0.58
Market Sale 01-Jun-2018 (46363) 740184 0.54
Market Sale 08-Jun-2018 (122034) 618150 0.45
Market Sale 15-Jun-2018 (46291) 571859 0.42
Market Sale 22-Jun-2018 (50014) 521845 0.38
Market Sale 30-Jun-2018 (71114) 450731 0.33
Market Sale 06-Jul-2018 (62246) 388485 0.28
Market Sale 13-Jul-2018 (40465) 348020 0.26
Market Sale 20-Jul-2018 (47130) 300890 0.22
Market Sale 27-Jul-2018 (169405) 131485 0.10
Market Sale 03-Aug-2018 (120869) 10616 0.01
Market Sale 10 -Aug-2018 (10616) - -
13 Vantage Equity Fund 865000 0.63 865000 0.63
Market Sale 24-Aug-2018 (25759) 1158241 0.85
Market Sale 31-Aug-2018 (108615) 1049626 0.77
Market Sale 07-Sep-2018 (229650) 819976 0.60
Market Sale 14-Sep-2018 (409785) 410191 0.30
Market Sale 21-Sep-2018 (410191) - -
(v) Shareholding of Directors and Key Managerial Personnel:

None of the Directors or KMP, except Shri Deepak C. Mehta and Shri Maulik D. Mehta (covered under point (ii) above), hold any Shares of
the Company and except as disclosed above, there has not been any change in such holdings during the Financial Year 2018-19.

v. INDEBTEDNESS:
Indebtedness of the Company including interest outstanding/accrued but not due for payment
(` In Lakhs)
Indebtedness at the beginning of the Secured Loans Unsecured Deposits Total
Financial Year 2018-19 excluding Loans Indebtedness
deposits
i) Principal Amount 28,748.21 17,428.56 - 46,176.77
ii) Interest due but not paid - - - -
iii) Interest accrued but not due 105.66 78.94 - 184.60
Total (i+ii+iii) 28,853.87 17,507.50 - 46,361.37
Change in Indebtedness during the
· Addition 6,159.71 98.81 - 6,258.52
· Reduction 5,530.27 14,143.94 - 19,674.21
Net Change 11,689.98 14,242.75 - 25,932.73
Indebtedness at the end of the
i) Principal Amount 29,377.65 3,383.43 - 32,761.08
ii) Interest due but not paid - - - -
iii) Interest accrued but not due 71.82 25.47 - 97.29
Total (i+ii+iii) 29,449.47 3,408.90 - 32,858.36
VI. REMUNERATION OF DIRECTORS AND KEY MANAGERIAL PERSONNEL:

A. Remuneration to Managing Director, Whole-time Directors and/or Manager: (` In Lakhs)
Sr. Particulars of Remuneration Name of MD/WTD/Manager Total Amount

No
Shri Deepak Shri Umesh Shri Maulik Shri Sanjay
C. Mehta Asaikar Mehta Upadhyay
1 Gross Salary
(a)
Salary as per provisions 275.00 533.15 154.16 262.79 1,225.10
contained in Section 17(1) of
the Income Tax Act, 1961
(b) Value of Perquisites u/s 17(2) 31.60 55.71 16.90 31.61 135.82
Income Tax Act, 1961
(c) Profits in lieu of salary under - - - - -
Section 17(3) Income Tax Act,
1961
2. Stock Option - - - - -
3. Sweat Equity - - - - -
4. Commission
- as % of profit 600.00 - - - 600.00
- others - - - - -
5. Others, please specify - - - - -
Total (A) 906.60 588.86 171.06 294.40 1960.92
Ceiling as per the Act ` 2,647.98 Lakhs (being 11% of Net Profits of the Company calculated as per Section 198 of the Companies
Act, 2013)

Corporate OVERVIEW
statutory reportS
B. Remuneration to other Directors: (` In Lakhs)

Particulars of Name of Directors Total
Remuneration Non- Executive Directors Amount
Shri Shri Sudhin Shri Sudhir Dr. R. H. Shri S. K. Dr. S. Prof. Indira Shri Ajay C.
Nimesh Choksey Mankad Rupp Anand Sivaram Parikh Mehta
Kampani
Fee for attending
Board/Committee 1.50 2.70 2.85 1.20 3.60 1.80 0.60 1.20 15.45
Meetings
Commission 8.00 10.00 10.00 10.00 25.00 8.00 4.00 - 75.00
Total (B) 9.50 12.70 12.85 11.20 28.60 9.80 4.60 1.20 90.45
Ceiling as per the Act ` 240.73 Lakhs (being 1% of Net Profits of the Company calculated as per Section 198 of the Companies Act, 2013)
Total Managerial Remuneration ` 2,035.92 Lakhs
Overall Ceiling as per the Act ` 2,647.98 Lakhs (being 11% of Net Profits of the Company calculated as per Section 198 of the Companies Act, 2013)
C. Remuneration to Key Managerial Personnel other than MD/MANAGER/WTD (` In Lakhs)
Sr. Particulars of Remuneration Company

No. Secretary
1 Gross Salary
(a) Salary as per provisions contained in Section 17(1) of the Income Tax Act, 1961 43.81
(b) Value of Perquisites u/s 17(2) Income Tax Act, 1961 0.53
(c) Profits in lieu of salary under Section 17(3) Income Tax Act, 1961 -
2. Stock Option -
3. Sweat Equity -
4. Commission
- as % of profit -
- others, specify -
5. Others, please specify -
Total 44.34
VII. Penalties/Punishment/Compounding of offences:

Type Section of the Brief Description Details of Penalty/ Authority Appeal made, if
Companies Punishment/ [RD/NCLT/COURT] any (give Details)
Act 2013 Compounding
fees imposed
A. Company
Penalty
NIL
Punishment
Compounding
B. Directors
Penalty
NIL
Punishment
Compounding
C. Other Officers in default
Penalty
NIL
Punishment
Compounding
Deepak C. Mehta
Place: Vadodara Chairman & Managing Director
Date: May 3, 2019 (DIN: 00028377)

Annexure - G
DISCLOSURE UNDER SECTION 197(12) OF THE COMPANIES ACT, 2013:
PART (A) – DISCLOSURE AS REQUIRED UNDER RULE 5(1) OF THE COMPANIES (APPOINTMENT AND REMUNERATION OF MANAGERIAL
PERSONNEL) RULES, 2014:
1. Ratio of remuneration of each Director to the median remuneration of the employees of the Company for the Financial Year ended
March 31, 2019 and the percentage increase in remuneration of each Director, Chief Financial Officer, Chief Executive Officer, Company
Secretary or Manager in the Financial Year ended March 31, 2019:
Name of the Director / KMP Remuneration* % Increase in Ratio to Median

(` In Lakhs) Remuneration* in Remuneration*
the FY 2018-19
Shri Deepak C. Mehta, Chairman & Managing Director 906.60 79.25 188.88
Shri Umesh Asaikar, Executive Director & CEO 588.86 25.10 122.68
Shri Sanjay Upadhyay, Director-Finance & CFO 294.40 43.14 61.33
Shri Maulik Mehta, Whole-time Director 171.06 66.05 35.64
Shri Ajay C. Mehta, Non-Executive Director# 1.20 - 0.25
Shri Nimesh Kampani, Independent Director 9.50 47.29 1.98
Shri Sudhin Choksey, Independent Director 12.70 27.64 2.65
Shri Sudhir Mankad, Independent Director 12.85 31.12 2.68
Shri S. K. Anand, Independent Director 28.60 171.09 5.96
Dr. R. H. Rupp, Independent Director 11.20 9.80 2.33
Dr. S. Sivaram, Independent Director 9.80 68.97 2.04
Prof. Indira Parikh, Independent Director 4.60 (1.08) 0.96
Shri Arvind Bajpai, Company Secretary 44.34 8.00 NA
* Including sitting fees.
# Shri Ajay C. Mehta ceased to be the Managing Director of the Company with effect from December 1, 2017. He remains on the Board as a Non-Executive
Director.
1. In the Financial Year 2018-19, there was an increase of 13.74% in the median remuneration of employees.
2. There were 1,362 permanent employees on the rolls of the Company as on March 31, 2019.
3. Average Percentile increase already made in the salaries of employees other than Managerial Personnel in the last Financial Year
was 10% and average percentile increase in remuneration of Managerial Personnel was 52.58%.
Average increase in remuneration of both, managerial and non-managerial personnel were determined based on the overall
performance of the Company and individual performance as per policy of the Company.
Key result areas of the Managerial Personnel are broadly to achieve Company’s growth and performance target, achieving the same
against various adverse externalities globally, devising sustenance strategy to combat global forces like competition, exchange
rate etc, which, in turn, enhance shareholders’ value. Remuneration of the Managerial Personnel is based on the Nomination &
Remuneration Policy of the Company and as recommended by the Nomination & Remuneration Committee and approved by the
Board of Directors.
As against above, Remuneration for non-managerial personnel is based on an internal evaluation of assigned target area which
are derived from the key result area of their superiors / managerial personnel.
4. It is affirmed that the Remuneration is as per the Nomination & Remuneration Policy of the Company.
Deepak C. Mehta
Place: Vadodara Chairman & Managing Director
Date: May 3, 2019 (DIN: 00028377)

Corporate OVERVIEW
statutory reportS
Annexure - H
Information required under section 134(3)(m) of the Companies Act, 2013 read with Rule 8(3) of the Companies
(Accounts) Rules, 2014 pertaining to Conservation of Energy, Technology Absorption, Foreign Exchange
Earnings and Outgo
(A) Conservation of Energy
(i) Steps taken or impact on conservation of energy:
- Improvements in - Flash stream and condensate recovery, column packings, boiler & chilling units efficiency improvements,
air leakage survey in plant.
- Processes improved to reduce utility and improve energy conservation.
(ii) Steps taken for utilizing alternate sources of energy:
- Power generation by using back pressure turbine
- Power trading through open access and bilateral agreements
(iii) Capital Investment on energy conservation equipments: ` 272.69 Lakhs
(B) Technology Absorption:

(i) Efforts made towards technology absorption:
- Technology developed for import substituted products
- Developed continuous process of existing batch process .
(ii) Benefits derived like product improvement, cost reduction, product development or import substitution:
- Processes developed for import substituted products in the in-house Research & Development
- Continuous chemical processes developed to reduce raw materials consumption norms and by-products formation, also
evaluated alternative routes to make cheaper and cleaner technologies.
(iii) Information regarding technology imported, during the last 3 years: Nil
(iv) Expenditure incurred on Research and Development:

(` In Lakhs)
Particulars 2018-19 2017-18
a) Capital 192.91 117.90
b) Recurring 810.92 701.80
c) Total 1,003.83 819.70
d) Total R&D expenditure as a percentage to total turnover 0.56% 0.55%
(C) Foreign exchange Earnings and Outgo:

The Foreign Exchange earned in terms of actual inflows during the year and the Foreign Exchange outgo during the year in terms of
actual outflows.
(` In Lakhs)
Particulars 2018-19 2017-18

Total Foreign Exchange Earned 57,907.80 50,902.66
Total Foreign Exchange Outgo 31,810.19 22,374.30

Deepak C. Mehta
Date : May 3, 2019 (DIN: 00028377)

Corporate Governance Report
for the year ended March 31, 2019
1. COMPANY’S PHILOSOPHY ON CODE OF GOVERNANCE: Director & CEO of the Company for a period from May
Your Company’s philosophy on Corporate Governance 9, 2018 to May 31, 2020. The said re-appointment was
envisages the attainment of a high level transparency and approved by the Members at the 47th Annual General
accountability in the functioning of the Company and the Meeting of the Company held on August 3, 2018.
efficient conduct of its business, including its interaction with (2) Shri Deepak C. Mehta (DIN: 00028377) was re-appointed
employees, shareholders, depositors, creditors, consumers, as the Chairman & Managing Director of the Company
financial institutions and other lenders. Accountability w.e.f. December 14, 2018 for a period of five (5) years,
improves decision making and transparency helps to explain subject to the approval of Members of the Company.
the rationale behind decisions which in turn helps in building
confidence in the Company. The composition of the Board of Directors of the Company as
on March 31, 2019 was as under:
Your Company firmly believes that for a company to succeed
on a sustained basis, it must maintain global standards of Sr. No. Category Name of Director
Corporate Conduct. It also believes that Corporate Governance I. Promoter and Shri Deepak C. Mehta
is not simply a matter of creating checks and balances; it is Executive Director
about creating an outperforming organisation, which leads to II. Promoter and Non- Shri Ajay C. Mehta
increasing employee and customer satisfaction. Executive Director
III. Executive Directors Shri Umesh Asaikar
2. BOARD OF DIRECTORS: Shri Maulik D. Mehta
(i) Composition and Category of Directors Shri Sanjay Upadhyay
The Board of Directors of the Company comprises of an IV. Non-Executive Shri Nimesh Kampani
optimum combination of executive and non-executive and Independent Shri Sudhin Choksey
directors, which is in conformity with the requirements of SEBI Directors
Shri Sudhir Mankad
(Listing Obligations Disclosure Requirements) Regulations,
Dr. Richard H. Rupp
2015 (‘LODR or Listing Regulations’). As of the year ended
Shri Sandesh Kumar Anand
March 31, 2019, the Board consisted of twelve (12) Directors
comprising of four (4) Executive Directors, one (1) Non- Dr. Swaminathan Sivaram
Executive Director and seven (7) Independent Directors. The Prof. Indira Parikh
Chairman of the Board is an Executive Director.
(ii) Board Meetings
The Directors of the Company are highly experienced
During the Financial Year 2018-19, four (4) Board Meetings
professionals in their fields and brings in a wide range of skills
were held on May 4, 2018, August 2, 2018, October 26, 2018 and
and experience to the Board.
February 1, 2019. The maximum time gap between the two
During the year under review: Board Meetings was not more than one hundred twenty (120)
days as prescribed under the (‘Listing Regulations’).
(1) Shri Umesh Asaikar (DIN: 06595059) was re-appointed
as a Whole-time Director designated as the Executive
The attendance of Directors at the Board Meetings held during the year ended March 31, 2019, and at the last Annual
General Meeting and the directorship, chairmanship and membership in committees of the Directors in other companies as
on March 31, 2019:
Name of the Director Director No. of Board Meetings No. of Board Attendance No. of other No. of Committee
Identification held during the year/ Meetings at Last AGM Directorship position in other Public
Number (DIN) tenure of Director Attended Held (including Companies [Chairman
listed entities) (C)/ Member (M)]
Shri Deepak C. Mehta 00028377 4 4 YES 2 2(M)
Shri Ajay C. Mehta 00028405 4 4 YES 2 1(C) & 2(M)
Shri Maulik D. Mehta 05227290 4 4 YES - -

Corporate OVERVIEW
statutory reportS
Name of the Director Director No. of Board Meetings No. of Board Attendance No. of other No. of Committee
Identification held during the year/ Meetings at Last AGM Directorship position in other Public
Number (DIN) tenure of Director Attended Held (including Companies [Chairman
listed entities) (C)/ Member (M)]
Shri Nimesh Kampani 00009071 4 4 YES 7 6(M)
Shri Sudhin Choksey 00036085 4 3 YES 2 1(C)
Shri Sudhir Mankad 00086077 4 3 YES 6 1(C) & 2(M)
Dr. Richard H. Rupp 02205790 4 2 NO - -
Shri S. K. Anand 00001792 4 4 YES 2 2(C)
Dr. S. Sivaram 00009900 4 4 YES 6 2(C)
Shri Umesh Asaikar 06595059 4 4 YES - -
Prof. Indira Parikh 00143801 4 1 NO 7 4(M)
Shri Sanjay Upadhyay 01776546 4 4 YES 2 1(C)
Note:
(1) Number of other directorships held by Directors as mentioned above excludes directorships in Private Limited Companies, Section 8 companies,
Foreign Companies, Membership of Managing Committee of various chambers/bodies and alternate directorships.
(2) In accordance with the provisions of the Listing Regulations, Memberships / Chairmanships of only Audit Committee and Stakeholders’ Relationship
Committee in all public limited companies (excluding Deepak Nitrite Limited) have been considered.
As required under the Listing Regulations as amended w.e.f. April 1, 2019, the names of the listed entities (Including Deepak
Nitrite Limited) where the Director of the Company is a director and the category of directorship as on March 31, 2019 is
provided hereunder:
Name of Director Name of Listed Entity Category of Directorship
Shri Deepak C. Mehta Deepak Nitrite Limited Chairman & Managing Director
Shri Ajay C. Mehta Deepak Nitrite Limited Non-Executive Director
Tribhovandas Bhimji Zaveri Limited Independent Director
Shri Umesh Asaikar Deepak Nitrite Limited Executive Director & CEO
Shri Sanjay Upadhyay Deepak Nitrite Limited Director -Finance & CFO
Shri Maulik D. Mehta Deepak Nitrite Limited Whole-time Director
Shri Nimesh Kampani Deepak Nitrite Limited Independent Director
Britannia Industries Limited Independent Director
Chambal Fertilisers and Chemicals Limited Independent Director
Apollo Tyres Limited Independent Director
JM Financials Limited Non-Executive Chairman
Shri Sudhin Choksey Deepak Nitrite Limited Independent Director
Gujarat Ambuja Exports Limited Independent Director
GRUH Finance Limited Managing Director
Shri Sudhir Mankad Deepak Nitrite Limited Independent Director
Navin Fluorine International Limited Independent Director
Swaraj Engines Limited Non-Executive Chairman
GRUH Finance Limited Independent Director
Dr. Richard H. Rupp Deepak Nitrite Limited Independent Director
Shri S. K. Anand Deepak Nitrite Limited Independent Director
Dr. S. Sivaram Deepak Nitrite Limited Independent Director
Supreme Petrochem Limited Independent Director
Asian Paints Limited Independent Director
GMM Pfaudler Limited Independent Director
APCOTEX Industries Limited Independent Director
Prof. Indira Parikh Deepak Nitrite Limited Independent Director
Johnson Controls- Hitachi Air-conditioning India Limited Independent Director
Force Motors Limited Independent Director

(iii) Board Procedure The Board confirms that the Independent Directors fulfill the
The Board meets at regular intervals to discuss and decide conditions specified in Section 149 of the Act and Regulation
various business items. The tentative annual calendar of the 16(1)(b) of the Listing Regulations and are independent of the
Board meetings is circulated to the Directors, well in advance management.
to facilitate them to plan their schedule and to ensure
meaningful participation in the meetings. However, in case of (vii) Familiarisation program for Independent Directors
a special and urgent business needs, the Board’s approval is The Board members are from time to time provided with
taken by passing resolutions by circulation, as permitted by necessary documents/brochures, reports and internal policies
law, which is noted and confirmed at the subsequent board to enable them to familiarize themselves with the Company’s
meeting. The agenda is circulated well in advance to the Board procedures and practices. Periodic presentations are made
members, along with comprehensive back-ground information at the Board and the committee meetings on business and
on items in the agenda to enable the Board members to take performance updates of the Company, global business
informed decisions. The Agenda and related information are environment, business strategy and risks involved.
circulated in electronic form through a highly secured web-
Web link giving the details of familiarisation program imparted
based application, which is available to the Board members
through iPad/laptop. The information as required under Part A to Independent Directors is https://www.godeepak.com/
of Schedule II to the Listing Regulations is also made available investor-compliances/
to the Board, wherever applicable, for their consideration. The
Board also reviews the declarations made by the Chairman & (viii) Skills / Expertise / Competencies of the Board of Directors
Managing Director, Executive Director & CEO, Director - Finance The following is the list of core skills / expertise / competencies
& CFO and Company Secretary of the Company regarding identified by the Board of Directors as required in the context
compliance with all applicable laws, on a quarterly basis. of the Company’s business and that the said skills are available
with the Board Members:
(iv) Disclosure of relationships between Directors inter-se
(a)
Knowledge on Company’s businesses (Chemical
Shri Maulik D. Mehta, Whole-time Director is son of Shri Deepak
Intermediates), policies and culture (including the
C. Mehta, Chairman & Managing Director and nephew of Shri
Mission, Vision and Values) major risks / threats and
Ajay C. Mehta, Non-Executive Director of the Company. Shri
potential opportunities and knowledge of the industry in
Deepak C. Mehta, Chairman & Managing Director and Shri Ajay
which the Company operates;
C. Mehta, Non-Executive Director of the Company are brothers.
(b) Behavioral skills - attributes and competencies to use
No other Director of the Company is related to each other.
their knowledge and skills to contribute effectively to the
(v) Independent Directors growth of the Company;
The Independent Directors of the Company have been (c)
Business Strategy, Sales & Marketing, Corporate
appointed in terms of requirements of the Companies Act, Governance, Forex Management, Administration,
2013 and Listing Regulations. The selection of eminent people Decision Making;
for appointment as Independent Directors on the Board is
considered by the Nomination and Remuneration Committee. (d) Financial and Management skills;
The Committee, inter alia, considers qualification, positive (e) Legal expertise
attributes, area of expertise and number of directorships and
memberships held in various committees of other companies (f) Technical / Professional skills and specialized knowledge
by such person and recommend the same to the Board. The in relation to Company’s business.
Board considers the Committee’s recommendation and (ix) Performance Evaluation
takes appropriate decision. Formal letters of appointment
The Nomination and Remuneration Committee has specified
have been issued to the Independent Directors and the terms
the criteria for performance evaluation of the directors, the
and conditions of their appointment are disclosed on the
Board and its committees. The Board is committed to evaluate
Company’s website at www.godeepak.com. No Independent
its own performance as a Board and also the performance of
Director has resigned during the Financial Year 2018-19.
individual directors, in order to identify strengths and areas in
which it may improve functioning.
(vi) Declaration of Independence
The Company has received declarations on criteria of (x) Separate Meeting of Independent Directors
independence as prescribed in Section 149(6) of the Companies During the year, a separate meeting of Independent Directors
Act, 2013 (“Act”) and Regulation 16 (1) (b) of the Listing was held on March 15, 2019 without the presence of other
Regulations from the Directors of the Company who have been directors or management representatives, to review the
classified as Independent Directors as on March 31, 2019. performance of Non-Independent Directors, the Board and

Corporate OVERVIEW
statutory reportS
the Chairperson of the Company and to assess the quality, before submission to the Board for approval, with
quantity and timeliness of flow of information between the particular reference to:
management and the Board. • M
atters required to be included in the
director’s responsibility statement to 76 be
3. COMMITTEES OF BOARD OF DIRECTORS: included in the Board’s Report in terms of
The Board committees are set up to carry out clearly defined clause (c) of sub-section (3) of Section 134 of
roles which are considered to be performed by members of the Companies Act, 2013;
the Board, as a part of good governance practice. Minutes • C
hanges, if any, in accounting policies and
of proceedings of committee meetings are circulated to the practices and reasons for the same;
directors and placed before Board meetings for noting. The
• M
ajor accounting entries involving estimates
Board has currently established the following Committees:
based on the exercise of judgment by
management;
(A) Audit Committee:
(i) Composition of Audit Committee • S
ignificant adjustments made in the Financial
Statements arising out of Audit findings;
The Audit Committee comprises of the following
members: • C
ompliance with listing and other legal
Name of Member Designation Category
requirements relating to Financial Statements;
Shri Sudhin Choksey Chairman Independent Director • Disclosure of any Related Party Transactions; and
Shri Sudhir Mankad Member Independent Director • Modified opinion(s) in the draft Audit Report.
Shri S. K. Anand Member Independent Director
5) Reviewing, with the management, the quarterly
The Committee’s composition meets with requirements financial statements before submission to the
of Section 177 of the Companies Act, 2013 and Listing board for approval;
Regulations. All members of the Audit Committee are
6) Reviewing and monitoring, with the management,
financially literate and Shri Sudhin Choksey possesses
the statement of uses/ application of funds
financial / accounting expertise.
raised through an issue (public issue, rights issue,
The Statutory Auditors, Internal Auditors and other preferential issue, etc.), the statement of funds
relevant senior management persons are invited to utilized for purposes other than those stated in the
attend the meetings of Audit Committee. offer document / prospectus / notice and the report
submitted by the monitoring agency monitoring
Shri Sudhin Choksey, Chairman of the Audit Committee,
the utilisation of proceeds of a public or rights
was present at the last Annual General Meeting held on
issue, and making appropriate recommendations
August 3, 2018.
to the board to take up steps in this matter;
The Company Secretary acts as a Secretary to the 7)
Reviewing and monitoring the auditor’s
Committee. independence and performance, and effectiveness
(ii) Brief Description of Terms of Reference of the Audit of audit process;
Committee 8)
Approval or any subsequent modification of
In accordance with the provisions of the Companies Act, transactions of the Company with related parties;
2013 and Listing Regulations, the terms of reference for
9) Scrutiny of inter-corporate loans and investments;
the Audit Committee of Directors are as under:
10) Valuation of undertakings or assets of the listed
1)
Oversight of the Company’s financial reporting
entity, wherever it is necessary;
process and the disclosure of its financial
information to ensure that the financial statement 11) Evaluation of internal financial controls and risk
is correct, sufficient and credible; management systems;
2) Recommendation for appointment, remuneration 12) Reviewing, with the management, performance of
and terms of appointment of auditors of the statutory and internal auditors, adequacy of the
Company; internal control systems;
3) Approval of payment to Statutory Auditors for any 13) Reviewing the adequacy of internal audit function,
other services rendered by the Statutory Auditors; if any, including the structure of the internal audit
department, staffing and seniority of the official
4)
Reviewing, with the management, the annual heading the department, reporting structure
financial statements and Auditor’s report thereon coverage and frequency of internal audit;

14) Discussion with internal auditors of any significant (B) Nomination and Remuneration Committee:
findings and follow up there on; (i) Composition of Nomination and Remuneration
15) Reviewing the findings of any internal investigations Committee
by the internal auditors into matters where there
The Nomination and Remuneration Committee
is suspected fraud or irregularity or a failure of comprises of the following members:
internal control systems of a material nature and
reporting the matter to the Board; Name of Member Designation Category
Shri Sudhir Mankad Chairman Independent Director
16) Discussion with statutory auditors before the audit
commences, about the nature and scope of audit Shri S. K. Anand Member Independent Director
as well as post-audit discussion to ascertain any Shri Sudhin Choksey Member Independent Director
area of concern; Prof. Indira Parikh Member Independent Director
17) To look into the reasons for substantial defaults in
The Committee’s composition meets with the
the payment to the Depositors, Debenture Holders, requirement of Section 178 of the Companies Act, 2013
Shareholders (in case of non-payment of declared
and requirements of the Listing Regulations.
Dividends) and Creditors;
The Company Secretary acts as a Secretary to the
18) To review the functioning of the Whistle Blower
Committee.
Mechanism;
19) Approval of appointment of Chief Financial Officer (ii) Terms of Reference
after assessing the qualifications, experience and In accordance with the provisions of the Companies
background, etc. of the candidate; Act, 2013 and Listing Regulations, the terms of reference
20) Carrying out any other function as is mentioned in for the Nomination and Remuneration Committee of
the terms of reference of the Audit Committee; Directors are as under:
21) Reviewing the utilization of loans and/or advances 1)

Formulation of the criteria for determining
from/investment by the holding company in the qualifications, positive attributes and
subsidiary exceeding ` 100 Crores or 10% of the independence of a Director and recommend to
asset size of the subsidiary, whichever is lower the Board of Directors a policy relating to the
including existing loans/advances/ investments remuneration of the directors, key managerial
existing as on the date of coming into force of this personnel and senior management.
provision; and
2)
specify the manner for effective evaluation
22)
Such other terms as may be prescribed under of performance of Board, its Committee and
the Companies Act, 2013 or The SEBI (LODR)
individual Directors;
Regulations, 2015.
3) Devising a policy on diversity of Board of Directors;
(iii) Meetings of Audit Committee and Attendance
thereat 4) Identifying persons who are qualified to become
Directors and who may be appointed in senior
Four (4) meetings of the Audit Committee were held
during the financial year 2018-19 on May 3, 2018, August management in accordance with the criteria
2, 2018, October 25, 2018 and January 28, 2019. laid down, and recommend to the Board their
appointment and removal;
The attendance at the Audit Committee meetings held
during financial year 2018-19 was as under: 5)
Whether to extend or continue the term of
appointment of the Independent Director, on the
Name of Member No. of Audit No. of Audit
basis of the report of performance evaluation of
Committee Committee Meetings
Independent Directors;
Meetings held attended
Shri Sudhin Choksey 4 4 6) To recommend to the Board, all remuneration, in
Shri Sudhir Mankad 4 4 whatever form, payable to senior management;
Shri S. K. Anand 4 4 and
All the recommendations of the Audit Committee were 7) Such other terms as may be required under the
accepted by the Board of Directors of the Company. Companies Act, 2013 or the Listing Regulations.

Corporate OVERVIEW
statutory reportS
(iii) Meetings and Attendance thereat (C) Stakeholders’ Relationship & Investors Grievance
Two (2) meetings of the Nomination and Remuneration Committee:
Committee were held during the Financial Year 2018-19 (i) Composition
on May 4, 2018 and October 25, 2018. The Stakeholders’ Relationship & Investors Grievance
The attendance at the Nomination and Remuneration Committee comprises of the following Directors:
Committee meetings held during financial year 2018-19 Name of Member Designation Category
was as under:
Shri S. K. Anand Chairman Independent Director
Name of Member No. of No. of Nomination
Shri A. C. Mehta Member Non-Executive Director
Nomination and and Remuneration
Remuneration Committee Shri Umesh Asaikar Member Executive Director & CEO
Committee Meetings attended Prof. Indira Parikh* Member Independent Director
Meetings held
* Prof. Indira Parikh inducted as a member with effect from
Shri Sudhin Choksey 2 2 February 1, 2019.
Shri Sudhir Mankad 2 2
Shri Arvind Bajpai, Company Secretary, is the Compliance Officer.
Shri S. K. Anand 2 2
Prof. Indira Parikh 2 0
(ii) Terms of Reference
Shri Sudhir Mankad, Chairman of the Nomination and In accordance with the provisions of the Companies Act,
Remuneration Committee, was present at the last Annual 2013 and Listing Regulations, the terms of reference for
General Meeting of the Company held on August 3, 2018. the Stakeholder’s Relationship & Investors’ Grievances
All the recommendations of the Nomination and Committee of Directors are as under:
Remuneration Committee were accepted by the Board 1) Resolving the grievances of the security holders
of Directors of the Company. of the listed entity including complaints related
to transfer/transmission of shares, non-receipt of
(iv) Performance evaluation criteria for Independent annual report, non-receipt of declared dividends,
Directors issue of new/duplicate certificates, general
The criteria for performance evaluation of Independent meetings etc.;
Directors has been disclosed in the Directors’ Report.
2) Review of measures taken for effective exercise of
(v) Remuneration Policy voting rights by shareholders;

The Company has adopted a Nomination and
3)
Review of adherence to the service standards
Remuneration Policy for Directors, Key Managerial
adopted by the listed entity in respect of various
Personnel and Senior Management and is annexed
services being rendered by the Registrar & Share
to the Directors’ Report. The said Policy is directed
Transfer Agent;
towards rewarding performance, based on review of
achievements periodically and is in consonance with the 4)
Review of the various measures and initiatives
existing industry practice. The key factors considered in taken by the listed entity for reducing the quantum
formulating the Policy are as under: of unclaimed dividends and ensuring timely receipt
a)
The level and composition of remuneration is of dividend warrants/annual reports/statutory
reasonable and sufficient to attract, retain and notices by the shareholders of the company; and
motivate Directors to run the Company successfully; 5) Such other terms as may be required under the
b)
Relationship of remuneration to performance Companies Act, 2013 or Listing Regulations.
is clear and meets appropriate performance
benchmarks; and (iii) Investors Grievance
c)
Remuneration to Directors, Key Managerial Continuous efforts are being made to ensure that
Personnel and Senior Management involves a investor’s grievances are expeditiously redressed to the
balance between fixed and incentive pay reflecting satisfaction of the investors.
short and long-term performance objectives The Company and Link Intime India Pvt. Ltd. (Registrar
appropriate to the working of the Company and its & Share Transfer Agent) attend to all the grievances of
goals. the investors promptly on their receipt, whether received
The Company does not have any Employee Stock Option directly or through SEBI, Stock Exchanges, Ministry of
Scheme. Corporate Affairs etc.

Details of shareholders’ complaints received during All the recommendations of the Corporate and Social
the Financial Year 2018-19 and status thereof: Responsibility Committee were accepted by the Board of
Directors of the Company.
Number of pending complaints at the beginning of 00
the Financial Year (E) Project Committee:
Number of complaints received during the Financial 03 (i) Composition
Year A Project Committee has been constituted by the Board
Number of complaints resolved during the Financial 03
which meets from time to time to review various projects
Year
of the Company.
Number of complaints pending at the end of the 00 The Project Committee comprises of the following
Financial Year Directors:
Number of complaints not solved to the satisfaction 00 Name of Member Designation Category
of shareholders Shri S. K. Anand Chairman Independent Director
Dr. R. H. Rupp Member Independent Director
(D) Corporate Social Responsibility Committee:
Dr. S. Sivaram Member Independent Director
(i) Composition
Pursuant to the requirement of Section 135 of the (ii) Terms of Reference
Companies Act, 2013, a duly constituted Corporate The Project Committee is constituted inter alia to
Social Responsibility Committee is in place. evaluate the proposed projects / expansion plans and
recommend them to the Board for approval and also to
The Corporate Social Responsibility Committee review the progress of ongoing projects.
comprises of the following members:
(F) Risk Management Committee:
Name of Member Designation Category (i) Composition
Shri Sudhir Mankad Chairman Independent Director The Company has a comprehensive Risk Management
Dr. S. Sivaram Member Independent Director Framework and the same is periodically reviewed by the
Shri Deepak C. Mehta Member Chairman & Managing Board of Directors of the Company. A Risk Management
Director Committee has been constituted by the Board to
Shri Umesh Asaikar Member Executive Director & monitor and review the Risk Management Framework of
CEO the Company.
(ii) Terms of Reference The Risk Management Committee comprises of the

following Directors:
The terms of reference of Corporate Social Responsibility
Committee are as under: Name of Member Designation Category
Shri Deepak C. Mehta Chairman Chairman & Managing
1)
To formulate and recommend to the Board a
Director
Corporate Social Responsibility Policy (“CSR
Shri S. K. Anand Member Independent Director
Policy”).
Dr. Swaminathan Member Independent Director
2)
Recommend the amount of expenditure to be Sivaram
incurred on the activities listed in CSR Policy. Shri Umesh Asaikar Member Executive Director &
CEO
3) Monitor the CSR Policy of the Company from time
to time. Shri Sanjay Upadhyay Member Director-Finance & CFO
Shri Maulik Mehta Member Whole-time Director
4)
Such other roles and functions as may be
prescribed in the Companies Act, 2013 and Rules (ii) Terms of Reference
made thereunder. In accordance with the provisions of Listing Regulations,
the terms of reference for the Risk Management
(iii) Report on CSR activities Committee of Directors are as under:
As required under the Companies Act, 2013 and Rules 1) To ensure that appropriate methodology, processes
made thereunder, the information on the CSR activities and systems are in place to monitor, evaluate and
undertaken by the Company during the year ended report risks associated with the business of the
March 31, 2019 is annexed to the Directors’ Report. Company;

Corporate OVERVIEW
statutory reportS
2) To review the adequacy of the existing measures to mitigate risks covering various functions of the Company;
3) To evaluate and approve mitigation measures that may be recommended by the Risk Manager(s) in respect of any function
and review the action taken for its implementation on an on-going basis;
4) To review and recommend to the Board, amendment of any of the provisions of the Risk Management Framework;
5) Monitoring and reviewing the risk mitigation plan related to cyber security; and
6) Such other terms as may be required under the Listing Regulations.
All the recommendations of the Risk Management Committee were accepted by the Board of Directors of the Company.
4. REMUNERATION OF DIRECTORS:
(A) Chairman & Managing Director / Executive Directors
The remuneration of Chairman & Managing Director comprises of salary, allowances, perquisites and other benefits. In addition, the
Chairman & Managing Director is also paid a commission, calculated with reference to the Net Profits of the Company in a particular
Financial Year, as may be determined by the Board of Directors, subject to the overall ceiling stipulated in Section 197 and other relevant
provisions of the Companies Act, 2013.
The remuneration of Executive Directors comprise of fixed pay and variable pay which ranges from 0% to 20% of their respective costs
to company for a particular Financial Year based on the performance rating depending upon their individual and also the Company’s
performance as per policy of the Company.
The details of remuneration of Chairman & Managing Directors and Executive Directors for the Financial Year 2018-19 are as under:
(` In Lakhs)
Salary & Perquisites Retirement Commission /
Name Total
Allowances Benefits Variable Pay
Shri Deepak C. Mehta 236.83 31.60 38.17 600.00 906.60
Shri Umesh Asaikar 365.70 55.71 53.83 113.62 588.86
Shri Maulik D. Mehta 74.81 16.90 13.47 65.88 171.06
Shri Sanjay Upadhyay 158.57 31.61 24.89 79.33 294.40
Shri Ajay C. Mehta, Shri Umesh Asaikar, Shri Sanjay Upadhyay and Shri Maulik Mehta are liable to retire by rotation.
There is no provision for payment of severance fees.
(B) Independent Director and Non-Independent Non-Executive Directors

The Independent Director and Non-Independent Non-Executive Directors of the Company are paid sitting fees for attending meetings of
the Board and of Committees of which they are members. Apart from the sitting fees, the Independent Director and Non-Independent
Non-Executive Directors are also paid commission not exceeding 1% of the Net Profits of the Company for a particular year, computed
in accordance with the provisions of Companies Act, 2013.
The amount of Commission to Independent Director and Non-Independent Non-Executive Directors is determined on the basis of the
attendance of respective Director at the Board, Committee or General Meeting(s) of the Company during the particular year, the number
of memberships/chairmanships held of Committees of the Board and the time devoted on various matters of the Company.
The details of remuneration paid/payable to Independent Director and Non-Independent Non-Executive Directors for the Financial Year
2018-19 are as under:
(` In Lakhs)
Name Sitting Fees Commission Total
Shri Nimesh Kampani 1.50 8.00 9.50
Shri Sudhin Choksey 2.70 10.00 12.70
Shri Sudhir Mankad 2.85 10.00 12.85
Dr. R. H. Rupp 1.20 10.00 11.20
Shri S. K. Anand 3.60 25.00 28.60
Dr. S. Sivaram 1.80 8.00 9.80
Prof. Indira Parikh 0.60 4.00 4.60
Shri Ajay C. Mehta 1.20 - 1.20

The details of Equity Shares of the Company held by Non-Executive Directors as on March 31, 2019 are as under:
Sr. No. Name of Non-Executive Director No. of shares held
1 Shri Ajay C. Mehta Nil
2 Shri Nimesh Kampani Nil
3 Shri Sudhin Choksey Nil
4 Dr. R. H. Rupp Nil
5 Shri Sudhir Mankad Nil
6 Shri S. K. Anand Nil
7 Dr. S. Sivaram Nil
8 Prof. Indira Parikh Nil
The Company has no pecuniary relationship or transactions with its Non-Executive and Independent Directors other than payment of
sitting fees to them for attending Board and Committee meetings and commission as approved by the Members for their invaluable
services to the Company.
5. GENERAL BODY MEETINGS:

(i) Details of last three Annual General Meetings held:
Meeting Date Time Venue No. of Special Resolution Passed
45th AGM August 5, 2016 10.30 A.M. Hotel Surya Palace, Sayajigunj, Vadodara 390 020 -
46 AGM
th
June 26, 2017 10.30 A.M. Hotel Surya Palace, Sayajigunj, Vadodara 390 020 -
47th AGM August 3, 2018 10.00 A.M. Grand Mercure Vadodara Surya Palace, Opp. Parsi -
Agiyari, Sayajigunj, Vadodara – 390 020
(ii) Postal Ballot conducted during the year and procedure thereof:
During the year under review and upto the date of this Report, Postal Ballot exercise was undertaken by the Company in the month of
March 2019 and result of the Postal Ballot was declared on April 1, 2019. The details and voting pattern of the Special Resolutions passed
through the said Postal Ballot exercise are as under:
Sr. Resolution Special / No. of Valid No. and % of No. and % of
No. Ordinary Votes received Votes in Favour Votes Against
1 Approval for continuation of Shri Special 99041139 99034953 6186
Sandesh Kumar Anand (DIN: 00001792) (99.99%) (0.01%)
as Non- Executive and Independent
Director, who has attained the age of
2 Approval for continuation of Prof. Special 99041141 97991148 1049993
Indira Parikh (DIN: 00143801) as Non- (98.94%) (1.06%)
Executive and Independent Director,
who has attained the age of seventy
five (75) years.
Shri Dinesh Joshi, Practicing Company Secretary, Designated Partner of M/s. KANJ & Co., LLP, Company Secretaries, Pune was appointed
as the Scrutinizer for carrying out the above Postal Ballot process in a fair and transparent manner.
The Company has followed the procedure prescribed for conducting Postal Ballot under the provisions of the Companies Act, 2013 and
rules made thereunder read with Listing Regulations.
No Special Resolution is proposed to be conducted through Postal Ballot
6. MEANS OF COMMUNICATION:
The Quarterly and Half yearly results are published in widely circulating national and local dailies such as, The Business Standard
(English); The Indian Express and The Financial Express (English and Gujarati). These are not sent individually to the shareholders.
The Company’s results are displayed on the Company’s website at www.godeepak.com. The website also displays official news releases.
Presentation(s) were made to the institutional investors and to the Analysts during the year under review.

Corporate OVERVIEW
statutory reportS
7. GENERAL SHAREHOLDER INFORMATION:

(i) Annual General Meeting:
Day & Date : Friday, June 28, 2019
Time : 10:30 a.m.
Venue : Grand Mercure Vadodara Surya Palace, Opp. Parsi Agiyari, Sayajigunj, Vadodara 390 020
Financial Year : April 1 to March 31
Date of Book Closure : Friday, June 21, 2019 to Friday, June 28, 2019
Dividend Payment Date : Within the statutory time limit of 30 days, subject to Members’ approval
(ii) Financial Calendar:

Results for the Quarter ending Tentative Time of Reporting
June 30, 2019 On or before August 14, 2019
September 30, 2019 On or before November 14, 2019
December 31, 2019 On or before February 14, 2019
Audited Annual Accounts for the year ended March 31, 2020 On or before May 30, 2020
(iii) Listing on Stock Exchanges:

The Company’s Equity Shares are listed on the following Stock Exchanges:
Name: BSE Limited (BSE)
Address: Pheroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai - 400 001.
Name: National Stock Exchange of India Limited (NSE)
Address: Exchange Plaza, C-1,Block-G, Bandra Kurla Complex, Bandra (E) Mumbai- 400 051.
Listing fees for Financial Year 2019-20 has been paid to both the exchanges.
The Securities of the Company have not been suspended from trading during the Financial Year 2018-19.
Stock Code for Equity Shares (BSE): 506401
Stock Symbol for Equity Shares (NSE): DEEPAKNTR
ISIN Number for Equity Shares (NSDL & CDSL): INE288B01029
(iv) Market Price Data of Equity Shares:

Monthly High & Low during the financial year 2018-19 at BSE and NSE:
BSE NSE
Month
High (`) Low (`) High (`) Low (`)
April, 2018 281.50 245.00 281.85 244.10
May, 2018 273.65 235.00 273.40 238.75
June, 2018 258.00 215.00 258.60 215.50
July, 2018 252.65 216.00 253.30 215.50
August, 2018 292.50 233.30 292.00 232.40
September, 2018 305.00 250.00 305.00 249.00
October, 2018 292.35 225.00 289.20 212.50
November, 2018 285.85 241.65 286.50 245.50
December, 2018 262.95 204.60 263.20 205.05
January, 2019 233.00 206.05 232.50 206.00
February, 2019 235.00 211.00 235.20 211.40
March, 2019 282.70 232.25 282.50 233.05
Source: Respective Websites of BSE and NSE.

DNL Share Price Vs BSE Sensex
350 40000
300 39000
DNL Share Price (`)
38000
250
BSE Sensex
37000
200 36000
150 35000
34000
100
33000
50
32000
0 31000
Apr-18 May-18 Jun-18 Jul-18 Aug-18 Sep-18 Oct-18 Nov-18 Dec-18 Jan-19 Feb-19 Mar-19
DNL Share Price BSE Sensex
(v) Distribution of Shareholding as on March 31, 2019:

Range No. of Holders % No. of Shares %
1 – 500 30973 80.57 3796771 2.78
501 – 1000 2964 7.71 2404685 1.76
1001 – 5000 3410 8.88 8012253 5.88
5001 – 10000 609 1.58 4278319 3.14
10001 & above 486 1.26 117901013 86.44
TOTAL 38442 100.00 136393041 100.00
(vi) Shareholding Pattern as on March 31, 2019:

Category of Shareholders No. of Shares % to Equity Capital
Promoters & Promoter Group 61172468 44.85
Mutual Fund 20393369 14.95
Financial Institutions, Banks, Insurance Companies 702324 0.52
Foreign Portfolio Investor 14023615 10.28
Bodies Corporate 9272433 6.80
Non Resident Individuals 1055365 0.77
Resident Individuals 2767859 2.03
Others 27005608 19.80
TOTAL 136393041 100.00
The Company does not have any outstanding global depository receipts or American depository receipts or warrants or any convertible
instruments.
(vii) Dematerialisation of Equity Shares:

Electronic holding by Members comprises 99.02 % of the paid up Equity Capital of the Company as on March 31, 2019 held through
National Securities Depository Limited and Central Depository Services (India) Limited.
(viii) Share Transfer System:

Share transfers are processed and Share Certificates duly endorsed are delivered within a period of 15 days from the date of receipt,
subject to documents being valid and complete in all respects. All requests for dematerialisation of securities are processed and the
confirmation is given to the depositories within 15 days.
Pursuant to Regulation 40(9) of the Listing Regulations, certificates, on half yearly basis have been issued by a Company Secretary-
in-Practice for due compliance of share transfer formalities by the Company. Pursuant to Regulation 76 of SEBI (Depositories and
Participants) Regulation, 2018, certificates have been received from a Company Secretary-in-Practice for timely dematerialisation of
shares and for reconciliation of the share capital of the Company on a quarterly basis.

Corporate OVERVIEW
statutory reportS
(ix) Registrar and Share Transfer Agent:

Contact details of Link Intime India Private Limited:
Mumbai Office: Investor Relation Centre :
C-101, 247 Park, L.B.S. Marg, B-102-103, Shangrila Complex, 1st Floor, Opp. HDFC Bank,
Vikhroli (W), Near Radhakrishna Chhar Rasta,
Mumbai - 400 083. Akota, Vadodara - 390 020.
Tel: 022 - 2594 6970 Tel: 0265 - 2356 573 / 2356 794
Toll free number: 1800 1020 878 Fax: 0265 - 2356 791
Email: rnt.helpdesk@linkintime.co.in E-mail : vadodara@linkintime.co.in
(x) Address for Correspondence and Investor Assistance:

Deepak Nitrite Limited Telephone Numbers : (0265) 235 1013, 233 4481
Aaditya-I, Chhani Road, Fax No. : (0265) 233 0994
Vadodara - 390024 E-mail : investor@godeepak.com
Contact Person: Shri Arvind Bajpai Website : www.godeepak.com
Shareholders holding shares in electronic mode should address all their correspondence related to change of address or bank details
or NECS mandate to their respective Depository Participants.
(xi) Unclaimed/Unpaid Dividend:

As per the provisions of Section 124 of the Companies Act, 2013, the Company is required to transfer unclaimed dividends, matured
deposits and interest accrued thereon remaining unclaimed and unpaid for a period of seven years from the due date to the Investor
Education and Protection Fund (IEPF) set by the Central Government.
Given below are the due dates for transfer of unclaimed and unpaid dividend to the Investors Education & Protection Fund (IEPF) by the
Company:
Financial Year Dividend Payment Date Proposed Date for transfer to IEPF*
2011-2012 August 9, 2012 August 8, 2019
2012-2013 August 5, 2013 August 4, 2020
2013-2014 August 11, 2014 August 10, 2021
2014-2015 August 10, 2015 August 9, 2022
2015-2016 August 8, 2016 August 7, 2023
2016-2017 June 26, 2017 June 25, 2024
2017-2018 August 3, 2018 August 2, 2025
* Indicative dates, actual date may vary.
(xii) Commodity Price risk or Foreign Exchange risk and hedging activities:
The Company has adequate risk assessment and minimisation system in place including foreign exchange. The foreign exchange risk is
managed through the hedging strategy of the Company which is reviewed periodically.
The Company does not have material exposure of any commodity and accordingly, no hedging activities for the same is carried
out. Therefore, there is no disclosure to offer in terms of SEBI circular no. SEBI/HO/CFD/CMD1/ CIR/P/2018/0000000141 dated
November 15, 2018.
(xiii) Plant Locations:

1. Nitrite & Nitroaromatics Division 2. Taloja Chemicals Division
4/12 GIDC Chemical Complex Plot Nos. K/9-10, MIDC Taloja,
Nandesari - 391 340. Dist. Vadodara Dist. Raigad - 410 208
3. Roha Division 4. Hyderabad Specialities Division :

Plot Nos. 1, 2, 26 & 27 Plot Nos. 90-F/70-A and B,
MIDC Dhatav, Roha - 402 116, Dist. Raigad Phase II, Industrial Development Area, Jedimetla,
Tal. Quthbullapur Mandal, Dist. Ranga Reddy,
5. Dahej Division: 12/B/2, GIDC, Hyderabad - 500 055
Dahej, Dist. Bharuch,
Gujarat – 392 130

(xiv) Credit Ratings: (iv) Details of Compliance with Mandatory requirements
During the Financial Year 2018-19, ICRA Limited has re-affirmed and adoption of Non-mandatory / discretionary
the long-term rating of Line of credit at [ICRA] A+ (pronounced requirements:
ICRA A plus) and Short Term rating at [ICRA] A1+ (pronounced The Company has complied with all the mandatory
ICRA A one plus) assigned to the fund based limits and non- requirements of the Listing Regulations.
fund based limits of the Company. The outlook on the long-
(v) Policy for Material Subsidiaries
term rating was revised from Stable to Positive.
In accordance with the provisions of the Listing Regulations,
ICRA has also re-affirmed the rating at [ICRA] A1+ (pronounced the Company has framed a policy for Material Subsidiaries in
ICRA A one plus) assigned to the Commercial Paper programme order to determine the Material Subsidiaries and to provide
of DNL. governance framework for such subsidiaries. The said policy
has been placed on the website of the Company and weblink
Further, CRISIL Limited has assigned the long-term rating for
to the same is as under:
Bank Loan facilities of ` 750 crores as CRISIL AA- Stable and
assigned Short Term rating as CRISIL A1+ to the Company. https://www.godeepak.com/investor-compliances/.
8. DISCLOSURE: (vi) Details of Directors seeking appointment or

(i) Related Party Transactions re-appointment:
All transactions entered into by the Company with related The details of Directors seeking appointment or
re-appointment form part of Notes to the Notice convening
parties as defined under the Companies Act, 2013 and the
the 48th Annual General Meeting of the Company.
Listing Regulations, during the Financial Year 2018-19 were in
the ordinary course of business and on arm’s length pricing (vii) Demat Suspense Account – Unclaimed Share Certificates
basis. There were no materially significant transactions with In terms of the provisions of the Listing Regulations, the
the related parties during the Financial Year which were in Company has transferred the shares issued pursuant to the
conflict with the interest of Company. public issues or any other issue, the certificates of which
Necessary disclosures as required under the Accounting remained unclaimed, to an Unclaimed Suspense Account and
Standards have been made in the Financial Statements. The these shares are being held by the Company in Demat form on
behalf of the beneficial owners of the said shares.
Board has approved a policy on materiality of related party
transactions and on dealing with related party transactions The disclosures with respect to the Demat Suspense Account
and the same is disclosed on the website of the Company at are as under:
the link https://www.godeepak.com/investor-compliances/.
Particulars Number of Number
Shareholders of Shares
(ii) Details of non-compliance
Aggregate number of 310 256630
There were no non-compliance by the Company nor any shareholders and the
penalty or stricture imposed on the Company by any Stock outstanding shares in the
Exchanges, SEBI or any other statutory authority on any matter suspense account lying at the
relating to capital markets during the last three years. beginning of the year:
Number of shareholders who 02 3650
(iii) Whistle Blower Policy approached the Company for
The Company promotes ethical behavior in all its business transfer of shares from suspense
activities and has put in place a mechanism for reporting account during the year
illegal or unethical behavior including actual or suspected leak Number of shareholders to 02 3650
of unpublished price sensitive information. The Company has whom shares were transferred
established a vigil mechanism for Directors and employees to from suspense account during
report concern about unethical behavior, actual or suspected the year
fraud or violation of the Company’s code of conduct or ethics Aggregate number of 308 252980
policy and also actual or suspected leak of unpublished shareholders and the
price sensitive information. During the year under review, no outstanding shares in the
personnel was denied access to the Audit Committee. suspense account lying at the
end of the year
The Whistle Blower Policy is placed on the website of the
The voting rights on these shares shall remain frozen till
Company and weblink to the same is as under:
rightful owner of such shares claims the shares.rightful owner
https://www.godeepak.com/investor-compliances/. of such shares claims the shares.

Corporate OVERVIEW
statutory reportS
(viii) Certificate from Company Secretary in Practice (b) Shareholder Rights

The following certificates from Shri Dinesh Joshi, Practicing The half year Financial Results are not sent individually
Company Secretary, Designated Partner of M/s. KANJ & Co., to the shareholders and are displayed on the Company’s
LLP, Company Secretaries, Pune, are enclosed to this Report: website at www.godeepak.com.
(a)
Compliance Certificate regarding compliance of (c) Modified Opinion(s) in Audit Report
conditions of Corporate Governance; and The Auditors have issued the Audit Report of the year
(b) Certificate that none of the Directors on the Board of the ended March 31, 2019 with unmodified opinion.
Company have been debarred or disqualified from being (d) Reporting of Internal Auditor
appointed or continuing as directors of companies by The Internal Auditor reports to the Audit Committee.
SEBI / Ministry of Corporate Affairs or any such statutory
authority. (xiii) The Company has complied with the Corporate Governance
Requirements specified in Regulations 17 to 27 and clauses (b)
(ix) Utilization of funds raised through Qualified Institutions to (i) of sub-regulation (2) of Regulation 46.
Placement
The funds raised through Qualified Institutions Placement 9. CODE OF CONDUCT:
in earlier years have been utilized fully in accordance with The Company has framed and adopted a Code of Conduct for
the objects stated in the Placement Document issued to the the members of the Board and the Senior Management (“the
Qualified Institutional Buyers. Code”) in terms of requirements of the Listing Regulations.
The Code has been circulated to all the members of the Board
(x) Total Fees to Statutory Auditors and Senior Management and the same is also posted on the
Total fees for all services paid by the Company and its Company’s website at www.godeepak.com. The Code lays
subsidiaries, on a consolidated basis, to the Deloitte Haskins & the general principles designed to guide all Directors and
Sells, Statutory Auditor of the Company and all entities in the members of the Senior Management for ethical conduct of
network firm/network entity of which the Statutory Auditor is a business and compliance of laws.
part is given below:
All Directors and members of the Senior Management have
(` In Lakhs)
affirmed their adherence to the provisions of the Code. A
Payment to Statutory Auditors FY 2018-19
declaration to that effect signed by the Executive Director &
Statutory Audit Fees 29.75
CEO is given below:
Quarterly Limited Review 21.00
Tax Audit Fees 2.00 DECLARATION
Taxation Matters 3.75 As per requirements of the Listing Regulations, this is to
Other Certification 2.61 confirm that all the members of the Board and Senior
Total 59.11 Management Personnel have affirmed compliance with
the Code of Conduct of the Company for the Financial Year
(xi) Disclosure under the Sexual Harassment of Women at 2018-19.
Workplace (Prevention, Prohibition and Redressal) Act,
2013 Vadodara Umesh Asaikar
Number of complaints filed during the Financial Year 0 May 3, 2019 Executive Director & CEO
2018-19
Number of complaints disposed off during the Financial 0 10. CEO / CFO CERTIFICATION:
Year 2018-19 The Chief Executive Officer and the Chief Financial Officer
Number of complaints pending as at the end of the 0 of the Company give annual certification on financial
Financial Year 2018-19 reporting and internal controls to the Board in terms of
requirements of the Listing Regulations. The Chief Executive
(xii) Disclosure regarding adoption of discretionary Officer and the Chief Financial Officer also give quarterly
requirements as specified in Part E of Schedule II of certification on financial results while placing the financial
Listing Regulations results before the Board.
(a) The Board
The Chairman of the Company is a Non-Executive
Director hence, not applicable.

Certificate of Compliance with the Corporate Governance Requirements
To,
The Members,
Deepak Nitrite Limited,
Vadodara – 390 024
Gujrat
We have examined the compliance of conditions of Corporate Governance by DEEPAK NITRITE LIMITED (“the Company”) having
CIN L24110GJ1970PLC001735 for the financial year ended March 31, 2019 as per the relevant provisions of the Securities and Exchange
Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’).
The compliance of conditions of Corporate Governance is the responsibility of the Management. Our examination was limited to
procedures and implementation thereof, adopted by the Company for ensuring the compliance of the conditions of Corporate
Governance. It is neither an audit nor an expression on financial statements of the Company.
In our opinion and to the best of our information and according to the explanations given to us, we certify that the Company has complied
with the conditions of Corporate Governance as stipulated in the above-mentioned Listing Regulations, as applicable.
We further state that such compliance is neither an assurance as to future viability of the Company nor the efficiency or effectiveness with
which the management has conducted the affairs of the Company.
For KANJ & CO. LLP
Company Secretaries
Dinesh Joshi
To,
The Members
DEEPAK NITRITE LIMITED
Vadodara -390 024
Gujarat
This is to certify that on verification of declarations made by the Directors and records maintained by DEEPAK NITRITE LIMITED
(“the Company”), none of the Directors on the Board of the Company have been debarred or disqualified from being appointed or
continuing as Directors of the companies by the Securities Exchange Board of India (SEBI) /Ministry of Corporate Affairs or any such
Statutory Authority, as per the requirements of point 10(i) of Part C of Schedule V of the Securities Exchange Board of India (Listing
Obligations and Disclosure Requirement) Regulations, 2015.
For KANJ & CO. LLP

Company Secretaries
Dinesh Joshi

Corporate OVERVIEW
statutory reportS
Independent Auditor’s Report

To The Members of Deepak Nitrite Limited
Report on the Audit of the Standalone Financial Statements
Opinion
We have audited the accompanying standalone financial statements of Deepak Nitrite Limited (“the Company”), which comprise the Balance
Sheet as at 31st March 2019, and the Statement of Profit and Loss (including Other Comprehensive Income), the Statement of Cash Flows
and the Statement of Changes in Equity for the year then ended, and a summary of significant accounting policies and other explanatory
information.
In our opinion and to the best of our information and according to the explanations given to us, the aforesaid standalone financial statements
give the information required by the Companies Act, 2013 (“the Act”) in the manner so required and give a true and fair view in conformity with
the Indian Accounting Standards prescribed under section 133 of the Act read with the Companies (Indian Accounting Standards) Rules, 2015,
as amended, (“Ind AS”) and other accounting principles generally accepted in India, of the state of affairs of the Company as at 31 March 2019,
and its profit, total comprehensive income, its cash flows and the changes in equity for the year ended on that date.
Basis for Opinion

We conducted our audit of the standalone financial statements in accordance with the Standards on Auditing specified under section
143(10) of the Act (SAs). Our responsibilities under those Standards are further described in the Auditor’s Responsibility for the Audit of the
Standalone Financial Statements section of our report. We are independent of the Company in accordance with the Code of Ethics issued by
the Institute of Chartered Accountants of India (ICAI) together with the ethical requirements that are relevant to our audit of the standalone
financial statements under the provisions of the Act and the Rules made thereunder, and we have fulfilled our other ethical responsibilities
in accordance with these requirements and the ICAI’s Code of Ethics. We believe that the audit evidence obtained by us, is sufficient and
appropriate to provide a basis for our audit opinion on the standalone financial statements.
Key Audit Matters

Key audit matters are those matters that, in our professional judgment, were of most significance in our audit of the standalone financial
statements of the current period. These matters were addressed in the context of our audit of the standalone financial statements as a whole,
and in forming our opinion thereon, and we do not provide a separate opinion on these matters. We have determined the matter described
below to be the key audit matters to be communicated in our report.
Revenue recognition
Revenue recognition is significant audit risk across all units within the Company. Risk exists that revenue is recognized without substantial
transfer of control and is not in accordance with Ind AS-115 “Revenue from Contracts with Customers”.
Auditor’s Response
Principal Audit Procedures
Our audit consisted testing of the design and operating effectiveness of the internal controls and substantive testing as follows:
• We evaluated the design of internal controls relating to revenue recognition.
• We selected sample of Sales transactions and tested the operating effectiveness of the internal control relating to revenue recognition.
We carried out a combination of procedures involving enquiry and observation, reperformance and inspection.
• We have tested sample of Sale transactions to their respective customer contracts, underlying invoices and related documents.
• We have performed cut-off procedures for sample of revenue transactions at year-end in order to conclude on whether they were
recognised in accordance with Ind-AS 115.
Information Other than the Financial Statements and Auditor’s Report Thereon
• The Company’s Board of Directors is responsible for the other information. The other information comprises the information included
in the Management Discussion and Analysis report, but does not include the consolidated financial statements, standalone financial
statements and our auditor’s report thereon.

• Our opinion on the standalone financial statements does not cover the other information and we do not express any form of assurance
conclusion thereon.
• In connection with our audit of the standalone financial statements, our responsibility is to read the other information and, in doing so,
consider whether the other information is materially inconsistent with the standalone financial statements or our knowledge obtained
during the course of our audit or otherwise appears to be materially misstated.
• We have nothing to report in this regard.
Management’s Responsibility for the Standalone Financial Statements

The Company’s Board of Directors is responsible for the matters stated in section 134(5) of the Act with respect to the preparation of these
standalone financial statements that give a true and fair view of the financial position, financial performance including other comprehensive
income, cash flows and changes in equity of the Company in accordance with the Ind AS and other accounting principles generally
accepted in India. This responsibility also includes maintenance of adequate accounting records in accordance with the provisions of the
Act for safeguarding the assets of the Company and for preventing and detecting frauds and other irregularities; selection and application
of appropriate accounting policies; making judgments and estimates that are reasonable and prudent; and design, implementation and
maintenance of adequate internal financial controls, that were operating effectively for ensuring the accuracy and completeness of the
accounting records, relevant to the preparation and presentation of the standalone financial statement that give a true and fair view and are
free from material misstatement, whether due to fraud or error.
In preparing the standalone financial statements, management is responsible for assessing the Company’s ability to continue as a going
concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless management
either intends to liquidate the Company or to cease operations, or has no realistic alternative but to do so.
Those Board of Directors are also responsible for overseeing the Company’s financial reporting process.
Auditor’s Responsibility for the Audit of the Standalone Financial Statements

Our objectives are to obtain reasonable assurance about whether the standalone financial statements as a whole are free from material
misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level
of assurance, but is not a guarantee that an audit conducted in accordance with SAs will always detect a material misstatement when it exists.
Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected
to influence the economic decisions of users taken on the basis of these standalone financial statements.
As part of an audit in accordance with SAs, we exercise professional judgment and maintain professional skepticism throughout the audit.
We also:
• Identify and assess the risks of material misstatement of the standalone financial statements, whether due to fraud or error, design and
perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for
our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud
may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.
• Obtain an understanding of internal financial control relevant to the audit in order to design audit procedures that are appropriate in
the circumstances. Under section 143(3)(i) of the Act, we are also responsible for expressing our opinion on whether the Company has
adequate internal financial controls system in place and the operating effectiveness of such controls.
• Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures
made by the management.
• Conclude on the appropriateness of management’s use of the going concern basis of accounting and, based on the audit evidence
obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Company’s ability
to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor’s
report to the related disclosures in the standalone financial statements or, if such disclosures are inadequate, to modify our opinion.
Our conclusions are based on the audit evidence obtained up to the date of our auditor’s report. However, future events or conditions
may cause the Company to cease to continue as a going concern.
• Evaluate the overall presentation, structure and content of the standalone financial statements, including the disclosures, and whether
the standalone financial statements represent the underlying transactions and events in a manner that achieves fair presentation.
Materiality is the magnitude of misstatements in the standalone financial statements that, individually or in aggregate, makes it probable
that the economic decisions of a reasonably knowledgeable user of the standalone financial statements may be influenced. We consider

Corporate OVERVIEW
statutory reportS
quantitative materiality and qualitative factors in (i) planning the scope of our audit work and in evaluating the results of our work; and (ii) to
evaluate the effect of any identified misstatements in the standalone financial statements.
We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and
significant audit findings, including any significant deficiencies in internal control that we identify during our audit.
We also provide those charged with governance with a statement that we have complied with relevant ethical requirements regarding
independence, and to communicate with them all relationships and other matters that may reasonably be thought to bear on our
independence, and where applicable, related safeguards.
From the matters communicated with those charged with governance, we determine those matters that were of most significance in the
audit of the standalone financial statements of the current period and are therefore the key audit matters. We describe these matters in
our auditor’s report unless law or regulation precludes public disclosure about the matter or when, in extremely rare circumstances, we
determine that a matter should not be communicated in our report because the adverse consequences of doing so would reasonably be
expected to outweigh the public interest benefits of such communication.
Report on Other Legal and Regulatory Requirements

1. As required by Section 143(3) of the Act, based on our audit, we report,:
a) We have sought and obtained all the information and explanations which to the best of our knowledge and belief were necessary
for the purposes of our audit.
b) In our opinion, proper books of account as required by law have been kept by the Company so far as it appears from our
examination of those books.
c) The Balance Sheet, the Statement of Profit and Loss including Other Comprehensive Income, the Statement of Cash Flows and
Statement of Changes in Equity dealt with by this Report are in agreement with the books of account.
d) In our opinion, the aforesaid standalone financial statements comply with the Ind AS specified under Section 133 of the Act.
e) On the basis of the written representations received from the directors as on 31st March, 2019 taken on record by the Board of
Directors, none of the directors is disqualified as on 31st March, 2019 from being appointed as a director in terms of Section 164(2)
of the Act.
f) With respect to the adequacy of the internal financial controls over financial reporting of the Company and the operating
effectiveness of such controls, refer to our separate Report in “Annexure A”. Our report expresses an unmodified opinion on the
adequacy and operating effectiveness of the Company’s internal financial controls over financial reporting.
g) With respect to the other matters to be included in the Auditor’s Report in accordance with the requirements of section 197(16) of
the Act, as amended.
In our opinion and to the best of our information and according to the explanations given to us, the remuneration paid by the
Company to its directors during the year is in accordance with the provisions of section 197 of the Act.
h) With respect to the other matters to be included in the Auditor’s Report in accordance with Rule 11 of the Companies (Audit and
Auditors) Rules, 2014, as amended in our opinion and to the best of our information and according to the explanations given to us:
i. The Company has disclosed the impact of pending litigations on its financial position in its standalone financial statements.
ii. The Company has made provision, as required under the applicable law or accounting standards, for material foreseeable
losses, if any, on long-term contracts including derivative contracts;
iii. There has been no delay in transferring amounts, required to be transferred, to the Investor Education and Protection Fund
by the Company.
2. As required by the Companies (Auditor’s Report) Order, 2016 (“the Order”) issued by the Central Government in terms of Section
143(11) of the Act, we give in “Annexure B” a statement on the matters specified in paragraphs 3 and 4 of the Order.
For Deloitte Haskins & Sells LLP

(Firm’s Registration No. 117366W/W-100018)
Place: Ahmedabad (Kartikeya Raval)

Date: 3rd May, 2019 (Partner)
(Membership No. 106189)

Annexure “A” to Independent Auditor’s Report
(Referred to in paragraph 1 (f) under ‘Report on Other Legal and Regulatory Requirements’ section of our report of even date)
Report on the Internal Financial Controls Over Financial Reporting under Clause (i) of Sub-section 3 of Section
143 of the Companies Act, 2013 (“the Act”)
We have audited the internal financial controls over financial reporting of Deepak Nitrite Limited (“the Company”) as of March 31, 2019 in
conjunction with our audit of the standalone Ind AS financial statements of the Company for the year ended on that date.
Management’s Responsibility for Internal Financial Controls

The Company’s management is responsible for establishing and maintaining internal financial controls based on the internal control over
financial reporting criteria established by the Company considering the essential components of internal control stated in the Guidance Note
on Audit of Internal Financial Controls Over Financial Reporting issued by the Institute of Chartered Accountants of India. These responsibilities
include the design, implementation and maintenance of adequate internal financial controls that were operating effectively for ensuring the
orderly and efficient conduct of its business, the safeguarding of its assets, the prevention and detection of frauds and errors, the accuracy
and completeness of the accounting records, and the timely preparation of reliable financial information, as required under the Companies
Act, 2013.
Auditor’s Responsibility
Our responsibility is to express an opinion on the Company’s internal financial controls over financial reporting of the Company based on our
audit. We conducted our audit in accordance with the Guidance Note on Audit of Internal Financial Controls Over Financial Reporting (the
“Guidance Note”) issued by the Institute of Chartered Accountants of India and the Standards on Auditing prescribed under Section 143(10) of
the Companies Act, 2013, to the extent applicable to an audit of internal financial controls. Those Standards and the Guidance Note require
that we comply with ethical requirements and plan and perform the audit to obtain reasonable assurance about whether adequate internal
financial controls over financial reporting was established and maintained and if such controls operated effectively in all material respects.
Our audit involves performing procedures to obtain audit evidence about the adequacy of the internal financial controls system over
financial reporting and their operating effectiveness. Our audit of internal financial controls over financial reporting included obtaining
an understanding of internal financial controls over financial reporting, assessing the risk that a material weakness exists, and testing and
evaluating the design and operating effectiveness of internal control based on the assessed risk. The procedures selected depend on the
auditor’s judgement, including the assessment of the risks of material misstatement of the financial statements, whether due to fraud or error.
We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion on the Company’s
internal financial controls system over financial reporting.
Meaning of Internal Financial Controls Over Financial Reporting

A company’s internal financial control over financial reporting is a process designed to provide reasonable assurance regarding the reliability
of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting
principles. A company’s internal financial control over financial reporting includes those policies and procedures that (1) pertain to the
maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company;
(2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance
with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with
authorisations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection
of unauthorised acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
Inherent Limitations of Internal Financial Controls Over Financial Reporting

Because of the inherent limitations of internal financial controls over financial reporting, including the possibility of collusion or improper
management override of controls, material misstatements due to error or fraud may occur and not be detected. Also, projections of any
evaluation of the internal financial controls over financial reporting to future periods are subject to the risk that the internal financial control
over financial reporting may become inadequate because of changes in conditions, or that the degree of compliance with the policies or
procedures may deteriorate.

Corporate OVERVIEW
statutory reportS
Opinion
In our opinion, to the best of our information and according to the explanations given to us, the Company has, in all material respects, an
adequate internal financial controls system over financial reporting and such internal financial controls over financial reporting were operating
effectively as at March 31, 2019, based on the internal control over financial reporting criteria established by the Company considering the
essential components of internal control stated in the Guidance Note on Audit of Internal Financial Controls Over Financial Reporting issued
by the Institute of Chartered Accountants of India.



Annexure “B” to Independent Auditor’s Report
(Referred to in paragraph 2 under ‘Report on Other Legal and Regulatory Requirements’ section of our report of even date)
(i) (a) The Company has maintained proper records showing full particulars, including quantitative details and situation of fixed assets.
(b) The Company has a regular program for verification of property, plant and equipment at every 2 years which, in our opinion,
is reasonable having regarding to the size of the Company and nature of its assets. The property, plant and equipment were
physically verified during the current year in accordance with this program. According to information and explanations given to us,
no material discrepancies were noticed on such verification.
(c) According to the information and explanations given to us and the records examined by us and based on the examination of
the registered sale deed / transfer deed / conveyance deed provided to us, we report that, the title deeds, comprising all the
immovable properties of land and buildings, are held in the name of the Company as at the balance sheet date. Immovable
properties of land and buildings whose title deeds have been pledged as security for loans are held in the name of the Company
based on the confirmations directly received by us from lenders. In respect of immovable properties of land and buildings that
have been taken on lease and disclosed as fixed asset in the financial statements, the lease agreements are in the name of the
Company, where the Company is the lessee in the agreement.
(ii) As explained to us, the inventories were physically verified during the year by the Management at reasonable intervals and no material
discrepancies were noticed on physical verification.
(iii) The Company has not granted any loans, secured or unsecured, to companies, firms, Limited Liability Partnerships or other parties
covered in the register maintained under section 189 of the Companies Act, 2013.
(iv) In our opinion and according to the information and explanations given to us, the Company has complied with the provisions of Sections
185 and 186 of the Companies Act, 2013 in respect of grant of loans, making investments and providing guarantees and securities, as
applicable.
(v) In our opinion and according to the information and explanations given to us, the Company has complied with the provisions of
Sections 73 to 76 or any other relevant provisions of the Companies Act, 2013 and the Companies (Acceptance of Deposits) Rules, 2014,
as amended, with regard to the deposits accepted. According to the information and explanations given to us, no order has been passed
by the Company Law Board or the National Company Law Tribunal or the Reserve Bank of India or any Court or any other Tribunal.
(vi) The maintenance of cost records has been specified by the Central Government under section 148(1) of the Companies Act, 2013.
We have broadly reviewed the cost records maintained by the Company pursuant to the Companies (Cost Records and Audit) Rules,
2014, as amended, prescribed by the Central Government under sub-section (1) of Section 148 of the Companies Act, 2013, and are of
the opinion that, prima facie, the prescribed cost records have been made and maintained. We have, however, not made a detailed
examination of the cost records with a view to determine whether they are accurate or complete.
(vii) According to the information and explanations given to us, in respect of statutory dues:
(a) The Company has generally been regular in depositing undisputed statutory dues, including Provident Fund, Employees’ State
Insurance, Income-tax, Sales Tax, Service Tax, Customs Duty, Excise Duty, Value Added Tax, Goods and Service Tax, cess and other
material statutory dues applicable to it to the appropriate authorities.
(b) There were no undisputed amounts payable in respect of Provident Fund, Employees’ State Insurance, Income-tax, Sales Tax,
Service Tax, Customs Duty, Excise Duty, Value Added Tax, Goods and Service Tax, cess and other material statutory dues in arrears
as at March 31, 2019 for a period of more than six months from the date they became payable.

Corporate OVERVIEW
statutory reportS
(c) Details of dues of Sales Tax , Excise Duty, Central Sales Tax, Value Added Tax and other statutory dues which have not been
deposited as on March 31, 2019 on account of disputes are given below:
Name of Statute Nature of Dues Forum where Dispute Period to which the Amount Amount
is Pending Amount Relates Involved Unpaid
(` in lakhs) (` in lakhs)
Central Excise Act 1944 Excise Duty Central Excise Asst. FY 2011 to FY 2017 76.65 71.62
Commissioner
Central Excise Act 1944 Excise Duty Central excise FY 1998 to FY 2016 54.73 32.35
commissioner
Central Excise Act 1944 Excise Duty Central excise FY 2008 to FY 2014 27.40 16.44
commissioner Appeals
Central Excise Act 1944 Excise Duty Central Excise & Service FY 2004 to FY 2015 127.78 104.89
Tax Appellate Tribunal
Central Sales Tax Act Sales Tax Sales Tax commissioner FY 2005 to FY 2014 115.05 109.05
(Appeal)
Gujarat Vat Act, 2004 VAT Assistant Commissioner FY 2010 to FY 2013 43.92 43.92
Appeals
Finance Act 1994 Service Tax Assistant Commissioner, FY 2015 to FY 2017 5.64 5.64
GST
Hyderabad Metropolitan Water Sewerage Cess High Court of FY 2008 to FY 2013 27.13 27.13
Supply & Sewerage Act 1989 Andhra Pradesh
The Gujarat Panchayats Law Property Tax Gram Panchayat FY 2013 to FY 2017 170.00 170.00
(Amendment) Act, 1963
here are no dues of Income-tax, Service Tax, Customs Duty, Goods and Service Tax and Value Added Tax that have not been deposited
T
as at 31st March, 2019 on account of disputes.
(viii) In our opinion and according to the information and explanations given to us, the Company has not defaulted in the repayment of loans
or borrowings to financial institutions, banks and government. The Company has not issued any debentures.
(ix) In our opinion and according to the information and explanations given to us, the Company has not raised money by way of initial
public offer/ further public offer (including debt instruments) and the term loans have been applied by the Company during the year for
the purposes for which they were raised.
(x) To the best of our knowledge and according to the information and explanations given to us, no material fraud by the Company and no
material fraud on the Company by its officers or employees has been noticed or reported during the year.
(xi) In our opinion and according to the information and explanations given to us, the Company has paid / provided managerial remuneration
in accordance with the requisite approvals mandated by the provisions of section 197 read with Schedule V to the Companies Act, 2013.
(xii) The Company is not a Nidhi Company and hence reporting under clause (xii) of paragraph 3 of the Order is not applicable.
(xiii) In our opinion and according to the information and explanations given to us the Company is in compliance with Section 188 and 177
of the Companies Act, 2013, where applicable, for all transactions with the related parties and the details of related party transactions
have been disclosed in the financial statements etc. as required by the applicable accounting standards.
(xiv) During the year, the Company has not made any preferential allotment or private placement of shares and debentures and hence
reporting under clause (xiv) of CARO 2016 is not applicable to the Company.
(xv) In our opinion and according to the information and explanations given to us, during the year the Company has not entered into any
non-cash transactions with its directors or persons connected with him and hence provisions of section 192 of the Companies Act, 2013
are not applicable.
(xvi) The Company is not required to be registered under section 45-IA of the Reserve Bank of India Act, 1934.


Balance Sheet as at March 31, 2019
` in Lakhs
Notes As at As at
March 31, 2019 March 31, 2018
I. ASSETS
Non-Current Assets
(a) Property, Plant and Equipment 2 58,507.40 56,465.24
(b) Capital Work-in-Progress 2 2,891.79 3,624.79
(c) Other Intangible Assets 3 429.75 453.97
(d) Financial Assets
Investments 4 56,287.10 43,382.67
Loans 5 135.51 131.01
Other Financial Assets 6 556.92 893.59
(e) Non-Current Tax Assets (Net) 7 192.72 255.40
(f) Other Non-Current Assets 8 380.23 353.91
Total Non-Current Assets 1,19,381.42 1,05,560.58
Current Assets
(a) Inventories 9 23,250.95 18,818.24
(b) Financial Assets
Investments 10 - 2,140.30
Trade Receivables 11 34,444.64 36,921.13
Cash and Cash Equivalents 12.A 281.29 118.65
Bank balances other than Cash and Cash Equivalents above 12.B 277.19 3,092.36
Other Financial Assets 13 190.66 6,871.07
(c) Other Current Assets 14 4,912.47 6,463.69
(d) Assets classified as held for sale 34.61 63.87
Total Current Assets 63,391.81 74,489.31
TOTAL ASSETS 1,82,773.23 1,80,049.89
II. EQUITY AND LIABILITIES
Equity
(a) Equity Share Capital 15 2,727.86 2,727.86
(b) Other Equity 16 103,056.69 91,656.63
Total Equity 1,05,784.55 94,384.49
Non-Current Liabilities
(a) Financial Liabilities
Borrowings 17 8,159.17 9,295.86
(b) Provisions 18 1,072.90 783.50
(c) Deferred Tax Liabilities (Net) 19 7,658.69 5,219.81
Total Non-Current Liabilities 16,890.76 15,299.17
Current Liabilities
Borrowings 20 18,441.91 26,406.01
Trade Payables
Total outstanding dues of
a) micro enterprises and small enterprises 21 775.13 104.43
b) creditors other than micro enterprises and small enterprises 21 31,710.28 31,300.03
Other Financial Liabilities 22 6,633.27 11,008.49
(b) Provisions 18 706.28 300.80
(c) Current Tax Liabilities (Net) 23 174.00 -
(d) Other Current Liabilities 24 1,657.05 1,246.47
Total Current Liabilities 60,097.92 70,366.23
Total Liabilities 76,988.68 85,665.40
TOTAL EQUITY AND LIABILITIES 1,82,773.23 1,80,049.89
Significant Accounting Policies 1
The accompanying notes form an integral part of the Financial Statements.
As per our report of even date For and on behalf of the Board
For DELOITTE HASKINS & SELLS LLP D.C. MEHTA UMESH ASAIKAR SUDHIN CHOKSEY
Chartered Accountants Chairman & Managing Director Executive Director & CEO Director
DIN: 00028377 DIN: 06595059 DIN: 00036085
Kartikeya Raval SANJAY UPADHYAY ARVIND BAJPAI SUDHIR MANKAD
Partner Director-Finance & CFO Company Secretary Director
DIN: 01776546 Membership No: F6713 DIN: 00086077
SANDESH ANAND
Director
DIN: 00001792
Ahmedabad: May 03, 2019 Vadodara: May 03, 2019

Corporate OVERVIEW
statutory reportS
Statement of Profit and Loss for the year ended March 31, 2019
` in Lakhs
Notes For the year For the year
March 31, 2019 March 31, 2018
I. Revenue from Operations 25 1,79,191.87 1,47,922.97
II. Other Income 26 259.52 1,153.57
III. Total Income (I+II) 1,79,451.39 1,49,076.54
IV. Expenses:
(a) Cost of Materials Consumed 27 1,02,784.87 83,992.79
(b) Changes in Inventories of Finished Goods and Work-in-Progress 28 (5,167.39) 389.15
(c) Excise Duty on Sale of Goods - 2,425.24
(d) Employee Benefits Expense 29 15,860.30 13,205.93
(e) Power & Fuel Expenses 30 14,093.72 11,987.90
(f) Finance Costs 31 4,284.57 4,034.00
(g) Depreciation and Amortisation Expense 32 5,287.82 5,194.92
(h) Other Expenses 33 21,057.53 15,638.19
Total Expenses (IV) 1,58,201.42 1,36,868.12
V. Profit Before Tax (III-IV) 21,249.97 12,208.42
VI. Tax Expense:
(a) Current Tax 4,864.34 2,594.99
(b) Deferred Tax 2,581.42 1,556.44
(c) Excess Provision of Earlier Years - (288.51)
VII. Profit for the Year (V-VI) 13,804.21 8,345.50
VIII. Other Comprehensive Income
(A) Items that will not be Reclassified to Profit and Loss:
(a) Remeasurement of Defined Benefit Obligations (Net) (416.94) 108.83
(b) Tax Effect of Remeasurement of Defined Benefit Liabilities / 145.26 (37.01)
(Assets)
(B) Items that will be Reclassified to Profit and Loss:
(a) Fair Value Gains on Investments 7.84 20.97
(b) Tax effect of Fair Value Gains on Investments (2.73) (7.13)
Total Other Comprehensive Income for the Year (VIII) (266.57) 85.66
IX. Total Comprehensive Income for the Year (VII+VIII) 13,537.64 8,431.16
Earnings Per Equity Share
(a) Basic (Nominal Value per Share ` 2) 10.12 6.34
(b) Diluted (Nominal Value per Share ` 2) 10.12 6.34
DIN: 00028377 DIN: 06595059 DIN: 00036085
SANDESH ANAND
Director
DIN: 00001792

Cash Flow Statement for the year ended March 31, 2019
` in Lakhs
For the year For the year
March 31, 2019 March 31, 2018
(A) CASH FLOW FROM OPERATING ACTIVITIES
Profit for the year 13,804.21 8,345.50
Add: Income Tax Expense recognised in the Statement of Profit and Loss 7,445.76 3,862.92
Profit Before Tax 21,249.97 12,208.42
Non-cash adjustment to reconcile Profit Before Tax to net Cash Flows
1. Depreciation / Amortisation 5,287.82 5,194.92
2. Loss on Sale of Fixed Assets 428.72 529.99
3. Provision for Doubtful Debts 83.82 263.41
4. Gain on Redemption of Investment (44.11) (345.81)
5. Interest Expenses 4,284.57 4,034.00
6. Interest Income (80.38) (131.95)
7. Dividend Income (0.01) (0.01)
8. Fair Value (Gains)/Loss 3.40 (9.64)
Operating Profit Before Change in Operating Assets and Liabilities 31,213.80 21,743.33
Movements in Working Capital :
1. (Increase)/Decrease in Inventories (4,432.71) (4,753.84)
2. (Increase)/Decrease in Trade Receivables 2,392.68 (5,639.47)
3. (Increase)/Decrease in Non-Current Loans (4.50) 4.93
4. (Increase)/Decrease in Other Financial Assets 212.80 405.02
5. (Increase)/Decrease in Other Assets 1,526.98 (871.52)
6. Increase/(Decrease) in Trade Payables 1,080.95 13,132.58
7. Increase/(Decrease) in Other Financial Liabilities (4.25) (6.28)
8. Increase/(Decrease) in Other Liabilities 422.11 129.06
9. Increase/(Decrease) in Provisions 277.94 53.55
Cash Generated from Operations 32,685.80 24,197.36
Less: Income Tax paid (net of refund) 4,600.00 2,780.88
Net Cash Inflow from Operating Activities (A) 28,085.80 21,416.48
(B) CASH FLOW FROM INVESTING ACTIVITIES
1. Purchase of Property, Plant & Equipment, including Capital Work in Progress, (7,020.91) (5,510.77)
Capital Advances & Payable for Capital Expenditure
2. Purchase of Intangible assets (134.29) (53.95)
3. Proceeds from Sale of Property, Plant & Equipment 169.37 111.96
4. Insurance claims Received 1,782.71 750.00
5. Investment in Subsidiaries (7,900.00) (20,100.00)
6. Proceeds from Redemption of Investment - 225.43
7. Purchase of Current Investments (10,776.65) (29,664.77)
8. Proceeds from Redemption/Maturity of Current Investments 12,961.06 38,194.47
9. Deposit with Bank 3,026.22 (3,026.22)
10. Interest received 89.66 131.51
11. Dividend received 0.01 0.01
Net Cash Outflow from Investing Activities (B) (7,802.82) (18,942.33)

Corporate OVERVIEW
statutory reportS
` in Lakhs
March 31, 2019 March 31, 2018
(C) CASH FLOW FROM FINANCING ACTIVITIES
1. Proceeds from Issue of Equity Shares including Securities Premium - 14,627.98
2. Proceeds from Non-Current Borrowings 5,000.00 9,950.00
3. Repayment of Non-Current Borrowings (10,451.59) (16,812.08)
4. Net Proceeds from Current Borrowings (7,964.10) (4,346.12)
5. Interest paid (4,372.91) (4,015.98)
6. Dividend paid on Equity Shares (1,764.15) (1,560.31)
7. Tax on Equity Dividend paid (364.47) (319.32)
8. Margin Money Deposit (203.12) (0.11)
Net Cash Outflow from Financing Activities (C) (20,120.34) (2,475.94)
Net Increase/(Decrease) in Cash and Cash Equivalents (A+B+C) 162.64 (1.79)
Cash and Cash Equivalents at the Beginning of the Financial Year 118.65 120.44
Cash and Cash Equivalents at the end of the Financial Year 281.29 118.65
Reconciliation of Cash and Cash Equivalents
Balances with Banks:
In Current Accounts 120.47 105.73
In EEFC Accounts 151.02 11.45
Cash on Hand 9.80 1.47
Total Cash and Cash Equivalents as per Note 12 A 281.29 118.65
The Cash Flow Statement has been prepared under the ‘Indirect Method’ set out in Ind AS 7 ‘Cash Flow Statement’.
The accompanying Notes form an integral part of the Financial Statements.
DIN: 00028377 DIN: 06595059 DIN: 00036085
SANDESH ANAND
Director
DIN: 00001792

Statement of Changes in Equity for the year ended March 31, 2019
(A) EQUITY SHARE CAPITAL
` in Lakhs
Note Amount
As at March 31, 2017 2,614.23
Issued during the year (Refer Note 15 (b) (iv)) 113.63
As at March 31, 2018 15 2,727.86
Issued during the year -
As at March 31, 2019 2,727.86
(B) OTHER EQUITY

` in Lakhs
Other
Reserves and Surplus Comprehensive
Income
Equity
Total
Capital Securities Instruments
Retained Capital General
Redemption Premium through Other
Earnings Reserve Reserve
Reserve Reserve Comprehensive
Income
Balance as at 31.03.2017 34,202.32 71.27 7,390.13 15.00 28,902.22 18.04 70,598.98
Profit for the year 8,345.50 - - - - - 8,345.50
Other Comprehensive Income 71.82 - - - - 13.84 85.66
Dividend (1,568.53) - - - - - (1,568.53)
Tax on Dividend (319.32) - - - - - (319.32)
Transfer to/from Retained Earnings (500.00) - 500.00 - - - -
Receipt of Securities Premium from - - - - 14,514.34 - 14,514.34
issue of Equity Shares to Qualified
Institutional Buyers (Net) (Refer
Note 15 (b) (iv))
Balance as at 31.03.2018 40,231.79 71.27 7,890.13 15.00 43,416.56 31.88 91,656.63
Other Comprehensive income (271.68) - - - - 5.11 (266.57)
Dividend (1,773.11) - - - - - (1,773.11)
Tax on dividend (364.47) - - - - - (364.47)
Transfer to/from retained earnings (500.00) - 500.00 - - - -
Balance as at 31.03.2019 51,126.74 71.27 8,390.13 15.00 43,416.56 36.99 103,056.69
DIN: 00028377 DIN: 06595059 DIN: 00036085
SANDESH ANAND
Director
DIN: 00001792

Corporate OVERVIEW
statutory reportS
Notes forming part of the Financial Statements

as at and for the year ended March 31, 2019
Company overview
Deepak Nitrite Limited (‘DNL’ or ‘the Company’) is a prominent chemical manufacturing public limited company incorporated and domiciled
in India. Its registered office is located at Aaditya-I Chhani Road, Vadodara- 390 024, Gujarat, India and its manufacturing facilities are located
in the states of Gujarat, Maharashtra and Telangana.
The Company manufactures Basic Chemicals, Fine & Speciality Chemicals and Performance Products.
Application of New Ind AS

Ind AS 115, ‘Revenue from Contracts with Customers’: On March 28, 2018, the MCA notified the Ind AS 115. The core principle of the new
standard is that an entity will recognise revenue to depict the transfer of promised goods or services to customers in an amount that reflects
the consideration to which the entity expects to be entitled in exchange for those goods or services. Further, the new standard requires
enhanced disclosures about the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers of
the Company. The standard permits two possible methods of transaction:
a) Retrospective approach – Under this approach the standard will be applied retrospectively to each prior reporting period presented in
accordance with Ind AS 8, ‘Accounting Policies, Changes in Accounting Estimates and Errors’.
b) Retrospectively with cumulative effect of initially applying the standard recognised at the date of initial application (Cumulative catch–
up approach).
The effective date of adoption of Ind AS 115 is financial period beginning on or after April 01, 2018.
The Company has adopted the standard on April 01, 2018 by using the cumulative catch-up transition method and accordingly,
comparatives for the year ending or ended March 31, 2018 will not be retrospectively adjusted. There is no material impact on adoption
of Ind AS 115.
Changes in Accounting Standard and recent accounting pronouncements

On March 30, 2019, the Ministry of Corporate Affairs issued the Companies (Indian Accounting Standards) (Amendments) Rules, 2019, notifying
Ind AS 116 on Leases. Ind AS 116 would replace the existing leases standard Ind AS 17. The standard sets out the principles for the recognition,
measurement, presentation and disclosures for both parties to a contract, i.e. the lessee and the lessor. Ind AS 116 introduces a single lease
accounting model and requires a lessee to recognise assets and liabilities for all leases with a term of more than 12 months, unless the
underlying asset is of low value. Currently for operating lease, rentals are charged to the statement of profit and loss. The Company is currently
evaluating the implication of Ind AS 116 on the financial statements.
The Companies (Indian Accounting Standards) Amendment Rules, 2019 also notified amendments to the following accounting standards.
The amendments would be effective from April 1, 2019
1. Ind AS 12, Income taxes – Appendix C on uncertainty over income tax treatment
2. Ind AS 12, Income Taxes - Accounting for Dividend Distribution Taxes.
3. Ind AS 23, Borrowing costs
4. Ind AS 28 – investment in associates and joint ventures
5. Ind AS 103 and Ind AS 111 – Business combinations and joint arrangements
6. Ind AS 109 – Financial instruments
7. Ind AS 19 – Employee benefits
The Company is in the process of evaluating the impact of such amendments.
1. Significant Accounting Policies

This Note provides a list of the significant Accounting Policies adopted by the Company in the preparation of these Financial Statements.
These policies have been consistently applied to all the years presented, unless otherwise stated.

(a) Basis of preparation
(i) Compliance with Ind AS
The Financial Statements comply in all material respects with Indian Accounting Standards (Ind AS) notified under Section 133 of
the Companies Act, 2013 (the Act) [Companies (Indian Accounting Standards) Rules, 2015] and other relevant provisions of the Act.
The Financial Statements have been prepared on a historical cost basis except for the following assets and liabilities which have
been measured at fair value or revalued amount:
(a) Certain items of Property, Plant and Equipment
(b) Certain financial assets and financial liabilities measured at fair value
(c) Derivative Financial instruments
(d) Defined benefit plan – plan assets measured at fair value
Historical cost is generally based on the fair value of the consideration given in exchange for goods and services.
Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between
market participants at the measurement date, regardless of whether that price is directly observable or estimated using another
valuation technique. In estimating the fair value of an asset or a liability, the Company takes into account the characteristics of the
asset or liability if the market participants would take those characteristics into account when pricing the asset or liability at the
measurement date. Fair value measurement and/or disclosure purposes in the financial statements is determined on such a basis
except for leasing transactions that are within the scope of Ind AS 17, and measurements that have some similarities to fair value
but are not fair value, such as net realisable value in Ind AS 2 or value in use in Ind AS 36.
In addition, for financial reporting purposes, fair value measurements are categorised into Level 1, 2 or 3 based on the degree to
which the inputs to the fair value measurements are observable and the significance of the inputs to the fair value measurement
in its entirety, which are described as follows:
• Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the entity can access at
the measurement date;
• Level 2 inputs are inputs, other than quoted prices included in Level 1, that are observable for the asset or liability, either
directly or indirectly; and
• Level 3 inputs are unobservable inputs for the asset or liability.
(ii) Functional and Presentation Currency

Items included in the Financial Statements of the Company are measured using the currency of the primary economic environment
in which the Company operates (‘functional currency’). The Financial Statements of the Company are presented in Indian currency
(`), which is also the functional and presentation currency of the Company.
(iii) Use of estimates and critical accounting judgements

Preparation of the Financial Statements requires use of accounting estimates which, by definition, will be equal to the actual
results. The estimates and the associated assumptions are based on historical experience and other factors that are considered to
be relevant. Actual results may differ from these estimates.
The estimates and the underlying assumptions are reviewed on an on-going basis. Revisions to accounting estimates are
recognised in the period in which the estimate is revised and future periods affected.
Critical judgements in applying accounting policies
The following are the critical judgements, apart from those involving estimations that the management have made in the process
of applying the Company’s accounting policies and that have the most significant effect on the amounts recognized in the financial
statements.
Useful lives and residual value of property, plant and equipment
The Company reviews the useful life and residual value of property, plant and equipment at the end of each reporting period. This
reassessment may result in change in depreciation expense in future periods.

Corporate OVERVIEW
statutory reportS
Allowance for expected credit losses

The expected credit allowance is based on the ageing of the days receivables which are past due and the rates derived based on
past history of defaults in the provision matrix.
Fair value of investments
The Company has invested in the equity instruments of various companies. However, the percentage of shareholding of the
Company in such investee companies is very low and hence, it has not been provided with future projections including projected
statement of profit and loss by those investee companies. Hence, the valuation exercise carried out by the Company with the help
of an independent valuer has estimated fair value at each reporting period based on available historical annual reports and other
information in the public domain.
Income taxes
Significant judgements are involved in determining the provision for income taxes, including amount expected to be paid/
recovered for uncertain tax positions.
(b) Current versus non-current classification

Assets and liabilities are classified as Current or Non-Current as per the provisions of the Schedule III notified under the Companies
Act, and the Company’s normal operating cycle.
An asset is treated as current when it is:
(i) Expected to be realised or intended to be sold or consumed in normal operating cycle;
(ii) Held primarily for the purpose of trading;
(iii) Expected to be realised within twelve months after the reporting period, or
(iv) Cash or cash equivalent unless restricted from being exchanged or used to settle a liability for at least twelve months after
the reporting period.
All other assets are classified as non-current.
A liability is current when:
(i) It is expected to be settled in normal operating cycle;
(ii) It is held primarily for the purpose of trading;
(iii) It is due to be settled within twelve months after the reporting period, or
(iv) There is no unconditional right to defer the settlement of the liability for at least twelve months after the reporting period
All other liabilities are classified as non-current.
The operating cycle is the time between the acquisition of assets for processing and their realisation in cash and cash equivalents.
Based on the nature of business and its activities, the Company has ascertained its operating cycle as twelve months for the
purpose of Current & Non-Current classification of assets and liabilities.
(c) Revenue Recognition

Sale of Goods
Revenue from the sale of goods is only recognized – net of Goods & Service Tax, cash discounts, discounts and rebates – if the
following conditions are met:
• The significant risks and rewards of ownership of the goods have been transferred to the buyer.
• The Company retains neither continuing managerial involvement to the degree usually associated with ownership nor
effective control over the goods sold.
• The amount of revenue can be measured reliably.
• It is probable that the economic benefits associated with the transaction will flow to the Company.
• The costs incurred or to be incurred in respect of the transaction can be measured reliably.

Revenue from Services is recognised in the accounting period in which the services are rendered.
Interest Income
Interest income from Financial Assets is recognised when it is probable that the economic benefits will flow to the company and
the amount of income is measured reliably. Interest income is accrued on time basis, by reference to the principle outstanding and
using the effective interest rate method. The effective interest rate is the rate that exactly discounts estimated future cash receipts
through the expected life of the financial asset to the gross carrying amount of a financial asset. When calculating the effective
interest rate, the Company estimates the expected cash flows by considering all the contractual terms of the financial instrument
(for example, prepayment, extension, call and similar options) but does not consider the expected credit losses.
Eligible export incentives are recognised in the year in which the conditions precedent is met and there is no significant
uncertainty about the collectability.
Revenue in respect of other income is recognised to the extent that the Company is reasonably certain of its ultimate realisation.

(d) Leasing
Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership
to the lessee. All other leases are classified as operating leases.
As a lessor
Rental income from operating leases is generally recognised on a straight line basis over the term of the relevant lease.
As a lessee
Assets acquired under finance leases are initially recognised at fair value or present value of Minimum Lease payments at the
inception of the lease, whichever is lower. Lease payments under operating leases are recognised as an expense on a straight line
basis in net profit in the Statement of Profit and Loss over the lease term.
(e) Foreign Currency Transactions
In preparing the financial statements of the Company, transactions in currencies other than the entity’s functional currency
(foreign currencies) are recognised at the rates of exchange prevailing at the dates of the transactions. At the end of each reporting
period, monetary items denominated in foreign currencies are retranslated at the rates prevailing at that date. Non-monetary
items carried at fair value that are denominated in foreign currencies are retranslated at the rates prevailing at the date when
the fair value was determined. Non-monetary items that are measured in terms of historical cost in a foreign currency are not
retranslated.
Exchange differences on monetary items are recognised in Statement of profit and loss in the period in which they arise.
Exchange difference arising either on settlement or on translation, in case of long-term foreign currency borrowings, in so far as
they relate to property, plant and equipment are capitalised.
Foreign exchange differences regarded as an adjustment to borrowing costs are presented in the Statement of Profit and Loss,
within finance costs.
The Company enters into a variety of derivative financial instruments to manage its exposure to interest rate and foreign exchange
rate risks, including foreign exchange forward contracts, option contracts and interest rate swaps.
Derivatives are initially recognised at fair value at the date the derivative contracts are entered into and are subsequently
remeasured to their fair value at the end of each reporting period. The resulting gain or loss is recognised in the Statement of profit
and loss immediately.
(f) Borrowing Costs
General and specific borrowing costs that are directly attributable to the acquisition, construction or production of a qualifying
asset are capitalised during the period of time that is required to complete and prepare the asset for its intended use or sale.
Qualifying assets are assets that necessarily take a substantial period of time to get ready for their intended use or sale. Investment
income earned on the temporary investment of specific borrowings pending their expenditure on qualifying assets is deducted
from the borrowing costs eligible for capitalisation. Other borrowing costs are recognised in the Statement of Profit and Loss in the
period in which they are incurred.

Corporate OVERVIEW
statutory reportS
(g) Government Grants

(i) Grants from the Government are recognised at their fair value where there is a reasonable assurance that the grant will be received
and the Company will comply with all attached conditions.
(ii) Government grants relating to the purchase of property, plant and equipment are included in non-current liabilities as deferred
income and are credited in the Statement of Profit and Loss in proportion to fulfillment of associated export obligations and
presented within other income.
(iii) Government grants relating to income are deferred and recognised in the Statement of Profit and Loss over the period necessary
to match them with the costs that they are intended to compensate and presented within other income.
(h) Employee Benefits

(i) Retirement Benefit Costs and Termination Benefits
Payments to defined contribution retirement benefit plans are recognised as an expense when employees have rendered
service entitling them to the contributions.
For defined benefit plans in respect of an approved gratuity plan, the cost of providing benefits is determined using
projected unit credit method, with actuarial valuations being carried out at the end of each reporting period.
Remeasurement, comprising actuarial gains and losses, the effect of the changes to the asset ceiling (if applicable) and
the return on plan assets (excluding net interest), is reflected immediately in the balance sheet with a charge or credit
recognised in other comprehensive income is reflected in the period in which they occur. Remeasurement recognised
in other comprehensive income and is reflected immediately in retained earnings and is not reclassified to Statement
of Profit and Loss. Past service cost is recognised in Statement of Profit and Loss in the period of a plan amendment.
Net interest is calculated by applying the discount rate at the beginning of the period to the net defined benefit liability
or asset. Defined benefit costs are categorised as follows:
• service cost (including current service cost, past service cost, as well as gains and curtailments and settlements)
• net interest expense or income; and
• remeasurement
The first two components of defined benefit costs are recognised in the Statement of Profit and Loss in the line item
‘Employee benefits expense’. Gains or losses on the curtailment or settlement of any defined benefit plan are recognised
when the curtailment or settlement occurs.
(ii) Short-Term and Other Long-Term Employee Benefits

Liabilities recognised in respect of short-term employee benefits are measured at the undiscounted amount of the benefits
expected to be paid in exchange for the related service.
Liabilities recognised in respect of other long-term employee benefits are measured at the Present Value of the estimated
future cash outflows expected to be made in respect of services provided by employees up to the reporting date.
(iii) Compensated Absence and Earned Leaves

The Company’s current policy permits eligible employees to accumulate compensated absences up to a prescribed limit
and receive cash in lieu thereof in accordance with the terms of the policy. The Company measures the expected cost of
accumulating compensated absences as the additional amount that the Company expects to pay as a result of unused
entitlement that has accumulated as at the reporting date. The expected cost of these benefits is calculated using the
projected unit credit method by qualified actuary every year. Actuarial gains and losses arising from experience adjustment
and changes in actuarial assumptions are recognised in the Statement of Profit and Loss in the period in which they arise.
(i) Income Taxes

The income tax expense represents the sum of the tax currently payable and deferred tax.
The current income tax charge is calculated on the basis of the tax laws enacted or substantively enacted at the end of the reporting
period. The Management periodically evaluates positions taken in tax returns with respect to situations in which applicable tax
regulation is subject to interpretation. It establishes provisions where appropriate on the basis of amounts expected to be paid

to the tax authorities. Current tax assets and tax liabilities are offset where the entity has a legally enforceable right to offset and
intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously. Current and deferred tax is
recognised in the Statement of Profit and Loss, except to the extent that it relates to items recognised in Other Comprehensive
Income or directly in Equity. In this case, the tax is also recognised in Other Comprehensive Income or directly in Equity, respectively.
Minimum Alternate Tax (‘MAT’) under the provisions of the Income Tax Act, 1961 is recognised as deferred tax in the Statement
of Profit and Loss. The credit available under the Act in respect of MAT paid will be recognised as an asset only when and to the
extent there is convincing evidence that the Company will pay normal income tax during the period for which the MAT credit can
be carried forward for set off against the normal tax liability. Such an asset is reviewed at each Balance Sheet date.
Deferred tax is recognised on temporary differences between the carrying amount of assets and liabilities in the financial statements
and the corresponding tax bases used in the computation of taxable profits. However, deferred tax liabilities are not recognised
if they arise from the initial recognition of Goodwill. Deferred tax is also not accounted for if it arises from initial recognition of an
asset or liability in a transaction other than a business combination that at the time of the transaction affects neither accounting
profit nor taxable profit /(tax loss). Deferred tax is determined using tax rates (and laws) that have been enacted or substantially
enacted by the Balance Sheet date and are expected to apply when the related deferred income tax asset is realised or the deferred
income tax liability is settled.
Deferred tax assets are recognised for all deductible temporary differences and unused tax losses only if it is probable that future
taxable amounts will be available to utilise those temporary differences and losses.
Deferred tax assets and liabilities are classified as non-current assets and liabilities. Deferred tax assets and liabilities are offset
when there is a legally enforceable right to offset current tax assets and liabilities and when the deferred tax balances relate to the
same taxation authority.
Dividend distribution tax arising out of payment of dividends to shareholders under the Income Tax Act, 1961 regulation are
recognised in statement of changes in equity as part of associated dividend payment.
(j) Property, Plant and Equipment

Property, plant and equipment held for use in the production or supply of goods or services are stated at cost less accumulated
depreciation and accumulated impairment losses if any.
Subsequent costs are included in the carrying amount of asset or recognised as a separate asset, as appropriate, only when it
is probable that future economic benefits associated with the item will flow to the Company and the cost of the item can be
measured reliably. All other repairs and maintenance expenses are charged to the Statement of Profit and Loss during the period
in which they are incurred.
Spare parts, stand-by equipment and servicing equipment are recognised as property, plant and equipment if they are held for use
in the production or supply of goods or services and are expected to be used during more than one period.
Property, plant and equipment which are not ready for intended use as on the date of Balance Sheet are disclosed as ‘Capital
work-in-progress’.
Depreciation Methods, Estimated Useful Lives and Residual Value
Depreciation on all tangible assets is provided at the rates and in the manner prescribed by Schedule II to the Companies Act,
2013 and certain components of plant & equipment such as Reactors, Centrifuge, Cooling towers, Air Compressor etc. which are
depreciated over its useful life as technically assessed by Independent/ Internal Technical Personnel after taking into consideration
past experience of the company, chemical process & chemical industry norms.
Asset Category Estimated Useful Life

Building 30 years
Plant & Equipment 3 to 40 years
Furniture & Fixture 10 years
Vehicle 8 years
Office Equipment 5 years
Road 5 years
Freehold land is stated at historical cost and is not depreciated.

Corporate OVERVIEW
statutory reportS
An item of property, plant and equipment is derecognised upon disposal or when no future economic benefits are expected to
arise from the continued use of the asset. Any gain or loss arising on the disposal or retirement of an item of property, plant and
equipment is determined as the difference between the sales proceeds and the carrying amount of the asset and is recognised in
the Statement of Profit and Loss.
In respect of depreciable assets for which Impairment Loss is recognised, depreciation/amortisation is charged on the revised
carrying amount over the remaining useful life of the assets computed on the basis of the life prescribed in schedule II to the
Companies Act, 2013.
The residual values, useful lives and method of depreciation of property, plant and equipment is reviewed at each financial year
end and adjusted prospectively, if appropriate.
(k) Intangible Assets
Intangible assets are stated at their original cost of acquisition, less accumulated amortisation and impairment losses, if any.
An Intangible Asset is recognised, where it is probable that the future economic benefits attributable to the Asset will flow to the
enterprise and where its cost can be reliably measured.
The cost of intangible assets is amortised over the estimated useful life, in any case, not exceeding ten years, on a straight-line
basis. A detail of estimated useful life is given below:
Software and related implementation costs 6 years

Rights to use facilities 5 years
Technical Know How 10 years
(l) Impairment of Tangible and Intangible Assets

The carrying amount of cash generating units/assets is reviewed at the Balance Sheet date to determine whether there is any
indication of impairment. If such indication exists, the recoverable amount is estimated as the net selling price or value in use,
whichever is higher. While assessing value in use, the estimated future cash flows are discounted to the present value by using pre-
tax discount rate that reflects current market assessments of the time value of money and the risk specific to the asset.
Impairment loss, if any, is recognised whenever carrying amount exceeds the recoverable amount. The impairment loss recognised
in prior accounting period is reversed if there has been a change in the estimate of recoverable amount.
(m) Cash and Cash Equivalents

Cash and cash equivalents include cash in hand, demand deposits with bank and other short-term deposits (3 months or less from
the date of acquisition), highly liquid investments that are readily convertible into cash and which are subject to an insignificant risk of
changes in value.
(n) Inventories
Raw materials and components, stores and spares are valued at cost determined on period-moving weighted average basis and
are net of Cenvat, VAT & GST. Cost comprises all costs of purchase, costs of conversion and other costs incurred in bringing the
inventory to the present location and condition. Due allowances are made for slow moving and obsolete inventories based on
estimates made by the Company. Items such as spare parts, stand-by equipment and servicing equipment which is not plant and
equipment gets classified as inventory.
Finished Goods and Stock-in-process are valued at cost of purchase of raw materials and conversion thereof, including the cost
incurred in the normal course of business in bringing the inventories up to the present condition or at the net realisable value,
whichever is lower. The inventories of joint products are valued by allocating the costs to the joint products by `Relative Sales
Value’ method. By-products are valued at net realisable price.
(o) Financial Instruments

Financial Assets and Financial Liabilities are recognised when the company becomes a party to the contractual provisions of
the instruments. Financial Assets and Financial Liabilities are initially measured at Fair Value. Transaction costs that are directly
attributable to the acquisition or issue of financial assets and financial liabilities (other than financial assets and financial liabilities

at fair value through profit or loss) are added to or deducted from the fair value of the financial assets or financial liabilities, as
appropriate, on initial recognition. Transaction costs directly attributable to the acquisition of financial assets or financial liabilities
at fair value through profit or loss are recognised immediately in Statement of Profit and Loss.
Financial Assets
All regular way purchases or sales of financial assets are recognised and derecognised on a trade date basis. Regular way purchases
or sales are purchases or sales of financial assets that require delivery of assets within the time frame established by regulation or
convention in the market place.
All recognised financial assets are subsequently measured in their entirety at either amortised cost or fair value, depending on the
classification of the financial assets.
(i) Classification of Financial Assets
Debt instruments that meet the following conditions are subsequently measured at amortised cost (except for debt
instruments that are designated as at fair value through profit or loss on initial recognition)
• the asset is held within a business model whose objective is to hold assets in order to collect contractual cash flows; and
• the contractual terms of the instrument give rise on specified dates to cash flows that are solely payments of principal
and interest on the principal amount outstanding.
Debt instruments that meet the following conditions are subsequently measured at fair value through other comprehensive
income (except for debt instruments that are designated as at fair value through profit or loss on initial recognition)
• the asset is held within a business model whose objective is achieved both by collecting contractual cash flows and
selling financial assets; and
(ii) Effective interest method
The effective interest method is a method of calculating the amortised cost of a debt instrument and of allocating interest
income over the relevant period. The effective interest rate is the rate that exactly discounts estimated future cash receipts
through the expected life of the debt instrument, or, where appropriate, a shorter period, to the net carrying amount on
initial recognition. Income is recognised on an effective interest basis for debt instruments other than those financial assets
classified as at FVTPL. Interest income is recognised in Statement of Profit and Loss and is included in the “Other Income” line
item.
(iii) Investments in Equity Instruments

On initial recognition, the company can make an irrevocable election (on an instrument-by-instrument basis) to present
the subsequent changes in fair value in other comprehensive income pertaining to investments in equity instruments. This
election is not permitted if the equity investment is held for trading. These elected investments are initially measured at fair
value with gains and losses arising from changes in fair value recognised in other comprehensive income and accumulated
in the ‘Reserve for equity instruments through other comprehensive income’. The cumulative gain or loss is reclassified
to Statement of Profit and Loss on disposal of the investments. Investments in subsidiary companies carried at cost less
accumulated impairment losses, if any. Where an indication of impairment exists, the carrying amount of the investment is
assessed and written down immediately to its recoverable amount. On disposal of investments in subsidiary companies the
difference between net disposal proceeds and the carrying amounts are recognised in the Statement of Profit and Loss.
Dividends on these investments in equity instruments are recognised in Statement of Profit and Loss when the
Company’s right to receive the dividends is established, it is probable that the economic benefits associated with the
dividend will flow to the entity, the dividend does not represent a recovery a part of cost of the investment and the
amount of dividend can be measured reliably. Dividends recognised in Statement of Profit and Loss are included in the
‘Other income’ line item.

Corporate OVERVIEW
statutory reportS
(iv) Financial Assets at fair value through profit or loss (FVTPL)

Investments in equity instruments are classified as at FVTPL, unless the company irrevocably elects on initial recognition to
present subsequent changes in fair value in other comprehensive income for investments in equity instruments which are
not held for trading.
Debt instruments that do not meet the amortised cost criteria or FVTOCI criteria are measured at FVTPL. In addition, debt
instruments that meet the amortised cost criteria or the FVTOCI criteria but are designated as at FVTPL are measured at
FVTPL.
A financial asset that meets the amortised cost criteria or debt instruments that meet the FVTOCI criteria may be designated
as at FVTPL upon initial recognition if such designation eliminates or significantly reduces a measurement or recognition
inconsistency that would arise from measuring assets or liabilities or recognising the gains and losses on them on different
bases.
Financial assets at FVTPL are measured at fair value at the end of each reporting period, with any gains or losses arising on
remeasurement recognised in Statement of Profit and Loss. The net gain or loss recognised in Statement of Profit and Loss
incorporates any dividend or interest earned on the financial asset and is included in the Other income line item. Dividend
on financial assets at FVTPL is recognised when the company’s right to receive the dividends is established, it is probable that
the economic benefits associated with the dividend will flow to the entity, the dividend does not represent a recovery of part
of cost of the investment and the amount of dividend can be measured reliably.
(v) Impairment of Financial Assets

The Company applies the expected credit loss model for recognising impairment loss on financial contractual rights to receive
cash or other financial asset, and financial guarantees not designated as at assets at amortised cost, debt instruments at FVTOCI
lease receivables, trade receivables, other contractual rights to receive cash or other financial assets.
Expected credit losses are the weighted average of credit losses with the respective risks of default occurring as the weights.
Credit loss is the difference between all contractual cash flows that are due to the Company in accordance with the contract
and all the cash flows that the Company expects to receive (i.e. all cash shortfalls), discounted at the original effective interest
rate (or credit-adjusted effective interest rate for purchased or originated credit-impaired financial assets).
The Company estimates cash flows by considering all contractual terms of the financial instrument (for example, prepayment
extension, call and similar options) through the expected life of that financial instrument.
The Company measures the loss allowance for a financial instrument at an amount equal to the lifetime expected credit
losses if the credit risk on that financial instrument has increased significantly since initial recognition. If the credit risk on
a financial instrument has not increased significantly since initial recognition, the Company measures the loss allowance
for that financial instrument at an amount equal to 12-month expected credit losses, 12-month expected credit losses are
portion of the life-time expected credit losses and represent the lifetime cash shortfalls that will result if default occurs within
the 12 months after the reporting date and thus, are not cash shortfalls that are predicted over the next 12 months.
If the Company measured loss allowance for a financial instrument at lifetime expected credit loss model in the previous
period, but determines at the end of a reporting period that the credit risk has not increased significantly since initial
recognition due to improvement in credit quality as compared to the previous period, the Company can again measures the
loss allowance based on 12-month expected credit losses.
When making the assessment of whether there has been a significant increase in credit risk since initial recognition, the
Company uses the change in the risk of a default occurring over the expected life of the financial instrument instead of the
change in the amount of expected credit losses. To make that assessment, the Company compares the risk of a default
occurring on the financial instrument as at the reporting date with the risk of a default occurring on the financial instrument
as at the date of initial recognition and considers reasonable and supportable information, that is available without cost or
effort that is indicative of significant increases in credit risk since initial recognition.
Further, for the purpose of measuring lifetime expected credit loss allowance for trade receivables, the Company has used
a practical expedient as permitted under Ind AS 109. This expected credit loss allowance is computed based on a provision
matrix which takes into account historical credit loss experience and adjusted for forward-looking information.

The impairment requirements for the recognition and measurement of a loss allowance are equally applied to debt
instruments at FVTOCI except that the loss allowance is recognised in other comprehensive income and is not reduced from
the carrying amount in the balance sheet.
(vi) Derecognition of financial assets

The Company derecognises a financial asset when the contractual rights to the cash flows from the asset expire, or when it
transfers the financial asset and substantially all the risks and rewards of ownership of the asset to another party.
On derecognition of a financial asset in its entirety, the difference between the asset’s carrying amount and the sum of the
consideration received and receivable and the cumulative gain or loss that had been recognised in other comprehensive
income and accumulated in equity is recognised in Statement of Profit and Loss if such gain or loss would have otherwise
been recognised in Statement of Profit and Loss on disposal of that financial asset.
On derecognition of a financial asset other than in its entirety, the Company allocates the previous carrying amount of the
financial asset between the part it continues to recognise under continuing involvement, and the part it no longer recognises
on the basis of the relative fair values of those parts on the date of the transfer. The difference between the carrying amount
allocated to the part that is no longer recognised and the sum of the consideration received for the part no longer recognised
and any cumulative gain or loss allocated to it that had been recognised in other comprehensive income is recognised in
Statement of Profit and Loss if such gain or loss would have otherwise been recognised in Statement of Profit and Loss on
disposal of that financial asset.
A cumulative gain or loss that had been recognised in other comprehensive income is allocated between the part it continues
to be recognised and the part that is no longer recognised on the basis of the relative fair values of those parts.
(vii) Foreign exchange gains and losses

The fair value of financial assets denominated in a foreign currency is determined in that foreign currency and translated at
the spot rate at the end of each reporting period.
• For foreign currency denominated financial assets measured at amortised cost and FVTPL, the exchange differences are
recognised in Statement of Profit and Loss.
• Changes in the carrying amount of investments in equity instruments at FVTOCI relating to changes in foreign currency
rates are recognised in other comprehensive income.
• For the purposes of recognising foreign exchange gains and losses, FVTOCI debt instruments are treated as financial assets
measured at amortised cost. Thus, the exchange difference on amortised cost are recognised in Statement of Profit and
Loss and other changes in the fair value of FVTOCI financial assets are recognised in other comprehensive income.
(p) Financial Liabilities and equity instruments

(i) Classification as Debt and Equity
Debt and Equity instruments issued by the company are classified as either financial liabilities or as equity in accordance
with the substance of the contractual arrangements and the definitions of a financial liability and an equity instrument.
(ii) Equity Instruments

An equity instrument is any contract that evidences a residual interest in the assets of an entity after deducting all of its
liabilities. Equity instruments issued by the Company are recognised at the proceeds received, net of direct issue costs.
Repurchase of the Company’s own equity instruments is recognised and deducted directly in equity. No gain or loss is
recognised in Statement of Profit and Loss on the purchase, sale, issue or cancellation of the Company’s own equity
instruments.
(iii) Financial Liabilities

All financial liabilities are subsequently measured at amortised cost using the effective interest method or at FVTPL.

Corporate OVERVIEW
statutory reportS
However, financial liabilities that arise when a transfer of a financial asset does not qualify for derecognition or when the
continuing involvement approach applies, financial guarantee contracts issued by the Company, and commitments issued
by the Company to provide a loan at below-market interest rate are measured in accordance with the specific accounting
policies set out below.
a) Financial Liabilities at FVTPL
Financial liabilities are classified as at FVTPL when the financial liability is held for trading or it is designated as at FVTPL.
A financial liability is classified as held for trading if:
• it has been incurred principally for the purpose of repurchasing it in the near term; or
• on initial recognition it is part of a portfolio of identified financial instruments that the Company manages together
and has a recent actual pattern of short-term profit-taking; or
• it is a derivative that is not designated and effective as a hedging instrument
A financial liability other than a financial liability held for trading may be designated as at FVTPL upon initial recognition if:
• such designation eliminates or significantly reduces a measurement or recognition inconsistency that would
otherwise arise;
• the financial liability forms part of a group of financial assets or financial liabilities or both, which is managed and its
performance is evaluated on a fair value basis, in accordance with the Company’s documented risk management or
investment strategy, and information about the grouping is provided internally on that basis; or
• it forms part of a contract containing one or more embedded derivatives, and Ind AS 109 permits the entire combined
contract to be designated as at FVTPL in accordance with Ind AS 109.
Financial liabilities at FVTPL are stated at fair value, with any gains or losses arising on remeasurement recognised in
Statement of Profit and Loss. The net gain or loss recognised in Statement of Profit and Loss incorporates any interest
paid on the financial liability and is included in the ‘Other income’ line item.
However, for non-held-for-trading financial liabilities that are designated as at FVTPL, the amount of change in the
fair value of the financial liability that is attributable to changes in the credit risk of that liability is recognised in other
comprehensive income, unless the recognition of the effects of changes in the liability’s credit risk in other comprehensive
income would create or enlarge an accounting mismatch in Statement of Profit and Loss, in which case these effects of
changes in credit risk are recognised in Statement of Profit and Loss. The remaining amount of change in the fair value
of liability is always recognised in Statement of Profit and Loss. Changes in fair value attributable to a financial liability’s
credit risk that are recognised in other comprehensive income are reflected immediately in retained earnings and are not
subsequently reclassified to Statement of Profit and Loss.
b) Financial Liabilities subsequently measured at Amortised Cost

Financial liabilities that are not held-for-trading and are not designated as at FVTPL are measured at amortised cost at
the end of subsequent accounting periods. The carrying amount of financial liabilities that are subsequently measured
at amortised cost are determined based on the effective interest method. Interest expense that is not capitalised as part
of costs of an asset is included in the ‘Finance costs’ line item.
The effective interest method is a method of calculating the amortised cost of a financial liability and of allocating
interest expense over the relevant period. The effective interest rate is the rate that exactly discounts estimated future
cash payments (including all fees and points paid or received that form an integral part of the effective interest rate,
transaction costs and other premiums or discounts) through the expected life of the financial liability, or (where
appropriate) a shorter period, to the net carrying amount on initial recognition.
c) Foreign exchange gains and losses

For financial liabilities that are denominated in a foreign currency and are measured at amortised cost at the end of each
reporting period, the foreign exchange gains and losses are determined based on the amortised cost of the instruments
and are recognised in ‘Other income’.

The fair value of financial liabilities denominated in a foreign currency is determined in that foreign currency and
translated at the spot rate at the end of the reporting period. For financial liabilities that are measured as at FVTPL, the
foreign exchange component forms part of the fair value gains or losses.
d) Derecognition of financial liabilities

The Company derecognises financial liabilities when, and only when, the Company’s obligations are discharged,
cancelled or have expired. An exchange between with a lender of debt instruments with substantially different terms is
accounted for as an extinguishment of the original financial liability and the recognition of new financial liability. Similarly,
a substantial modification of the terms of an existing financial liability (whether or not attributable to the financial
difficulty of the debtor) is accounted for as an extinguishment of the original financial liability and the recognition of a
new financial liability. The difference between the carrying amount of the financial liability and the consideration paid
and payable is recognised in Statement of Profit and Loss.
(q) Offsetting Financial Instruments

Financial assets and liabilities are offset and the net amount is reported in the Balance Sheet where there is a legally enforceable
right to offset the recognised amounts and there is an intention to settle on a net basis or realise the asset and settle the liability
simultaneously.
(r) Provisions and Contingent Liabilities

Provisions are recognised when the Company has a present legal or constructive obligation as a result of past events, it is probable
that an outflow of resources will be required to settle the obligation and the amount can be reliably estimated. These are reviewed
at each year end and reflect the best current estimate. Provisions are not recognised for future operating losses. Where there are a
number of similar obligations, the likelihood that an outflow will be required in settlement is determined by considering the class
of obligations as a whole. A provision is recognised even if the likelihood of an outflow with respect to any one item included in
the same class of obligations may be small. Provisions are measured at the present value of best estimate of the Management of
the expenditure required to settle the present obligation at the end of the reporting period. The discount rate used to determine
the present value is a pre-tax rate that reflects current market assessments of the time value of money and the risks specific to the
liability. The increase in the provision due to the passage of time is recognised as interest expense.
Contingent liabilities are disclosed when there is a possible obligation arising from past events, the existence of which will be
confirmed only by the occurrence or non-occurrence of one or more uncertain future events not wholly within the control of the
Company or a present obligation that arises from past events where it is either not probable that an outflow of resources will be
required to settle the obligation or a reliable estimate of the amount cannot be made.
(s) Research and Development Expenditure

Research and Development expenditure is charged to revenue under the natural heads of account in the year in which it is incurred.
Research and Development expenditure on property, plant and equipment is treated in the same way as expenditure on other
property, plant and equipment.
(t) Earnings Per Share

Basic Earnings per share (EPS) is calculated by dividing the net profit or loss for the period attributable to Equity Shareholders by
the weighted average number of Equity shares outstanding during the period. Diluted Earnings per Equity Share are computed
by dividing net income by the weighted average number of Equity Shares adjusted for the effects of all dilutive potential Equity
Shares. Earnings considered in ascertaining the EPS is the net profit for the period after attributable tax thereto for the period.

Corporate OVERVIEW
statutory reportS
(u) Segment Reporting - Basis of Information

The Company has determined 3 (three) reporting Segments, based on the information reviewed by chief operating decision maker
as primary segments viz.
(i) Basic Chemicals,
(ii) Fine & Speciality Chemicals and
(iii) Performance Products.
Inter segment transfer prices are normally negotiated amongst the segments with reference to the costs, market prices and
business risks, within an overall optimisation objective of the Company.
Revenue and expenses have been accounted on the basis of their relationship to the operating activities of the segment. Revenue
and expenses, which relate to the enterprise as a whole and are not allocable to segments on reasonable basis, have been included
under “Other unallocable”. Assets and liabilities which relate to the enterprise as a whole but are not allocable to segments on a
reasonable basis, have been included under “Unallocable Assets/Liabilities”.
Secondary segment have been identified with reference to geographical location of external customers. Composition of secondary
segment is as follows: (i) India and (ii) Outside India.

2. PROPERTY, PLANT AND EQUIPMENT
154
` in Lakhs
Owned assets Capital
Freehold Leasehold Building Plant and Furniture Vehicle Office Road Total Work-in-
Land Land Equipment and Fixture Equipment Progress
Net Carrying Amount as at March 578.68 1,597.01 9,053.59 43,725.78 422.42 494.38 158.79 194.38 56,225.03 4,072.77
31, 2017
Additions during the year 2017-18 - 314.24 289.06 4,796.63 60.92 21.97 56.65 10.24 5,549.71 5,101.73
Deductions during the year 2017-18 - - (87.02) (199.07) (0.34) (29.07) (6.08) - (321.58) (5,549.71)
Depreciation for the year 2017-18 - (20.12) (434.39) (4,231.67) (67.15) (102.01) (64.08) (104.40) (5,023.82) -

Depreciation on disposal during the - - 5.93 16.32 0.30 7.92 5.43 - 35.90 -
year 2017-18
31, 2018
Deductions during the year 2018-19 - - (33.52) (612.51) - (68.63) (1.87) - (716.53) (7,874.38)
Depreciation on disposal during the - - 2.21 112.95 - 31.66 1.09 - 147.91 -
year 2018-19
31, 2019
Notes:
1 Property, Plant and Equipment hypothecated/mortgaged as security for borrowings are disclosed under note 17 and note 20.
2 Building includes ` 1,080.00 Lakhs (` 1,080.00 Lakhs at March 31, 2018) in respect of ownership of premises in a co-operative housing society by way of 10 Shares.
3 The useful lives of Plant & Machinery have been changed from Financial Year 2017-18 which is based on technical evaluation done by the Management experts which are in accordance
to the useful life prescribed in Part C of Schedule II to the Act, in order to reflect the actual usage of the assets.
4 Capitalised borrowing costs
Addition to Property, Plant & Equipment include borrowing costs (including exchange difference considered as adjustments to borrowings cost) amounting to ` 168.90 Lakhs
(Previous year, ` 5.31 Lakhs)
` in Lakhs
Capitalised during the Capitalised during the
Current Year Previous Year
Exchange loss/(Gain) Capitalised (Refer note below)
(a) Plant & Machinery 159.28 5.01
(b) Factory & Other Building 9.62 0.30
Total 168.90 5.31

Note: Pursuant to the provisions contained in the Companies (Accounting Standards) Amendment Rules, 2009, and related notifications of Ministry of Corporate Affairs, the Company
in 2018-19 has adjusted to Property, Plant & Equipment, foreign exchange differences amounting to ` 168.90 Lakhs (Previous year, ` 5.31 Lakhs) on revaluation of long term foreign
currency borrowing for acquisition of Property, Plant & Equipment as an adjustment to borrowing costs.
5 Capital Work in Progress
` in Lakhs
As at As at
March 31, 2019 March 31, 2018
(a) Capital Work in Progress (Building) - 397.88
(b) Capital Work in Progress (Others) 2,891.79 3,226.91
Capital Work in Progress 2,891.79 3,624.79
6 Research & Development Assets included in Property, Plant & Equipment

` in Lakhs
Owned assets
Building Plant and Furniture and Vehicle Office Computer Total
Equipment Fixture Equipment Software
Net Carrying Amount as at March 31, 2017 51.78 646.99 114.19 20.43 12.25 2.01 847.65
Additions during the year 2017-18 8.95 64.71 23.78 - 4.14 16.33 117.91
Depreciation for the year 2017-18 (3.54) (80.12) (10.52) (3.23) (3.23) (0.88) (101.52)
Additions during the year 2018-19 - 188.12 - - 0.61 4.17 192.90
Depreciation for the year 2018-19 (3.93) (83.47) (12.47) (3.22) (3.81) (3.14) (110.04)
3. OTHER INTANGIBLE ASSETS

` in Lakhs
Computer Others Total
Software
Net Carrying Amount as at March 31, 2017 325.28 245.84 571.12
Additions during the year 2017-18 53.95 - 53.95
Depreciation for the year 2017-18 (96.50) (74.60) (171.10)
Additions during the year 2018-19 126.79 7.50 134.29
Deductions during the year 2018-19 (1.39) - (1.39)
Depreciation on disposal during the year 2018-19 1.39 - 1.39
Promises Made. Promises Delivered.

statutory reportS
Corporate OVERVIEW
155
4. Non-Current Investments
` in Lakhs
As at As at
March 31, 2019 March 31, 2018
(a) Investments in equity instruments of subsidiary companies measured at cost 28,047.68 28,047.68
(b) Investments in Preference shares of subsidiary companies measured at cost 28,000.00 15,100.00
Subtotal 56,047.68 43,147.68
(a) Investments in equity instruments of other companies measured at FVTPL 7.30 10.71
(b) Investments in equity instruments of other companies measured at FVOCI 232.11 224.27
(c) Investments in Government or Trust Securities measured at amortised cost 0.01 0.01
Subtotal 239.42 234.99
Total 56,287.10 43,382.67
` in Lakhs
As at March 31, 2019 As at March 31, 2018
Face Value No. of Amount No. of Amount
Shares Shares
(a) Investment in Equity Instruments (fully paid-up)
(i) Subsidiary Companies measured at cost (Unquoted)
In Indian subsidiary company measured at cost
Deepak Phenolics Limited ` 10/- 28,00,00,000 28,000.00 28,00,00,000 28,000.00
In Foreign subsidiary company measured at cost
Deepak Nitrite Corporation, Inc. US $ 10/- 7,500 47.68 7,500 47.68
(ii) Other Companies measured at FVTPL
Quoted
IDBI Bank ` 10/- 6,240 2.91 6,240 4.51
Dena Bank (Refer Note 1 below) ` 10/- 29,400 3.72 29,400 5.53
Unquoted
Nandesari Environment Control Limited ` 10/- 800 0.08 800 0.08
Baroda Co-operative Bank Ltd. ` 50/- 10 0.01 10 0.01
Shamrao Vitthal Co-op Bank Ltd. ` 25/- 2,000 0.50 2,000 0.50
New India Co-op Bank Ltd. ` 10/- 798 0.08 798 0.08
(iii) Other Companies measured at FVOCI
Unquoted
Jedimetla Effluent Treatment Ltd. ` 100/- 52,342 84.56 52,342 80.08
Deepak International Limited GBP 1/- 73,706 66.72 73,706 68.01
Deepak Gulf LLC Omani 45,000 80.83 45,000 76.18
Riyal 1/-
(b) Investment in Preference Shares(fully paid-up)
Subsidiary Company measured at cost
Unquoted
7% Non- Cumulative Optionally Convertible Preference Shares ` 100/- 2,80,00,000 28,000.00 1,51,00,000 15,100.00
(c) Investments in Government or Trust Securities measured at
amortised cost
National Savings Certificate - 0.01 - 0.01
Total 308,217,796 56,287.10 295,317,796 43,382.67
Notes:
1. The Company has received 3,234 shares of Bank of Baroda in the scheme of amalgamation against 29,400 shares of the Dena Bank
in the month of April 2019.
2. ` in Lakhs
As at As at
March 31, 2019 March 31, 2018
(a) Aggregate amount of Unquoted Investments 56,280.47 43,372.63
(b) Aggregate amount of Quoted Investments 6.63 10.04

Corporate OVERVIEW
statutory reportS
5. LOANS
` in Lakhs
As at As at
March 31, 2019 March 31, 2018
Loans to Employees
Unsecured, considered good
(a) Key Managerial Personnel and Directors 0.27 0.89
(b) Others 135.24 130.12
Total 135.51 131.01
These financial assets are carried at amortised cost.
6. OTHER NON-CURRENT FINANCIAL ASSETS

` in Lakhs
As at As at
March 31, 2019 March 31, 2018
Security Deposits
(a) Related parties (Refer Note below) - 383.09
(b) Others 556.92 510.50
Total 556.92 893.59
Security Deposits from related parties for the previous year include Deposit towards lease of residential premises of ` 400.00 Lakhs
accounted at Fair Value using appropriate discount rate.
7. NON-CURRENT TAX ASSETS

` in Lakhs
As at As at
March 31, 2019 March 31, 2018
Non-Current Tax Assets
Advance Income Tax (Net of provisions) 192.72 255.40
Total 192.72 255.40
8. OTHER NON-CURRENT ASSETS

` in Lakhs
As at As at
March 31, 2019 March 31, 2018
(a) Capital Advances 258.02 255.93
(b) Prepaid Expenses 29.15 37.31
(c) Advance against Salary 93.06 60.67
Total 380.23 353.91

9. INVENTORIES [At lower of cost and net realisable value]
` in Lakhs
As at As at
March 31, 2019 March 31, 2018
(a) Raw materials and components 7,507.80 6,654.68
Goods-in-transit 2,492.94 3,427.14
10,000.74 10,081.82
(b) Stores and Spares 1,604.46 1,683.39
Sub-Total 11,605.20 11,765.21
(c) Work-in-progress 2,729.28 3,820.16
(d) Finished goods 9,665.07 3,406.80
Provision for obsolescence (748.60) (173.93)
Sub-Total 11,645.75 7,053.03
Total 23,250.95 18,818.24
Inventories hypothecated as security for borrowings are disclosed under note 17 and note 20.
10. CURRENT INVESTMENTS

` in Lakhs
As at As at
March 31, 2019 March 31, 2018
Investments measured at FVTPL (Quoted)
Investments in Mutual Funds - 2,140.30
Total - 2,140.30
11. TRADE RECEIVABLES

` in Lakhs
As at As at
March 31, 2019 March 31, 2018
Current
(a) Unsecured, Considered Good
(i) Trade Receivables 34,048.05 36,412.36
(ii) Related Parties 396.59 508.77
(b) Trade Receivables - Credit Impaired 678.37 594.56
Allowance for credit losses (678.37) (594.56)
Total 34,444.64 36,921.13
The credit period on sales of goods varies with business segments/ markets and generally ranges between 30 to 180 days. For financial

risk related to Trade Receivables refer note 39.5 and 39.6.
Trade receivables hypothecated/mortgaged as security for borrowings are disclosed under note 17 and note 20.
12a. CASH AND CASH EQUIVALENTS

` in Lakhs
As at As at
March 31, 2019 March 31, 2018
(a) Cash on hand 9.80 1.47
(b) Balances with banks
In Current accounts 120.47 105.73
Total 281.29 118.65

Corporate OVERVIEW
statutory reportS
12b. BANK BALANCES OTHER THAN CASH AND CASH EQUIVALENTS ABOVE
` in Lakhs
As at As at
March 31, 2019 March 31, 2018
(a) Earmarked Balances with Bank 72.26 64.33
(b) Deposits with banks with maturity less than 3 months - 3,026.22
(c) Margin Money Deposits 204.93 1.81
Total 277.19 3,092.36
13. OTHER CURRENT FINANCIAL ASSETS

` in Lakhs
As at As at
March 31, 2019 March 31, 2018
(a) Loans to employees
(i) Key Managerial Personnel and Directors 0.62 0.62
(ii) Others 76.29 124.07
(b) Interest Receivable 59.58 68.86
(c) Insurance Claim Receivable (Refer Note (i) below) - 1,446.03
(d) Security Deposits 15.03 9.62
(e) Earnest Money 15.61 11.23
(f) Loan to Company (Refer Note (ii) below) - 187.90
(g) Advance to company towards Share Application money (Refer Note (iii) below) - 5,000.00
(h) Others 23.53 22.74
Total 190.66 6,871.07
(i) With respect to fire incident in October 2016, the Company had provisionally recognised ` 2,250 Lakhs (` 1,832.90 Lakhs Net of
loss on account of fire) both for replacement value of the damaged facilities and loss of profits due to business interruption in the
previous year ended March 31, 2018 . During the current year, upon final settlement of both the claims the Company recognised
` 348.36 Lakhs in the Statement of Profit and Loss under Fine & Speciality Chemicals Segment.
(ii) Loans to Company have been given for business purpose.
(iii) The Company has paid ` 5,000.00 Lakhs for the year ended March 31, 2018 towards Share Application Money pending allotment
to Deepak Phenolics Limited (Wholly Owned Subsidiary).
14. OTHER CURRENT ASSETS

` in Lakhs
As at As at
March 31, 2019 March 31, 2018
(a) Balance with Government Authorities 2,794.32 4,928.68
(c) Advances to Suppliers 1,939.30 1,224.82
(d) Other Receivables 11.63 16.11
Total 4,912.47 6,463.69

15. Equity Share Capital
` in Lakhs
As at As at
March 31, 2019 March 31, 2018
Authorised
15,00,00,000 Equity shares of ` 2 each 3,000.00 3,000.00
20,00,000 Preference shares of ` 100 each 2,000.00 2,000.00
Total 5,000.00 5,000.00
Issued, Subscribed and fully paid up
Equity shares of ` 2 each 2,727.86 2,727.86
Total 2,727.86 2,727.86
(a) Reconciliation of number of Equity Shares outstanding at the beginning and at the end of the period:
` in Lakhs
No. of Amount No. of Amount
Shares Shares
Equity Shares
Shares outstanding at the beginning of the period 13,63,93,041 2,727.86 13,07,11,266 2,614.23
Issued during the year- issued to QIB
- - 56,81,775 113.63
(Refer Note (b) (iv) below)
Shares outstanding at the end of the period 13,63,93,041 2,727.86 13,63,93,041 2,727.86
(b) Shares: Terms/Rights

(i) The Company has Authorised capital of Equity and Preference shares.
(ii) Each holder of the Equity Share is entitled to one vote per Share. The Company declares and pays dividend in Indian Rupees.
The dividend proposed by the Board of Directors is subject to approval of the shareholders at the ensuing Annual General
Meeting.
(iii) In the event of liquidation of the Company, the holders of Equity Shares shall be entitled to receive remaining assets of the
Company, after distribution of all preferential amounts. The distribution will be in proportion to the number of Equity Shares
held by the Shareholders. No preferential amounts exist as on the Balance Sheet date.
(iv) During the previous year, the Company offered Equity Shares to Qualified Institutional Buyers (“QIBs”) through Qualified
Institutions Placement in accordance with Chapter VIII of SEBI (Issue of Capital and Disclosure Requirements) Regulations,
2009. Accordingly, 56,81,775 Equity Shares of ` 2/- each were allotted to QIBs on January 30, 2018 at an issue price of ` 264
per Equity Share (including premium of ` 262 per Equity Share).
The issue proceeds has been fully utilised for the object stated in the offer document.
(c) Details of shares held by each shareholder holding more than 5% Equity shares of ` 2 each fully paid in the Company :
Name of the Shareholder As at March 31, 2019 As at March 31, 2018
No. % Holding No. % Holding
Shri Deepak Chimanlal Mehta 2,12,16,331 15.56 2,12,36,331 15.57
Stiffen Credits & Capital Pvt. Ltd. 83,79,940 6.14 83,79,940 6.14
Reliance Capital Trustee Co. Ltd. 74,97,953 5.50 64,21,199 4.71
Aditya Birla Sun Life Trustee Private Limited 73,58,733 5.40 40,88,798 3.00
Checkpoint Credits & Capital Pvt. Ltd. 72,06,050 5.28 72,06,050 5.28
Stepup Credits & Capital Pvt. Ltd. 69,15,580 5.07 69,15,580 5.07
(d) During the year 2014-15, Company has allotted 52,269,095 Bonus Equity Shares of ` 2/- (Rupees Two Only) each, fully paid up, in
the ratio of 1:1 (one Bonus Equity Shares of ` 2/- each).

Corporate OVERVIEW
statutory reportS
16. OTHER EQUITY

` in Lakhs
As at As at
March 31, 2019 March 31, 2018
Reserves & Surplus
(a) Retained Earnings 51,126.74 40,231.79
(b) General Reserve 8,390.13 7,890.13
(c) Capital Reserve 71.27 71.27
(d) Capital Redemption Reserve 15.00 15.00
(e) Securities Premium 43,416.56 43,416.56
Reserves Representing Unrealised Gains/(Losses)
Equity Instruments through Other Comprehensive Income 36.99 31.88
Total 1,03,056.69 91,656.63
` in Lakhs
As at As at
March 31, 2019 March 31, 2018
(a) Retained Earnings
Balance at beginning of year 40,231.79 34,202.32
Add: Profit attributable to owners of the Company (Profit for the year) 13,532.53 8,417.32
Less: Payment of Dividend on Equity Shares 1,773.11 1,568.53
Less: Payment of Dividend Distribution Tax 364.47 319.32
Less: Transferred to General Reserve 500.00 500.00
Balance at end of year 51,126.74 40,231.79
Retained earnings represents the Company’s undistributed earnings after taxes.
(b) General Reserve
Add: Transferred from Surplus Balance in the Statement of Profit and Loss 500.00 500.00
The general reserve is used for purposes as specified under the Companies Act, 2013. As
the general reserve is created by transfer from one component of equity to another and
is not an item of other comprehensive income, items included in the general reserve will
not be reclassified subsequently to the statement of profit and loss.
(c) Capital Reserve
Balance at beginning of year 71.27 71.27
Balance at end of year 71.27 71.27
(d) Capital Redemption Reserve
Capital redemption reserve has been created pursuant to the requirements of the Act
under which the Company is required to transfer certain amounts on redemption of the
debentures. The Company has redeemed the underlying debentures in the earlier years.
The capital redemption reserve can be utilised for issue of bonus shares.
(e) Securities Premium
Add: Receipt of Securities Premium from issue of Equity Shares to QIBs - 14,886.25
Less: Share issue Expenses - 371.91
Securities premium reserve represents the amount received in excess of the face value
of the equity shares. The utilisation of the securities premium reserve is governed by the
Section 52 of the Companies Act, 2013. Share issue expenses includes fees of Statutory
Auditors of ` 15.00 Lakhs in the previous year for work related to Qualified Institutions
Placement.

` in Lakhs
As at As at
March 31, 2019 March 31, 2018
(f) Reserve for equity instruments through other comprehensive income
Add: Gain on revaluation of Equity Instruments 5.11 13.84
This reserve represents the cumulative gains and losses arising on the revaluation of
equity instruments measured at fair value through other comprehensive income, net of
amounts reclassified to retained earnings when those assets have been disposed off.
17. NON-CURRENT BORROWINGs

` in Lakhs
As at As at
March 31, 2019 March 31, 2018
Term Loans from Banks at amortised cost
Secured 12,319.17 11,797.45
Unsecured 2,000.00 7,950.00
Sub-Total 14,319.17 19,747.45
Less:
Current maturities of Non-Current Borrowings disclosed under “Other Current Financial 6,160.00 10,451.59
Liabilities” (Refer Note 22 (a))
Total 8,159.17 9,295.86
Secured Term Loans:-

Term loan from Banks are secured by first pari passu charge by way of hypothecation of all existing movable property, plant and
equipment and mortgage of immovable properties of the Company.
Repayment Schedule:-
(i) Rate of interest of Rupee loan from Banks are in the range of MCLR plus 0.00% to 1.40% p.a. and is repayable on monthly/quarterly
basis with last instalment payable from April, 2020 to March, 2026.
(ii) Rate of interest of External Commercial Borrowings are in the range of LIBOR plus 2.65% p.a. and is repayable on quarterly/half-
yearly basis with a step up repayment schedule and last instalment paid in November, 2018.
(iii) Unsecured Term Loan from Banks is repayable on quarterly basis with last instalment payable in September, 2019.
18. PROVISIONS
` in Lakhs
As at As at
March 31, 2019 March 31, 2018
Non-current
Provision for Employee Benefit Obligations
Provision for Leave Benefits (Refer Note 37 (B)) 1,072.90 783.50
Total-Non-Current 1,072.90 783.50
Current
Provision for Leave Benefits (Refer Note 37 (B)) 326.35 298.04
Provision for Gratuity (Refer Note 37 (A)(iii)) 379.93 2.76
Total-Current 706.28 300.80

Corporate OVERVIEW
statutory reportS
19. DEFERRED TAX LIABILITY (NET)

` in Lakhs
As at As at
March 31, 2019 March 31, 2018
(a) Break up of deferred tax liability as at year end:
Nature of timing difference
Property, Plant and Equipment 9,045.67 8,204.75
Total Deferred Tax Liability 9,045.67 8,204.75
(b) Break up of deferred tax asset as at year end:
Disallowances u/s 43B and Others 1,386.98 507.09
MAT Credit Entitlement - 2,477.85
Total Deferred Tax Asset 1,386.98 2,984.94
Deferred Tax Liability (Net) (a-b) 7,658.69 5,219.81
20. CURRENT BORROWINGs

` in Lakhs
As at As at
March 31, 2019 March 31, 2018
Working Capital Borrowings from Banks
(a) Secured 17,058.48 16,927.45
(b) Unsecured 1,383.43 9,478.56
Total 18,441.91 26,406.01
(i) Working Capital borrowings from banks represent Cash Credit, Working Capital Demand Loan, Export Packing Credit with rate of
interest as MCLR of respective banks plus spread ranging from 0% -1.25% p.a., Packing Credit in Foreign Currency, Buyers’ Credit
against Letter of Undertaking with rate of interest ranging from LIBOR/EURIBOR plus spread ranging from 0.30% p.a. to 1.50% p.a.
These borrowings are repayable on demand.
(ii) Working Capital borrowings are secured by way of first Hypothecation charge over Company’s Raw Materials, Semi-Finished
and Finished Goods, Consumable Stores and Book Debts and second charge on all Property, Plant & Equipment by way of
hypothecation and mortgage.
(iii) Commercial Paper placed by the Company during the year are unsecured and carries interest rate ranging from 7.20% p.a. to
8.60% p.a., tenure of each placement ranging from 55 days to 90 days.
21. TRADE PAYABLES

` in Lakhs
As at As at
March 31, 2019 March 31, 2018
(a) To outstanding dues of Micro, Small and Medium Enterprises 775.13 104.43
(b) To outstanding dues of Creditors other than Micro, Small and Medium Enterprises 31,710.28 31,300.03
Total 32,485.41 31,404.46
The average credit period on goods purchased or services received ranges between 30 days to 180 days.

22. OTHER FINANCIAL LIABILITIES - CURRENT
` in Lakhs
As at As at
March 31, 2019 March 31, 2018
(a) Current maturities of Long term Borrowings (Refer Note 17) 6,160.00 10,451.59
(b) Security Deposits 287.30 286.11
(c) Investor Education and Protection Fund will be credited by following amounts (as and
when due)
Unpaid Dividend 70.02 61.06
Unclaimed Matured Deposits (Refer Note below) 7.44 7.84
Unpaid Interest on Matured Fixed Deposits 2.24 3.27
(d) Interest accrued but not due on Borrowings 97.29 184.60
(e) Others 8.98 14.02
Total 6,633.27 11,008.49
The Unclaimed Matured deposits of ` 7.44 Lakhs outstanding as at March 31, 2019 represents an aggregate amount of certain cheques
issued towards compulsory repayment of the outstanding fixed deposits as on March 31, 2015, which have not been presented to the
bank for payment by the depositors.
23. CURRENT TAX LIABILITIES

` in Lakhs
As at As at
March 31, 2019 March 31, 2018
Current Tax Liabilities
Provision for Tax (Net of Advances) 174.00 -
Total 174.00 -
24. OTHER CURRENT LIABILITIES

` in Lakhs
As at As at
March 31, 2019 March 31, 2018
(a) Advances received from Customers 650.10 89.77
(b) Payable for capital expenditure 585.96 597.49
(c) Statutory Dues 420.99 559.21
Total 1,657.05 1,246.47
25. REVENUE FROM OPERATIONS

` in Lakhs
March 31, 2019 March 31, 2018
(a) Sale of Products 1,75,806.10 1,42,962.65
(b) Sale of Services 970.85 884.21
(c) Other Operating Revenues
Export Incentives 1,734.28 1,605.37
Scrap Sale 310.16 218.76
Insurance Claims (Refer Note 13 (i)) 370.48 2,251.97
1,79,191.87 1,47,922.97

Corporate OVERVIEW
statutory reportS
26. OTHER INCOME

` in Lakhs
March 31, 2019 March 31, 2018
(a) Interest Income 80.38 131.95
(b) Profit on redemption of Investments 44.11 345.81
(c) Rent 68.21 10.48
(d) Miscellaneous Receipts 66.81 36.59
(e) Dividend Income 0.01 0.01
(f) Foreign Exchange Gain - 221.20
(g) Fair Value Gains on Financial Assets - 9.65
(h) Write back of provision for Impairment - 397.88
Total 259.52 1,153.57
27. COST OF RAW MATERIAL AND COMPONENTS CONSUMED

` in Lakhs
March 31, 2019 March 31, 2018
(a) Raw Material and Components Consumed
Inventory at the beginning of the year 10,081.82 5,292.93
Add: Purchases during the year 1,00,106.77 86,409.77
1,10,188.59 91,702.70
Less: Inventory at the end of the year 10,000.74 10,081.82
Cost of Raw Material and Components Consumed 1,00,187.85 81,620.88
(b) Packing Material Consumed 2,597.02 2,371.91
Cost of Packing Material and Consumed 2,597.02 2,371.91
Total 1,02,784.87 83,992.79
28. CHANGES IN INVENTORIES OF FINISHED GOODS AND WORK-IN-PROGRESS

` in Lakhs
March 31, 2019 March 31, 2018
Inventories at the beginning of the year
Stock in Process 3,820.16 3,529.68
Finished Goods 3,406.80 4,086.43
7,226.96 7,616.11
Less:
Inventories at the end of the year
12,394.35 7,226.96
Total (5,167.39) 389.15
29. EMPLOYEE BENEFITS EXPENSE

` in Lakhs
March 31, 2019 March 31, 2018
(a) Salaries & Wages 14,323.58 11,747.48
(b) Contribution to provident fund and other funds (Refer Note No.37C) 738.86 688.43
(c) Gratuity Expenses (Refer Note No.37A(iv)) 115.29 124.37
(d) Staff Welfare Expenses 682.57 645.65
Total 15,860.30 13,205.93

30. POWER & FUEL EXPENSES
` in Lakhs
March 31, 2019 March 31, 2018
(a) Consumption of Gas 1,997.80 2,404.45
(b) Consumption of Furnace Oil 1,324.35 714.61
(c) Consumption of High Speed Diesel 129.19 93.80
(d) Consumption of Coal & Coke 3,909.44 3,556.30
(e) Electricity Expenses 5,993.11 4,565.45
(f) Water Charges 723.30 621.33
(g) Other Expenses 16.53 31.96
Total 14,093.72 11,987.90
31. FINANCE COSTS

` in Lakhs
March 31, 2019 March 31, 2018
(a) Interest on Borrowings 3,489.26 3,636.07
(b) Exchange difference to the extent considered as an adjustment to Borrowing Costs 795.31 397.93
Total 4,284.57 4,034.00
32. DEPRECIATION AND AMORTISATION EXPENSES

` in Lakhs
March 31, 2019 March 31, 2018
(a) Depreciation on Tangible assets 5,129.31 5,023.82
(b) Amortisation of Intangible assets 158.51 171.10
Total 5,287.82 5,194.92
33. OTHER EXPENSES

` in Lakhs
March 31, 2019 March 31, 2018
(a) Conversion Charges 547.85 528.49
(b) Excise duty Relating to Increase / (Decrease) in Closing Stocks - (330.22)
(c) Other Manufacturing Expenses 1,247.45 962.47
(d) Rent 234.84 283.42
(e) Repairs & Maintenance
Repairs to Building 116.02 100.55
Repairs and Maintenance to Plant and Equipment 2,614.67 2,200.36
Repairs and Maintenance to Others 69.82 70.47
(f) Consumption of stores & spare parts 1,583.64 1,520.16
(g) Insurance 359.22 329.04
(h) Rates & Taxes 366.72 232.03
(i) Bank Charges 194.41 152.81
(j) Travelling & Conveyance 437.16 423.76
(k) Freight & Forwarding Charges 5,788.41 4,203.79
(l) Loss on Sale of Property, Plant & Equipment 428.72 529.99
(m) Commission on sales 293.55 425.36
(n) CSR Expenses 250.00 225.00
(o) Provision for Doubtful Debts 357.92 275.67
Less: Reversal of Provision for Doubtful Debts 274.10 12.26
Provision for Doubtful Debts (Net) 83.82 263.41

Corporate OVERVIEW
statutory reportS
` in Lakhs
March 31, 2019 March 31, 2018
(p) Bad Debts written off 1,036.61 9.57
(q) Vehicle Expenses 353.21 299.89
(r) Legal & Professional Expenses 1,012.16 947.53
(s) General Expenses 2,782.06 2,181.29
(t) Payment to Auditor 59.11 57.29
(u) Director's Sitting Fees 15.45 18.00
(v) Provision for Inventory Obsolescence 574.67 3.73
(w) Foreign Exchange Loss 607.96 -
21,057.53 15,638.19
Note: Payment to Auditor

` in Lakhs
March 31, 2019 March 31, 2018
(a) As Auditor:
Audit fees 29.75 29.90
Tax Audit fees 2.00 2.00
Quarterly Limited Review 21.00 21.00
(b) In Other Capacity:
Taxation Matters 3.75 2.76
Other Services (Certification fees) 2.61 1.63
59.11 57.29
34. Related Parties Disclosures

A) Name of Related Party and Nature of Relationship
(i) Subsidiary Companies
Deepak Nitrite Corporation Inc., United States of America
(ii) Key Management Personnel

Shri Deepak C. Mehta Chairman & Managing Director
Shri Maulik D. Mehta Whole Time Director
Shri Umesh Asaikar Executive Director & Chief Executive Officer
Shri Sanjay Upadhyay Director-Finance & Chief Financial Officer
(iii) Entities over which Key Managerial Personnel or their Relatives are able to Exercise Significant Influence
Check Point Credits & Capital Private Limited * Deepak Cybit Private Limited * Deepak Fertilizers and Petrochemicals
Corporation Limited *Deepak Gulf LLC, Sultanate of Oman* Deepak Foundation * Deepak International Limited * Deepak
Medical Foundation * Deepak Research and Development Foundation * Deepak Novochem Technologies Limited. * Forex
Leafin Private Limited * Hardik Leafin Private Limited * Pranawa Leafin Private Limited * Skyrose Finvest Private Limited *
Sofotel Infra Private Limited * Stepup Credits & Capital Private Limited * Stiffen Credits and Capital Private Limited * Stigma
Credit & Capital Private Limited * Storewell Credits and Capital Private Limited* Sundown Finvest Private Limited
(iv) Relative of Key Management Personnel

Shri C. K. Mehta
Shri Ajay C. Mehta
Shri Meghav D. Mehta

B) Transaction with Related Parties
168
` in Lakhs
March 31, 2019 March 31, 2018
Sr. Nature of Transaction Subsidiary Key Entities over Relative TOTAL Subsidiary Key Entities over Relative TOTAL
No. Companies Management which key of Key Companies Management which key of Key
Personnel managerial Management Personnel managerial Management
personnel or Personnel personnel or Personnel
their relatives their relatives
are able to are able to
exercise exercise
significant significant
Influence Influence

1 Purchase of Goods
Deepak Fertilisers & Petrochemicals - - 7,890.93 - 7,890.93 - - 8,077.65 - 8,077.65
Corporation Limited
Deepak Novochem Technologies Limited - - - - - - - 34.19 - 34.19
Deepak Phenolics Limited 677.53 - - - 677.53 422.75 - - - 422.75
2 Sale of Goods/Services
Deepak Novochem Technologies Limited - - 695.88 - 695.88 - - 902.21 - 902.21
Deepak Phenolics Limited - - - - - 26.25 - - - 26.25
3 Conversion Charges Received
Deepak Novochem Technologies Limited - - 968.33 - 968.33 - - 1,032.50 - 1,032.50
4 Sale of Fixed Assets
Deepak Phenolics Limited - - - - - 87.02 - - - 87.02
5 Sharing of Utilities
Deepak Phenolics Limited 151.72 - - - 151.72 - - - - -
6 Rendering of Services / Reimbursement of
Expenses
Storewell Credits and Capital Private Limited - - 10.04 - 10.04 - - 8.80 - 8.80
7 Sale of Investments
Forex Leafin Private Ltd - - - - - - - 131.13 - 131.13
8 Receiving of services / Reimbursement of
Expenses
Deepak Fertilisers & Petrochemicals - - 60.05 - 60.05 - - 7.47 - 7.47
Corporation Limited
Deepak Foundation - - 1.25 - 1.25 - - 0.78 - 0.78
Deepak Medical Foundation - - 18.99 - 18.99 - - 8.90 - 8.90
Deepak Nitrite Corporation Inc. 125.28 - - - 125.28 335.65 - - - 335.65
Deepak Cybit Private Limited - - 21.68 - 21.68 - - 24.97 - 24.97
Shri Deepak C. Mehta - 7.20 - - 7.20 - 9.60 - - 9.60
Shri C.K. Mehta - - - - - - - - - -
Shri Maulik D.Mehta - - - - - - - - - -
Shri Meghav D. Mehta - - - 54.78 54.78 - - - 53.55 53.55
Shri Ajay C. Mehta - - - 1.20 1.20 - - - 0.60 0.60
` in Lakhs
March 31, 2019 March 31, 2018
Sr. Nature of Transaction Subsidiary Key Entities over Relative TOTAL Subsidiary Key Entities over Relative TOTAL
No. Companies Management which key of Key Companies Management which key of Key
Personnel managerial Management Personnel managerial Management
personnel or Personnel personnel or Personnel
exercise exercise
Influence Influence
9 Managerial Remuneration
Shri Ajay C. Mehta - - - - - - 72.79 - - 72.79
Shri Maulik D. Mehta - 171.06 - - 171.06 - 103.02 - - 103.02
Shri Umesh Asaikar - 588.86 - - 588.86 - 470.73 - - 470.73
Shri Sanjay Upadhyay - 294.39 - - 294.39 - 205.67 - - 205.67
10 Subscription of Investment / Acquisition of
Investment/ Liquidation of Investment
Deepak Phenolics Limited 7,900.00 - - - 7,900.00 20,100.00 - - - 20,100.00
11 Dividend Paid
Checkpoint Credits & Capitals Private Limited - - 93.68 - 93.68 - - 86.47 - 86.47
Stigma Credits & Capital Private Limited - - 80.32 - 80.32 - - 74.14 - 74.14
Stiffen Credits & Capital Private Limited - - 108.94 - 108.94 - - 100.56 - 100.56
Stepup Credits & Capital Private Limited - - 89.90 - 89.90 - - 82.99 - 82.99
Skyrose Finvest Private Limited - - 49.11 - 49.11 - - 44.30 - 44.30
Shri C.K. Mehta - - - 1.02 1.02 - - - 0.94 0.94
Shri Maulik D. Mehta - 1.71 - - 1.71 - 1.58 - - 1.58
Shri Meghav D. Mehta - - - 0.61 0.61 - - - 0.57 0.57
Others - - 72.47 17.76 90.23 - - 66.89 16.39 83.28
12 Donation / CSR Activity
Deepak Medical Foundation - - - - - - - 16.65 - 16.65
Deepak Foundation - - 261.92 - 261.92 - - 211.33 - 211.33
13 Net Accounts Receivable / (Payable)
Deepak Fertilisers & Petrochemicals - - (1,288.34) - (1,288.34) - - (1,795.43) - (1,795.43)
Corporation Limited
Deepak Phenolics Limited (245.53) - - - (245.53) (412.61) - - - (412.61)
Deepak Nitrite Corporation Inc. (78.54) - - - (78.54) (65.79) - - - (65.79)
Deepak Cybit Private Limited - - (0.19) - (0.19) - - - - -
Deepak Medical Foundation - - (0.50) - (0.50) - - - - -
Shri Deepak C. Mehta - (600.00) - - (600.00) - 200.00 - - 200.00
Shri Ajay C. Mehta - - - - - - (20.60) - - (20.60)
Shri Maulik D. Mehta - (65.88) - - (65.88) - (11.34) - - (11.34)

Shri Umesh Asaikar - (113.62) - - (113.62) - (45.44) - - (45.44)
Shri Sanjay Upadhyay - (79.33) - - (79.33) - (24.25) - - (24.25)
statutory reportS
Corporate OVERVIEW
169
35. Contingent Liabilities and Commitments (to the extent not provided for)
` in Lakhs
As at As at
March 31, 2019 March 31, 2018
I.
Claims against the Company not acknowledged as debts in respect of
(a) Matters relating to Income Tax from AY 2012-13 is being contested at various levels 58.64 98.60
of Tax authorities.
(b) Matters relating to Sales Tax/VAT from AY 2005-06 to FY 2013-14 is being contested at 158.97 86.41
various level of Indirect Tax authorities.
(c) Matters relating to Excise duty from FY 1998-99 to FY 2016-17 is being contested at 292.20 479.33
(d) Bank Guarantees:
Financial 1,702.90 1,479.06
Performance 1,593.73 2,717.92
(e) Disputed Labour Matters Amount Not Amount Not
ascertainable ascertainable
Management is not expecting any future cash outflow in respect of (a) to (c) & (e)
Total (I) 3,806.44 4,861.32
II. Commitments
Capital Commitments (Net of Advances) 2,349.72 1,335.18
Total (II) 2,349.72 1,335.18
36. Tax Expense

A. Income Tax Expense Recognised in the Statement of Profit and Loss
` in Lakhs
March 31, 2019 March 31, 2018
I. Expense / (Benefit) recognised in the statement of profit and loss
Current tax on profit for the year 4,864.34 2,594.99
Increase in deferred tax liabilities 2,581.42 1,556.44
Excess provision of earlier years - (288.51)
Total 7,445.76 3,862.92
II. Expense / (Benefit) recognised in statement of other comprehensive income
Re-measurement gains / (losses) on defined benefit plans (145.26) 37.01
Equity instruments through other comprehensive income 2.73 7.13
Total (142.53) 44.14
B. The reconciliation between the provision of income tax and amounts computed by applying the Indian statutory
income tax rate to profit before taxes is as follows
` in Lakhs
March 31, 2019 March 31, 2018
Profit before taxes 21,249.97 12,208.42
Enacted income tax rate in India 34.94% 34.61%
Computed expected tax expense 7,425.57 4,225.09
Effect of
Weighted deduction for R&D Expenditure (172.56) (155.66)
Income taxed at higher/ (lower) rates - (21.48)
Others (Net) 192.75 103.48
Total income tax expense 7,445.76 3,862.92

Corporate OVERVIEW
statutory reportS
C. Deferred Tax Liabilities (Net)

The balance comprises temporary differences attributable to the below items and corresponding movement in deferred tax
liabilities/(assets)
` in Lakhs
As at Recognised in As at Recognised in As at
March 31, Statement of March 31, Statement of March 31,
2019 Profit and Loss 2018 Profit and Loss 2017
/OCI /OCI
Property, plant and equipment 9,045.67 840.92 8,204.75 1,148.15 7,056.60
Total Deferred Tax Liabilities (a) 9,045.67 840.92 8,204.75 1,148.15 7,056.60
Disallowances u/s 43B and Others 1,386.98 879.89 507.09 (55.12) 562.21
MAT Credit Entitlement - (2,477.85) 2,477.85 (108.79) 2,586.64
Total Deferred Tax Assets (b) 1,386.98 (1,597.96) 2,984.94 (163.91) 3,148.85
Net Deferred Tax (Asset)/Liabilities (a-b) 7,658.69 2,438.88 5,219.81 1,312.06 3,907.75
37. Employee Benefit Obligations

A. Gratuity
The Company has covered its Gratuity Liability by a Group Gratuity Policy named ‘Employee Group Gratuity Assurance Scheme’ issued
by Life Insurance Corporation of India. Under this plan, an employee at retirement is eligible for benefit, which will be equal to 15 days
salary for each completed year of service. Thus, it is a defined benefit plan and the aforesaid insurance policy is the Plan Asset.
(i) Reconciliation of opening and closing balances of Defined Benefit Obligation
` in Lakhs
As at As at
March 31, 2019 March 31, 2018
Balance at the beginning of the year 1,826.99 1,794.01
Current Service Cost 116.35 109.45
Interest Cost 141.95 130.93
Actuarial (gain)/losses 384.31 (100.62)
Benefits Paid (150.37) (106.78)
Balance at the end of the year 2,319.23 1,826.99
(ii) Reconciliation of Opening and Closing Balances of Fair Value of Plan Assets
` in Lakhs
As at As at
March 31, 2019 March 31, 2018
Interest Income 143.01 122.91
Return on Plan Assets (32.62) 8.21
Contribution by the Company 155.06 131.26
Benefits Paid (150.37) (111.28)
Actual Return on Plan Assets 7.54% to 7.88% 7.12% to 7.88%
(iii) Assets and Liabilities Recognised in the Balance Sheet

` in Lakhs
As at As at
March 31, 2019 March 31, 2018
Present Value of Defined Benefit Obligation 2,319.23 1,826.99
Less: Fair Value of Plan Assets: 1,939.30 1,824.23
Amounts recognised as liability 379.93 2.76
Recognised under
Short Term provision (Refer Note 18) 379.93 2.76
Total 379.93 2.76

(iv) Expenses Recognised in the Statement of Profit and Loss
` in Lakhs
March 31, 2019 March 31, 2018
Net Interest Cost (1.06) 8.02
Liability Transferred - 6.90
Total Expenses (Refer Note No. 29) 115.29 124.37
(v) Expenses Recognised in the Other Comprehensive Income

` in Lakhs
March 31, 2019 March 31, 2018
Actuarial gain/(losses) on Obligation for the period (384.31) 100.62
Return on Plan assets excluding Interest Income (32.63) 8.21
Total Expenses recognised in OCI (416.94) 108.83
(vi) Major Category of Plan Assets

As at As at
March 31, 2019 March 31, 2018
` in Lakhs % ` in Lakhs %
GOI Securities - - - -
Public Securities - - - -
State Government Securities - - - -
Insurance Policies 1,939.30 100.00 1,824.23 100.00
Others - - - -
Risk exposure
The Company is exposed to a number of risks, the most significant of which are detailed below:
Interest rate risk: A fall in the discount rate which is linked to the G.Sec. Rate will increase the present value of the liability
requiring higher provision. A fall in the discount rate generally increases the mark to market value of the assets depending on
the duration of asset.
Salary Risk: The present value of the defined benefit plan liability is calculated by reference to the future salaries of members.
As such, an increase in the salary of the members more than assumed level will increase the plan’s liability.
Investment Risk: The present value of the defined benefit plan liability is calculated using a discount rate which is determined
by reference to market yields at the end of the reporting period on government bonds. If the return on plan asset is below this
rate, it will create a plan deficit. Currently, for the plan in India, it has a relatively balanced mix of investments in government
securities, and other debt instruments.
Asset Liability Matching Risk: The plan faces the ALM risk as to the matching cash flow. Since the plan is invested in lines of
Rule 101 of Income Tax Rules, 1962, this generally reduces ALM risk.
Mortality risk: Since the benefits under the plan is not payable for life time and payable till retirement age only, plan does not
have any longevity risk.
Concentration Risk: Plan is having a concentration risk as all the assets are invested with the insurance company and a
default will wipe out all the assets. Although probability of this is very less as insurance companies have to follow regulatory
guidelines.

Corporate OVERVIEW
statutory reportS
(vii) Actuarial Assumptions

` in Lakhs
As at As at
March 31, 2019 March 31, 2018
Discount Rate 7.79% 7.85%
Expected Return on Plan Assets 7.79% 7.85%
Salary Growth Rate 8.00% 6.50%
Attrition Rate 2.00% 2.00%
(viii) Sensitivity Analysis

Significant Actuarial Assumptions for the determination of the defined benefit obligation are discount trade, expected
salary increase and employee turnover. The sensitivity analysis below, have been determined based on reasonably possible
changes of the assumptions occurring at end of the reporting period, while holding all other assumptions constant. The
result of Sensitivity analysis is given below:
Impact on Defined Benefit Obligation
Change in Assumptions
Increase in Assumptions Decrease in Assumptions
As at As at As at As at As at As at
March 31, March 31, March 31, March 31, March 31, March 31,
2019 2018 2019 2018 2019 2018
% % ` in Lakhs ` in Lakhs ` in Lakhs ` in Lakhs
Discount Rate 1.00% 1.00% (126.62) (94.37) 144.31 106.81
Salary Growth Rate 1.00% 1.00% 142.45 107.15 (127.38) (96.31)
Attrition Rate 1.00% 1.00% (4.96) 7.48 5.29 (8.46)
In practice, this is unlikely to occur, and changes in some of the assumptions may be correlated. When calculating the
sensitivity of the defined benefit obligation to significant actuarial assumptions the same method (present value of the
defined benefit obligation calculated with the projected unit credit method at the end of the reporting period) has been
applied as when calculating the defined benefit liability recognised in the Balance Sheet. The methods and types of
assumptions used in preparing the sensitivity analysis did not change as compared to the prior year.
B. Leave Encashment
(a) The Leave Encashment Benefit Scheme is a Defined Benefit Plan and is wholly unfunded. Hence, there are no plan assets
attributable to the obligation.
(b) The accumulated balance of Leave Encashment (unfunded) provided in the books as at March 31, 2019, is ` 1,399.25 Lakhs
(Previous year ` 1,081.54 Lakhs), which is determined on actuarial basis using Projected Unit Credit Method.
(c) Principal Actuarial Assumptions
As at As at
March 31, 2019 March 31, 2018
C. Defined Contribution Plan

Contribution to Defined Contribution Plans, recognised in Statement of Profit and Loss, for the year is as under
` in Lakhs
March 31, 2019 March 31, 2018
Employer's Contribution to Provident Fund and other funds except superannuation 565.51 523.11
Employer's Contribution to Superannuation Fund 173.35 165.32
Expected Contribution for the next year ` in Lakhs

Employer's Contribution to Provident Fund and other funds except superannuation 610.75
Employer's Contribution to Superannuation Fund 187.22

38. Capital Management
The key objective of the Company’s capital management is to ensure that it maintains a stable capital structure with the focus on total
equity to uphold investor, creditor, and customer confidence and to ensure future development of its business.
The Company focused on keeping strong total equity base to ensure independence, security, as well as a high financial flexibility for
potential future borrowings, if required without impacting the risk profile of the Company.
For the purpose of Capital Management, the Company considers the following components of its Balance Sheet to manage capital.
The Capital Structure of the Company was as follows
` in Lakhs
As at As at
March 31, 2019 March 31, 2018
Total Equity (A) 1,05,784.55 94,384.49
Non-Current Borrowings (including current maturities) 14,319.17 19,747.45
Current Borrowings 18,441.91 26,406.01
Total Borrowings (B) 32,761.08 46,153.46
Total Capital (A+B) 1,38,545.63 1,40,537.95
Total Borrowings as % of Total Capital 23.65% 32.84%
Total Borrowings as % of Total Equity 30.97% 48.90%
The Interest Coverage Ratio for the reporting period was as follows
` in Lakhs
March 31, 2019 March 31, 2018
EBITDA (excluding other income) 30,562.84 20,283.77
Interest 4,284.57 4,034.00
Interest Coverage Ratio 7.13 5.03
39. Financial Instruments

39.1. Categories of Financial Instruments
The Carrying Value of Financial Instruments by Categories as of March 31, 2019 is as follows
` in Lakhs
Fair Value through Fair Value Amortised Cost
Other Comprehensive through Profit
Income or Loss
Financial Assets
Cash and Cash Equivalents - - 281.29
Other Balances with Banks - - 277.19
Quoted Investments (Level 1) - 6.63 -
Unquoted Investments (Level 3) 232.11 0.67 56,047.68
Government Securities - - 0.01
Trade Receivables - - 34,444.64
Loans - - 212.42
Other Financial Assets - - 670.67
Total 232.11 7.30 91,933.90
Financial Liabilities
Current Borrowings - - 18,441.91
Non-Current Borrowings (including current maturities) - - 14,319.17
Trade Payables - - 32,485.41
Other Financial Liabilities - 8.98 464.29
Total - 8.98 65,710.78

Corporate OVERVIEW
statutory reportS
` in Lakhs
Income or Loss
Financial Assets
Other Balances with Banks - - 3,092.36
Quoted Investments (Level 1) - 2,150.34 -
Unquoted Investments (Level 3) 224.27 0.67 43,147.68
Trade Receivables - - 36,921.13
Loans - - 255.70
Other Financial Assets - - 7,639.97
Total 224.27 2,151.01 91,175.50
Other Financial Liabilities - 14.02 542.88
Total - 14.02 78,100.80
39.2. Fair Value Hierarchy

The table below analyses financial instruments carried at fair value, by valuation method. The different levels have been defined
as follows:
Level 1 – Quoted prices in active markets for identical assets or liabilities.
Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly (i.e. as
prices) or indirectly (i.e. derived from prices).
Level 3 – Inputs for the assets or liabilities that are not based on observable market data (unobservable inputs).
Fair Value Hierarchy as at March 31, 2019
` in Lakhs
Level 1 Level 2 Level 3 Total
Financial Assets
Investments in Quoted Instruments 6.63 - - 6.63
Investments in Unquoted Instruments - - 232.78 232.78
` in Lakhs
Financial Assets
Investments in Quoted Instruments 2,150.34 - - 2,150.34

Reconciliation of Level 3 Fair Value Measurements
` in Lakhs
Investment in unquoted shares
irrevocably designated as FVTOCI
Opening Balance as at March 31, 2017 137.44
Reclassification of Investments 65.86
Total gains/losses in other comprehensive income 20.97
Closing balance as at March 31, 2018 224.27
Total gains in other comprehensive income 7.84
Comparative Market Multiples method has been used for estimating the fair value of such Investment. The fair valuation estimates
are based on historical annual accounts/annual reports and based on information collected from public domain. Information
pertaining to future expected performance of investee companies including projections about their profitability, balance sheet
status and cash flow expectations are not available.
39.3. Financial Risk Management objectives

The Company has adequate internal processes to assess, monitor and manage financial risks. These risks include market risk
(including currency risk, interest rate risk and other price risk), credit risk and liquidity risk.
The Company seeks to minimise the effects of these risks by using financial instruments such as foreign currency forward contracts,
option contracts and interest swaps to hedge risk exposures and appropriate risk management policies as detailed below. The use
of these financial instruments is governed by the Company’s policies, which outlines principles on foreign exchange risk, interest
rate risk, credit risk and deployment of surplus funds.
Item Primarily Effected by Risk Management Policies Reference

Market risk - currency risk Foreign Currency balances and exposure Mitigating foreign currency risk using foreign currency Note 39.4.1
towards trade payables, buyer’s credit, forward contracts and option contracts.
exports, short-term and long-term
borrowings
Market risk - interest rate risk Change in market interest rates Maintaining a combination of fixed and floating rate Note 39.4.2
debt; interest rate swaps for long-term borrowings;
cash management policies
Credit risk Ability of customers or counterparties to Credit approval and monitoring practices; Note 39.5.
financial instruments to meet contractual counterparty credit policies and limits; arrangements
obligations. with financial institutions
Liquidity risk Fluctuations in cash flows Preparing and monitoring forecasts of cash flows; Note 39.6.
cash management policies; multiple-year credit and
banking facilities
39.4. Market Risk

The Company’s financial instruments are exposed to market rate changes. The Company is exposed to the following significant
market risks
• Foreign currency risk
• Interest rate risk
Market risk exposures are measured using sensitivity analysis. There has been no change to the Company’s exposure to market
risks or the manner in which these risks are being managed and measured.
39.4.1 Foreign Currency Risk management
The Company is exposed to foreign exchange risk on account of following
1. Imports of raw materials and services.
2. Exports of finished goods.
3. Foreign currency borrowings in the form of Term loans, External Commercial Borrowings, buyers credit, packing credit etc.
availed for meeting its funding requirements.

Corporate OVERVIEW
statutory reportS
The Company has a forex policy in place whose objective is to mitigate foreign exchange risk by deploying the appropriate hedging
strategies through combination of various hedging instruments such as foreign currency forward contracts, options contracts and
has a dedicated forex desk to monitor the currency movement and respond swiftly to market situations. The Company follows
netting principle for managing the foreign exchange exposure.
(a) The carrying amounts of the Company’s foreign currency denominated monetary assets and liabilities based on
gross exposure at the end of the reporting period is as under:
Currency Liabilities Assets
As at As at As at As at
March 31, 2019 March 31, 2018 March 31, 2019 March 31, 2018
USD (Lakhs) 212.66 319.66 101.70 280.66
` (Lakhs) 14,709.65 20,609.06 7,034.72 18,162.49
GBP (Lakhs) - 1.29 - -
` (Lakhs) - 110.71 - -
JPY (Lakhs) - 7.09 - -
` (Lakhs) - 4.35 - -
EURO (Lakhs) 15.10 17.30 13.99 11.14
` (Lakhs) 1,173.30 1,388.19 1,087.05 893.45
The foreign currency risk on above exposure is mitigated by derivative contracts. The outstanding contracts as at the Balance
Sheet date are as follows
(b) Foreign currency forward, option contracts and interest rate swaps outstanding as at the Balance Sheet date
As at As at
March 31, 2019 March 31, 2018
Buy Sell Buy Sell
Forward Contracts (USD Lakhs) - - - 60.00
Forward Contracts (EURO Lakhs) 7.50 - - -
Option Contracts (USD Lakhs) - - - 35.00
Interest rate Swaps ECB (USD Lakhs) - - - 36.00
The forward and option contracts have been entered into to hedge the foreign currency risk on trade receivables and trade
payables. The swap contracts have been entered into to hedge the interest rate risks on the external commercial borrowings
of the Company.
(c) Net Open Exposures Outstanding as at the Balance Sheet Date

USD (Lakhs) 110.96 99.00 - -
GBP (Lakhs) - 1.29 - -
JPY (Lakhs) - 7.09 - -
EURO (Lakhs) - 6.16 6.39 -
(d) Foreign currency sensitivity analysis

The Company is mainly exposed to fluctuations in US Dollar. The following table details the Company’s sensitivity to a ` 1
increase and decrease against the US Dollar. ` 1 is the sensitivity used when reporting foreign currency risk internally to key
management personnel and represents management’s assessment of the reasonably possible change in foreign exchange
rates. The sensitivity analysis includes only net outstanding foreign currency denominated monetary items and adjusts their
translation at the period end for a ` 1 change in foreign currency rates. A positive number below indicates an increase in

profit where the Rupee strengthens by ` 1 against the US Dollar. For a ` 1 weakening against the US Dollar, there would be a
comparable impact on the profit before tax.
` in Lakhs
Currency USD Impact on Profit or Loss As at As at
March 31, 2019 March 31, 2018
Impact of ` 1 strengthening against US Dollar 104.73 177.09
Impact of ` 1 weakening against US Dollar (104.73) (167.09)
The above sensitivity analysis does not include effect of Foreign Exchange (loss)/gain capitalised as the same does not affect
profit or loss or total equity.
39.4.2 Interest Rate Risk Management

The Company issues commercial papers, draws working capital demand loans, avails cash credit, foreign currency borrowings
including buyers credit, Packing Credit etc. for meeting its funding requirements. Interest rates on these borrowings are exposed
to change in respective benchmark rates. The Company manages the interest rate risk by maintaining appropriate mix/portfolio
of the borrowings.
(a) Interest rate swap contract
The Company had entered into the swap contracts to hedge the interest rate risks on the external commercial borrowings.
Using interest rate swap, Company agrees to exchange LIBOR floating interest rate to LIBOR fixed interest rate on agreed
notional principal amounts. Such contracts enable the company to mitigate the interest rate risk. Refer details of the principal
and interest rate swaps under Note 39.4.1(b).
(b) Interest rate sensitivity analysis
The sensitivity analysis in para below has been determined for borrowings assuming the amount of borrowings outstanding
at the end of the reporting period was outstanding for the whole year. A 10 basis points increase or decrease in case of foreign
currency borrowings and 25 basis points increase or decrease in case of rupee borrowings is used when reporting interest
rate risk internally to key management personnel and represents management’s assessment of the reasonably possible
change in interest rates.
If interest rate had been 10 basis points higher/ lower in case of foreign currency borrowings and 25 basis points higher/ lower
in case of rupee borrowings and all other variables were held constant, the Company’s profit for the year ended March 31,
2019 would decrease/ increase by ` 77.66 Lakhs (March 31, 2018: ` 99.53 Lakhs)
39.5. Credit Risk Management

Credit risk refers to the risk that a counterparty will default on its contractual obligations resulting in financial loss to the Company.
The Company is exposed to credit risk from its operating activities (primarily trade receivables) and from its financing activities,
including deposits with banks and financial institutions, foreign exchange transactions and other financial instruments.
Customer credit risk is managed by each business unit subject to the Company’s established policy, procedures and control
relating to the customer credit risk management. The Company uses financial information and past experience to evaluate
credit quality of majority of its customers and individual credit limits are defined in accordance with this assessment through
third party experts. Outstanding receivables and the credit worthiness of its counterparties are periodically monitored and
taken upon case to case basis.
The Company evaluates the concentration of risk with respect to trade receivables as low, as its customers are located in several
jurisdictions representing large number of minor receivables operating in independent markets.
The credit risk on cash and bank balances, derivative financial instruments is limited because the counterparties are banks with
high credit ratings assigned by international credit rating agencies.
Historical experience of collecting receivables of the Company is supported by low level of past default and hence the credit risk is
perceived to be low.

Corporate OVERVIEW
statutory reportS
The Company has used a practical expedient by computing the expected credit loss allowance for trade receivables based on the
provision matrix. The expected credit loss allowance is based on the ageing of the days the receivables are due and the rates as
given in the provision matrix. The provision matrix at the end of the reporting period is as follows:
Ageing
Expected Credit Loss (%)
Within the Credit period 0.42%
91 to <=180 days 48.15%
>180 days 100.00%
Age of receivables
As at As at
March 31, 2019 March 31, 2018
Within the Credit period 34,488.05 32,619.02
91 to <=180 days 193.70 2,008.27
>180 days 441.26 2,888.40
Reconciliation of loss allowance provision - Trade receivables

` in Lakhs
Loss allowance on March 31, 2017 331.15
Changes in loss allowance 263.41
39.6. Liquidity Risk Management

The Company manages liquidity risk by maintaining adequate reserves, banking facilities and reserve borrowing facilities, by
continuously monitoring forecast and actual cash flows, and by matching the maturity profiles of financial assets and liabilities.
The table below provides details regarding the contractual maturities of financial (liabilities)/assets including estimated interest
payments as at March 31, 2019
` in Lakhs
Amount Upto 1 year 1-3 year More than Total Cash
3 year Flows
Trade Payables (32,485.41) (32,485.41) (32,485.41)
Borrowings (32,761.08) (24,601.91) (7,159.17) (1,000.00) (32,761.08)
Other Financial Liabilities (6,633.27) (6,633.27) (6,633.27)
Foreign Currency Forward Contracts, option (8.98) (8.98) (8.98)
contracts and interest swaps
Trade Receivables (Gross) 35,123.01 35,123.01 - - 35,123.01
The table below provides details of financial assets as at March 31, 2019
` in Lakhs
Carrying Amount
Loans 212.42
Other financial assets 670.67
Total 883.09

payments as at March 31 2018
` in Lakhs
3 year Flows
Trade Payables (31,404.46) (31,404.46) - - (31,404.46)
Borrowings (46,153.46) (36,857.60) (9,295.86) - (46,153.46)
Other Financial Liabilities (11,008.49) (11,008.49) - - (11,008.49)
Foreign Currency Forward Contracts, option contracts (14.02) (14.02) - - (14.02)
and interest swaps
` in Lakhs
Carrying Amount
Loans 255.70
Other financial assets 7,639.97
Total 7,895.67
40. Segment Information

(a) Primary Segment Information
The information reported to the Chief Operating Decision Maker (CODM) for the purpose of resource allocation and assessment of
segment performance is based on types of goods delivered. Accordingly, the Company’s reportable segments under Ind AS 108 are
as follows
(i) Basic Chemicals
(ii) Fine & Speciality Chemicals
(iii) Performance Products
The accounting policies of the reportable segments are same as the Company’s accounting policies. Segment profit represents the
profit before interest and tax earned by each segment without allocation of central administrative costs and other income. This is
the measure reported to the CODM.
Transfer prices between operating segments are on arm’s length basis in a manner similar to transactions with third parties.
` in Lakhs
March 31, 2019 March 31, 2018
I) Segment Revenue
(a) Basic Chemicals 89,319.14 76,160.62
(b) Fine & Speciality Chemicals 53,563.58 46,324.06
(c) Performance Products 40,288.89 29,931.00
(d) Un- allocable - 7.19
TOTAL 1,83,171.61 1,52,422.87
Less: Inter Segment Revenue 3,979.74 4,499.90
Net Sales/Income from operations 1,79,191.87 147,922.97
II) Segment Results
Profit (Loss) Before Tax & Interest
(c) Performance Products 8,318.27 (808.08)
TOTAL 35,508.46 21,335.92
Less : (i) Interest Expenses 4,284.57 4,034.00
(ii) Other un-allocable expenditure net of un-allocable Income 9,973.92 5,093.50
III) Profit Before Tax 21,249.97 12,208.42

Corporate OVERVIEW
statutory reportS
` in Lakhs
March 31, 2019 March 31, 2018
IV) Segment Assets
(d) Un- allocable 60,990.66 59,013.31
TOTAL 1,82,773.23 1,80,049.89
V) Segment Liabilities
(d) Un- allocable 45,416.56 53,606.85
TOTAL 76,988.68 85,665.40
VI) Capital Expenditure
(c) Performance Products 661.40 1,251.27
(d) Un- allocable 443.23 286.62
TOTAL 7,874.38 5,603.66
VII) Depreciation
(d) Un- allocable 433.19 432.74
TOTAL 5,287.82 5,194.92
(b) Secondary Segment Information

The following table shows the distribution of the Company’s Revenue and Assets by geographical market:
` in Lakhs
Revenue As at As at
March 31, 2019 March 31, 2018
In India 1,21,152.80 96,838.30
Outside India 58,039.07 51,084.67
Total 1,79,191.87 1,47,922.97
` in Lakhs
Carrying Amount of Segment Assets For the year For the year
March 31, 2019 March 31, 2018
In India 1,74,456.40 1,60,718.66
Outside India 8,316.83 19,331.23
Total 1,82,773.23 1,80,049.89

` in Lakhs
Addition to Fixed Assets For the year For the year
March 31, 2019 March 31, 2018
In India
- Tangible 7,740.09 5,549.71
- Intangible 134.29 53.95
Outside India
- Tangible - -
- Intangible - -
Total 7,874.38 5,603.66
41. Earnings Per Share
As at As at
March 31, 2019 March 31, 2018
Basic and Diluted Earnings per Share
Number of Shares at the beginning (Nos. in Lakhs) 1,363.93 1,307.11
Number of Shares at the end (Nos. in Lakhs) 1,363.93 1,363.93
Weighted Average Number of Shares considered for Basic Earnings Per Share 1,363.93 1,316.45
(Nos. in Lakhs)
Weighted Average Number of Shares considered for Diluted Earnings Per Share 1,363.93 1,316.45
(Nos. in Lakhs)
Net Profit after Tax available for Equity Shareholders (` in Lakhs) 13,804.21 8,345.50
Basic Earnings (in Rupees) Per Share of ` 2/- each 10.12 6.34
Diluted Earnings (in Rupees) Per Share of ` 2/- each. 10.12 6.34
42 a. Research and Development Expenses

` in Lakhs
March 31, 2019 March 31, 2018
(i) Capital Expenditure (Refer Note 2.6) 192.90 117.90
(ii) Revenue Expenditure
Materials 81.32 51.21
Utilities 15.51 5.21
Maintenance 8.67 17.54
Personnel 474.34 438.19
Others 121.03 88.13
700.87 600.28
Depreciation 110.05 101.52
110.05 101.52
Total Revenue Expenditure 810.92 701.80
(iii) Total Capital & Revenue Expenditure ((i)+(ii)) 1,003.82 819.70

Corporate OVERVIEW
statutory reportS
42 B. R & D Disclosure for Department of Scientific & Industrial Research (DSIR)

` in Lakhs
2018-19 2017-18 2016-17 2015-16 2014-15
(i) Capital Expenditure
Nandesari 99.02 105.05 117.90 158.95 97.48
Roha 93.89 12.85 - - -
Total 192.91 117.90 117.90 158.95 97.48
(ii) Revenue Expenditure
Nandesari 784.62 676.01 677.48 648.77 673.67
Roha 26.30 25.79 31.63 13.90 86.32
Total 810.92 701.80 709.11 662.67 759.99
(iii) Total Capital & Revenue Expenditure
Nandesari 883.64 781.06 795.39 807.72 771.15
Roha 120.19 38.64 31.63 13.90 86.32
Total 1,003.83 819.70 827.01 821.62 857.47
43. Disclosures under Micro, Small and Medium Enterprise Development Act, 2006
To the extent, the company has received intimation from the “suppliers” regarding their status under the Micro, Small and Medium
Enterprises Development Act, 2006, the details are provided as under
` in Lakhs
March 31, 2019 March 31, 2018
(i) Principal amount remaining unpaid 775.13 104.43
(ii) Interest due thereon remaining unpaid
(iii) Interest paid by the Company in terms of Section 16 of the Micro, Small and - 0.07
Medium Enterprises Development Act, 2006, along with the amount of the
payment made to the supplier beyond the appointed day during the year.
(iv) Interest due and payable for the period of delay in making payment (which have - -
been paid but beyond the appointed day during the year) but without adding the
interest specified under the Micro, Small and Medium Enterprises Development
Act, 2006
(v) Interest accrued and remaining unpaid (net of tax deducted at source) - -
(vi) Interest remaining due and payable even in the succeeding years, until such date - -
when the interest dues as above are actually paid to the small enterprise.
44. During FY 2018-19, the Company has spent ` 250.00 Lakhs on Corporate Social Responsibility activities, against the requirement of
` 213.00 Lakhs, being 2% of average of the net profits for the preceding three years.
45. The Income Tax Department has conducted search operations during the year at the premises of the Company. The Company believes
that the search operations will not have any material adverse impact on its performance.
46. Events occurring after the balance sheet date: The Board of Directors has recommended, subject to the approval of shareholders,
dividend of ` 2/- (Rupees Two only) per equity share of face value of ` 2/- (Rupees Two only) each for the year ended March 31, 2019 on
13,63,93,041 equity shares amounting to ` 3,288.58 Lakhs (including tax on dividend of ` 560.72 Lakhs)
47. The Financial Statements were approved for issue by the Board of Directors on May 03, 2019.
D.C. MEHTA UMESH ASAIKAR SUDHIN CHOKSEY SANDESH ANAND

Chairman & Managing Director Executive Director & CEO Director Director
DIN: 00028377 DIN: 06595059 DIN: 00036085 DIN: 00001792
SANJAY UPADHYAY ARVIND BAJPAI SUDHIR MANKAD

Director-Finance & CFO Company Secretary Director

Vadodara: May 03, 2019

Form AOC-I
(Pursuant to First Proviso to Sub-section (3) of Section 129 Read with Rule 5 of Companies (Accounts) Rules, 2014)
Statement Containing Salient Features of the Financial Statement of Subsidiaries
Part “A”: Subsidiaries
1 Name of the subsidiary Deepak Phenolics Limited Deepak Nitrite Corporation, Inc.
2 Reporting period for the subsidiary concerned, if different 2018-19 2018-19
from the holding company’s reporting period
3 Reporting currency and Exchange rate as on the last ` US$
date of the relevant Financial year in the case of foreign 1 US$ = ` 69.17
subsidiaries.
4 Share Capital (` in Lakhs) 56,000.00 47.68
5 Reserves & Surplus (` in Lakhs) 1,831.82 30.47
6 Total Assets (` in Lakhs) 1,66,784.95 82.81
7 Total Liabilities (` in Lakhs) 1,08,953.13 3.53
8 Investments (` in Lakhs) - -
9 Turnover (` in Lakhs) 91,350.22 125.28
10 Profit before Tax (` in Lakhs) 5,572.88 4.76
11 Provision for Tax (` in Lakhs) 1,984.58 1.35
12 Profit after Tax (` in Lakhs) 3,588.30 3.41
13 Total Comprehensive Income (` in Lakhs) 3,570.95 3.41
14 Proposed Dividend (` in Lakhs) - -
15 % of Shareholding 100% 100%

DIN: 00028377 DIN: 06595059 DIN: 00036085 DIN: 00001792



Corporate OVERVIEW
statutory reportS
Independent Auditor’s Report

To The Members of Deepak Nitrite Limited
Report on the Audit of the Consolidated Financial Statements
Opinion
We have audited the accompanying consolidated financial statements of Deepak Nitrite Limited (“the Parent”) and its subsidiaries, (the
Parent and its subsidiaries together referred to as “the Group”) , which comprise the Consolidated Balance Sheet as at 31st March 2019,
and the Consolidated Statement of Profit and Loss (including Other Comprehensive Income), the Consolidated Statement of Cash Flows
and the Consolidated Statement of Changes in Equity for the year then ended, and a summary of significant accounting policies and other
explanatory information.
In our opinion and to the best of our information and according to the explanations given to us, and based on the consideration of reports
of the other auditors on separate financial statements of the subsidiaries referred to in the Other Matters paragraph below, the aforesaid
consolidated financial statements give the information required by the Companies Act, 2013 (“the Act”) in the manner so required and give
a true and fair view in conformity with the Indian Accounting Standards prescribed under section 133 of the Act read with the Companies
(Indian Accounting Standards) Rules, 2015, as amended (‘Ind AS’), and other accounting principles generally accepted in India, of the
consolidated state of affairs of the Group as at 31 March 2019, and their consolidated profit, their consolidated total comprehensive income,
their consolidated cash flows and their consolidated changes in equity for the year ended on that date.
Basis for Opinion

We conducted our audit of the consolidated financial statements in accordance with the Standards on Auditing specified under section
143 (10) of the Act (SAs). Our responsibilities under those Standards are further described in the Auditor’s Responsibility for the Audit of
the Consolidated Financial Statements section of our report. We are independent of the Group in accordance with the Code of Ethics
issued by the Institute of Chartered Accountants of India (ICAI) together with the ethical requirements that are relevant to our audit of the
consolidated financial statements under the provisions of the Act and the Rules made thereunder, and we have fulfilled our other ethical
responsibilities in accordance with these requirements and the ICAI’s Code of Ethics. We believe that the audit evidence obtained by us and
the audit evidence obtained by the other auditors in terms of their reports referred to in the Other Matters paragraph below, is sufficient and
appropriate to provide a basis for our audit opinion on the consolidated financial statements.
Key Audit Matters

Key audit matters are those matters that, in our professional judgment, were of most significance in our audit of the consolidated financial
statements of the current period. These matters were addressed in the context of our audit of the consolidated financial statements as a
whole, and in forming our opinion thereon, and we do not provide a separate opinion on these matters. We have determined the matters
described below to be the key audit matters to be communicated in our report.
Sr.
Key Audit Matter Auditor’s Response
No.
1. Revenue recognition Principal Audit Procedures
Revenue recognition is significant audit risk across all Our audit consisted testing of the design and operating effectiveness of the
units within the Company. Risk exists that revenue is internal controls and substantive testing as follows:
recognized without substantial transfer of control and • We evaluated the design of internal controls relating to revenue
is not in accordance with Ind AS-115 “Revenue from recognition.
Contracts with Customers”.
• We selected sample of Sales transactions and tested the operating
effectiveness of the internal control relating to revenue recognition.
We carried out a combination of procedures involving enquiry and
observation, reperformance and inspection.
• We have tested sample of Sale transactions to their respective
customer contracts, underlying invoices and related documents.
We have performed cut-off procedures for sample of revenue transactions
at year-end in order to conclude on whether they were recognised in
accordance with Ind-AS 115.

Sr.
Key Audit Matter Auditor’s Response
No.
2 Inventory Valuation at component as reported by Principal Audit Procedures
component auditor As principal auditors, we had issued written communication to the auditor
Inventory valuation is a key audit matter as the of the component (‘Other Auditors’) for audit procedures to be performed.
prices of raw materials, primarily being crude based In accordance with such communication, the procedures performed by the
and consequently the finished goods tend to vary Other Auditors, as reported by them, have been provided below:
significantly during the accounting period. Inventory
We have :
is valued at lower of cost or net realizable value and
complex calculations are involved in arriving at carrying • Assessed the inventory valuation practices and checked the workings
value. on a test check basis.
• Checked the valuation of inventory of raw material, WIP and finished
goods on the basis of the production norms made available by the
management.
Additionally, audit oversight procedures carried out by us over the work
performed by the Other Auditors consisted of :
a) Reviewing a written summary of the audit procedures performed by
the Other Auditors.
b) Discussing with Other Auditors and the Management of component
to understand the inventory valuation practices and the basis of
valuations.
Information Other than the Financial Statements and Auditor’s Report Thereon
• The Parent’s Board of Directors is responsible for the other information. The other information comprises the information included
in the Management Discussion and Analysis report, but does not include the consolidated financial statements, standalone financial
statements and our auditor’s report thereon.
• Our opinion on the consolidated financial statements does not cover the other information and we do not express any form of assurance
conclusion thereon.
• In connection with our audit of the consolidated financial statements, our responsibility is to read the other information, compare with
the financial statements of the subsidiaries, to the extent it relates to these entities and, in doing so, place reliance on the work of the
other auditors and consider whether the other information is materially inconsistent with the consolidated financial statements or our
knowledge obtained during the course of our audit or otherwise appears to be materially misstated. Other information so far as it relates
to the subsidiaries, is traced from their financial statements audited by the other auditors.
• We have nothing to report in this regard.
Management’s Responsibility for the Consolidated Financial Statements

The Parent’s Board of Directors is responsible for the matters stated in section 134(5) of the Act with respect to the preparation of these
consolidated financial statements that give a true and fair view of the consolidated financial position, consolidated financial performance
including other comprehensive income, consolidated cash flows and consolidated changes in equity of the Group in accordance with the Ind
AS and other accounting principles generally accepted in India. The respective Board of Directors of the companies included in the Group are
responsible for maintenance of adequate accounting records in accordance with the provisions of the Act for safeguarding the assets of the
Group and for preventing and detecting frauds and other irregularities; selection and application of appropriate accounting policies; making
judgments and estimates that are reasonable and prudent; and design, implementation and maintenance of adequate internal financial
controls, that were operating effectively for ensuring the accuracy and completeness of the accounting records, relevant to the preparation
and presentation of the financial statements that give a true and fair view and are free from material misstatement, whether due to fraud
or error, which have been used for the purpose of preparation of the consolidated financial statements by the Directors of the Parent, as
aforesaid.
In preparing the consolidated financial statements, the respective Board of Directors of the companies included in the Group are responsible
for assessing the ability of the Group to continue as a going concern, disclosing, as applicable, matters related to going concern and using
the going concern basis of accounting unless the management either intends to liquidate or cease operations, or has no realistic alternative
but to do so.
The respective Board of Directors of the companies included in the Group are also responsible for overseeing the financial reporting process
of the Group.

Corporate OVERVIEW
statutory reportS
Auditor’s Responsibility for the Audit of the Consolidated Financial Statements

Our objectives are to obtain reasonable assurance about whether the consolidated financial statements as a whole are free from material
misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level
of assurance, but is not a guarantee that an audit conducted in accordance with SAs will always detect a material misstatement when it exists.
Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected
to influence the economic decisions of users taken on the basis of these consolidated financial statements.
As part of an audit in accordance with SAs, we exercise professional judgment and maintain professional skepticism throughout the audit.
We also:
• Identify and assess the risks of material misstatement of the consolidated financial statements, whether due to fraud or error, design
and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis
for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud
may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.
• Obtain an understanding of internal financial control relevant to the audit in order to design audit procedures that are appropriate in
the circumstances. Under section 143(3)(i) of the Act, we are also responsible for expressing our opinion on whether the Parent has
adequate internal financial controls system in place and the operating effectiveness of such controls.
• Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures
made by the management.
• Conclude on the appropriateness of management’s use of the going concern basis of accounting and, based on the audit evidence
obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the ability of the
Group to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor’s
report to the related disclosures in the consolidated financial statements or, if such disclosures are inadequate, to modify our opinion.
Our conclusions are based on the audit evidence obtained up to the date of our auditor’s report. However, future events or conditions
may cause the Group to cease to continue as a going concern.
• Evaluate the overall presentation, structure and content of the consolidated financial statements, including the disclosures, and whether
the consolidated financial statements represent the underlying transactions and events in a manner that achieves fair presentation.
• Obtain sufficient appropriate audit evidence regarding the financial information of the business activities within the Group and to express
an opinion on the consolidated financial statements. We are responsible for the direction, supervision and performance of the audit
of the financial statements of business activities included in the consolidated financial statements of which we are the independent
auditors. For the other entities included in the consolidated financial statements, which have been audited by the other auditors, such
other auditors remain responsible for the direction, supervision and performance of the audits carried out by them. We remain solely
responsible for our audit opinion.
Materiality is the magnitude of misstatements in the consolidated financial statements that, individually or in aggregate, makes it probable
that the economic decisions of a reasonably knowledgeable user of the consolidated financial statements may be influenced. We consider
quantitative materiality and qualitative factors in (i) planning the scope of our audit work and in evaluating the results of our work; and (ii) to
evaluate the effect of any identified misstatements in the consolidated financial statements.
We communicate with those charged with governance of the Parent and such other entities included in the consolidated financial statements
of which we are the independent auditors regarding, among other matters, the planned scope and timing of the audit and significant audit
findings, including any significant deficiencies in internal control that we identify during our audit.
We also provide those charged with governance with a statement that we have complied with relevant ethical requirements regarding
independence, and to communicate with them all relationships and other matters that may reasonably be thought to bear on our
independence, and where applicable, related safeguards.
From the matters communicated with those charged with governance, we determine those matters that were of most significance in the
audit of the consolidated financial statements of the current period and are therefore the key audit matters. We describe these matters in
our auditor’s report unless law or regulation precludes public disclosure about the matter or when, in extremely rare circumstances, we
determine that a matter should not be communicated in our report because the adverse consequences of doing so would reasonably be
expected to outweigh the public interest benefits of such communication.
Other Matters
We did not audit the financial statements of two subsidiaries, whose financial statements reflect total assets of Rs. 166,856.40 lacs as at
31st March, 2019, total revenues of Rs. 92,811.36 lacs and net cash outflows amounting to Rs. 813.41 lacs for the year ended on that date, as
considered in the consolidated financial statements. These financial statements have been audited by other auditors whose reports have
been furnished to us by the Management and our opinion on the consolidated financial statements, in so far as it relates to the amounts and

disclosures included in respect of these subsidiaries and our report in terms of subsection (3) of Section 143 of the Act, in so far as it relates to
the aforesaid subsidiaries is based solely on the reports of the other auditors.
One of the subsidiary company is located outside India whose financial statements and other financial information have been prepared in
accordance with accounting principles generally accepted in the country and which have been audited by other auditor under generally
accepted auditing standards applicable in the country. The Parent’s management has converted the financial statements of such subsidiary
located outside India from accounting principles generally accepted in its country to accounting principles generally accepted in India. We
have audited these conversion adjustments made by the Parent’s management. Our opinion in so far as it relates to the balances and affairs
of such subsidiary located outside India is based on the report of other auditor and the conversion adjustments prepared by the management
of the Parent and audited by us.
Our opinion on the consolidated financial statements above and our report on Other Legal and Regulatory Requirements below, is not
modified in respect of the above matter with respect to our reliance on the work done and the reports of the other auditors.
Report on Other Legal and Regulatory Requirements

1. As required by Section 143(3) of the Act, based on our audit and on the consideration of the reports of the other auditors on the separate
financial statements of the subsidiaries referred to in the Other Matters section above we report, to the extent applicable that:
a) We have sought and obtained all the information and explanations which to the best of our knowledge and belief were necessary
for the purposes of our audit of the aforesaid consolidated financial statements.
b) In our opinion, proper books of account as required by law relating to preparation of the aforesaid consolidated financial
statements have been kept so far as it appears from our examination of those books, returns and the reports of the other auditors.
c) The Consolidated Balance Sheet, the Consolidated Statement of Profit and Loss including Other Comprehensive Income the
Consolidated Statement of Cash Flows and the Consolidated Statement of Changes in Equity dealt with by this Report are in
agreement with the relevant books of account maintained for the purpose of preparation of the consolidated financial statements.
d) In our opinion, the aforesaid consolidated financial statements comply with the Ind AS specified under Section 133 of the Act.
e) On the basis of the written representations received from the directors of the Parents on 31st March, 2019 taken on record by the
Board of Directors of the Company and the reports of the statutory auditors of subsidiary company incorporated in India, none
of the directors of the Group companies incorporated in India is disqualified as on 31st March, 2019 from being appointed as a
director in terms of Section 164 (2) of the Act.
f) With respect to the adequacy of the internal financial controls over financial reporting and the operating effectiveness of such
controls, refer to our separate Report in “Annexure A” which is based on the auditors’ reports of the Parent and subsidiary company
incorporated in India. Our report expresses an unmodified opinion on the adequacy and operating effectiveness of internal
financial controls over financial reporting of those companies.
g) With respect to the other matters to be included in the Auditor’s Report in accordance with the requirements of section 197(16)
of the Act, as amended, in our opinion and to the best of our information and according to the explanations given to us, the
remuneration paid by the Parent to its directors during the year is in accordance with the provisions of section 197 of the Act.
h) With respect to the other matters to be included in the Auditor’s Report in accordance with Rule 11 of the Companies (Audit and
Auditors) Rules, 2014,as amended in our opinion and to the best of our information and according to the explanations given to us:
i) The consolidated financial statements disclose the impact of pending litigations on the consolidated financial position of
the Group ;
ii) Provision has been made in the consolidated financial statements, as required under the applicable law or accounting
standards, for material foreseeable losses, if any, on long-term contracts including derivative contracts;
iii) There has been no delay in transferring amounts, required to be transferred, to the Investor Education and Protection Fund
by the Parent and its subsidiary company incorporated in India.



Corporate OVERVIEW
statutory reportS
Annexure “A” to the Independent Auditor’s Report

(Referred to in paragraph (f) under ‘Report on Other Legal and Regulatory Requirements’ section of our report of even date)
Report on the Internal Financial Controls Over Financial Reporting under Clause (i) of Sub-section 3 of Section 143 of the
Companies Act, 2013 (“the Act”)
In conjunction with our audit of the consolidated Ind AS financial statements of the Company as of and for the year ended March 31, 2019, we have audited the
internal financial controls over financial reporting of Deepak Nitrite Limited (hereinafter referred to as “Parent”) and its subsidiary company which is company
incorporated in India, as of that date.
Management’s Responsibility for Internal Financial Controls
The respective Board of Directors of the Parent and its subsidiary company, which is company incorporated in India, are responsible for establishing and
maintaining internal financial controls based on the internal control over financial reporting criteria established by the respective Companies considering the
essential components of internal control stated in the Guidance Note on Audit of Internal Financial Controls Over Financial Reporting issued by the Institute
of Chartered Accountants of India (ICAI). These responsibilities include the design, implementation and maintenance of adequate internal financial controls
that were operating effectively for ensuring the orderly and efficient conduct of its business, including adherence to the respective company’s policies, the
safeguarding of its assets, the prevention and detection of frauds and errors, the accuracy and completeness of the accounting records, and the timely
preparation of reliable financial information, as required under the Companies Act, 2013.
Auditor’s Responsibility
Our responsibility is to express an opinion on the internal financial controls over financial reporting of the Parent and its subsidiary company, which is company
incorporated in India, based on our audit. We conducted our audit in accordance with the Guidance Note on Audit of Internal Financial Controls Over Financial
Reporting (the “Guidance Note”) issued by the Institute of Chartered Accountants of India and the Standards on Auditing, prescribed under Section 143(10) of
the Companies Act, 2013, to the extent applicable to an audit of internal financial controls. Those Standards and the Guidance Note require that we comply
with ethical requirements and plan and perform the audit to obtain reasonable assurance about whether adequate internal financial controls over financial
reporting was established and maintained and if such controls operated effectively in all material respects.
Our audit involves performing procedures to obtain audit evidence about the adequacy of the internal financial controls system over financial reporting and
their operating effectiveness. Our audit of internal financial controls over financial reporting included obtaining an understanding of internal financial controls
over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control
based on the assessed risk. The procedures selected depend on the auditor’s judgement, including the assessment of the risks of material misstatement of the
financial statements, whether due to fraud or error.
We believe that the audit evidence we have obtained and the audit evidence obtained by the other auditors of the subsidiary company, which is company
incorporated in India, in terms of their reports referred to in the Other Matters paragraph below, is sufficient and appropriate to provide a basis for our audit
opinion on the internal financial controls system over financial reporting of the Parent and its subsidiary company, which is company incorporated in India.
Meaning of Internal Financial Controls Over Financial Reporting
A company’s internal financial control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial
reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal
financial control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail,
accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded
as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures
of the company are being made only in accordance with authorisations of management and directors of the company; and (3) provide reasonable assurance
regarding prevention or timely detection of unauthorised acquisition, use, or disposition of the company’s assets that could have a material effect on the
financial statements.
Inherent Limitations of Internal Financial Controls Over Financial Reporting
Because of the inherent limitations of internal financial controls over financial reporting, including the possibility of collusion or improper management
override of controls, material misstatements due to error or fraud may occur and not be detected. Also, projections of any evaluation of the internal financial
controls over financial reporting to future periods are subject to the risk that the internal financial control over financial reporting may become inadequate
because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
Opinion
In our opinion to the best of our information and according to the explanations given to us and based on the consideration of the report of the other auditor
referred to in the Other Matters paragraph below, the Parent and its subsidiary company, which is company incorporated in India, have, in all material respects,
an adequate internal financial controls system over financial reporting and such internal financial controls over financial reporting were operating effectively as
at March 31, 2019, based on the criteria for internal financial control over financial reporting established by the respective companies considering the essential
components of internal control stated in the Guidance Note on Audit of Internal Financial Controls Over Financial Reporting issued by the Institute of Chartered
Accountants of India.
Other Matter
Our aforesaid report under Section 143(3)(i) of the Act on the adequacy and operating effectiveness of the internal financial controls over financial reporting
insofar as it relates to one subsidiary company, which is company incorporated in India, is based solely on the corresponding report of the auditor of such
company incorporated in India.
Our opinion is not modified in respect of the above matter.


Consolidated Balance Sheet as at March 31, 2019
` in Lakhs
Notes As at As at
March 31, 2019 March 31, 2018
I. ASSETS
Non-Current Assets
(a) Property, Plant and Equipment 2 1,70,056.75 58,291.07
(b) Capital Work-in-Progress 2 3,386.79 95,450.66
(c) Other Intangible Assets 3 1,526.68 465.26
(d) Financial Assets
Investments 4 239.42 234.99
Loans 5 135.51 131.01
Other Financial Assets 6 675.67 992.02
(e) Non-Current Tax Assets (Net) 7 204.08 265.62
(f) Other Non-Current Assets 8 381.37 3,937.54
Total Non-Current Assets 1,76,606.27 1,59,768.17
Current Assets
(a) Inventories 9 41,073.15 32,541.59
(b) Financial Assets
Investments 10 - 2,941.69
Trade Receivables 11 57,496.42 41,177.18
Cash and Cash Equivalents 12.A 296.04 942.66
Bank balances other than Cash and Cash Equivalents above 12.B 2,280.95 3,877.28
Other Financial Assets 13 190.66 1,871.07
(c) Other Current Assets 14 14,800.35 15,872.49
(d) Assets classified as held for sale 34.61 63.87
Total Current Assets 1,16,172.18 99,287.83
TOTAL ASSETS 2,92,778.45 2,59,056.00
II. EQUITY AND LIABILITIES
Equity
(a) Equity Share Capital 15 2,727.86 2,727.86
(b) Other Equity 16 1,04,430.60 89,485.97
Total Equity 1,07,158.46 92,213.83
Non-Current Liabilities
(a) Financial Liabilities 17
Borrowings 18 86,986.39 55,045.79
(b) Provisions 19 1,144.23 793.73
(c) Deferred Tax Liabilities (Net) 20 7,746.00 4,540.19
(d) Other Non-Current Liabilities 1,380.41 1,702.99
Total Non-Current Liabilities 97,257.03 62,082.70
Current Liabilities
Borrowings 21 25,505.29 33,157.01
Trade Payables
Total outstanding dues of
a) micro enterprises and small enterprises 22 777.43 104.43
b) creditors other than micro enterprises and small enterprises 22 49,678.25 48,891.54
Other Financial Liabilities 23 9,594.54 11,069.47
(b) Provisions 17 762.09 353.82
(c) Current Tax Liabilities (Net) 24 374.37 -
(d) Other Current Liabilities 25 1,670.99 11,183.20
Total Current Liabilities 88,362.96 1,04,759.47
Total Liabilities 1,85,619.99 1,66,842.17
TOTAL EQUITY AND LIABILITIES 2,92,778.45 2,59,056.00
Significant Accounting Policies 1
The accompanying Notes form an integral part of the Consolidated Financial Statements.
DIN: 00028377 DIN: 06595059 DIN: 00036085
SANDESH ANAND
Director
DIN: 00001792

Corporate OVERVIEW
statutory reportS
Consolidated Statement of Profit and Loss

` in Lakhs
Notes 2018-19 2017-18
I. Revenue from Operations 26 2,69,992.45 1,67,618.20
II. Other Income 27 1,512.00 1,229.27
III. Total Income (I+II) 2,71,504.45 1,68,847.47
IV. Expenses:
(a) Cost of Materials Consumed 28 1,74,826.92 84,058.07
(b) Purchase of Traded Goods 29 5,201.73 18,749.93
(c) Changes in Inventories of Finished Goods, Work-in-Progress and 30 (15,359.07) 1,070.78
Traded Goods
(d) Excise Duty on Sale of Goods - 2,472.80
(e) Employee Benefits Expense 31 17,977.25 13,615.26
(f) Power & Fuel Expenses 32 20,732.97 11,987.90
(g) Finance Costs 33 8,324.54 4,514.74
(h) Depreciation and Amortisation Expense 34 7,779.27 5,259.97
(i) Other Expenses 35 25,223.03 16,032.85
Total Expenses (IV) 2,44,706.64 1,57,762.30
V. Profit Before Tax (III-IV) 26,797.81 11,085.17
VI. Tax Expense:
(a) Current Tax 6,073.99 2,595.30
(b) Deferred Tax 3,357.69 876.81
(c) Excess Provision of Earlier Years - (288.51)
VII. Profit for the Year (V-VI) 17,366.13 7,901.57
VIII. Other Comprehensive Income
(A) Items that will not be Reclassified to Profit and Loss:
(a) Remeasurement of Defined Benefit Obligations (Net) (443.59) 108.69
(b) Tax Effect of Remeasurement of Defined Benefit Liabilities / 154.57 (37.01)
(Assets)
(B) Items that will be Reclassified to Profit and Loss:
(a) Fair Value Gains on Investments 7.84 20.97
(b) Tax effect of Fair Value Gains on Investments (2.73) (7.13)
Total Other Comprehensive Income for the Year (VIII) (283.91) 85.52
IX. Total Comprehensive Income for the Year (VII+VIII) 17,082.22 7,987.09
X. Profit is attributable to
Owners of the company 17,366.13 7,901.57
Non-Controlling Interest - -
XI. Other Comprehensive Income is attributable to:
Owners of the company (283.91) 85.52
XII. Total Comprehensive Income is attributable to:
Owners of the company 17,082.22 7,987.09
Earnings Per Equity Share
(a) Basic (Nominal Value per Share ` 2) 12.73 6.00
(b) Diluted (Nominal Value per Share ` 2) 12.73 6.00
DIN: 00028377 DIN: 06595059 DIN: 00036085
SANDESH ANAND
Director
DIN: 00001792

Consolidated Cash Flow Statement
` in Lakhs
2018-19 2017-18
(A) CASH FLOW FROM OPERATING ACTIVITIES
Profit for the year 17,366.13 7,901.57
Add: Income Tax Expense recognised in the consolidated statement of Profit and Loss 9,431.68 3,183.60
Profit Before Tax 26,797.81 11,085.17
Non-cash adjustment to reconcile Profit Before Tax to net Cash Flows
1. Depreciation / Amortisation 7,779.27 5,275.97
2. Loss on Sale of Fixed Assets 428.46 547.34
3. Provision for Doubtful Debts 73.28 314.57
4. Gain on redemption of investment (46.96) (395.37)
5. Interest expenses 8,324.54 4,514.74
6. Interest Income (147.77) (155.88)
7. Dividend Income (0.01) (0.01)
8. Fair Value Gains (0.37) (9.64)
9. Amortisation Expense 1.05
Operating Profit Before Change in Operating Assets and Liabilities 43,208.25 21,177.94
Movements in Working Capital :
1. (Increase)/Decrease in Inventories (8,517.08) (15,825.23)
2. (Increase)/Decrease in Trade Receivables (16,185.75) (5,304.06)
3. (Increase)/Decrease in Non Current Loans (4.50) 4.93
4. (Increase)/Decrease in Other Financial Assets 212.80 508.13
5. (Increase)/Decrease in Other Assets 1,025.19 (7,982.04)
6. Increase/(Decrease) in Trade Payables 1,277.14 26,612.13
7. Increase/(Decrease) in Other financial liabilities (9,429.86) (6.28)
8. Increase/(Decrease) in Other liabilities 77.25 1,834.03
9. Increase/(Decrease) in Provisions 315.18 66.29
Cash Generated from Operations 11,978.62 21,085.84
Less: Income Tax paid (net of refund) 5,609.28 2,785.90
Net Cash Inflow from Operating Activities (A) 6,369.34 18,299.94
(B) CASH FLOW FROM INVESTING ACTIVITIES
1. Purchase of Property, Plant & Equipment, including Capital Work in Progress, (24,273.80) (62,174.28)
Capital Advances & Payable for Capital Expenditure
2. Purchase of Intangible Assets (1,279.20) (53.95)
3. Proceeds from Sale of Property, Plant & Equipment 169.90 111.96
4. Insurance claims received 1,782.71 750.00
5. Proceeds from Redemption of Investment - 527.96
6. Purchase of Current Investments (10,777.79) (29,664.77)
7. Proceeds from sale/maturity of Current Investments 13,765.30 38,194.47
8. Deposit with bank 1,807.37 (3,026.22)
9. Interest received 157.04 155.44
10. Dividend received 0.01 0.01
11. Increase/(Decrease) in Liabilities related to Capital Assets 2,393.34 2,706.62
Net Cash Outflow from Investing Activities (B) (16,255.12) (52,472.77)

Corporate OVERVIEW
statutory reportS
` in Lakhs
2018-19 2017-18
(C) CASH FLOW FROM FINANCING ACTIVITIES
1. Proceeds from issue of Equity Shares including Securities Premium - 14,627.98
2. Proceeds from Non-Current Borrowings 38,077.28 47,575.75
3. Repayment of Non-Current Borrowings (10,451.59) (16,812.08)
4. Net Proceeds from Current Borrowings (7,641.92) (4,336.32)
5. Proceeds/(repayment) from/of Short-Term Borrowings - (169.10)
6. Interest paid (8,412.87) (4,496.72)
7. Dividend paid on Equity Shares (1,764.15) (1,560.31)
8. Tax on Equity Dividend paid (364.47) (319.32)
9. Margin Money Deposit (203.12) 21.58
Net Cash Outflow from Financing Activities (C) 9,239.16 34,531.46
Net Increase/(Decrease) in Cash and Cash Equivalents (A+B+C) (646.62) 358.64
Cash and Cash Equivalents at the Beginning of the Financial Year 942.66 584.02
Cash and Cash Equivalents at the end of the Financial Year 296.04 942.66
Reconciliation of Cash and Cash Equivalents
Balances with Banks:
In Current Accounts 135.22 929.74
Cash on Hand 9.80 1.47
Total Cash and Cash Equivalents as per Note 12 A 296.04 942.66
The Cash Flow Statement has been prepared under the ‘Indirect Method’ set out in Ind AS 7 ‘Cash Flow Statement’.
DIN: 00028377 DIN: 06595059 DIN: 00036085
SANDESH ANAND
Director
DIN: 00001792

Consolidated Statement of Changes in Equity
(A) EQUITY SHARE CAPITAL

` in Lakhs
Note Amount
As at March 31, 2017 2,614.23
Issued during the year (Refer Note 15 (b) (iv)) 113.64
As at March 31, 2018 15 2,727.87
Issued during the year -
As at March 31, 2019 2,727.87
(B) OTHER EQUITY

` in Lakhs
Other
Reserves and Surplus Comprehensive
Income
Equity
Total
Capital Securities Instruments
Retained Capital General
Redemption Premium through Other
Earnings Reserve Reserve
Reserve Reserve Comprehensive
Income
Balance as at March 31, 2017 32,475.72 71.27 7,390.13 15.00 28,902.22 18.04 68,872.38
Other Comprehensive income 71.68 - - - - 13.84 85.52
Dividend (1,568.53) - - - - - (1,568.53)
Tax on dividend (319.32) - - - - - (319.32)
Transfer to/from retained earnings - - - - - - -
Receipt of Securities Premium from (500.00) - 500.00 - 14,514.34 - 14,514.34
issue of Equity Shares to Qualified
Institutional Buyers (Net) (Refer
Note 15 (b) (iv))
Balance as at March 31, 2018 38,061.12 71.27 7,890.13 15.00 43,416.56 31.88 89,485.97
Other Comprehensive income (289.02) - - - - 5.11 (283.91)
Dividend (1,773.11) - - - - - (1,773.11)
Tax on dividend (364.47) - - - - - (364.47)
Transfer to/from retained earnings (500.00) - 500.00 - - - -
Balance as at March 31, 2019 52,500.65 71.27 8,390.13 15.00 43,416.56 36.99 1,04,430.60
DIN: 00028377 DIN: 06595059 DIN: 00036085
SANDESH ANAND
Director
DIN: 00001792

Corporate OVERVIEW
statutory reportS
Notes forming part of the Consolidated Financial Statements

as at and for the year ended March 31, 2019
Company overview
Deepak Nitrite Limited (‘DNL’ or ‘the Company’) is a prominent chemical manufacturing public limited company incorporated and domiciled
in India. Its registered office is located at Aaditya-I Chhani Road, Vadodara- 390 024, Gujarat, India and its manufacturing facilities are located
in the states of Gujarat, Maharashtra and Telangana.
The Company with its two subsidiaries namely Deepak Phenolics Limited and Deepak Nitrite Corporation Inc. are referred to as the Group
here under.
The Group manufactures Basic Chemicals, Fine & Speciality Chemicals, Performance Products and Phenolics.
Application of New Ind AS

Ind AS 115, ‘Revenue from Contracts with Customers’: On March 28, 2018, the MCA notified the Ind AS 115. The core principle of the new
standard is that an entity will recognise revenue to depict the transfer of promised goods or services to customers in an amount that reflects
the consideration to which the entity expects to be entitled in exchange for those goods or services. Further, the new standard requires
enhanced disclosures about the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers of
the Group.
The standard permits two possible methods of transaction:
a) Retrospective approach – Under this approach the standard will be applied retrospectively to each prior reporting period presented in
accordance with Ind AS 8, ‘Accounting Policies, Changes in Accounting Estimates and Errors’.
b) Retrospectively with cumulative effect of initially applying the standard recognised at the date of initial application (Cumulative catch–
up approach)
The effective date of adoption of Ind AS 115 is financial period beginning on or after April 01, 2018.
The Group has adopted the standard on April 01, 2018 by using the cumulative catch-up transition method and accordingly, comparatives for
the year ending or ended March 31, 2018 will not be retrospectively adjusted. There is no material impact on adoption of Ind AS 115.
Changes in Accounting Standard and recent accounting pronouncements

On March 30, 2019, the Ministry of Corporate Affairs issued the Companies (Indian Accounting Standards) (Amendments) Rules, 2019, notifying
Ind AS 116 on Leases. Ind AS 116 would replace the existing leases standard Ind AS 17. The standard sets out the principles for the recognition,
measurement, presentation and disclosures for both parties to a contract, i.e. the lessee and the lessor. Ind AS 116 introduces a single lease
accounting model and requires a lessee to recognise assets and liabilities for all leases with a term of more than 12 months, unless the
underlying asset is of low value. Currently for operating lease, rentals are charged to the statement of profit and loss. The Group is currently
evaluating the implication of Ind AS 116 on the financial statements.
The Companies (Indian Accounting Standards) Amendment Rules, 2019 also notified amendments to the following accounting standards.
The amendments would be effective from April 1, 2019
1. Ind AS 12, Income taxes – Appendix C on uncertainty over income tax treatment
2. Ind AS 12, Income Taxes - Accounting for Dividend Distribution Taxes.
3. Ind AS 23, Borrowing costs
4. Ind AS 28 – investment in associates and joint ventures
5. Ind AS 103 and Ind AS 111 – Business combinations and joint arrangements
6. Ind AS 109 – Financial instruments
7. Ind AS 19 – Employee benefits
The Group is in the process of evaluating the impact of such amendments.

1. Significant Accounting Policies
This Note provides a list of the significant Accounting Policies adopted by the Group in the preparation of these Consolidated Financial
Statements. These policies have been consistently applied to all the years presented, unless otherwise stated. The Financial Statements
are for the Group consisting of the Company and its subsidiary companies.
(a) I. Basis of preparation

(i) Compliance with Ind AS
The Consolidated Financial Statements comply in all material respects with Indian Accounting Standards (Ind AS) notified under
Section 133 of the Companies Act, 2013 (the Act) [Companies (Indian Accounting Standards) Rules, 2015] and other relevant
provisions of the Act.
The Consolidated Financial Statements have been prepared on a historical cost basis except for the following assets and liabilities
which have been measured at fair value or revalued amount:
(a) Certain items of Property, Plant and Equipment
(b) Certain financial assets and financial liabilities measured at fair value
(c) Derivative Financial instruments
(d) Defined benefit plan – plan assets measured at fair value
Historical cost is generally based on the fair value of the consideration given in exchange for goods and services.
Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between
market participants at the measurement date, regardless of whether that price is directly observable or estimated using another
valuation technique. In estimating the fair value of an asset or a liability, the Group takes into account the characteristics of the
asset or liability if the market participants would take those characteristics into account when pricing the asset or liability at the
measurement date. Fair value measurement and/or disclosure purposes in the financial statements is determined on such a basis
except for leasing transactions that are within the scope of Ind AS 17, and measurements that have some similarities to fair value
but are not fair value, such as net realisable value in Ind AS 2 or value in use in Ind AS 36.
In addition, for financial reporting purposes, fair value measurements are categorised into Level 1, 2 or 3 based on the degree to
which the inputs to the fair value measurements are observable and the significance of the inputs to the fair value measurement
in its entirety, which are described as follows:
• Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the entity can access at
the measurement date;
• Level 2 inputs are inputs, other than quoted prices included in Level 1, that are observable for the asset or liability, either
directly or indirectly; and
• Level 3 inputs are unobservable inputs for the asset or liability.
(ii) Functional and Presentation Currency

Items included in the Consolidated Financial Statements of the Company are measured using the currency of the primary
economic environment in which the Company operates (‘functional currency’). The Consolidated Financial Statements of the
Company are presented in Indian currency (`), which is also the functional and presentation currency of the Company.
(iii) Use of estimates and critical accounting judgements

Preparation of the Consolidated Financial Statements requires use of accounting estimates which, by definition, will be equal to
the actual results. The estimates and the associated assumptions are based on historical experience and other factors that are
considered to be relevant. Actual results may differ from these estimates.
The estimates and the underlying assumptions are reviewed on an on-going basis. Revisions to accounting estimates are
recognised in the period in which the estimate is revised and future periods affected.

Corporate OVERVIEW
statutory reportS
Critical judgements in applying accounting policies

The following are the critical judgements, apart from those involving estimations that the management have made in the process
of applying the Group’s accounting policies and that have the most significant effect on the amounts recognized in the financial
statements.
Useful lives and residual value of property, plant and equipment
The Group reviews the useful life and residual value of property, plant and equipment at the end of each reporting period. This
reassessment may result in change in depreciation expense in future periods.
Allowance for expected credit losses
The expected credit allowance is based on the ageing of the days receivables which are past due and the rates derived based on
past history of defaults in the provision matrix.
Fair value of investments
The Group has invested in the equity instruments of various companies. However, the percentage of shareholding of the Group in
such investee companies is very low and hence, it has not been provided with future projections including projected statement of
profit and loss by those investee companies. Hence, the valuation exercise carried out by the Group with the help of an independent
valuer has estimated fair value at each reporting period based on available historical annual reports and other information in the
public domain.
Income taxes
Significant judgements are involved in determining the provision for income taxes, including amount expected to be paid/
recovered for uncertain tax positions.
(a) II. Principles of Consolidation :

The Consolidated Financial Statements (CFS) comprise the Financial Statements of Deepak Nitrite Limited and its subsidiaries as
at 31 March 2019. The consolidated financial statements of the Group have been prepared to comply with the Indian Accounting
standards (‘Ind AS’), including the rules notified under the relevant provisions of the Companies Act, 2013. The basis for preparing
the consolidated financial statements is given below:
Subsidiary companies are all entities over which the Group has control. The Group controls an entity when the Group is exposed
to, or has rights to, variable returns from its involvement with the entity and has the ability to affect those returns through its
power to direct the relevant activities of the entity. Subsidiary companies are fully consolidated from the date on which control is
transferred to the Group. They are deconsolidated from the date that control ceases.
The Group combines the Financial Statements of the parent and its subsidiary companies line by line adding together like items
of assets, liabilities, equity, income and expenses. Intercompany transactions, balances, cashflows and unrealised gains on
transactions between Group companies are eliminated. Unrealised losses are also eliminated unless the transaction provides
evidence of an impairment of the transferred asset. Accounting Policies of subsidiary companies are consistent with the policies
adopted by the Group.
In case of foreign subsidiary revenue items are consolidated at the average rate that approximates the actual rate at the date of
transaction. All monetary items are translated in to Consolidated financial statements at exchange rate in effect at the balance
sheet date. Any exchange difference arising on consolidation is recognised in the Consolidated Statement of Profit and Loss.
Profit or Loss and each component of Other Comprehensive Income are attributed to the owners of the Company and to the
non-controlling interests. Total Comprehensive Income of subsidiaries is attributed to the owners of the Company and to the non-
controlling interests even if this results in the non-controlling interests having a deficit balance.
Name of Entity Ownership in % Either Directly or Nature Country of Incorporation

Through Subsidiaries
2018-19 2017-18
Deepak Phenolics Limited 100% 100% Subsidiary India
Deepak Nitrite Corporation, Inc. 100% 100% Subsidiary United States of America

Changes in ownership interest
When the Group ceases to consolidate or equity account for an investment because of a loss of significant influence, any retained
interest in the entity is remeasured to its fair value with the change in carrying amount recognised in profit or loss. This fair value
becomes the initial carrying amount for the purpose of subsequently accounting for the retained interest as an associate company
or financial asset.
(b) Current versus non-current classification

Assets and Liabilities are classified as Current or Non-Current as per the provisions of the Schedule III notified under the Companies
Act, and the Group’s normal operating cycle.
An asset is treated as current when it is:
(i) Expected to be realised or intended to be sold or consumed in normal operating cycle;
(ii) Held primarily for the purpose of trading;
(iii) Expected to be realised within twelve months after the reporting period, or
(iv) Cash or cash equivalent unless restricted from being exchanged or used to settle a liability for at least twelve months after
the reporting period.
All other assets are classified as non-current.
A liability is current when:
(i) It is expected to be settled in normal operating cycle;
(ii) It is held primarily for the purpose of trading;
(iii) It is due to be settled within twelve months after the reporting period, or
(iv) There is no unconditional right to defer the settlement of the liability for at least twelve months after the reporting period.
All other liabilities are classified as non-current.
The operating cycle is the time between the acquisition of assets for processing and their realisation in cash and cash equivalents.
Based on the nature of business and its activities, the Group has ascertained its operating cycle as twelve months for the purpose
of Current & Non-Current classification of assets and liabilities.
(c) Revenue Recognition

Sale of Goods
Revenue from the sale of goods is only recognized – net of Goods & Service Tax, cash discounts, discounts and rebates – if the
following conditions are met:
• The significant risks and rewards of ownership of the goods have been transferred to the buyer.
• The Group retains neither continuing managerial involvement to the degree usually associated with ownership nor effective
control over the goods sold.
• The amount of revenue can be measured reliably.
• It is probable that the economic benefits associated with the transaction will flow to the Group.
• The costs incurred or to be incurred in respect of the transaction can be measured reliably.
Revenue from Services is recognised in the accounting period in which the services are rendered.
Interest Income
Interest income from Financial Assets is recognised when it is probable that the economic benefits will flow to the Group and the
amount of income is measured reliably. Interest income is accrued on time basis, by reference to the principle outstanding and

Corporate OVERVIEW
statutory reportS
using the effective interest rate method. The effective interest rate is the rate that exactly discounts estimated future cash receipts
through the expected life of the financial asset to the gross carrying amount of a financial asset. When calculating the effective
interest rate, the Group estimates the expected cash flows by considering all the contractual terms of the financial instrument (for
example, prepayment, extension, call and similar options) but does not consider the expected credit losses.
Eligible export incentives are recognised in the year in which the conditions precedent is met and there is no significant
uncertainty about the collectability.
Revenue in respect of other income is recognised to the extent that the Group is reasonably certain of its ultimate realisation.
(d) Leasing
Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership
to the lessee. All other leases are classified as operating leases.
The Group as a lessor
Rental income from operating leases is generally recognised on a straight line basis over the term of the relevant lease.
The Group as a lessee
Assets acquired under finance leases are initially recognised at fair value or present value of Minimum Lease Payments at the
inception of the lease, whichever is lower. Lease payments under operating leases are recognised as an expense on a straight line
basis in net profit in the Statement of Profit and Loss over the lease term.
(e) Foreign Currency Transactions

In preparing the Consolidated Financial Statements of the Group, transactions in currencies other than the entity’s functional
currency (foreign currencies) are recognised at the rates of exchange prevailing at the dates of the transactions. At the end of each
reporting period, monetary items denominated in foreign currencies are retranslated at the rates prevailing at that date. Non-
monetary items carried at fair value that are denominated in foreign currencies are retranslated at the rates prevailing at the date
when the fair value was determined. Non-monetary items that are measured in terms of historical cost in a foreign currency are not
retranslated.
Exchange differences on monetary items are recognised in Consolidated Statement of Profit and Loss in the period in which they
arise.
Exchange difference arising either on settlement or on translation, in case of long-term foreign currency borrowings, in so far as
they relate to property, plant and equipment are capitalised.
Foreign exchange differences regarded as an adjustment to borrowing costs are presented in the Consolidated Statement of Profit
and Loss, within finance costs.
The Group enters into a variety of derivative financial instruments to manage its exposure to interest rate and foreign exchange
rate risks, including foreign exchange forward contracts, option contracts and interest rate swaps.
Derivatives are initially recognised at fair value at the date the derivative contracts are entered into and are subsequently
remeasured to their fair value at the end of each reporting period. The resulting gain or loss is recognised in the Consolidated
Statement of Profit and Loss immediately.
(f) Borrowing Costs

General and specific borrowing costs that are directly attributable to the acquisition, construction or production of a qualifying
asset are capitalised during the period of time that is required to complete and prepare the asset for its intended use or sale.
Qualifying assets are assets that necessarily take a substantial period of time to get ready for their intended use or sale. Investment
income earned on the temporary investment of specific borrowings pending their expenditure on qualifying assets is deducted
from the borrowing costs eligible for capitalisation. Other borrowing costs are recognised in the Consolidated Statement of Profit
and Loss in the period in which they are incurred.

(g) Government Grants
(i) Grants from the Government are recognised at their fair value where there is a reasonable assurance that the grant will be
received and the Group will comply with all attached conditions.
(ii) Government grants relating to the purchase of property, plant and equipment are included in non-current liabilities as
deferred income and are credited in the Consolidated Statement of Profit and Loss in proportion to fulfillment of associated
export obligations and presented within other income.
(iii) Government grants relating to income are deferred and recognised in the Consolidated Statement of Profit and Loss over the
period necessary to match them with the costs that they are intended to compensate and presented within other income.
(h) Employee Benefits

(i) Retirement Benefit Costs and Termination Benefits
Payments to defined contribution retirement benefit plans are recognised as an expense when employees have rendered
service entitling them to the contributions.
For defined benefit plans in respect of an approved gratuity plan, the cost of providing benefits is determined using projected
unit credit method, with actuarial valuations being carried out at the end of each reporting period.
Remeasurement, comprising actuarial gains and losses, the effect of the changes to the asset ceiling (if applicable) and the
return on plan assets (excluding net interest), is reflected immediately in the balance sheet with a charge or credit recognised
in other comprehensive income and is reflected in the period in which they occur. Remeasurement recognised in other
comprehensive income is reflected immediately in retained earnings and is not reclassified to Consolidated Statement of
Profit and Loss.
Past service cost is recognised in Consolidated Statement of Profit and Loss in the period of a plan amendment. Net interest
is calculated by applying the discount rate at the beginning of the period to the net defined benefit liability or asset. Defined
benefit costs are categorised as follows:
• service cost (including current service cost, past service cost, as well as gains and curtailments and settlements)
• net interest expense or income; and
• remeasurement
The first two components of defined benefit costs are recognised in the Consolidated Statement of Profit and Loss in the line
item ‘Employee benefits expense’. Gains or losses on the curtailment or settlement of any defined benefit plan are recognised
when the curtailment or settlement occurs.
(ii) Short-Term and Other Long-Term Employee Benefits

Liabilities recognised in respect of short-term employee benefits are measured at the undiscounted amount of the benefits
expected to be paid in exchange for the related service.
Liabilities recognised in respect of other long-term employee benefits are measured at the Present Value of the estimated
future cash outflows expected to be made in respect of services provided by employees up to the reporting date.
(iii) Compensated Absence and Earned Leaves

The Group’s current policy permits eligible employees to accumulate compensated absences up to a prescribed limit and
receive cash in lieu thereof in accordance with the terms of the policy. The Group measures the expected cost of accumulating
compensated absences as the additional amount that the Group expects to pay as a result of unused entitlement that has
accumulated as at the reporting date. The expected cost of these benefits is calculated using the projected unit credit method
by qualified actuary every year. Actuarial gains and losses arising from experience adjustment and changes in actuarial
assumptions are recognised in the Consolidated Statement of Profit and Loss in the period in which they arise.

Corporate OVERVIEW
statutory reportS
(i) Income Taxes

The income tax expense represents the sum of the tax currently payable and deferred tax.
The current income tax charge is calculated on the basis of the tax laws enacted or substantively enacted at the end of the reporting
period. The Management periodically evaluates positions taken in tax returns with respect to situations in which applicable tax
regulation is subject to interpretation. It establishes provisions where appropriate on the basis of amounts expected to be paid
to the tax authorities. Current tax assets and tax liabilities are offset where the entity has a legally enforceable right to offset and
intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously. Current and deferred tax is
recognised in the Consolidated Statement of Profit and Loss, except to the extent that it relates to items recognised in Other
Comprehensive Income or directly in Equity. In this case, the tax is also recognised in Other Comprehensive Income or directly in
Equity, respectively.
Minimum Alternate Tax (‘MAT’) under the provisions of the Income Tax Act, 1961 is recognised as deferred tax in the Consolidated
Statement of Profit and Loss. The credit available under the Act in respect of MAT paid will be recognised as an asset only when and
to the extent there is convincing evidence that the Group will pay normal income tax during the period for which the MAT credit can
be carried forward for set off against the normal tax liability. Such an asset is reviewed at each Consolidated Balance Sheet date.
Deferred tax is recognised on temporary differences between the carrying amount of assets and liabilities in the Consolidated
Financial Statements and the corresponding tax bases used in the computation of taxable profits.
However, deferred tax liabilities are not recognised if they arise from the initial recognition of Goodwill. Deferred tax is also not
accounted for if it arises from initial recognition of an asset or liability in a transaction other than a business combination that at
the time of the transaction affects neither accounting profit nor taxable profit /(tax loss).
Deferred tax is determined using tax rates (and laws) that have been enacted or substantially enacted by the Balance Sheet date
and are expected to apply when the related deferred income tax asset is realised or the deferred income tax liability is settled.
Deferred tax assets are recognised for all deductible temporary differences and unused tax losses only if it is probable that future
taxable amounts will be available to utilise those temporary differences and losses.
Deferred tax assets and liabilities are classified as non-current assets and liabilities. Deferred tax assets and liabilities are offset
when there is a legally enforceable right to offset current tax assets and liabilities and when the deferred tax balances relate to the
same taxation authority.
Dividend distribution tax arising out of payment of dividends to shareholders under the Income Tax Act, 1961 regulation are
recognised in Consolidated Statement of Changes in Equity as part of associated dividend payment.
(j) Property, Plant and Equipment

Property, plant and equipment held for use in the production or supply of goods or services are stated at cost less accumulated
depreciation and accumulated impairment losses if any.
Subsequent costs are included in the carrying amount of asset or recognised as a separate asset, as appropriate, only when it is
probable that future economic benefits associated with the item will flow to the Group and the cost of the item can be measured
reliably. All other repairs and maintenance expenses are charged to the Consolidated Statement of Profit and Loss during the
period in which they are incurred.
Spare parts, stand-by equipment and servicing equipment are recognised as property, plant and equipment if they are held for use
in the production or supply of goods or services and are expected to be used during more than one period.
Property, plant and equipment which are not ready for intended use as on the date of Consolidated Balance Sheet are disclosed
as ‘Capital work-in-progress’.
Depreciation Methods, Estimated Useful Lives and Residual Value
Depreciation on all tangible assets is provided at the rates and in the manner prescribed by Schedule II to the Companies Act,
2013 and certain components of plant & equipment such as Reactors, Centrifuge, Cooling towers, Air Compressor etc. which are

depreciated over its useful life as technically assessed by Independent/ Internal Technical Personnel after taking into consideration
past experience of the Group, chemical process & chemical industry norms.
Asset Category Estimated Useful Life

Building 30 years
Plant & Equipment 3 to 40 years
Furniture & Fixture 10 years
Vehicle 8 years
Office Equipment 5 years
Road 5 years
Freehold land is stated at historical cost and is not depreciated.

An item of property, plant and equipment is derecognised upon disposal or when no future economic benefits are expected to
arise from the continued use of the asset. Any gain or loss arising on the disposal or retirement of an item of property, plant and
equipment is determined as the difference between the sales proceeds and the carrying amount of the asset and is recognised in
the Consolidated Statement of Profit and Loss.
In respect of depreciable assets for which Impairment Loss is recognised, depreciation/amortisation is charged on the revised
carrying amount over the remaining useful life of the assets computed on the basis of the life prescribed in schedule II to the
Companies Act, 2013.
The residual values, useful lives and method of depreciation of property, plant and equipment is reviewed at each financial year
end and adjusted prospectively, if appropriate.
Assets held for disposal are classified as Current Assets at lower of its carrying amount and fair value less costs to sell, difference
being recognised in the Consolidated Statement of Profit and Loss.
(k) Intangible Assets

Intangible assets are stated at their original cost of acquisition, less accumulated amortisation and impairment losses, if any.
An Intangible Asset is recognised, where it is probable that the future economic benefits attributable to the Asset will flow to the
enterprise and where its cost can be reliably measured.
The cost of intangible assets is amortised over the estimated useful life, in any case, not exceeding ten years, on a straight-line
basis. A detail of estimated useful life is given below:
Software and related implementation costs 6 years

Rights to use facilities 5 years
Technical Know How 10 years
(l) Impairment of Tangible and Intangible Assets

The carrying amount of cash generating units/assets is reviewed at the Consolidated Balance Sheet date to determine whether
there is any indication of impairment. If such indication exists, the recoverable amount is estimated as the net selling price or value
in use, whichever is higher. While assessing value in use, the estimated future cash flows are discounted to the present value by
using pre-tax discount rate that reflects current market assessments of the time value of money and the risk specific to the asset.
Impairment loss, if any, is recognised whenever carrying amount exceeds the recoverable amount. The impairment loss recognised
in prior accounting period is reversed if there has been a change in the estimate of recoverable amount.
(m) Cash and Cash Equivalents

Cash and cash equivalents include cash in hand, demand deposits with bank and other short-term deposits (3 months or less from
the date of acquisition), highly liquid investments that are readily convertible into cash and which are subject to an insignificant
risk of changes in value.

Corporate OVERVIEW
statutory reportS
(n) Inventories
Raw materials and components, stores and spares are valued at cost determined on period-moving weighted average basis and
are net of Cenvat, VAT & GST. Cost comprises all costs of purchase, costs of conversion and other costs incurred in bringing the
inventory to the present location and condition. Due allowances are made for slow moving and obsolete inventories based on
estimates made by the Group. Items such as spare parts, stand-by equipment and servicing equipment which is not plant and
equipment gets classified as inventory.
Finished Goods and Stock-in-process are valued at cost of purchase of raw materials and conversion thereof, including the cost
incurred in the normal course of business in bringing the inventories up to the present condition or at the net realisable value,
whichever is lower. The inventories of joint products are valued by allocating the costs to the joint products by ‘Relative Sales
Value’ method. By-products are valued at net realisable price.
(o) Financial Instruments

Financial Assets and Financial Liabilities are recognised when the Group becomes a party to the contractual provisions of the
instruments.
Financial Assets and Financial Liabilities are initially measured at Fair Value. Transaction costs that are directly attributable to
the acquisition or issue of financial assets and financial liabilities (other than financial assets and financial liabilities at fair value
through profit or loss) are added to or deducted from the fair value of the financial assets or financial liabilities, as appropriate, on
initial recognition.
Transaction costs directly attributable to the acquisition of financial assets or financial liabilities at fair value through profit or loss
are recognised immediately in Consolidated Statement of Profit and Loss.
Financial Assets
All regular way purchases or sales of financial assets are recognised and derecognised on a trade date basis. Regular way purchases
or sales are purchases or sales of financial assets that require delivery of assets within the time frame established by regulation or
convention in the market place.
All recognised financial assets are subsequently measured in their entirety at either amortised cost or fair value, depending on the
classification of the financial assets.
(i) Classification of Financial Assets
Debt instruments that meet the following conditions are subsequently measured at amortised cost (except for debt
instruments that are designated as at fair value through profit or loss on initial recognition)
• the asset is held within a business model whose objective is to hold assets in order to collect contractual cash flows; and
Debt instruments that meet the following conditions are subsequently measured at fair value through other comprehensive
income (except for debt instruments that are designated as at fair value through profit or loss on initial recognition)
• the asset is held within a business model whose objective is achieved both by collecting contractual cash flows and
selling financial assets; and
(ii) Effective interest method
The effective interest method is a method of calculating the amortised cost of a debt instrument and of allocating interest
income over the relevant period. The effective interest rate is the rate that exactly discounts estimated future cash receipts
through the expected life of the debt instrument, or, where appropriate, a shorter period, to the net carrying amount on initial
recognition.
Income is recognised on an effective interest basis for debt instruments other than those financial assets classified as at FVTPL.
Interest income is recognised in Consolidated Statement of Profit and Loss and is included in the “Other Income” line item.

(iii) Investments in Equity Instruments
On initial recognition, the Group can make an irrevocable election (on an instrument-by-instrument basis) to present the
subsequent changes in fair value in other comprehensive income pertaining to investments in equity instruments. This
election is not permitted if the equity investment is held for trading. These elected investments are initially measured at fair
value with gains and losses arising from changes in fair value recognised in other comprehensive income and accumulated
in the ‘Reserve for equity instruments through other comprehensive income’.
The cumulative gain or loss is reclassified to Consolidated Statement of Profit and Loss on disposal of the investments.
Dividends on these investments in equity instruments are recognised in Consolidated Statement of Profit and Loss when the
Group’s right to receive the dividends is established, it is probable that the economic benefits associated with the dividend
will flow to the entity, the dividend does not represent a recovery a part of cost of the investment and the amount of dividend
can be measured reliably. Dividends recognised in Consolidated Statement of Profit and Loss are included in the ‘Other
income’ line item.
(iv) Financial Assets at fair value through profit or loss (FVTPL)

Investments in equity instruments are classified as at FVTPL, unless the Group irrevocably elects on initial recognition to
present subsequent changes in fair value in other comprehensive income for investments in equity instruments which are
not held for trading.
Debt instruments that do not meet the amortised cost criteria or FVTOCI criteria are measured at FVTPL. In addition, debt
instruments that meet the amortised cost criteria or the FVTOCI criteria but are designated as at FVTPL are measured at
FVTPL.
A financial asset that meets the amortised cost criteria or debt instruments that meet the FVTOCI criteria may be designated
as at FVTPL upon initial recognition if such designation eliminates or significantly reduces a measurement or recognition
inconsistency that would arise from measuring assets or liabilities or recognising the gains and losses on them on different
bases.
F inancial assets at FVTPL are measured at fair value at the end of each reporting period, with any gains or losses arising on
remeasurement recognised in Consolidated Statement of Profit and Loss. The net gain or loss recognised in Consolidated
Statement of Profit and Loss incorporates any dividend or interest earned on the financial asset and is included in the Other
income or other expenses line item. Dividend on financial assets at FVTPL is recognised when the Group’s right to receive
the dividends is established, it is probable that the economic benefits associated with the dividend will flow to the entity,
the dividend does not represent a recovery of part of cost of the investment and the amount of dividend can be measured
reliably.
(v) Impairment of Financial Assets
The Group applies the expected credit loss model for recognising impairment loss on financial contractual rights to receive
cash or other financial asset, and financial guarantees not designated as at assets at amortised cost, debt instruments at
FVTOCI, lease receivables, trade receivables and other contractual rights to receive cash or other financial asset.
Expected credit losses are the weighted average of credit losses with the respective risks of default occurring as the weights.
Credit loss is the difference between all contractual cash flows that are due to the Group in accordance with the contract and
all the cash flows that the Group expects to receive (i.e. all cash shortfalls), discounted at the original effective interest rate (or
credit-adjusted effective interest rate for purchased or originated credit-impaired financial assets). The Group estimates cash
flows by considering all contractual terms of the financial instrument (for example, prepayment, extension, call and similar
options) through the expected life of that financial instrument.
The Group measures the loss allowance for a financial instrument at an amount equal to the lifetime expected credit losses if
the credit risk on that financial instrument has increased significantly since initial recognition. If the credit risk on a financial
instrument has not increased significantly since initial recognition, the Group measures the loss allowance for that financial
instrument at an amount equal to 12-month expected credit losses, 12-month expected credit losses are portion of the life-
time expected credit losses and represent the life-time cash shortfalls that will result if default occurs within the 12 months
after the reporting date and thus, are not cash shortfalls that are predicted over the next 12 months.

Corporate OVERVIEW
statutory reportS
If the Group measured loss allowance for a financial instrument at life-time expected credit loss model in the previous period,
but determines at the end of a reporting period that the credit risk has not increased significantly since initial recognition due
to improvement in credit quality as compared to the previous period, the Group can again measure the loss allowance based
on 12-month expected credit losses.
When making the assessment of whether there has been a significant increase in credit risk since initial recognition, the
Group uses the change in the risk of a default occurring over the expected life of the financial instrument instead of the
change in the amount of expected credit losses. To make that assessment, the Group compares the risk of a default occurring
on the financial instrument as at the reporting date with the risk of a default occurring on the financial instrument as at the
date of initial recognition and considers reasonable and supportable information, that is available without cost or effort that
is indicative of significant increases in credit risk since initial recognition.
Further, for the purpose of measuring lifetime expected credit loss allowance for trade receivables, the Group has used a
practical expedient as permitted under Ind AS 109. This expected credit loss allowance is computed based on a provision
matrix which takes into account historical credit loss experience and adjusted for forward-looking information.
The impairment requirements for the recognition and measurement of a loss allowance are equally applied to debt
instruments at FVTOCI except that the loss allowance is recognised in other comprehensive income and is not reduced from
the carrying amount in the Consolidated Balance Sheet.
(vi) Derecognition of financial assets

The Group derecognises a financial asset when the contractual rights to the cash flows from the asset expires, or when it
transfers the financial asset and substantially all the risks and rewards of ownership of the asset to another party.
On derecognition of a financial asset in its entirety, the difference between the asset’s carrying amount and the sum of the
consideration received and receivable and the cumulative gain or loss that had been recognised in other comprehensive
income and accumulated in equity is recognised in Consolidated Statement of Profit and Loss if such gain or loss would have
otherwise been recognised in Consolidated Statement of Profit and Loss on disposal of that financial asset.
On derecognition of a financial asset other than in its entirety, the Group allocates the previous carrying amount of the
financial asset between the part it continues to recognise under continuing involvement, and the part it no longer recognises
on the basis of the relative fair values of those parts on the date of the transfer. The difference between the carrying amount
allocated to the part that is no longer recognised and the sum of the consideration received for the part no longer recognised
and any cumulative gain or loss allocated to it that had been recognised in other comprehensive income is recognised
in Consolidated Statement of Profit and Loss if such gain or loss would have otherwise been recognised in Consolidated
Statement of Profit and Loss on disposal of that financial asset.
A cumulative gain or loss that had been recognised in other comprehensive income is allocated between the part it continues
to be recognised and the part that is no longer recognised on the basis of the relative fair values of those parts.
(vii) Foreign exchange gains and losses

The fair value of financial assets denominated in a foreign currency is determined in that foreign currency and translated at
the spot rate at the end of each reporting period.
• For foreign currency denominated financial assets measured at amortised cost and FVTPL, the exchange differences are
recognised in Consolidated Statement of Profit and Loss.
• Changes in the carrying amount of investments in equity instruments at FVTOCI relating to changes in foreign currency
rates are recognised in Other Comprehensive Income.
• For the purposes of recognising foreign exchange gains and losses, FVTOCI debt instruments are treated as financial assets
measured at amortised cost. Thus, the exchange difference on amortised cost are recognised in Consolidated Statement
of Profit and Loss and other changes in the fair value of FVTOCI financial assets are recognised in Other Comprehensive
Income.

(p) Financial Liabilities and equity instruments
(i) Classification as Debt and Equity
Debt and Equity instruments issued by the Group are classified as either financial liabilities or as equity in accordance with
the substance of the contractual arrangements and the definitions of a financial liability and an equity instrument.
(ii) Equity Instruments

An equity instrument is any contract that evidences a residual interest in the assets of an entity after deducting all of its
liabilities. Equity instruments issued by the Group are recognised at the proceeds received, net of direct issue costs.
Repurchase of the Group’s own equity instruments is recognised and deducted directly in equity. No gain or loss is
recognised in Consolidated Statement of Profit and Loss on the purchase, sale, issue or cancellation of the Group’s own
equity instruments.
(iii) Financial Liabilities

All financial liabilities are subsequently measured at amortised cost using the effective interest method or at FVTPL.
However, financial liabilities that arise when a transfer of a financial asset does not qualify for derecognition or when the
continuing involvement approach applies, financial guarantee contracts issued by the Group, and commitments issued by
the Group to provide a loan at below-market interest rate are measured in accordance with the specific accounting policies
set out below.
a) Financial Liabilities at FVTPL
Financial liabilities are classified as at FVTPL when the financial liability is held for trading or it is designated as at FVTPL.
A financial liability is classified as held for trading if:
• it has been incurred principally for the purpose of repurchasing it in the near term; or
• on initial recognition it is part of a portfolio of identified financial instruments that the Group manages together and has
a recent actual pattern of short-term profit-taking; or
• it is a derivative that is not designated and effective as a hedging instrument.
A financial liability other than a financial liability held for trading may be designated as at FVTPL upon initial recognition if:
• such designation eliminates or significantly reduces a measurement or recognition inconsistency that would otherwise
arise;
• the financial liability forms part of a group of financial assets or financial liabilities or both, which is managed and
its performance is evaluated on a fair value basis, in accordance with the Group’s documented risk management or
investment strategy, and information about the grouping is provided internally on that basis; or
• it forms part of a contract containing one or more embedded derivatives, and Ind AS 109 permits the entire combined
contract to be designated as at FVTPL in accordance with Ind AS 109.
Financial liabilities at FVTPL are stated at fair value, with any gains or losses arising on remeasurement recognised in
Consolidated Statement of Profit and Loss. The net gain or loss recognised in Consolidated Statement of Profit and Loss
incorporates any interest paid on the financial liability and is included in the ‘Other income’ or ‘Other Expenses’ line item.
However, for non-held-for-trading financial liabilities that are designated as at FVTPL, the amount of change in the
fair value of the financial liability that is attributable to changes in the credit risk of that liability is recognised in other
comprehensive income, unless the recognition of the effects of changes in the liability’s credit risk in other comprehensive
income would create or enlarge an accounting mismatch in Consolidated Statement of Profit and Loss, in which case
these effects of changes in credit risk are recognised in Consolidated Statement of Profit and Loss. The remaining amount
of change in the fair value of liability is always recognised in Consolidated Statement of Profit and Loss. Changes in fair
value attributable to a financial liability’s credit risk that are recognised in other comprehensive income are reflected
immediately in retained earnings and are not subsequently reclassified to Consolidated Statement of Profit and Loss.

Corporate OVERVIEW
statutory reportS
b) Financial Liabilities subsequently measured at Amortised Cost

Financial liabilities that are not held-for-trading and are not designated as at FVTPL are measured at amortised cost at
the end of subsequent accounting periods. The carrying amount of financial liabilities that are subsequently measured
at amortised cost are determined based on the effective interest method. Interest expense that is not capitalised as part
of costs of an asset is included in the ‘Finance costs’ line item.
The effective interest method is a method of calculating the amortised cost of a financial liability and of allocating
interest expense over the relevant period. The effective interest rate is the rate that exactly discounts estimated future
cash payments (including all fees and points paid or received that form an integral part of the effective interest rate,
transaction costs and other premiums or discounts) through the expected life of the financial liability, or (where
appropriate) a shorter period, to the net carrying amount on initial recognition.
c) Foreign exchange gains and losses

For financial liabilities that are denominated in a foreign currency and are measured at amortised cost at the end of each
reporting period, the foreign exchange gains and losses are determined based on the amortised cost of the instruments
and are recognised in ‘Other income’ or ‘Other expenses’.
The fair value of financial liabilities denominated in a foreign currency is determined in that foreign currency and
translated at the spot rate at the end of the reporting period. For financial liabilities that are measured as at FVTPL, the
foreign exchange component forms part of the fair value gains or losses.
d) Derecognition of financial liabilities

The Group derecognises financial liabilities when, and only when, the Group’s obligations are discharged, cancelled or
have expired. An exchange between a lender of debt instruments with substantially different terms is accounted for as
an extinguishment of the original financial liability and the recognition of new financial liability. Similarly, a substantial
modification of the terms of an existing financial liability (whether or not attributable to the financial difficulty of the
debtor) is accounted for as an extinguishment of the original financial liability and the recognition of a new financial
liability. The difference between the carrying amount of the financial liability and the consideration paid and payable is
recognised in Consolidated Statement of Profit and Loss.
(q) Offsetting Financial Instruments
Financial assets and liabilities are offset and the net amount is reported in the Consolidated Balance Sheet where there is a legally
enforceable right to offset the recognised amounts and there is an intention to settle on a net basis or realise the asset and settle
the liability simultaneously.
(r) Provisions and Contingent Liabilities

Provisions are recognised when the Group has a present legal or constructive obligation as a result of past events, it is probable
that an outflow of resources will be required to settle the obligation and the amount can be reliably estimated. These are reviewed
at each year end and reflect the best current estimate. Provisions are not recognised for future operating losses. Where there are a
number of similar obligations, the likelihood that an outflow will be required in settlement is determined by considering the class
of obligations as a whole. A provision is recognised even if the likelihood of an outflow with respect to any one item included in
the same class of obligations may be small. Provisions are measured at the present value of best estimate of the Management of
the expenditure required to settle the present obligation at the end of the reporting period. The discount rate used to determine
the present value is a pre-tax rate that reflects current market assessments of the time value of money and the risks specific to the
liability. The increase in the provision due to the passage of time is recognised as interest expense.
Contingent liabilities are disclosed when there is a possible obligation arising from past events, the existence of which will be
confirmed only by the occurrence or non-occurrence of one or more uncertain future events not wholly within the control of the
Group or a present obligation that arises from past events where it is either not probable that an outflow of resources will be
required to settle the obligation or a reliable estimate of the amount cannot be made.
(s) Research and Development Expenditure

Research and Development expenditure is charged to revenue under the natural heads of account in the year in which it is incurred.
Research and Development expenditure on property, plant and equipment is treated in the same way as expenditure on other
property, plant and equipment.

(t) Earnings Per Share
Basic Earnings per Equity Share (EPS) is calculated by dividing the net profit or loss for the period attributable to Equity Shareholders
by the weighted average number of Equity shares outstanding during the period. Diluted Earnings per Equity Share are computed
by dividing net income by the weighted average number of Equity Shares adjusted for the effects of all dilutive potential Equity
Shares. Earnings considered in ascertaining the EPS is the net profit for the period after attributable tax thereto for the period.
(u) Segment Reporting - Basis of Information

Pursuant to commencement of commercial operations of plant for manufacturing Phenol and Acetone under the Company’s
wholly owned subsidiary, Deepak Phenolics Limited, its results have been classified under new segment “Phenolics”.
Accordingly, the Group has determined 4 (four) reporting Segments, based on the information reviewed by chief operating decision
maker as primary segments viz.
(i) Basic Chemicals ,
(ii) Fine & Speciality Chemicals,
(iii) Performance Products and
(iv) Phenolics.
Inter segment transfer prices are normally negotiated amongst the segments with reference to the costs, market prices and
business risks, within an overall optimisation objective of the Group.
Revenue and expenses have been accounted on the basis of their relationship to the operating activities of the segment. Revenue
and expenses, which relate to the enterprise as a whole and are not allocable to segments on reasonable basis, have been included
under “Other unallocable”. Assets and liabilities which relate to the enterprise as a whole but are not allocable to segments on a
reasonable basis, have been included under “Unallocable Assets/Liabilities”.
Secondary segment have been identified with reference to geographical location of external customers. Composition of secondary
segment is as follows:
(i) India and
(ii) Outside India.

2. PROPERTY, PLANT AND EQUIPMENT
` in Lakhs
Owned assets Total Capital
Freehold Leasehold Building Plant and Furniture Vehicle Office Road Work-in-
Land Land Equipment and Fixture Equipment Progress
Net Carrying amount as at March 578.68 3,221.05 9,053.59 43,757.28 496.87 517.10 189.41 194.38 58,008.36 34,919.04
31, 2017
Deductions during the year 2017-18 - - - (211.01) (0.34) (29.07) (6.08) - (246.50) (5,549.71)
Depreciation on disposal during the - - - 16.32 0.31 7.92 5.42 - 29.97 -
year 2017-18
Net Carrying amount as at March 578.68 3,494.98 8,908.04 44,129.11 474.20 412.47 193.37 100.22 58,291.07 95,450.66
31, 2018
Additions during the year 2018-19 - 30.84 4,400.96 113,237.40 126.85 195.70 169.05 1,750.73 119,911.53 29,126.87
Deductions during the year 2018-19 - - (33.52) (614.04) - (68.63) (1.87) - (718.06) (121,190.73)
Depreciation on disposal during the - - 2.21 114.19 - 31.66 1.09 - 149.15 -
year 2018-19
Net Carrying Amount as at March 578.68 3,475.29 12,750.17 1,50,298.59 495.14 465.56 272.13 1,721.19 1,70,056.75 3,386.79
31, 2019
Notes:
1 Property, Plant and Equipment hypothecated/mortgaged as security for borrowings are disclosed under note 17 and note 21.
2 Building includes ` 1,080.00 Lakhs (` 1,080.00 Lakhs) in respect of ownership of premises in a co-operative housing society by way of 10 Shares.
3 The useful lives of Plant & Machinery have been changed from Financial Year 2017-18 which is based on technical evaluation done by the Management experts which are in accordance
to the useful life prescribed in Part C of Schedule II to the Act, in order to reflect the actual usage of the assets.
4 Capital Work in Progress
` in Lakhs
As at As at
March 31, 2018 March 31, 2018
(a) Capital Work in Progress (Building) - 397.88
(b) Capital Work in Progress (Projects) - 76,286.90
(c) Capital Work in Progress (Others) 3,386.79 18,765.87
Capital Work in Progress (Net) 3,386.79 95,450.65
3. OTHER INTANGIBLE ASSETS

` in Lakhs
Computer Others Total
Software
Net Carrying amount as at March 31, 2017 339.28 245.84 585.12
Additions during the year 2017-18 53.95 - 53.95
Net Carrying amount as at March 31, 2018 294.02 171.24 465.26
Additions during the year 2018-19 252.66 1,026.54 1,279.20
Deductions during the year 2018-19 (1.39) - (1.39)

Depreciation on disposal during the year 2018-19 1.39 - 1.39
statutory reportS
Corporate OVERVIEW
Net Carrying Amount as at March 31, 2019 410.99 1,115.68 1,526.68

209
4. Non-Current Investments
` in Lakhs
As at As at
March 31, 2019 March 31, 2018
(a) Investments in equity instruments of other companies measured at FVTPL 7.30 10.71
(b) Investments in equity instruments of other companies measured at FVOCI 232.11 224.27
(c) Investments in Government or Trust Securities measured at amortised cost 0.01 0.01
Total 239.42 234.99
` in Lakhs
Face Value No. of Amount No. of Amount
Shares Shares
(a) Investment in Equity Instruments (fully paid-up)
(i) Other Companies measured at FVTPL
Quoted
IDBI Bank ` 10/- 6,240 2.91 6,240 4.51
Dena Bank (Refer Note 1 below) ` 10/- 29,400 3.72 29,400 5.53
Unquoted
Nandesari Environment Control Limited ` 10/- 800 0.08 800 0.08
Baroda Co-operative Bank Ltd. ` 50/- 10 0.01 10 0.01
Shamrao Vitthal Co-op Bank Ltd. ` 25/- 2,000 0.50 2,000 0.50
New India Co-op Bank Ltd. ` 10/- 798 0.08 798 0.08
(ii) Other Companies measured at FVOCI
Unquoted
Jedimetla Effluent Treatment Ltd. ` 100/- 52,342 84.56 52,342 80.08
Deepak International Limited GBP 1/- 73,706 66.72 73,706 68.01
Deepak Gulf LLC Omani 45,000 80.83 45,000 76.18
Riyal 1/-
(b) Investments in Government or Trust Securities measured at
amortised cost
National Savings Certificate - 0.01 - 0.01
Total 2,10,296 239.42 2,10,296 234.99
Note:
1. The Group has received 3,234 shares of Bank of Baroda in the scheme of amalgamation against 29,400 shares of the Dena Bank in
the month of April 2019.
2. ` in Lakhs
As at As at
March 31, 2019 March 31, 2018
(a) Aggregate amount of Unquoted Investments 232.79 224.95
(b) Aggregate amount of Quoted Investments 6.63 10.04
5. LOANS
` in Lakhs
As at As at
March 31, 2019 March 31, 2018
Loans to Employees
(a) Key Managerial Personnel and Directors 0.27 0.89
(b) Others 135.24 130.12
Total 135.51 131.01
These financial assets are carried at amortised cost.

Corporate OVERVIEW
statutory reportS
6. OTHER NON-CURRENT FINANCIAL ASSETS

` in Lakhs
As at As at
March 31, 2019 March 31, 2018
Security Deposits
(a) Related parties (Refer Note below) - 383.09
(b) Others 675.67 608.93
Total 675.67 992.02
Security Deposits from related parties for the previous year include Deposit towards lease of residential premises of ` 400.00 Lakhs
accounted at Fair Value using appropriate discount rate.
7. NON-CURRENT TAX ASSETS

` in Lakhs
As at As at
March 31, 2019 March 31, 2018
Non-Current Tax Assets
Advance Income Tax (Net of provisions) 204.08 265.62
Total 204.08 265.62
8. OTHER NON-CURRENT ASSETS

` in Lakhs
As at As at
March 31, 2019 March 31, 2018
(a) Capital Advances 258.02 3,834.69
(c) Advance against Salary 94.20 65.54
Total 381.37 3,937.54
9. INVENTORIES [At lower of cost and net realisable value]

` in Lakhs
As at As at
March 31, 2019 March 31, 2018
(a) Raw materials and components 12,181.09 18,410.58
Goods-in-transit 2,715.78 3,427.14
14,896.87 21,837.72
(b) Stores and Spares 2,371.40 1,683.39
(c) Traded goods - 1,967.45
Sub-Total 17,268.27 25,488.56
(d) Work-in-progress 5,877.79 3,820.16
(e) Finished goods 18,675.69 3,406.80
Provision for obsolescence (748.60) (173.93)
Sub-Total 23,804.88 7,053.03
Total 41,073.15 32,541.59
Inventories hypothecated as security for borrowings are disclosed under note 17 and note 21.

10. CURRENT INVESTMENTS
` in Lakhs
As at As at
March 31, 2019 March 31, 2018
Investments measured at FVTPL (Quoted)
Investments in Mutual Funds - 2,941.69
Total - 2,941.69
11. TRADE RECEIVABLES

` in Lakhs
As at As at
March 31, 2019 March 31, 2018
Current
(a) Unsecured, Considered Good
(i) Trade Receivables 57,100.13 40,668.72
(ii) Related Parties 396.29 508.46
(b) Trade Receivables - Credit Impaired 718.97 645.73
Allowance for credit losses (718.97) (645.73)
Total 57,496.42 41,177.18
The credit period on sales of goods varies with business segments/ markets and generally ranges between 30 to 180 days. For financial
risk related to Trade Receivables refer note 41.5 and 41.6.
Trade receivables hypothecated/mortgaged as security for borrowings are disclosed under note 17 and note 21.

12a. CASH AND CASH EQUIVALENTS

` in Lakhs
As at As at
March 31, 2019 March 31, 2018
(a) Cash on hand 9.80 1.47
(b) Balances with banks
In Current accounts 135.22 929.74
Total 296.04 942.66
12b. BANK BALANCES OTHER THAN CASH AND CASH EQUIVALENTS ABOVE
` in Lakhs
As at As at
March 31, 2019 March 31, 2018
(a) Earmarked Balances with Bank 72.26 64.33
(b) Deposits with banks with maturity less than 3 months - 3,026.22
(c) Deposits with banks with maturity more than 3 months but less than 12 months 2,003.76 -
(Refer Note below)
(d) Margin Money Deposits
- Maturity less than 3 months 204.93 707.43
- Maturity more than 3 months but less than 12 months - 79.30
Total 2,280.95 3,877.28
Deposit to bank is given for Debt Service Reserve Account (DSRA).

Corporate OVERVIEW
statutory reportS
13. OTHER CURRENT FINANCIAL ASSETS

` in Lakhs
As at As at
March 31, 2019 March 31, 2018
(a) Loans to employees
(i) Key Managerial Personnel and Directors 0.62 0.62
(ii) Others 76.29 124.07
(b) Interest Receivable 59.58 68.86
(c) Insurance Claim Receivable (Refer Note (i) below) - 1,446.03
(d) Security Deposits 15.03 9.62
(e) Earnest Money 15.61 11.23
(f) Loan to Company (Refer Note (ii) below) - 187.90
(g) Others 23.53 22.74
Total 190.66 1,871.07
(i) With respect to fire incident in October 2016, the Company had provisionally recognised ` 2,250 Lakhs (` 1,832.90 Lakhs Net of
loss on account of fire) both for replacement value of the damaged facilities and loss of profits due to business interruption in the
previous year ended March 31, 2018 . During the current year, upon final settlement of both the claims the Company recognised
` 348.36 Lakhs in the Statement of Profit and Loss under Fine & Speciality Chemicals Segment.
(ii) Loans to Company have been given for business purpose.
14. OTHER CURRENT ASSETS

` in Lakhs
As at As at
March 31, 2019 March 31, 2018
(a) Balance with Government Authorities 11,534.82 14,243.91
(c) Advances to Suppliers 2,866.33 1,224.82
(d) Other Receivables 11.63 16.11
Total 14,800.35 15,872.49
15. Equity Share Capital

` in Lakhs
As at As at
March 31, 2019 March 31, 2018
Authorised
15,00,00,000 Equity shares of ` 2 each 3,000.00 3,000.00
20,00,000 Preference shares of ` 100 each 2,000.00 2,000.00
Total 5,000.00 5,000.00
Issued, Subscribed and fully paid up
Equity shares of ` 2 each 2,727.86 2,727.86
Total 2,727.86 2,727.86

(a) Reconciliation of number of Equity Shares outstanding at the beginning and at the end of the period:
` in Lakhs
No. of Amount No. of Amount
Shares Shares
Equity Shares
Shares outstanding at the beginning of the period 13,63,93,041 2,727.86 13,07,11,266 2,614.23
Issued during the year- issued to QIB
- - 56,81,775 113.64
(Refer Note (b) (iv) below)
Shares outstanding at the end of the period 13,63,93,041 2,727.86 13,63,93,041 2,727.86
(b) Shares:- Terms/Rights:

(i) The Company has Authorised capital of Equity and Preference shares.
(ii) Each holder of the Equity Share is entitled to one vote per Share. The Company declares and pays dividend in Indian Rupees.
The dividend recommended by the Board of Directors is subject to approval of the shareholders at the ensuing Annual
General Meeting.
(iii) In the event of liquidation of the Company, the holders of Equity Shares shall be entitled to receive remaining assets of the
Company, after distribution of all preferential amounts. The distribution will be in proportion to the number of Equity Shares
held by the Shareholders. No preferential amounts exist as on the Balance Sheet date.
(iv) During the previous year, the Company offered Equity Shares to Qualified Institutional Buyers (“QIBs”) through Qualified
Institutions Placement in accordance with Chapter VIII of SEBI (Issue of Capital and Disclosure Requirements) Regulations,
2009. Accordingly, 56,81,775 Equity Shares of ` 2/- each were allotted to QIBs on January 30, 2018 at an issue price of ` 264
per Equity Share (including premium of ` 262 per Equity Share).
The issue proceeds has been fully utilised for the object stated in the offer document.
(c) Details of shares held by each shareholder holding more than 5% Equity shares of ` 2 each fully paid in the Company :
Name of the Shareholder As at March 31, 2019 As at March 31, 2018
No. % Holding No. % Holding
Shri Deepak Chimanlal Mehta 2,12,16,331 15.56 2,12,36,331 15.57
Stiffen Credits & Capital Pvt. Ltd. 83,79,940 6.14 83,79,940 6.14
Reliance Capital Trustee Co. Ltd. 74,97,953 5.50 64,21,199 4.71
Aditya Birla Sun Life Trustee Private Limited 73,58,733 5.40 40,88,798 3.00
Checkpoint Credits & Capital Pvt. Ltd. 72,06,050 5.28 72,06,050 5.28
Stepup Credits & Capital Pvt. Ltd. 69,15,580 5.07 69,15,580 5.07
(d) During the year 2014-15, Company has allotted 52,269,095 Bonus Equity Shares of ` 2/- (Rupees Two Only) each, fully paid up, in
the ratio of 1:1 (one Bonus Equity Shares of ` 2/- each).
16. OTHER EQUITY

` in Lakhs
As at As at
March 31, 2019 March 31, 2018
Reserves & Surplus
(a) Retained Earnings 52,500.65 38,061.12
(b) General Reserve 8,390.13 7,890.13
(c) Capital Reserve 71.27 71.27
(d) Capital Redemption Reserve 15.00 15.00
(e) Securities Premium 43,416.56 43,416.56
Reserves Representing Unrealised Gains/(Losses)
Equity Instruments through Other Comprehensive Income 36.99 31.88
Total 1,04,430.60 89,485.97

Corporate OVERVIEW
statutory reportS
` in Lakhs
As at As at
March 31, 2019 March 31, 2018
(a) Retained Earnings
Add: Profit attributable to owners of the Company (Profit for the year) 17,077.11 7,973.25
Less: Payment of Dividend on Equity Shares 1,773.11 1,568.53
Less: Payment of Dividend distribution tax 364.47 319.32
Less: Transferred to General Reserve 500.00 500.00
Retained earnings represents the Company’s undistributed earnings after taxes.
(b) General Reserve
Add: Transferred from Surplus Balance in the Statement of Profit and Loss 500.00 500.00
The general reserve is used from time to time to transfer profits from retained earnings
for appropriation purposes as per Companies Act, 2013. As the general reserve is
created by transfer from one component of equity to another and is not an item of other
comprehensive income, items included in the general reserve will not be reclassified
subsequently to the statement of profit and loss.
(c) Capital Reserve
(d) Capital Redemption Reserve
Capital redemption reserve has been created pursuant to the requirements of the Act
under which the Company is required to transfer certain amounts on redemption of the
debentures. The Company has redeemed the underlying debentures in the earlier years.
The capital redemption reserve can be utilised for issue of bonus shares.
(e) Securities Premium
Add: Receipt of Securities Premium from issue of Equity Shares to QIBs - 14,886.25
Less: Share issue Expenses - 371.91
Securities premium reserve represents the amount received in excess of the face value
of the equity shares. The utilisation of the securities premium reserve is governed by the
Section 52 of the Companies Act, 2013. Share issue expenses includes fees of Statutory
Auditors of ` 15.00 Lakhs in the previous year for work related to Qualified Institutions
Placement.
(f) Reserve for equity instruments through other comprehensive income
Add: Gain on revaluation of Equity Instruments 5.11 13.84
This reserve represents the cumulative gains and losses arising on the revaluation of
equity instruments measured at fair value through other comprehensive income, net of
amounts reclassified to retained earnings when those assets have been disposed off.

17. NON-CURRENT BORROWINGs
` in Lakhs
As at As at
March 31, 2019 March 31, 2018
Term Loans from Banks at amortised cost
Secured 91,146.39 57,547.38
Unsecured 2,000.00 7,950.00
Sub-Total 93,146.39 65,497.38
Less:
Current maturities of Non-Current Borrowings disclosed under “Other Current Financial 6,160.00 10,451.59
Liabilities” (Refer Note 23 (a))
Total 86,986.39 55,045.79
Secured Term Loans:-

Term loan from Banks are secured by first pari passu charge by way of hypothecation of all movable property, plant and equipment and
mortgage of immovable properties of the Company, present and future, and second charge on entire current assets of the Company,
both present and future.
Repayment Schedule:-
(i) Rate of interest of Rupee loan from Banks are in the range of MCLR plus 0.00% to 2.20% p.a. and is repayable on monthly/quarterly
basis with last installment payable from April, 2020 to December, 2028.
(ii) Rate of interest of External Commercial Borrowings are in the range of LIBOR plus 2.65% p.a. and is repayable on quarterly/half-
yearly basis with a step up repayment schedule and last installment paid on November, 2018.
(iii) Unsecured Term Loan from Banks is repayable on quarterly basis with last installment payable in September, 2019.
18. PROVISIONS
` in Lakhs
As at As at
March 31, 2019 March 31, 2018
Non-current
Provision for leave benefits (Refer Note 39 B) 1,144.23 793.73
Total-Non-Current 1,144.23 793.73
Current
Provision for Employee benefit obligations
Provision for leave benefits (Refer Note 39 B) 334.26 341.39
Provision for Gratuity (Refer Note 39 (A)(iii)) 427.83 12.43
Total-Current 762.09 353.82
19. DEFERRED TAX LIABILITY (NET)

` in Lakhs
As at As at
March 31, 2019 March 31, 2018
(a) Break up of deferred tax liability as at year end:
Property, Plant and Equipment 10,983.74 8,204.75
Total Deferred Tax Liability (a) 10,983.74 8,204.75
(b) Break up of deferred tax asset as at year end:
Disallowances u/s 43B and Others 2,071.38 1,186.71
MAT Credit Entitlement 1,166.36 2,477.85
Total Deferred Tax Asset (b) 3,237.74 3,664.56
Deferred Tax Liability (Net) (a-b) 7,746.00 4,540.19

Corporate OVERVIEW
statutory reportS
20. OTHER NON-CURRENT LIABILITIES

` in Lakhs
As at As at
March 31, 2019 March 31, 2018
Export Obligations 1,380.41 1,702.99
Total 1,380.41 1,702.99
21. CURRENT BORROWINGs

` in Lakhs
As at As at
March 31, 2019 March 31, 2018
Working Capital Borrowings from Banks
(a) Secured 22,166.86 21,012.82
(b) Unsecured 1,383.43 9,488.35
Unsecured Short term Borrowings from Related Parties (Refer note (iv) below) 1,955.00 2,650.00
Buyers Credit for capital goods (Refer note (v) below) - 5.84
Total 25,505.29 33,157.01
(i) Working Capital borrowings from banks represent Cash Credit, Working Capital Demand Loan, Export Packing Credit with rate of
interest as MCLR of respective banks plus spread ranging from 0% - 1.30% p.a., Packing Credit in Foreign Currency, Buyers’ Credit
against Letter of Undertaking with rate of interest ranging from LIBOR/EURIBOR plus spread ranging from 0.20% p.a. to 1.50% p.a.
These borrowings are repayable on demand.
(ii) Working Capital borrowings are secured by way of first Hypothecation charge over Company’s Raw Materials, Semi-Finished
and Finished Goods, Consumable Stores and Book Debts and second charge on all Property, Plant & Equipment by way of
hypothecation and mortgage.
(iii) Commercial Paper placed by the Company during the year are unsecured and carries interest rate ranging from 7.20% p.a. to
8.60% p.a., tenure of each placement ranging from 55 days to 90 days.
(iv) Short term Borrowings from Related parties includes unsecured loan taken from related parties carrying interest rate of 10.50% p.a.
(v) Buyers Credit for capital goods against Letter of Undertaking carrying rate of interest ranging from 0.27% p.a. to 0.40 % p.a. availed
against sublimit of project loan of ` 84,000.00 Lakhs.
22. TRADE PAYABLES

` in Lakhs
As at As at
March 31, 2019 March 31, 2018
(a) To outstanding dues of Micro, Small and Medium Enterprises 777.43 104.43
(b) To outstanding dues of creditors other than Micro, Small and Medium Enterprises 49,678.25 48,891.54
Total 50,455.68 48,995.97
The average credit period on goods purchased or services received ranges between 30 days to 180 days.

23. OTHER CURRENT FINANCIAL LIABILITIES
` in Lakhs
As at As at
March 31, 2019 March 31, 2018
(a) Current maturities of Long term Borrowings (Refer Note 17) 6,160.00 10,451.59
(b) Security Deposits 587.40 330.42
(c) Investor Education and Protection Fund will be credited by following amounts (as and
when due)
Unpaid Dividend 70.02 61.06
Unclaimed Matured Deposits (Refer Note below) 7.44 7.84
Unpaid Interest on Matured Fixed Deposits 2.24 3.27
(d) Interest accrued but not due on Borrowings 364.96 201.27
(e) Others 2,402.48 14.02
Total 9,594.54 11,069.47
The Unclaimed Matured deposits of ` 7.44 Lakhs outstanding as at March 31, 2019 represents an aggregate amount of certain cheques
issued towards compulsory repayment of the outstanding fixed deposits as on March 31, 2015, which have not been presented to the
bank for payment by the depositors.
24. CURRENT TAX LIABILITIES

` in Lakhs
As at As at
March 31, 2019 March 31, 2018
Current Tax Liabilities
Provision for Tax (Net of Advances) 374.37 -
Total 374.37 -
25. OTHER CURRENT LIABILITIES

` in Lakhs
As at As at
March 31, 2019 March 31, 2018
(a) Advances received from Customers 650.10 90.65
(b) Payable for capital expenditure 585.96 10,530.04
(c) Statutory Dues 434.93 562.51
Total 1,670.99 11,183.20
26. REVENUE FROM OPERATIONS

` in Lakhs
March 31, 2019 March 31, 2018
(a) Sale of Products
Finished Goods 2,59,593.97 1,43,010.21
Traded Goods 6,955.16 19,647.60
(b) Sale of Services 970.85 884.21
(c) Other Operating Revenue
- Export Incentives 1,773.90 1,605.45
- Scrap Sale 328.09 218.76
- Insurance Claims (Refer Note 13 (i)) 370.48 2,251.97
Total 2,69,992.45 1,67,618.20

Corporate OVERVIEW
statutory reportS
27. OTHER INCOME

` in Lakhs
March 31, 2019 March 31, 2018
(a) Amortised Export Obligation 322.56 -
(b) Interest Income 147.77 155.88
(c) Profit on redemption of Investments 46.96 395.36
(d) Rent 12.18 10.48
(e) Penalties recovered 909.71 -
(f) Miscellaneous Receipts 72.81 36.59
(g) Dividend Income 0.01 0.01
(h) Foreign Exchange Gain - 223.42
(i) Fair Value Gains on Financial Assets - 9.65
(j) Write back of provision for Impairment - 397.88
Total 1,512.00 1,229.27
28. COST OF RAW MATERIAL AND COMPONENTS CONSUMED

` in Lakhs
March 31, 2019 March 31, 2018
(a) Raw Material and Components Consumed
Inventory at the beginning of the year 18,410.58 5,292.93
Add: Purchases during the year 165,938.53 94,738.58
184,349.11 100,031.51
Less: Inventory at the end of the year 12,181.09 18,410.58
Cost of Raw Material and Components Consumed 1,72,168.02 81,620.93
(b) Packing Material Consumed 2,658.90 2,437.14
Cost of Packing Material and Consumed 2,658.90 2,437.14
Total 1,74,826.92 84,058.07
29. PURCHASE OF TRADED GOODS

` in Lakhs
March 31, 2019 March 31, 2018
Purchase of Finished Goods for Resale 5,201.73 18,749.93
Total 5,201.73 18,749.93
30. CHANGES IN INVENTORIES OF FINISHED GOODS AND WORK-IN-PROGRESS

` in Lakhs
March 31, 2019 March 31, 2018
Inventories at the beginning of the year
Traded Goods 1,967.45 2,649.08
9,194.41 10,265.19
Less:
Inventories at the end of the year
Finished Goods 18,675.69 3,406.80
Traded Goods - 1,967.45
24,553.48 9,194.41
Total (15,359.07) 1,070.78

31. EMPLOYEE BENEFITS EXPENSE
` in Lakhs
March 31, 2019 March 31, 2018
(a) Salaries & Wages 16,213.63 12,126.95
(b) Contribution to provident fund and other funds (Refer Note 39C) 813.03 696.41
(c) Gratuity Expenses (Refer Note 39A(iv)) 131.25 129.30
(d) Staff Welfare Expenses 819.34 662.60
Total 17,977.25 13,615.26
32. POWER & FUEL EXPENSES

` in Lakhs
March 31, 2019 March 31, 2018
(a) Consumption of Gas 2,091.39 2,404.45
(b) Consumption of Furnace Oil 1,324.35 714.61
(c) Consumption of High Speed Diesel 129.19 93.80
(d) Consumption of Coal & Coke 6,393.84 3,556.30
(e) Electricity Expenses 9,833.23 4,565.45
(f) Water Charges 944.46 621.33
(g) Other Expenses 16.51 31.96
Total 20,732.97 11,987.90
33. FINANCE COSTS

` in Lakhs
March 31, 2019 March 31, 2018
(a) Interest on Borrowings 7,529.23 4,116.81
(b) Exchange difference to the extent considered as an adjustment to Borrowing Costs 795.31 397.93
Total 8,324.54 4,514.74
34. DEPRECIATION AND AMORTISATION EXPENSES

` in Lakhs
March 31, 2019 March 31, 2018
(a) Depreciation on Tangible assets 7,576.94 5,102.14
Less: Transferred to Pre-operative Expenses 15.46 15.98
7,561.48 5,086.16
(b) Amortisation of Intangible assets 217.78 173.81
Total 7,779.27 5,259.97

Corporate OVERVIEW
statutory reportS
35. OTHER EXPENSES

` in Lakhs
March 31, 2019 March 31, 2018
(a) Conversion Charges 562.40 542.61
(b) Excise duty Relating to Increase / (Decrease) in Closing Stocks - (330.22)
(c) Other Manufacturing Expenses 1,319.95 962.47
(d) Rent 400.88 242.99
(e) Repairs & Maintenance
Repairs to Building 116.02 100.55
Repairs and maintenance to Plant and Equipment 3,479.54 2,200.36
Repairs and maintenance to Others 98.22 70.64
(f) Consumption of stores & spare parts 1,676.85 1,520.16
(g) Insurance 512.84 369.60
(h) Rates & taxes 373.18 271.26
(i) Bank Charges 330.59 227.46
(j) Travelling & Conveyance 561.21 469.35
(k) Freight & Forwarding Charges 7,103.19 4,383.95
(l) Loss on Sale of Property, Plant & Equipment 428.46 547.34
(m) Commission on sales 290.81 463.94
(n) CSR Expenses 250.00 225.00
(o) Provision for Doubtful Debts 381.80 326.83
Less: Reversal of Provision for Doubtful Debts 308.52 12.26
Provision for Doubtful Debts (Net) 73.28 314.57
(p) Bad Debts written off 1,036.71 9.76
(q) Vehicle Expenses 491.79 309.72
(r) Legal & Professional Expenses 1,307.82 1,022.14
(s) General Expenses 3,558.24 2,015.87
(t) Payment to Auditors 80.68 68.44
(u) Director's Sitting Fees 18.85 21.16
(v) Provision for Inventory Obsolescence 574.67 3.73
(w) Foreign Exchange Loss 576.85 -
Total 25,223.03 16,032.85
Note: Payment to Auditors

` in Lakhs
March 31, 2019 March 31, 2018
(a) As Auditor:
Audit fees 44.75 38.40
Tax Audit fees 3.50 3.00
Quarterly Limited Review 25.50 21.00
(b) In Other Capacity:
Taxation Matters 3.75 2.76
Other Services (Certification fees) 3.18 3.28
80.68 68.44

36. Related Parties Disclosures
A) Name of Related Party and Nature of Relationship
(i) Subsidiary Companies
Deepak Nitrite Corporation Inc., United States of America
(ii) Key Management Personnel

Shri Deepak C. Mehta Chairman & Managing Director
Shri Maulik D. Mehta Whole Time Director
Shri Umesh Asaikar Executive Director & Chief Executive Officer
Shri Sanjay Upadhyay Director-Finance & Chief Financial Officer
(iii) Entities over which Key Managerial Personnel or their Relatives are able to Exercise Significant Influence
Check Point Credits & Capital Private Limited * Deepak Cybit Private Limited * Deepak Fertilizers and Petrochemicals
Corporation Limited * Deepak Gulf LLC, Sultanate of Oman* Deepak Foundation * Deepak International Limited * Deepak
Medical Foundation * Deepak Research and Development Foundation * Deepak Novochem Technologies Limited. * Forex
Leafin Private Limited * Hardik Leafin Private Limited * Pranawa Leafin Private Limited * Skyrose Finvest Private Limited *
Sofotel Infra Private Limited * Stepup Credits & Capital Private Limited * Stiffen Credits and Capital Private Limited * Stigma
Credit & Capital Private Limited *Storewell Credits and Capital Private Limited * Sundown Finvest Private Limited
(iv) Relative of Key Management Personnel

Shri C. K. Mehta
Shri Ajay C. Mehta
Shri Meghav D. Mehta

B) Transaction with Related Parties
` in Lakhs
March 31, 2019 March 31, 2018
Sr. Nature of Transaction Key Entities over Relative of Key TOTAL Key Entities over Relative of Key TOTAL
No. Management which key Management Management which key Management
Personnel managerial Personnel Personnel managerial Personnel
personnel or personnel or
exercise exercise
Influence. Influence.
1 Purchase of Goods
Deepak Fertilisers & Petrochemicals - 7,900.40 - 7,900.40 - 10,245.25 - 10,245.25
Corporation Limited
2 Sale of Goods
Deepak Novochem Technologies Limited - 695.88 - 695.88 - 902.21 - 902.21
3 Conversion Charges Received
Deepak Novochem Technologies Limited - 968.33 - 968.33 - 1,032.50 - 1,032.50
4 Rendering of Services /
Reimbursement of Expenses
Storewell Credits and Capital Private - 10.04 - 10.04 - 8.80 - 8.80
Limited
5 Receiving of services /
Reimbursement of Expenses
Deepak Fertilisers & Petrochemicals - 60.05 - 60.05 - 7.47 - 7.47
Corporation Limited
Deepak Foundation - 1.25 - 1.25 - 0.78 - 0.78
Deepak Medical Foundation - 66.86 - 66.86 - 12.52 - 12.52
Deepak Cybit Private Limited - 38.32 - 38.32 - 42.07 - 42.07
Shri Deepak C. Mehta 7.20 - - 7.20 9.60 - - 9.60
Shri Meghav D. Mehta - - 54.78 54.78 - - 53.55 53.55
Shri Ajay C. Mehta - - 1.20 1.20 - - 0.60 0.60
6 Sale of Investments
Forex Leafin Private Ltd - - - - - 131.13 - 131.13
7 Interest paid to Related Parties
Storewell Credits & Capital Private - 221.93 - 221.93 - 241.50 - 241.50
Limited

statutory reportS
Corporate OVERVIEW
223
` in Lakhs
224
March 31, 2019 March 31, 2018
Sr. Nature of Transaction Key Entities over Relative of Key TOTAL Key Entities over Relative of Key TOTAL
No. Management which key Management Management which key Management
Personnel managerial Personnel Personnel managerial Personnel
personnel or personnel or
exercise exercise
Influence. Influence.

8 Managerial Remuneration
Shri Ajay C. Mehta - - - - 72.79 - - 72.79
Shri Maulik D. Mehta 171.06 - - 171.06 103.02 - - 103.02
Shri Umesh Asaikar 588.86 - - 588.86 470.73 - - 470.73
Shri Sanjay Upadhyay 294.39 - - 294.39 205.67 - - 205.67
9 Dividend Paid
Checkpoint Credits & Capitals Private - 93.68 - 93.68 - 86.47 - 86.47
Limited
Stigma Credits & Capital Private Limited - 80.32 - 80.32 - 74.14 - 74.14
Stiffen Credits & Capital Private Limited - 108.94 - 108.94 - 100.56 - 100.56
Stepup Credits & Capital Private Limited - 89.90 - 89.90 - 82.99 - 82.99
Skyrose Finvest Private Limited - 49.11 - 49.11 - 44.30 - 44.30
Shri C.K. Mehta - - 1.02 1.02 - - 0.94 0.94
Shri Maulik D. Mehta 1.71 - - 1.71 1.58 - - 1.58
Shri Meghav D. Mehta - - 0.61 0.61 - - 0.57 0.57
Others - 72.47 17.76 90.23 - 66.89 16.39 83.28
10 Donation / CSR Activity
Deepak Medical Foundation - - - - - 16.65 - 16.65
Deepak Foundation - 261.92 - 261.92 - 211.33 - 211.33
11 Net Accounts Receivable / (Payable)

Deepak Fertilisers & Petrochemicals - (1,288.34) - (1,288.34) - (1,795.43) - (1,795.43)
Corporation Limited
Shri Deepak C. Mehta (600.00) - - (600.00) (150.00) - - (150.00)
Shri Ajay C. Mehta - - - - (20.60) - - (20.60)
Shri Maulik D. Mehta (65.88) - - (65.88) (11.34) - - (11.34)
Shri Umesh Asaikar (113.62) - - (113.62) (45.54) - - (45.54)
Shri Sanjay Upadhyay (79.33) - - (79.33) (24.25) - - (24.25)
Deepak Medical Foundation - 3.50 - 3.50 - 15.00 - 15.00
Deepak Cybit Ltd. - (0.19) - (0.19) - (2.50) - (2.50)
Storewell Credits and Capital Pvt Ltd - (1,955.00) - (1,955.00) - (2,300.00) - (2,300.00)
Corporate OVERVIEW
statutory reportS
37. Contingent Liabilities and Commitments (to the extent not provided for)
` in Lakhs
As at As at
March 31, 2019 March 31, 2018
I. Claims against the Company not acknowledged as debts in respect of:
(a) Matters relating to Income Tax from AY 2012-13 is being contested at various levels of Tax 58.64 98.60
authorities
(b) Matters relating to Sales Tax/VAT from AY 2005-06 to FY 2013-14 is being contested at 158.97 86.41
(c) Matters relating to Excise duty from FY 1998-99 to FY 2016-17 is being contested at various 292.20 479.33
level of Indirect Tax authorities.
(d) Bank Guarantees:
- Financial 1,702.90 3,060.55
- Performance 1,593.73 2,717.92
(e) Disputed Labour Matters Amount Not Amount Not
ascertainable ascertainable
Management is not expecting any future cash outflow in respect of (a) to (c) & (e)
Total (I) 3,806.44 6,442.81
II. Commitments
Capital Commitments (Net of Advances) 3,422.65 16,239.18
Total (II) 3,422.65 16,239.18
38. Tax Expense

A. Income Tax Expense Recognised in the Statement of Profit and Loss
` in Lakhs
March 31, 2019 March 31, 2018
I. Expense / (Benefit) recognised in the statement of profit and loss
Current tax on profit for the year 6,073.99 2,595.30
Increase in deferred tax liabilities 3,357.69 876.81
Total 9,431.68 3,183.60
II. Expense / (Benefit) recognised in statement of other comprehensive income
Re-measurement gains / (losses) on defined benefit plans (154.57) 37.01
Equity instruments through other comprehensive income 2.73 7.13
Total (151.84) 44.14
B. The reconciliation between the provision of income tax and amounts computed by applying the Indian statutory
income tax rate to profit before taxes is as follows
` in Lakhs
March 31, 2019 March 31, 2018
Profit before taxes 26,797.81 11,085.17
Enacted income tax rate in India 34.94% 34.61%
Computed expected tax expense 9,364.23 3,836.36
Effect of
Weighted deduction for R&D Expenditure (172.56) (155.66)
Income taxed at higher/ (lower) rates - (21.48)
Others (Net) 240.01 (187.11)
Total income tax expense 9,431.68 3,183.60

C. Deferred Tax Liabilities (Net)
The balance comprises temporary differences attributable to the below items and corresponding movement in deferred tax
liabilities/(assets)
` in Lakhs
As at Recognised in As at Recognised in As at
March 31, Statement of March 31, Statement of March 31,
2019 Profit and Loss 2018 Profit and Loss 2017
/OCI /OCI
Property, plant and equipment 10,983.74 2,778.99 8,204.75 1,148.15 7,056.60
Total Deferred Tax Liabilities (a) 10,983.74 2,778.99 8,204.75 1,148.15 7,056.60
Disallowances u/s 43B and Others 2,071.38 884.67 1,186.71 624.50 562.21
MAT Credit Entitlement 1,166.36 (1,311.49) 2,477.85 (108.79) 2,586.64
Total Deferred Tax Assets (b) 3,237.74 (426.82) 3,664.56 515.71 3,148.85
Net Deferred Tax (Asset)/Liabilities (a-b) 7,746.00 3,205.81 4,540.19 632.44 3,907.75
39. Employee Benefit Obligations

A. Gratuity
The Group has covered its Gratuity Liability by a Group Gratuity Policy named ‘Employee Group Gratuity Assurance Scheme’ issued by
Life Insurance Corporation of India. Under this plan, an employee at retirement is eligible for benefit, which will be equal to 15 days
salary for each completed year of service. Thus, it is a defined benefit plan and the aforesaid insurance policy is the Plan Asset.
(i) Reconciliation of opening and closing balances of Defined Benefit Obligation
` in Lakhs
As at As at
March 31, 2019 March 31, 2018
Interest Cost 144.76 132.51
Actuarial (gain)/losses 411.20 (99.08)
Benefits Paid (154.07) (106.77)
(ii) Reconciliation of Opening and Closing Balances of Fair Value of Plan Assets
` in Lakhs
As at As at
March 31, 2019 March 31, 2018
Interest Income 145.06 122.91
Return on Plan Assets (32.39) 9.25
Contribution by the Company 164.73 156.25
Benefits Paid (154.07) (111.27)
Actual Return on Plan Assets 7.54% to 7.88% 7.12% to 7.88%
(iii) Assets and Liabilities Recognised in the Balance Sheet

` in Lakhs
As at As at
March 31, 2019 March 31, 2018
Present Value of Defined Benefit Obligation 2,401.42 1,862.70
Less: Fair Value of Plan Assets: 1,973.59 1,850.27
Amounts recognised as liability 427.83 12.43
Recognised under:
Short Term provision (Refer Note 18) 427.83 12.43
Total 427.83 12.43

Corporate OVERVIEW
statutory reportS
(iv) Expenses Recognised in the Statement of Profit and Loss

` in Lakhs
March 31, 2019 March 31, 2018
Net Interest Cost (0.30) 9.60
Total Expenses (Refer Note No. 31) 131.25 129.30
(v) Expenses Recognised in the Other Comprehensive Income

` in Lakhs
March 31, 2019 March 31, 2018
Actuarial (gain)/losses on Obligation for the period 411.20 99.44
Return on Plan assets excluding Interest Income 32.39 9.25
Total Expenses recognised in OCI 443.59 108.69
(vi) Major Category of Plan Assets

As at As at
March 31, 2019 March 31, 2018
` in Lakhs % ` in Lakhs %
GOI Securities - - - -
Public Securities - - - -
State Government Securities - - - -
Insurance Policies 1,973.59 100.00 1,850.27 100.00
Others - - - -
Risk exposure
The Group is exposed to a number of risks, the most significant of which are detailed below:
Interest rate risk: A fall in the discount rate which is linked to the G.Sec. Rate will increase the present value of the liability
requiring higher provision. A fall in the discount rate generally increases the mark to market value of the assets depending on
the duration of asset.
Salary Risk: The present value of the defined benefit plan liability is calculated by reference to the future salaries of members.
As such, an increase in the salary of the members more than assumed level will increase the plan’s liability.
Investment Risk: The present value of the defined benefit plan liability is calculated using a discount rate which is determined
by reference to market yields at the end of the reporting period on government bonds. If the return on plan asset is below this
rate, it will create a plan deficit. Currently, for the plan in India, it has a relatively balanced mix of investments in government
securities, and other debt instruments.
Asset Liability Matching Risk: The plan faces the ALM risk as to the matching cash flow. Since the plan is invested in lines of
Rule 101 of Income Tax Rules, 1962, this generally reduces ALM risk.
Mortality risk: Since the benefits under the plan is not payable for life time and payable till retirement age only, plan does not
have any longevity risk.
Concentration Risk: Plan is having a concentration risk as all the assets are invested with the insurance company and a
default will wipe out all the assets. Although probability of this is very less as insurance companies have to follow regulatory
guidelines.

(vii) Actuarial Assumptions
` in Lakhs
As at As at
March 31, 2019 March 31, 2018
Expected Return on Plan Assets 7.79% 7.85%
Salary Growth Rate 8.00% 6.50%
Attrition Rate 2.00% 2.00%
(viii) Sensitivity Analysis

Significant Actuarial Assumptions for the determination of the defined benefit obligation are discount trade, expected
salary increase and employee turnover. The sensitivity analysis below, have been determined based on reasonably possible
changes of the assumptions occurring at end of the reporting period, while holding all other assumptions constant. The
result of Sensitivity analysis is given below:
Impact on Defined Benefit Obligation
Change in Assumptions
Increase in Assumptions Decrease in Assumptions
As at As at As at As at As at As at
March 31, March 31, March 31, March 31, March 31, March 31,
2019 2018 2019 2018 2019 2018
% % ` in Lakhs ` in Lakhs ` in Lakhs ` in Lakhs
Discount Rate 1.00% 1.00% (137.25) (98.62) 157.20 111.89
Salary Growth Rate 1.00% 1.00% 155.18 112.24 (138.08) (100.65)
Attrition Rate 1.00% 1.00% (6.74) 7.28 7.14 (8.33)
In practice, this is unlikely to occur, and changes in some of the assumptions may be correlated. When calculating the
sensitivity of the defined benefit obligation to significant actuarial assumptions the same method (present value of the
defined benefit obligation calculated with the projected unit credit method at the end of the reporting period) has been
applied as when calculating the defined benefit liability recognised in the Balance Sheet. The methods and types of
assumptions used in preparing the sensitivity analysis did not change as compared to the prior year.
B. Leave Encashment
(a) The Leave Encashment Benefit Scheme is a Defined Benefit Plan and is wholly unfunded. Hence, there are no plan assets
attributable to the obligation.
(b) The accumulated balance of Leave Encashment (unfunded) provided in the books as at March 31, 2019, is ` 1,478.49 Lakhs
(` 1,135.12 Lakhs), which is determined on actuarial basis using Projected Unit Credit Method.
(c) Principal Actuarial Assumptions
As at As at
March 31, 2019 March 31, 2018
C. Defined Contribution Plan

Contribution to Defined Contribution Plans, recognised in Statement of Profit and Loss, for the year is as under
` in Lakhs
March 31, 2019 March 31, 2018
Employer's Contribution to Provident Fund and other funds except superannuation 625.12 531.09
Employer's Contribution to Superannuation Fund 173.35 165.32
Expected Contribution for the next year ` in Lakhs

Employer's Contribution to Provident Fund and other funds except superannuation 740.13
Employer's Contribution to Superannuation Fund 187.22

Corporate OVERVIEW
statutory reportS
40. Capital Management

The key objective of the Group’s capital management is to ensure that it maintains a stable capital structure with the focus on total
equity to uphold investor, creditor, and customer confidence and to ensure future development of its business.
The Group focused on keeping strong total equity base to ensure independence, security, as well as a high financial flexibility for
potential future borrowings, if required without impacting the risk profile of the Group.
For the purpose of Capital Management, the Group considers the following components of its Balance Sheet to manage capital.
The Capital Structure of the Company was as follows
` in Lakhs
As at As at
March 31, 2019 March 31, 2018
Total Equity (A) 1,07,158.46 92,213.83
Non-Current Borrowings (including current maturities) 93,146.39 65,497.38
Current Borrowings 25,505.29 33,157.01
Total Borrowings (B) 1,18,651.68 98,654.39
Total Capital (A+B) 2,25,810.14 1,90,868.22
Total Borrowings as % of Total Capital 52.54% 51.69%
Total Borrowings as % of Total Equity 110.73% 106.98%
The Interest Coverage Ratio for the reporting period was as follows
` in Lakhs
March 31, 2019 March 31, 2018
EBITDA (excluding other income) 41,389.62 19,630.61
Interest 8,324.54 4,514.74
Interest Coverage Ratio 4.97 4.35
41. Financial Instruments

41.1. Categories of Financial Instruments
` in Lakhs
Income or Loss
Financial Assets
Quoted investments (Level 1) - 6.63 -
Unquoted investments (Level 3) 232.11 0.67 -
Trade receivables - - 57,496.42
Loans - - 212.42
Other financial asset - - 789.42
Total 232.11 7.30 61,075.26
Other Financial Liabilities - 9.14 3,425.40
Total - 9.14 1,72,532.76

` in Lakhs
Income or Loss
Financial Assets
Quoted investments (Level 1) - 2,951.73 -
Unquoted investments (Level 3) 224.27 0.67 -
Trade receivables - - 41,177.18
Loans - - 443.60
Other financial asset - - 2,550.50
Total 224.27 2,952.39 48,991.23
Other financial liabilities - 14.02 603.86
Total - 14.02 1,48,254.22
41.2. Fair Value Hierarchy
The table below analyses financial instruments carried at fair value, by valuation method. The different levels have been defined
as follows:
Level 1 – Quoted prices in active markets for identical assets or liabilities.
Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly (i.e. as
prices) or indirectly (i.e. derived from prices).
Level 3 – Inputs for the assets or liabilities that are not based on observable market data (unobservable inputs).
` in Lakhs
Financial Assets
Investments in Quoted Instruments 6.63 - - 6.63
` in Lakhs
Financial Assets
Investments in Quoted Instruments 2,951.73 - - 2,951.73
Reconciliation of Level 3 Fair Value Measurements

` in Lakhs
Investment in unquoted shares
irrevocably designated as FVTOCI
Opening Balance as at March 31, 2017 137.44
Reclassification of Investments 65.86
Total gains/losses in other comprehensive income 20.97
Total gains in other comprehensive income 7.84

Corporate OVERVIEW
statutory reportS
Comparative Market Multiples method has been used for estimating the fair value of such Investment. The fair valuation estimates
are based on historical annual accounts/annual reports and based on information collected from public domain. Information
pertaining to future expected performance of investee companies including projections about their profitability, balance sheet
status and cash flow expectations are not available.
41.3. Financial Risk Management objectives

The Group has adequate internal processes to assess, monitor and manage financial risks. These risks include market risk
(including currency risk, interest rate risk and other price risk), credit risk and liquidity risk.
The Group seeks to minimise the effects of these risks by using financial instruments such as foreign currency forward contracts,
option contracts and interest swaps to hedge risk exposures and appropriate risk management policies as detailed below. The use
of these financial instruments is governed by the Group’s policies, which outlines principles on foreign exchange risk, interest rate
risk, credit risk and deployment of surplus funds.
Item Primarily Effected by Risk Management Policies Reference

Market risk - currency risk Foreign Currency balances and exposure Mitigating foreign currency risk using foreign Note 41.4.1
towards trade payables, buyer’s credit, currency forward contracts and option contracts.
exports, short-term and long-term
borrowings
Market risk - interest rate Change in market interest rates Maintaining a combination of fixed and floating Note 41.4.2
risk rate debt; interest rate swaps for long-term
borrowings; cash management policies
Credit risk Ability of customers or counterparties Credit approval and monitoring practices; Note 41.5.
to financial instruments to meet counterparty credit policies and limits;
contractual obligations. arrangements with financial institutions
Liquidity risk Fluctuations in cash flows Preparing and monitoring forecasts of cash flows; Note 41.6.
cash management policies; multiple-year credit
and banking facilities
41.4. Market Risk
The Group’s financial instruments are exposed to market rate changes. The Group is exposed to the following significant market risks:
• Foreign currency risk
• Interest rate risk
Market risk exposures are measured using sensitivity analysis. There has been no change to the Group’s exposure to market risks
or the manner in which these risks are being managed and measured.
41.4.1 Foreign Currency Risk management

The Group is exposed to foreign exchange risk on account of following:
1. Imports of raw materials and services.
2. Exports of finished goods.
3. Foreign currency borrowings in the form of Term loans, external commercial borrowings, buyers credit, packing credit etc.
availed for meeting its funding requirements.
The Group has a forex policy in place whose objective is to mitigate foreign exchange risk by deploying the appropriate hedging
strategies through combination of various hedging instruments such as foreign currency forward contracts, options contracts and
has a dedicated forex desk to monitor the currency movement and respond swiftly to market situations. The Company follows
netting principle for managing the foreign exchange exposure.

(a) The carrying amounts of the Company’s foreign currency denominated monetary assets and liabilities based on
gross exposure at the end of the reporting period is as under:
USD (Lakhs) 212.68 549.32 107.89 280.66
` (Lakhs) 14,711.03 35,547.31 7,462.56 18,162.49
GBP (Lakhs) 0.02 1.31 - -
` (Lakhs) 1.70 112.44 - -
JPY (Lakhs) - 7.09 - -
` (Lakhs) - 4.35 - -
CHF (Lakhs) - 0.05 -
` (Lakhs) - 3.62 -
EURO (Lakhs) 15.10 23.99 13.99 11.14
` (Lakhs) 1,173.30 1,927.67 1,087.05 893.45
The foreign currency risk on above exposure is mitigated by derivative contracts. The outstanding contracts as at the Balance
Sheet date are as follows
(b) Foreign currency forward, option contracts and interest rate swaps outstanding as at the Balance Sheet date
As at As at
March 31, 2019 March 31, 2018
Buy Sell Buy Sell
Forward Contracts (USD Lakhs) - 3.00 110.72 60.00
Forward Contracts (EURO Lakhs) 7.50 - 6.39 -
Option Contracts (USD Lakhs) - - - 35.00
Interest rate Swaps ECB (USD Lakhs) - - - 36.00
The forward and option contracts have been entered into to hedge the foreign currency risk on trade receivables and trade
payables. The swap contracts have been entered into to hedge the interest rate risks on the external commercial borrowings
of the Company.
(c) Net Open Exposures Outstanding as at the Balance Sheet Date

USD (Lakhs) 107.79 217.94 - -
GBP (Lakhs) 0.02 1.31 - -
JPY (Lakhs) - 7.09 - -
CHF (Lakhs) - 0.05 - -
EURO (Lakhs) - 6.46 6.39 -
(d) Foreign currency sensitivity analysis

The Company is mainly exposed to fluctuations in US Dollar. The following table details the Company’s sensitivity to a ` 1
increase and decrease against the US Dollar. ` 1 is the sensitivity used when reporting foreign currency risk internally to key
management personnel and represents management’s assessment of the reasonably possible change in foreign exchange
rates. The sensitivity analysis includes only net outstanding foreign currency denominated monetary items and adjusts their
translation at the period end for a ` 1 change in foreign currency rates. A positive number below indicates an increase in

Corporate OVERVIEW
statutory reportS
profit where the Rupee strengthens by ` 1 against the US Dollar. For a ` 1 weakening against the US Dollar, there would be a
comparable impact on the profit before tax.
` in Lakhs
Currency USD Impact on Profit or Loss As at As at
March 31, 2019 March 31, 2018
Impact of ` 1 strengthening against US Dollar 110.90 33.70
Impact of ` 1 weakening against US Dollar (110.90) (23.70)
The above sensitivity analysis does not include effect of Foreign Exchange (loss)/gain capitalised as the same does not affect
profit or loss or total equity.
41.4.2 Interest Rate Risk Management
The Group issues commercial papers, draws working capital demand loans, avails cash credit, foreign currency borrowings
including buyers credit, Packing Credit etc. for meeting its funding requirements.
Interest rates on these borrowings are exposed to change in respective benchmark rates. The Group manages the interest rate risk
by maintaining appropriate mix/portfolio of the borrowings.
(a) Interest rate swap contract
The Company had entered into the swap contracts to hedge the interest rate risks on the external commercial borrowings.
Using interest rate swap, Company agrees to exchange LIBOR floating interest rate to LIBOR fixed interest rate on agreed
notional principal amounts. Such contracts enable the company to mitigate the interest rate risk. Refer details of the principal
and interest rate swaps under Note 41.4.1(b).
(b) Interest rate sensitivity analysis
The sensitivity analysis in para below has been determined for borrowings assuming the amount of borrowings outstanding
at the end of the reporting period was outstanding for the whole year. A 10 basis points increase or decrease in case of foreign
currency borrowings and 25 basis points increase or decrease in case of rupee borrowings is used when reporting interest
rate risk internally to key management personnel and represents management’s assessment of the reasonably possible
change in interest rates.
If interest rate had been 10 basis points higher/ lower in case of foreign currency borrowings and 25 basis points higher/ lower
in case of rupee borrowings and all other variables were held constant, the Company’s profit for the year ended March 31,
2019 would decrease/ increase by ` 296.34 Lakhs (` 230.80 Lakhs)
41.5. Credit Risk management
Credit risk refers to the risk that a counterparty will default on its contractual obligations resulting in financial loss to the Company.
The Group is exposed to credit risk from its operating activities (primarily trade receivables) and from its financing activities,
including deposits with banks and financial institutions, foreign exchange transactions and other financial instruments.
Customer credit risk is managed by each business unit subject to the Group’s established policy, procedures and control relating
to the customer credit risk management. The Group uses financial information and past experience to evaluate credit quality of
majority of its customers and individual credit limits are defined in accordance with this assessment through third party experts.
Outstanding receivables and the credit worthiness of its counterparties are periodically monitored and taken upon case to case
basis. The Group evaluates the concentration of risk with respect to trade receivables as low, as its customers are located in several
jurisdictions representing large number of minor receivables operating in independent markets.
The credit risk on cash and bank balances, derivative financial instruments is limited because the counterparties are banks with
high credit ratings assigned by international credit rating agencies.
Historical experience of collecting receivables of the Company is supported by low level of past default and hence the credit risk is
perceived to be low.

The Company has used a practical expedient by computing the expected credit loss allowance for trade receivables based on the
provision matrix. The expected credit loss allowance is based on the ageing of the days the receivables are due and the rates as
given in the provision matrix. The provision matrix at the end of the reporting period is as follows:
Ageing
Expected Credit Loss (%)
Within the Credit period 0.25%
91 to <=180 days 38.77%
>180 days 100.00%
Age of receivables
As at As at
March 31, 2019 March 31, 2018
Within the Credit period 57,492.52 37,806.37
91 to <=180 days 241.32 2,008.27
>180 days 481.56 2,940.75
Reconciliation of loss allowance provision - Trade receivables

` in Lakhs

41.6. Liquidity Risk Management

The Group manages liquidity risk by maintaining adequate reserves, banking facilities and reserve borrowing facilities, by
continuously monitoring forecast and actual cash flows, and by matching the maturity profiles of financial assets and liabilities.
payments as at March 31, 2019
` in Lakhs
3 year Flows
Trade payable (50,455.68) (50,455.68) - - (50,455.68)
Borrowings (1,18,651.68) (30,084.67) (15,199.96) (73,367.05) (1,18,651.68)
Foreign Currency Forward Contracts, option (9.14) (9.14) - - (9.14)
contracts and interest swaps
` in Lakhs
Carrying Amount
Loans 212.42
Other financial assets 789.42
Total 1,001.84

Corporate OVERVIEW
statutory reportS
payments as at March 31 2018
` in Lakhs
3 year Flows
Trade payable (48,995.97) (48,995.97) - - (48,995.97)
Borrowings (98,654.39) (43,608.59) (12,655.86) (42,389.94) (98,654.39)
Foreign Currency Forward Contracts, option contracts (14.02) (14.02) - - (14.02)
and interest swaps
` in Lakhs
Carrying Amount
Loans 443.60
Other financial assets 2,550.50
Total 2,994.10
42. Segment Information

(a) Primary Segment Information
The information reported to the Chief Operating Decision Maker (CODM) for the purpose of resource allocation and assessment of
segment performance is based on types of goods delivered.
Pursuant to commencement of commercial operations of plant for manufacturing Phenol and Acetone under the Company’s
wholly owned subsidiary, Deepak Phenolics Limited, its results have been classified under new segment “Phenolics”.
Accordingly, the Group’s reportable segments under Ind AS 108 are as follows:
(i) Basic Chemicals
(ii) Fine & Speciality Chemicals
(iii) Performance Products
(iv) Phenolics
The accounting policies of the reportable segments are same as the Group’s accounting policies. Segment profit represents the
profit before interest and tax earned by each segment without allocation of central administrative costs and other income. This is
the measure reported to the CODM.
Transfer prices between operating segments are on arm’s length basis in a manner similar to transactions with third parties.
` in Lakhs
March 31, 2019 March 31, 2018
I) Segment Revenue
(d) Phenolics 90,800.58 19,626.20
(e) Un- allocable - 7.19
TOTAL 2,73,972.19 1,72,118.10
Less: Inter Segment Revenue 3,979.74 4,499.90
Net Sales/Income from operations 2,69,992.45 1,67,618.20

` in Lakhs
March 31, 2019 March 31, 2018
II) Segment Results
Profit (Loss) Before Tax & Interest
(c) Performance Products 8,323.03 (814.13)
(d) Phenolics 9,578.55 (640.79)
TOTAL 45,091.77 20,693.41
Less : (i) Interest Expenses 8,324.54 4,514.74
(ii) Other un-allocable expenditure net of un-allocable Income 9,969.42 5,093.50
III) Profit Before Tax 26,797.81 11,085.17
IV) Segment Assets
(d) Phenolics 1,66,052.37 1,27,161.71
(e) Un- allocable 4,942.98 10,865.63
TOTAL 2,92,778.45 2,59,056.00
V) Segment Liabilities
(d) Phenolics 1,08,873.30 81,662.14
(e) Un- allocable 45,416.56 53,606.85
TOTAL 1,85,619.99 1,66,842.17
VI) Capital Expenditure
(c) Performance Products 661.40 1,251.27
(d) Phenolics 1,13,316.35 51.67
(e) Un- allocable 443.23 286.61
TOTAL 1,21,190.73 5,655.33
VII) Depreciation
(d) Phenolics 2,491.46 65.05
(e) Un- allocable 433.18 432.74
TOTAL 7,779.27 5,259.97
(b) Secondary Segment Information

The following table shows the distribution of the Company’s Revenue and Assets by geographical market:
` in Lakhs
Revenue As at As at
March 31, 2019 March 31, 2018
In India 2,10,654.90 1,16,421.84
Outside India 59,337.55 51,196.36
Total 2,69,992.45 1,67,618.20

Corporate OVERVIEW
statutory reportS
` in Lakhs
Carrying Amount of Segment Assets For the year For the year
March 31, 2019 March 31, 2018
In India 2,84,033.78 2,39,713.65
Outside India 8,744.67 19,342.36
Total 2,92,778.45 2,59,056.00
` in Lakhs
Addition to Fixed Assets For the year For the year
March 31, 2019 March 31, 2018
In India
- Tangible 1,19,911.53 5,601.38
- Intangible 1,279.20 53.95
Outside India
- Tangible - -
- Intangible - -
Total 1,21,190.73 5,655.33
43. Earnings Per Share
As at As at
March 31, 2019 March 31, 2018
Basic and Diluted Earnings per Share
Number of Shares at the beginning (Nos. in Lakhs) 1,363.93 1,307.11
Number of Shares at the end (Nos. in Lakhs) 1,363.93 1,363.93
Weighted Average Number of Shares considered for Basic Earnings Per Share (Nos. in 1,363.93 1,316.45
Lakhs)
Weighted Average Number of Shares considered for Diluted Earnings Per Share (Nos. 1,363.93 1,316.45
in Lakhs)
Net Profit after Tax available for Equity Shareholders (` in Lakhs) 17,366.13 7,901.57
Basic Earnings (in Rupees) Per Share of ` 2/- each 12.73 6.00
Diluted Earnings (in Rupees) Per Share of ` 2/- each 12.73 6.00
44. During FY 2018-19, the Company has spent ` 250.00 Lakhs on Corporate Social Responsibility activities.
45. The Income Tax Department has conducted search operations during the year at the premises of Deepak Nitrite Limited and Deepak
Phenolics Limited. The Companies believe that the search operations will not have any material adverse impact on the performance.
46. Events occurring after the balance sheet date: The Board of Directors has recommended, subject to the approval of shareholders,
dividend of ` 2/- (Rupees Two only) per equity share of face value of ` 2/- (Rupees Two only) each for the year ended March 31, 2019 on
13,63,93,041 equity shares amounting to ` 3,288.58 Lakhs (including tax on dividend of ` 560.72 Lakhs)
47. The Financial Statements were authorised for issue by the Board of Directors on May 03, 2019.

48. Additional Information in Consolidated Financial Statements as per Schedule III of Companies Act,2013
Net Assets, i.e., total assets Share in profit or loss Share in other Share in total
minus total liabilities comprehensive income comprehensive income
As % of Amount As % of Amount As % of Amount As % of Amount
consolidated ` in Lakhs consolidated ` in Lakhs consolidated ` in Lakhs consolidated ` in Lakhs
net assets profit or loss other total
comprehensive comprehensive
income income
Parent
Deepak Nitrite Limited 46.60% 49,937.31 79.49% 13,804.26 93.89% (266.55) 79.25% 13,537.71
Subsidiaries
1. Deepak Phenolics Limited 53.40% 57,221.54 20.49% 3,558.46 6.11% (17.36) 20.73% 3,541.10
2. Deepak Nitrite Corporation Inc. 0.00% (0.39) 0.02% 3.41 0.00% - 0.02% 3.41
Non Controlling Interests in - - - - - - - -
All Subsidiaries

DIN: 00028377 DIN: 06595059 DIN: 00036085 DIN: 00001792



Corporate OVERVIEW
statutory reportS
Notes
................................................................................................................................................................................................
................................................................................................................................................................................................
................................................................................................................................................................................................
................................................................................................................................................................................................
................................................................................................................................................................................................
................................................................................................................................................................................................
................................................................................................................................................................................................
................................................................................................................................................................................................
................................................................................................................................................................................................
................................................................................................................................................................................................
................................................................................................................................................................................................
................................................................................................................................................................................................
................................................................................................................................................................................................
................................................................................................................................................................................................
................................................................................................................................................................................................
................................................................................................................................................................................................
................................................................................................................................................................................................
................................................................................................................................................................................................
................................................................................................................................................................................................
................................................................................................................................................................................................
................................................................................................................................................................................................
................................................................................................................................................................................................
................................................................................................................................................................................................
................................................................................................................................................................................................
................................................................................................................................................................................................
................................................................................................................................................................................................

Notes
................................................................................................................................................................................................
................................................................................................................................................................................................
................................................................................................................................................................................................
................................................................................................................................................................................................
................................................................................................................................................................................................
................................................................................................................................................................................................
................................................................................................................................................................................................
................................................................................................................................................................................................
................................................................................................................................................................................................
................................................................................................................................................................................................
................................................................................................................................................................................................
................................................................................................................................................................................................
................................................................................................................................................................................................
................................................................................................................................................................................................
................................................................................................................................................................................................
................................................................................................................................................................................................
................................................................................................................................................................................................
................................................................................................................................................................................................
................................................................................................................................................................................................
................................................................................................................................................................................................
................................................................................................................................................................................................
................................................................................................................................................................................................
................................................................................................................................................................................................
................................................................................................................................................................................................
................................................................................................................................................................................................
................................................................................................................................................................................................

Investor’s Welfare Scheme
The Company’s scheme covers the risk of death and permanent (total/partial) disablement sustained due to an accident by
first-named shareholder of the Company solely and directly from external, violent and visible means.
Details of entitlement under the Personal Accident Policy are as under:
I. COVERAGE:
a. Death
b. Permanent (total/partial) disablement
EXPLANATION:
i. Permanent Total Disablement:
Loss of sight of both eyes or of actual loss by physical separation of the two entire hands or two entire feet.
ii. Permanent Partial Disablement:

Loss of sight of one eye or actual loss by physical separation of one entire hand or one entire foot.
II. AGE LIMIT:

18 to 65 years
III. SUM INSURED:

No. of Equity Shares held Sum Insured
Up to 1500 ` 40,000/-
1501 to 5000 ` 60,000/-
5001 and above ` 80,000/-
IV. BENEFITS:
The benefits available under the Group Personal Accident Insurance Policy are as under:
1. Fatal Accident (Death) : Sum Insured*
2. Permanent Total Disablement : Sum Insured*
3. Loss of two limbs or two eyes or one limb and one eye : Sum Insured*
4. Loss of one limb or one eye : 50% of the Sum Insured
5. Permanent Partial Disablement : Specific percentage of the Sum Insured*
depending on the extent of disablement.
[* Sum Insured as explained in para (III) above]
Note:
1. Temporary disablement, medical / hospitalisation expenses are out of the purview of the scheme.
2. Members who have not filed the Nomination Form earlier in respect of Personal Accident Policy may approach the Company for
obtaining the Nomination Form and return the same duly filled in and signed for registration with the Company.
Printed by: www.westernpress.in
Corporate & Registered Office:

Vadodara - 390 024,
Gujarat, India
Tel: +91-265-276 5200
Fax: +91-265-2765344
www.godeepak.com

Deepak 19 PDF

Uploaded by

Document Information

Original Description:

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Deepak 19 PDF

Uploaded by

Copyright:

Available Formats

Deepak Nitrite Limited

48th Annual Report 2018-19

AUDITORS Dahej Division

Promises Made. Promises Delivered. 01

Today, we take pride in having delivered on our commitments with enormous

02 48th Annual Report 2018-19

Our past performance

Promises Made. Promises Delivered. 03

We are elevating ourselves to a higher position of strength by

Our Vision We are…

04 48th Annual Report 2018-19

Some of the Industries We Cater to

Dyes and Pigments Agrochemicals Pharmaceuticals Colourants 30

Promises Made. Promises Delivered. 05

We are delivering sustained growth TO become a consistent and

Our Value Proposition

06 48th Annual Report 2018-19

Our Core Values

Innovativeness Ownership Responsiveness

Agility Performance Driven

We continue to drive our strategies through a key focus on introducing new

Promises Made. Promises Delivered. 07

08 48th Annual Report 2018-19

Taloja, Maharashtra Roha, Maharashtra

Hyderabad, Telangana Deepak Phenolics Limited, Dahej, Gujarat

Promises Made. Promises Delivered. 09

What Differentiates Us World-class infrastructure, R&D focus, custom

10 48th Annual Report 2018-19

Key R&D Strengths

Cost-effective and Advanced intermediates

Improving process chemistry, productivity and yield

Creating customer-centric solutions, impacting product performance

Working on cost leadership and creating value chain

Focussing on yield improvement with material and energy balance

Aiming at debottlenecking, energy reduction and time cycle reduction

Promises Made. Promises Delivered. 11

Map not to scale. For illustrative purposes only

12 48th Annual Report 2018-19

Sweden Turkey Oman Indonesia

Promises Made. Promises Delivered. 13

14 48th Annual Report 2018-19

Promises Made. Promises Delivered. 15

indicates our elevated We are “FUTURE-READY”

capabilities. transforming our organisation and

16 48th Annual Report 2018-19

Promises Made. Promises Delivered. 17

18 48th Annual Report 2018-19

Promises Made. Promises Delivered. 19

20 48th Annual Report 2018-19

Promises Made. Promises Delivered. 21

SHRI Deepak C. Mehta

SHRI Umesh Asaikar

SHRI Sanjay Upadhyay

SHRI Maulik Mehta

22 48th Annual Report 2018-19

SHRI Ajay C. Mehta

SHRI Nimesh Kampani

SHRI Sudhin Choksey

Promises Made. Promises Delivered. 23

DR. Richard H. Rupp

DR. Swaminathan Sivaram

24 48th Annual Report 2018-19

15) Ratification of remuneration of the Cost Auditor for the NOTES:

6. The Register of Members of the Company will be closed from